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ABSTRACT  
 
Vitamin D deficiency is associated with detrimental effects on bone health and is currently a 
major global public health issue, with increasing prevalence in both low and high latitude 
locations. Vitamin D can be synthesised in the skin via sunlight exposure as well as ingested 
through diet. This study aimed to investigate the interaction and relative contribution of vitamin 
D supplementation and individual sunlight exposure in raising vitamin D levels above 
recognized vitamin D cut-off points for deficiency/sufficiency, throughout winter, in ethnically 
identical adult women living in opposite latitudes. Within two parallel randomized controlled 
trials (RCT), 135 Brazilian women, (England, n=56, 51˚N; Brazil, n=79, 16˚S), were 
randomized to receive daily 15 µg vitamin D3 supplements or placebo, for 12 weeks. Oral 
vitamin D supplementation of 15 µg daily was significantly effective compared to placebo at 
raising 25(OH)D concentrations over winter, regardless of latitude, and response was 
dependent on initial 25(OH)D concentrations. Individual UV radiation level was strongly 
correlated with 25(OH)D concentrations. In both latitudes, supplementation prevented the 
seasonal concomitant increase in plasma parathyroid hormone (PTH) levels. This research 
shows: 1) an optimal vitamin D status for bone health around 70-80 nmol/l; 2) the required UV 
radiation to achieve this status was 1.5 SED; 3) the vitamin D dietary intakes required to 
achieve these serum levels are 4.5 μg/d at a low and 37 μg/d at higher latitude respectively, 
with a lower intake of 12 μg/d sufficient to achieve 50 nmol/l in high latitudes. The strength of 
these results is the novel analysis that directly links human in vivo individual sunlight radiation, 
increased vitamin D intake and 25(OH)D concentrations, within two parallel RCTs in opposite 
latitudes. This study demonstrates that a daily supplement of 15 µg vitamin D3 is an effective 
strategy to significantly raise vitamin D concentrations throughout the winter months in adult 
females, with important implications for bone health through the concomitant lowering of PTH, 
regardless of latitude.  
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1 
Introduction 
 
 
 
1.1 Introductory remarks  
 
The earliest humans evolved in environments with extremely high ultraviolet (UV) radiation 
from the sun, in equatorial Africa, and were dark skinned. Although UV radiation has 
detrimental effects to our cells when in excess, it is also essential for the production of vitamin 
D in the skin. Living at the equator, these primitive populations therefore received high 
amounts of UV radiation, but the melanin in their skin – responsible for skin pigmentation – 
functioned as an effective natural sunscreen against the cell degradations of sunlight exposure, 
still allowing for vitamin D production (1–3). 
 
As humans dispersed over time across the Globe, they faced, in the new high-latitude 
territories, an extremely different sunlight radiation, in both intensity and seasonality, and a 
significantly colder climate. In high latitude locations, during wintertime, the sun's rays reach 
the earth at a more oblique angle, taking therefore a longer path through the atmosphere, and 
are consequently less intense; indeed nearly no UVB (the adequate wavelength to produce 
vitamin D in the skin) is available at this time of the year at latitudes above 40°. It is thus 
believed that lightly pigmented skin evolved through time in order to adapt to the effects of the 
high latitude environment and optimize vitamin D production (1–3).  
 
Vitamin D is vital to bone health and prolonged severe deficiency can lead to rickets in children 
and osteomalacia/osteoporosis in adults. Vitamin D is an exceptional nutrient in that its main 
source is exposure of the skin to UV rays, whilst it can also be ingested through diet. 
Accordingly, it has been generally assumed that populations in sunny (low-latitude) countries 
are ensured sufficient vitamin D levels to, at the minimum, prevent detrimental effects to bone 
health throughout the year. 
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However, over the past two decades, there has been mounting scientific and clinical evidence 
that vitamin D inadequacy, defined as 25-hydroxyvitamin D (25(OH)D) concentrations below 
75 nmol/l, is a major public health issue not only across all age and ethnic groups, but also 
across different latitudes around the world. Whilst this has led to an increasing interest in 
vitamin D amongst the scientific community, governmental advisory bodies, the food and 
supplement industries, and more notably the general public, recommendations for optimal 
vitamin D status (25(OH)D concentrations above 75 nmol/l) as well as dietary intakes and 
sunlight exposure remain extremely controversial and are still much debated.  
 
The current challenge in reaching a consensus on recommendations for vitamin D is mostly 
due to the lack of robust and comparable data from randomized controlled trials specifically 
designed to understand: A) the functional effects of low levels of vitamin D on bone health and 
non-skeletal health outcomes throughout the life cycle; B) the real effects of sunlight exposure 
on vitamin D concentrations according to local environment and individual behaviour; C) the 
actual contribution of dietary intake, from both food and supplements, to maintain adequate 
vitamin D status; and D) the differences in factors influencing vitamin D status, particularly 
between different ethnic groups. In addition, the variability in assessment methods and the 
influence of baseline levels thwarts direct comparisons between studies conducted in different 
locations and population groups.  
 
Better understanding of the true unique contributions, as well as the interaction, of vitamin D 
dietary intake (from food and supplements) and sunlight exposure, along with influential 
factors, on serum vitamin D concentrations and consequent clinical outcomes, will greatly 
contribute to the determination of meaningful and context-specific recommendations for 
different populations. Subsequently, such knowledge will be key in determining public health 
strategies and policies for an efficient prevention and treatment of vitamin D inadequacy.  
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1.2 Vitamin D physiology and functions 
 
Vitamin D is a misnomer as it is not actually a vital amine, but a pro-hormone, required 
throughout life. Several tissues and cells in the human body have been found to be potentially 
capable of converting 25(OH)D to the active form, 1,25-dihydroxyvitamin D3 (1α,25(OH)2D3), 
and most of them actually have a vitamin D receptor.  
 
The major physiologic function of vitamin D and its metabolites is to maintain calcium 
homeostasis for metabolic functioning, signal transduction and neuromuscular activity. The 
biologically active metabolite 1α,25(OH)2D3 is involved in bone formation as well as bone 
maturation (4–6). Along with parathyroid hormone (PTH), it regulates calcium and 
phosphorous metabolism and enhances the absorption of calcium in the gut and reabsorption 
of filtered calcium in the kidney. 1α,25(OH)2D3 is the only known hormone to induce the 
proteins involved in active intestinal calcium absorption (1,7).  
 
When calcium concentrations decrease below normal physiologic levels, calcium-sensing 
proteins stimulate the secretion of PTH and the expression of PTH gene in order to restore 
calcium homeostasis. Consequently, the active 1α,25(OH)2D3 hormone stimulates intestinal 
calcium absorption or along with PTH, in the case of higher concentrations of the latter, 
increases mobilization of calcium from the bone and renal calcium reabsorption (4,7,8). If 
calcium concentrations exceed normal physiological concentrations, C-cells in the thyroid 
gland release calcitonin to supress calcium mobilization from bone. Circulating 1α,25(OH)2D3 
then supresses parathyroid gland activity directly, decreasing PTH levels (Figure 1.1) (7) 
 
With low vitamin D concentrations, calcium and phosphorus absorption in the small intestine 
are reduced to 10-15% and 60%, respectively. In contrast, with higher vitamin D 
concentrations, intestinal absorption can increase up to 30-40% for calcium and 80% for 
phosphorus (9).  
 
 
 
 
 
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although data is still largely observational, recent evidence has also emerged proposing 
Vitamin D may have an important role in the pathophysiology of conditions as diverse as 
inflammatory and heart diseases, type I and II diabetes, various types of cancer and multiple 
sclerosis (9–11). The biochemical and functional outcomes of vitamin D status on skeletal 
health are further discussed in Chapter 5. 
 
 
1.3 Vitamin D synthesis  
 
Vitamin D is the generic term for two different molecules, ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3) (Figure 1.2). Ergocalciferol is derived from UVB radiation on 
ergosterol, which is largely distributed in plants and fungi, whereas cholecalciferol is formed 
from the action of UVB rays in the skin and therefore present as well in animal origin foods 
(1,7). For the purpose of this thesis, vitamin D without a subscript represents either vitamin D2 
and/or D3, unless otherwise specified.  
 
 
 Figure 1.1 “Diagrammatic representation of the vitamin D endocrine system. Red arrows 
indicate suppression; black arrows indicate stimulation. Serum calcium concentrations are 
represented by a thermometer” Reproduced with permission from DeLuca 2004 (7). 
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               Ergocalciferol (Vitamin D2)                  Cholecalciferol (Vitamin D3) 
Figure 1.2 Structure of Vitamin D2 and D3, public domain from PubChem (PubChem 
Compound Database) (12) 
 
 
Casual exposure of the skin to the UVB radiation portion of sunlight (wavelength between 290-
315 nm) converts the molecule 7-dehydrocholesterol, naturally present in the epidermis, to pre-
vitamin D3. Pre-vitamin D3 is thermodynamically unstable and thus, is quickly metabolized to 
become vitamin D3 through a thermal izomeration. Vitamin D3 then binds to vitamin D binding 
protein (DBP) in the bloodstream and is transported to the liver, along with vitamin D from 
dietary intake (food and supplements) (1,7,13).  
 
In the liver, these molecules undergo a first hydroxylation by the cytochrome P450 enzyme 
CYP2R1 (25-hydroxylase) to produce the major circulating form, 25(OH)D. The molecule 
25(OH)D undergoes a further hydroxylation in the kidneys, by enzyme CYP27B1 (1α-
hydroxylase), resulting in the active form 1α,25(OH)2D3, which is the main biological active 
metabolite (1,7) (Figure 1.2). 
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Up to 90% of vitamin D in most individuals can come from the exposure of the skin to sunlight 
(1,2,14). However, human individual UV radiation from exposure to the sun depends mainly 
on sunlight availability (i.e. latitude and climate) but also the intensity and duration of direct 
exposure. Moreover the photochemical production of vitamin D depends on the amount of 
UVB rays actually reaching the skin and the amount of 7-dehydrocholesterol available in the 
epidermis (15–17). Hence, vitamin D synthesis is essentially dependent on a series of 
individual factors such as skin pigmentation, lifestyle, behaviour, age and adiposity. 
 
 
1.4 Vitamin D from sunlight  
 
Frequent casual exposure to sunlight has been long considered the most important source of 
vitamin D (2,18). Yet, cutaneous synthesis of vitamin D is mainly dependent on UVB rays 
reaching a 7-dehydrocholesterol molecule in the epidermis, which is influenced by the solar 
zenith angle and therefore latitude, local atmospheric conditions, season and time of the day 
(15,19,20). 
Sunlight 
7-dehydrocholesterol  pre-vitamin D3  
 
  Skin 
Vitamin D 
Dietary intake 
(food / 
supplements) 
Vitamin D3  
 25-hydroxylase (CYP2R1) 
25(OH)D3 
 
Liver 
25(OH)D3  
1α-hydroxylase (CYP27B1) 
1α,25(OH)2D3 
Kidney 
Figure 1.3 Vitamin D synthesis and metabolism pathway 
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The UV radiation level is a function of the position of the sun in the sky – the higher the sun 
in the sky, the higher the UV radiation level – varying with time of day and time of the year 
(season). The earth's tilted position with respect to its orbit around the sun, along with its yearly 
revolution and inherent daily rotation, determines the distribution of solar radiation over its 
surface. The solar zenith angle decreases with proximity to the equator, reducing the path 
length of sunlight through the atmosphere, and consequently increasing the effective level of 
UV radiation. Moreover, atmospheric conditions, such as cloud, ozone and humidity absorb 
much of the UV rays in sunlight before it reaches the surface (1,4,5). 
 
A simple measure of the UV radiation level at the Earth’s surface is expressed as a 
Solar/Erythemal UV Index, a system developed by the World Health Organization (WHO) to 
foster public awareness about the health effects of exposure to UV radiation (21). As UV 
radiation levels vary throughout the day so does the index value. A UV index report emphasises 
the maximum UV radiation level on a given day, specifically during the 4 hours period around 
local solar noon (21). With higher index values the potential for damage from exposure to sun 
radiation to the skin and eye increases and less time is required for the detrimental effect to 
occur (Table 1.1). 
 
       Table 1.1 UV radiation exposure index categories (21) 
Exposure Category UV Index Range 
Low < 2 
Moderate 3 - 5 
High 6 - 7 
Very high 8 - 10 
Extreme 11+ 
 
 
Based on the UV index categories, the WHO report suggests that within a UV index of 1-2 it 
is safe to stay outside; between 3-7 protection is required (shade, sunscreen or hats) especially 
during midday hours; and above 8 extra protection is needed and being outside during midday 
hours must be avoided (21). 
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In high latitude countries, there is no UVB radiation from the end of October to the end of 
March (4,18,22,23). In contrast, in low latitude countries there is an abundant radiation of this 
wavelength throughout all year (15,24). Figure 1.4 illustrates the evident difference between 
high latitude countries and low latitude countries in sunlight radiation availability, during 
summer and winter seasons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Winter at the Northern Hemisphere and summer in the Southern Hemisphere. 
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Summer at the North Hemisphere and winter in the Southern Hemisphere. 
 
Solar noon UV Index average for 1996-2002, based on GOME spectrometer data from ESA's ERS-2 satellite, as 
published by KNMI (Royal Netherlands Meteorological Institute) 
 
Due to the clear dependence on latitude gradient for adequate UV radiation for the production 
of vitamin D in the skin, it has been generally assumed that the most important determinant for 
optimal vitamin D levels is the geographical location where the individual lives. However, 
although the ambient and local UV radiation levels are objectively measured and defined, 
assessing the actual individual exposure of the skin is still a challenge and depends on many 
factors, which will be further discussed along this chapter.  
 
 
Figure 1.4 UV index at local solar noon across the globe (This work has been released into 
the public domain by its author, KNMI). 
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A commonly used measurement for individual exposure is the standard erythemal dose (SED), 
a fixed physical measure used to quantify UV radiation levels based on erythema risk and is 
equivalent to 100 J/m2. For instance, for a white-skinned adult, exposure of 6% of the body to 
sunlight, enough to result in slight pinkness to the skin 24 hours after exposure (1 minimal 
erythemal dose), could correspond to taking between 15 μg (600 IU) to 25 μg (1000 IU) of 
vitamin D orally (2,9,25). The minimal erythemal dose (MED) refers to the minimal radiation 
that will cause sunburn or redness to the skin, and thus will vary individually depending on 
skin type, time of year, behaviour and age.  
 
 
1.4.1 The paradox of vitamin D deficiency versus skin cancer 
 
In contrast with the benefits of casual sensible exposure to sunlight, prolonged exposure of the 
skin to intense solar UV radiation can lead to both acute and chronic health outcomes, including 
inflammatory effects, for the skin, eyes and immune system. In the long term the acute effects 
of sunburn and tanning from excessive exposure to sunlight can provoke further degenerative 
alterations in cells, and consequent premature skin ageing or development of cancerous cells 
(26).  
 
The UVB action spectrum for pre-vitamin D formation in the skin overlaps considerably with 
the spectrum for detrimental effects from sunburn (erythema); thus sun avoidance to reduce 
the negative consequences from sunburn is likely to lead to a concomitant reduction in vitamin 
D synthesis (27). Figure1.5 exemplify these paradoxical overlapping effects by showing the 
official action spectra for human erythema from the Commission Internationale de L’Eclairage 
(CIE) action spectra for pre-vitamin D synthesis (27). 
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Figure 1.5 Overlap of actions spectra for human erythema and the synthesis of pre-vitamin 
D. Reproduced with permission from Springbett, Buglass and Young, 2010 (27) 
 
 
 
1.4.2 Sunlight exposure recommendations 
 
Few studies to this date have been specifically designed to examine the actual typical individual 
exposure to sunlight in high latitude dwelling populations over the different seasons, and even 
fewer in low latitudes. Due to the complexity of guidance on sunlight exposure considering 
both vitamin D adequacy and risk of skin cancer, it is evident that recommendations must be 
latitude-specific.   
 
A recent study has shown that a white-skinned adult in the United Kingdom (latitude 51°N), 
spending 9-13 minutes outdoors at noon during spring/summer months in season-appropriate 
clothing would be able to maintain vitamin D concentrations at or above 25 nmol/l throughout 
the following winter (28). In the Unites States (latitude 37°N), it is generally recommended 
that exposure of arms and legs for 5 to 30 minutes between the hours of 10 a.m. and 3 p.m. 
twice a week would be enough for adequate levels, but taking into consideration time of day, 
season, latitude and skin pigmentation (9). 
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In contrast, for an adult with moderately fair skin pigmentation in Australia (latitude 25°S) and 
New Zealand (latitude 40°S), it is recommended that unprotected exposure to sunlight for 5-
10 minutes, mid morning or mid afternoon on most days of summer, and 7-30 minutes 
(depending on latitude), midday on most days of winter, is sufficient to maintain adequate 
vitamin D levels for bone health purposes. For darker skin individuals, recommendations range 
from 15-60 minutes, most days of summer, and 20 min – 3 hours (depending on latitude), most 
days of winter (29).  
 
In Brazil (latitude 14°S), there is no official guidance for sunlight exposure for the purpose of 
maintaining adequate vitamin D status. The Brazilian Society of Dermatology has very recently 
published a statement advising caution towards sunlight exposure due to the risks of skin 
cancer, especially in fair skinned individuals (30). This document recommended that exposure 
to sunlight in Brazil should be minimized or avoided between 10am and 3pm, and 
recommended the use of protective clothing and hats as well as the frequent use of sunscreen 
on uncovered body areas when out in the sun, at anytime of the day (30).  
 
A guidance report from FAO/WHO recommends that the most efficient physiological approach 
to acquiring vitamin D for populations at the equatorial latitude range (42°N - 42°S) is through 
endogenous synthesis via sunlight exposure. The report specifically suggests that daily 
exposure of arms and face, without sunscreen, for approximately 30 minutes would be enough 
to maintain adequate vitamin D levels. Nonetheless, it also recognizes the negative influence 
of several environmental and individual factors (such as latitude and season, ageing, skin 
pigmentation, clothing and sunscreen use) on the production of vitamin D in the skin. Finally, 
the report recommendations for future research includes the need to better understand the 
relationship between latitude, sun exposure, and synthesis of vitamin D (31). 
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1.4.3 Factors affecting individual UV radiation levels and consequent cutaneous 
synthesis of vitamin D3 
 
1.4.3.1 Physiological factors 
 
 
 Skin pigmentation 
 
Skin pigmentation can greatly reduce the UV-mediated synthesis of vitamin D. Cutaneous 
melanin pigment in human skin naturally competes for and absorbs the UVB photons 
responsible for the photolysis of 7-dihydrocholesterol to pre-vitamin D3. Therefore individuals 
with higher melanin (i.e. dark skinned) content in their skin require more UV light exposure to 
synthesize the same amount of vitamin D3 as individuals with less melanin (i.e. fair skinned) 
(16,22,32).  
 
In fact, observational studies consistently demonstrate that individuals with lighter skin have 
higher serum 25(OH)D concentrations than those with darker skin pigmentation (32,33). This 
difference was well observed in a study conducted in the United State, where white adults 
raised 25(OH)D concentrations more than 30 fold when compared to black adults exposed to 
the same amount of UVB radiation in a tanning bed (34). However, when the black adults were 
exposed to 5 times more UVB radiation, their blood level increased by about 15-fold (34).  
 
 
 Aging 
 
With aging, from 20 years of age onwards, the concentration of 7-dehydrocholesterol in the 
epidermis decreases linearly over the lifespan and thereby the capacity of the skin to produce 
vitamin D decreases and can be reduced by approximately 75% by 70 years of age (25,35). In 
a study with younger (<60 years) and older adults (60 – 80 years) exposed to a whole-body 
artificial UV radiation, mean 25(OH)D concentrations increased to a maximum  of 78.1 nmol/l 
compared to 20.8 nmol/l (36). 
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 Obesity 
 
A significant negative association between adiposity and low 25OHD in humans has been 
suggested in recent research. Reasonable explanations for this include sun exposure avoidance 
and limited mobility in overweight people, clothing habits, volumetric dilution in a larger body 
volume and decrease in bioavailability of vitamin D circulating as a consequence of enhanced 
uptake by adipose tissue (37–39). 
 
In the Framingham Heart Study cohort (n=3,890), vitamin D status was found to be strongly 
associated with variation in subcutaneous and especially visceral adiposity, showing that higher 
adiposity volumes were correlated with lower 25(OH)D concentrations across different 
categories of Body Mass Index (BMI), including in lean individuals (BMI <25 kg/m2) (40). 
 
 
 Genetic factors 
 
Inter-individual variability in vitamin D status could be reasonably explained by differences in 
the metabolism of vitamin D. The VDR gene plays an important role in Vitamin D metabolism 
and polymorphisms in this gene can potentially affect Vitamin D gene expression, meaning 
that genetic variation could explain the considerable differences in vitamin D levels among 
population independently of latitude and sunlight exposure (41–43). The heritability of vitamin 
D status has been estimated to be 43% in a sample of 1068 twin pairs (primarily female mean 
age 45 years) and 28.8% in a cross-sectional study of 1762 participants of the Framingham 
Offspring Study (919 women; mean age 59 years) (43,44). 
 
 
1.4.3.2 Limited sun exposure 
 
 Indoor environment 
 
Limited time outdoors can significantly reduce the amount of UV radiation received by the 
individual and therefore limit the cutaneous production of vitamin D. Modern society structures 
have developed in a way that in most countries nowadays, the urban industrialized setting 
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involves significantly higher amounts of time spent indoors rather than outdoors (3,45). That 
setting accounts for office-based working hours (usually during daylight hours) and a sedentary 
lifestyle, that besides reducing the amount of time outdoors in comparisons to active peers, also 
includes a preference for private or public automotive vehicles rather than cycling or walking 
for routine transit. Moreover, even for those who are physically active, it is not uncommon for 
sports training and physical activity to take place indoors. In fact, individuals training outdoors 
have been reported to present higher 25(OH)D concentrations compared with those training 
indoor have (1,46,47).  
Several studies have also shown that older, hospitalised or institutionalised populations are at 
a greater risk of having vitamin D inadequate levels due to the reduced or almost no time spent 
outdoors (48–51)  
 
 
 Sun avoidance (shade, sunscreen) and clothing cover 
 
Over the past decades, evidence of the associations between sunlight exposure and skin cancer 
have increased, especially in sunny, low latitude countries (26,52). This increasing awareness 
of higher risk of skin cancer related to direct sun exposure and might be influencing skin 
synthesis of vitamin D adversely. Regular use of sunscreen, direct sun avoidance and “covering 
up” are largely advised in sunny countries, particularly in countries with high incidence of skin 
cancer like Australia and Brazil (30,53,54).  
 
Sunscreen is the most common and practical approach for skin photo-protection. It is designed 
to absorb, reflect or scatter UVB radiation reaching the skin and therefore attenuates the solar 
radiation reaching the cells in the skin. Topical correct application of sunscreen, of a sun 
protection factor as low as 8, can significantly reduce the production of endogenous vitamin D 
(27,55). However, it has been recently argued that, although regular topical use has been proven 
to be effective against detrimental effects to the skin exposed areas, individuals are not likely 
to use sunscreen products appropriately enough to prevent vitamin D production (56,57).  
 
Clothing habits due to cultural or religious preferences are also an important influencing factor 
that may contribute to a significant reduction in the synthesis of vitamin D (15,58). Individuals 
16 
 
that wear clothing that covers most of the body have a greater risk of having vitamin D 
deficiency as the area exposed to sunlight is significantly reduced. 
 
 
 Air pollution 
 
Industrialized cities are likely to have considerable air pollution containing elevated amounts 
of ozone, which efficiently absorbs UVB radiation (more specifically solar radiation below 290 
nm). Less availability of UVB radiation reaching the skin reduces the production of 
endogenous vitamin D (15,59,60). Some studies suggest an association between air pollution 
levels and 25(OH)D status, where higher 25(OH)D concentrations observed in populations at 
less polluted areas of a city (59,61,62). 
 
 
 Cloud, Ozone and Altitude 
 
Atmospheric conditions, such as cloud, ozone and humidity can cause absorption or deflection 
of much of the UV rays in sunlight before it reaches the earth’s surface (5,63). Under cloudless 
skies UV radiation levels are significantly higher although even with cloud cover, UV radiation 
levels can be high depending on latitude and time of the day. Conversely, UV radiation can be 
reduced by 50% in the shadow (15,60).  
 
The thinner atmosphere at higher altitudes results in less UV radiation absorption (10% to 12% 
increase in radiation with every 1000 metres increase in altitude) (17,64). Few studies have 
directly assessed varying altitude and concurrent vitamin D production but one study, 
conducted at 27° N using ampoules of 7-dehydrocholesterol placed at varying altitudes 
between (ranging from 169m to 5350m above sea level), showed a 4 times greater vitamin D 
production at higher altitudes and 2 times greater at  intermediate altitudes (Kathmandu - 
1400m compared with Agra – 169m) (65). 
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 Season 
 
In summer, due to the sun’s higher position in the sky, its rays hit the Earth more directly, and 
therefore less radiation is spread out. In contrast, during winter the sun appears low in the sky, 
spreading its rays out over a much wider area, becoming less effective (15,17,60). Accordingly, 
a seasonal cycling of serum 25(OH)D concentrations has been shown in countries at mid-high  
(32,66,67) as well as low tropical latitudes (54,68,69). 
 
A recent two-centre cohort study with 518 postmenopausal women (age 55-70 years) assessed 
serum 25(OH)D at fixed three-monthly intervals from summer 2006 and observed  significant 
local, seasonal and ethnic differences in vitamin D status for postmenopausal women at high 
latitudes. At 57° N (Aberdeen, Scotland, UK), Caucasian women had lower 25(OH)D 
(p < 0.001) compared to 51° N (Surrey, South of England, UK). Median (interquartile range) 
in nmol/l were 43.0 (20.9) and 62.5 (26.6) in summer and 28.3 (18.9) and 39.9 (24.0) in winter, 
at 57° N and at 51° N, respectively. For Asian women at 51° N, median 25(OH)D was 24 (15.8) 
nmol/l in summer and 16.9 (15.9) nmol/l in winter (19).  
 
In lower latitudes, the same seasonal variation is observed, and although the minimal sunlight 
radiation during winter-time is still of high enough levels for adequate vitamin D production, 
the seasonal cycle in 25(OH)D concentrations has also been reported in such locations 
(54,68,69).   
 
 
1.5 Dietary Vitamin D  
 
1.5.1 Sources 
 
The two main forms of vitamin D are naturally present in a few foods, although in small 
quantities, with ergocalciferol (vitamin D2) from plant and/or fungal sources, such as 
mushrooms and cholecalciferol (D3) from animal origin foods such as oily fish, eggs and liver. 
It is important to appreciate that the nutrient content of foods can vary significantly between 
different countries as well as habitual intake of specific foods. Table 1.2 presents the vitamin 
D content of selected foods.  
18 
 
     Table 1.2 Dietary Vitamin D Content (μg/100g) of Selected Foods 
Food Source Vitamin D (μg/100g)1 
Eggs (raw) 3.2 
Meat 
Beef, steak, grilled 
Pork, grilled 
Chicken, grilled 
 
0.8 
0.9 
0.3 
Fish 
Salmon, wild, raw 
Salmon, farmed, raw 
Mackerel, raw 
Sardines, canned 
 
8.6 
4.7 
8.0 
3.6 
Mushrooms (wild) 13 - 30 
 
1 Values taken from McCance and Widdowson’s The Composition of Food (70) 
 
 
 
1.5.2 Dietary Recommendations  
 
The Institute of Medicine (IOM) and the Endocrine Society in the US and the Brazilian Society 
of Endocrinology and Metabology (SBEM) in Brazil all recommend to the general population 
a daily dietary intake of 15 µg of vitamin D for individuals between 1 and 70 years and 20 µg 
for those > 70 years. However, groups considered to be at high risk may need higher intakes 
(Table 1.2) (71–73).  
 
Previously in the UK, an Reference Nutrient Intake (RNI) for vitamin D was set only for 
population groups deemed to be at high risk of deficiency, assuming that for most people the 
amount of vitamin D synthesized in the skin by exposure to sunlight was sufficient to achieve 
serum 25OHD concentrations above ≥ 25 nmol/l throughout the year. However, increasing new 
evidence proved this not to be the case and a reviewed RNI for vitamin D of 10 µg/d has been 
recently proposed for the UK population aged 4 years and over, including individuals from 
minority ethnic groups with darker skin (Table 1.3) (74).  
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Table 1.3 Vitamin D Dietary recommendations from different Advisory bodies: IOM, SBEM, 
Endocrine Society and SACN (71–74) 1 
 IOM / SBEM / Endocrine Society  SACN 
Age groups General 
population (µg) 
Population at 
risk (µg) 
 
Whole 
population (µg) 2 
0 – 12 months 10 10 – 25   8.5 – 10 a 
1 – 4 years 10 15 – 25    10 a 
4 – 8 years 10 15 – 25  10 
9 – 18 years 15 15 – 25  10 
19 – 70 years 15 37.5 – 50  10 
> 70 years 20 37.5 – 50  10 
Pregnant women 14 – 18 years 15 15 – 25  10 
Pregnant women > 18 years 15 37.5 – 50  10 
Lactating 14 – 18 years 15 15 – 25  10 
Lactating > 18 years 15 37.5 – 50  10 
1 IOM: Institute of Medicine (US, 2011); SBEM: Brazilian Society of Endocrinology and Metabology (Brazil, 
2014); Endocrine Society (US, 2011); SACN: Scientific Advisory Committee on Nutrition (UK, 2016). 
2 A separate RNI is not required for at-risk groups; a ’Safe Intake’ 
 
 
1.5.3 Supplementation and fortification 
 
Due to the limited contribution of foods/diet to vitamin D status, vitamin D supplementation 
and/or food fortification have been increasingly proposed worldwide as an effective strategy 
to tackle vitamin D low levels. In fact, it is estimated that with a western diet, an individual is 
not likely to exceed 5 µg/day through diet alone (4). 
 
Vitamin D supplementation has been shown to improve serum 25(OH)D concentrations and 
subsequently improve the absorption of calcium and suppress PTH secretion (75–77). Vitamin 
D supplementation has gained an increasing popularity over the past decades, with widespread 
claims of preventive or therapeutic effects to a diverse range of health outcomes (10,78). A 
national survey from 2011-2012 in the United States reported that the prevalence of vitamin D 
supplementation in the population increased to 19% compared to 5.1% in 1999-2000 (79).  
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However, despite the increasing popularity of vitamin D supplements, the efficacy and safety 
is still much debated amongst scientific literature and more robust data from randomized 
control trials are needed, especially in regards to different health outcomes and different 
population groups. Moreover, vitamin D supplementation dose and regimen chosen should take 
into consideration the level of deficiency and the target to be achieved. 
 
Some countries already have evidence of vitamin D fortified foods making an impact in 
improving vitamin D status in their populations as a whole. A systematic review and meta-
analysis of randomised control trials assessing the impact of consuming vitamin D fortified 
foods on 25(OH)D status found that 11 μg (440 IU) per day resulted in an increase in 25(OH)D 
concentration of 19.4 nmol/l (80).   
 
It is possible to find commercially fortified foods (milk and dairy products, orange juice, bread 
and cereals), with amounts per portion varying by country (81). In the United Kingdom, for 
instance, although fortification is no longer mandatory, most margarines and fat spreads are 
presently still fortified with vitamin D on a voluntary basis (usual levels ranging from 2.5 μg 
to 7.5 μg per 100 g) (74). Other foods, such as breakfast cereals and dried or evaporated milks, 
may also be fortified on a voluntary basis, as well as infant formulas. In the United States, milk 
and milk substitutes are fortified, also on a voluntary basic around 1 µg per 100 g. In Canada 
fortification of milk and margarine is mandatory (81) at levels of 1 μg/100 g  and 13.5 μg/100 
g  respectively. In Australia, margarine and milk and milk products are currently fortified with 
vitamin D (29). In Brazil no official recommendations for fortification of foods with vitamin 
D have been established, although vitamin D fortified dairy products are available (usual levels 
ranging from 0.5 μg to 6 μg per 100 g) (82). 
 
Both vitamin D2 and D3 can be commercially manufactured and added to supplements and 
fortified foods. Nevertheless, daily vitamin D3 has been recently shown to be more effective 
than vitamin D2 in increasing serum 25(OH)D in the wintertime (83,84) and, consequently, 
Vitamin D3 supplementation/fortification has been currently recommended as better option to 
achieve optimal vitamin D status within the general population.  
 
 
21 
 
1.4 Vitamin D Status  
 
1.4.1 Measurement of serum 25(OH)D concentrations 
 
The metabolite 25(OH)D is the major circulating form of vitamin D, with a half-life of 
approximately 2 to 3 weeks and excellent stability, It reflects Vitamin D from both dietary 
intake and photo-chemically produced in the skin. Therefore it is universally accepted as the 
best indicator of vitamin D status (71,74). The active form 1,25(OH)2D is chemically unstable 
and has a half-life of a few hours, and therefore not recommend as an indicator of vitamin D 
status (1,4). 
 
Circulating 25(OH)D can be measured by several methods, including immunoassays, protein 
binding assays, high performance liquid chromatography (HPLC) and liquid chromatography–
tandem mass spectrometry (LC-MS/MS). The significant variability in results due to the 
availability of many differing methods poses a major challenge not only to the interpretation 
and to the comparison of different date sets, but particularly to the development of international 
evidence based recommendations. There is a general consensus that 25(OH)D assays should 
detect both metabolites 25(OH)D2 and 25(OH)D3. HPLC and LC-MS/MS methods detect both 
D2 and D3 metabolites and, thus, are currently considered the gold standard for 25(OH)D 
measurement. (85).  
 
Moreover, evidence has shown significant differences even in the same laboratory as inter-
assay variations in standard procedures may lead to very different results. The Vitamin D 
External Quality Assessment Scheme (DEQAS), established in 1989, has significantly helped 
to improve assay performance and development via external control of accuracy. In 2010, the 
NIH Office of Dietary Supplements (ODS) together with the CDC National Centre for 
Environmental Health (NCEH), National Institute of Standards and Technology (NIST) and 
Ghent University, proposed the Vitamin D Standardization Program (VDSP). The main 
objective of VDSP is to increase the comparability of data from different national surveys 
around the world (86–88).  
 
Although protocols for standardization of 25(OH)D data are a relevant facilitator of cross-
population comparisons, there are a few other critical aspects that should also be taken into 
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consideration in assessing vitamin D status. Individual variation might be driven by the time 
of the year the samples are collected, whilst results may over or under estimate ‘true’ values 
due to confounders such as holidays to a sunnier/colder location during the sampling period, 
vitamin D supplement intake, medication or medical treatment likely to affect vitamin D 
metabolism or use of sunbeds, etc. (20,24). 
 
 
1.4.2 Optimal vitamin D status 
 
The most common criteria used for determining the optimal serum 25(OH)D concentration for 
bone health in adults include the suppression of parathyroid hormone secretion, higher bone 
mineral density, reduced rates of bone loss and decreases in fractures and falls (8,9,89).  
 
There is still much debate and controversy about which levels of circulating 25(OH)D should 
be considered as deficient, insufficient and sufficient and consequently there is currently no 
consensus on a definition of optimal vitamin D status (Figure 1.6). There is though, a general 
agreement that circulating 25(OH)D concentrations of populations should not fall below 25 
nmol/l in order to preserve bone health (71,74,90). 
 
 
Blue lines indicate the deficiency cut-off for values below the respective number.  
Green lines indicate the adequacy cut-off for values above the respective number. 
 
Figure 1.6 Deficiency and adequacy thresholds for circulating 25(OH)D proposed by different 
international advisory agencies (in nmol/l) (25,71,74,91). 
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The UK Scientific Advisory Committee on Nutrition (SACN) defines vitamin D deficiency as 
25(OH)D concentrations below 25 nmol/l, the IOM in the US defines insufficiency as 
25(OH)D concentrations below 50 nmol/l and the US Endocrine Society proposes 75 nmol/l 
as the minimum level required to prevent detrimental effects to health (25,71,74).  
 
The Brazilian Society of Endocrinology and Metabology very recently proposed a new 
consensus on vitamin D status recommending that 25(OH)D levels should be above 50 nmol/l 
for the general population. Those considered at a higher risk for vitamin D deficiency should 
aim for serum concentrations between 75 and 150 nmol/l, and an upper tolerable concentration 
of up to 250 nmol/l (91). 
 
 
1.5 Toxicity and safety 
 
Remarkably, vitamin D metabolism is tightly regulated to counteract excess production of 
vitamin D from sunlight exposure, which could lead to severe toxicity and potentially 
hypercalcemia, causing renal failure and cardiac arrest (1,4,92,93). In the case of an excessive 
exposure to sunlight, pre-vitamin D3 and vitamin D3 are degraded into biologically inactive 
photoproducts (2,7,11). For dietary intake, the Food and Nutrition Board Dietary Reference 
Intakes (DRIs) proposes 2,500 IU of vitamin D3 daily as the safe Tolerable Upper Intake Level 
(UL) (94). 
 
There has been no adverse effects or toxicity cases reported in trials with adults receiving up 
to 10,000 IU of vitamin D3 daily (92,95,96). Moreover, the concentration that would be 
associated with hypercalcemia is estimated to be as high as 600 nmol/l and at doses above 
25,000 IU per day (625 mcg) (92,93,95,96). 
 
 
1.6 Vitamin D status and intake in populations worldwide 
 
Over the past three decades, increasing prevalence of inadequate vitamin D status has been 
reported in different populations worldwide (11,23,97–99). The majority of the data comes 
from studies and national surveys in high latitudes countries, which is not surprising due to the 
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known challenges of maintaining adequate vitamin D levels in these locations, especially 
during winter. More recently, evidence has emerged indicating alarming prevalence of low 
vitamin D concentrations in low latitude countries, despite the typical sunlight abundance 
(100–103). A review from the International Osteoporosis Foundation described the vitamin D 
status in the general population of 46 countries worldwide based on 200 publications from 
1990 to 2011, presenting the data on a global map (Figure 1.6) (104).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 ‘Snapshot’ of 25(OH)D levels around the globe, as identified in publications since 
the year 1990, by the International Osteoporosis Foundation. Reproduced with permission 
from (104) 
 
A recent study applying VDSP protocols to 14 studies, combined with 4 previously 
standardized studies, from representative European populations, estimated that 40% and 13% 
of 55,844 individuals had average year-round 25(OH)D concentrations below 50 and 30 nmol/l 
respectively. Remarkably, dark-skinned ethnic groups were estimated to have higher 
prevalence of levels below 75 nmol/, from 3 to up to 71 fold, compared to white individuals 
(99). 
 
A multinational study conducted in 2004/2005 that included 18 countries ranging from latitude 
64°N to 38°S with 2606 participants observed that low 25(OH)D concentrations were common 
amongst postmenopausal women with osteoporosis, with 64% of this sample having levels 
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below 75 nmol/l. Mean 25(OH)D concentration was 67 (SE 0.75) nmol/l and values ranged 
from 15 to 607 nmol/l, with regional mean concentrations lowest in the Middle East (51 nmol/l, 
SE 1.25) and highest in Latin America (74 nmol/l, SE 1.5) (48).  
 
In the United States, data from the National Health and Nutrition Examination Survey 
(NHANES) population reported that the number of individuals with 25(OH)D concentrations 
below 75 nmol/l almost doubled from 1994 to 2004 reaching nearly 75% of the American 
population. Within pigmented populations (Black, Hispanic and Asians) the prevalence of 
levels below 75 nmol/l was more than 90% in this cohort (105).  
 
In the UK, data from the National Diet and Nutrition Survey (NDNS) has provided evidence 
of an increased risk of vitamin D deficiency in all age/sex groups. Year-round, the proportion 
of children with a serum 25(OH)D concentration below 25 nmol/l ranged from 7.5% for 
children aged 1.5 to 3 years to 24.4% for girls aged 11 to 18 years and for adults ranged from 
16.9% for men aged 65 years and over to 24.1% for women aged 65 years and over. The 
proportion of participants with a serum 25(OH)D concentration below 25 nmol/l was higher in 
the winter months (106). The recent SACN report stated that the mean intake of vitamin D 
(from all sources, including supplements) for the general British was 2-4 µg/d for ages 1.5-64 
years of age and 5 µg/d for adults aged 65 years or over (74).  
 
A longitudinal cohort study in South Australia (latitude 34°S) with 2413 participants, 
conducted between 2008 and 2010, observed an overall mean serum 25(OH)D of 69.2 nmol/l 
with 22.7% of the population having concentrations below 50 nmol/l (54). Another study in 
Australia, with 126 healthy free-living adults (aged 18-87 years) found a prevalence of 10.2% 
and 32.3% of individuals with serum 25(OH)D concentrations below 25 and 50 nmol/l, 
respectively, at the end of winter (14).   
 
In Brazil, recent studies have shown a high prevalence of vitamin D insufficiency and 
inadequacy in different latitudes across the country. Studies conducted in several different 
cities in Brazil found a high prevalence of 25(OH)D concentrations below 50 nmol/l, with 
values as high as 42% in the city of São Paulo (latitude 23°S), 31.5% in Recife (latitude 8°S), 
63.7% in Curitiba (latitude 25°S), the latter with adolescents (100, 107,108). Alongside this, 
several national studies have shown that the Brazilian usual food intake is not a relevant source 
of vitamin D (Maeda et al. 2014). The most recent report on dietary intakes in the Brazilian 
26 
 
population estimated that the mean vitamin D intake in adults over 19 years of age was 3.2 
μg/d (128 IU) for men and 2.9 μg/d (116 IU) for women (109).  
 
 
1.7 Thesis Rationale 
 
Vitamin D production in the skin, via sunlight exposure, has been long considered the main 
determinant of adequate vitamin D status for the maintenance of calcium homeostasis and bone 
health. In higher latitudes during the winter months, as the distance from the equator increases, 
so too does the zenith angle of the sun. Consequently, the UV radiation reaching the earth’s 
surface is reduced, resulting in limited cutaneous production of vitamin D3. Thus, the cutaneous 
synthesis of vitamin D is expected to be greater in low- latitude regions due to greater exposure 
to UVB radiation.  
 
Over the past 15 years an increasing prevalence of low levels of serum vitamin D have been 
observed across a number of low latitude countries, contradicting the longstanding assumed 
location-dependence for the prevalence of vitamin D deficiency and insufficiency. Moreover, 
although still an important source when UVB radiation is inadequate, vitamin D dietary intake 
has been shown to be suboptimal in most countries across the world.  
 
Therefore, a robust full characterization of both the relative and combined contribution of diet 
and sunlight to achieving optimal vitamin D status is still required. Furthermore, the response 
of individuals to vitamin D supplementation is known to be variable in all population groups, 
since several individual and environmental characteristics may affect the conversion of pre-
vitamin D by sunlight, such as latitude and available UVB radiation throughout the year, skin 
pigmentation, age, individual behaviour, diet and genetic factors. 
 
 
1.7.1 Identification of Knowledge Gaps  
 
There is a clear need for consistent data to establish realistic and meaningful recommendations 
of vitamin D requirements, particularly for different ethnic/racial groups. Although the 
literature is unanimous on the major contribution of sunlight exposure to the production and 
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maintenance of adequate vitamin D levels, people in high latitude countries cannot rely on this 
source for half of the year while people in low latitude countries may not have the assumed 
ideal exposure to sunlight due to being consistently advised to protect against sun radiation or 
due to clothing cultural habits. Moreover, the dietary intake values recommended by most 
advisory bodies are currently not being achieved by the majority of populations worldwide due 
to a lack of foods naturally rich in vitamin D and a lack of mandatory fortification of common 
staples in most countries.  
 
The public health recommendations and messages around adequate sunlight exposure and 
vitamin D intakes (whether by diet or supplements) are currently confusing for most people, 
and do not take into account important influential factors such ethnicity and skin pigmentation, 
cultural behaviour, latitude of residence and season. Additionally, a lack of consensus on 
desirable 25(OH)D concentrations worldwide means it is difficult to recommend a vitamin D 
intake required to achieve an optimal level, again further confounded by potential ethnic 
differences in metabolism between different population groups. Another barrier to achieving 
consensus on optimal levels and subsequent lifestyle recommendations is the impossibility of 
making direct comparisons between, and thus extrapolating study findings from, countries 
located in different latitudes, with different cultural habits, availability of vitamin D food 
sources, skin pigmentation spectrums and lifestyle.  
 
Very few studies so far have been specifically designed to investigate the effect of vitamin D 
supplementation and spontaneous-individual sunlight exposure together on serum vitamin D 
levels in healthy adults. To our knowledge, to date, there are no studies that have conducted 
fundamentally comparable vitamin D supplementation randomized controlled trials (RCT) in 
significantly different latitudes, with identical methodologies and same sex and ethnicity 
populations, to investigate the real contribution of each vitamin D source and the real impact 
of latitude of residence on both serum 25(OH)D levels and the beneficial effects of  vitamin D 
supplementation, without the confounding from ethnicity.  
 
Therefore, the main objective of this thesis is to address this crucial knowledge gap by 
investigating the interaction and relative contribution of vitamin D supplementation and 
individual sunlight exposure in raising vitamin D levels above recognized minimal vitamin D 
status cut-off points, throughout winter months, in ethnically identical adult women living in 
opposite latitudes (Chapter 4). 
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To further contribute to the need for meaningful vitamin D intake recommendations, the 
secondary aims of this Thesis include: 
 
1) Examine the baseline serum vitamin D concentrations and potential influential 
factors in the studied populations within each country in order to account for the latitude 
difference (Chapter 3);  
 
2) Investigate if there is a threshold serum 25(OH)D concentration where a plateau in 
plasma PTH is evident, which could be useful in setting cut-off threshold for vitamin 
D adequacy in this population (Chapter 3); 
 
3) Explore on the association between vitamin D and bone parameters to further 
contribute to the understanding the important role of vitamin D in bone health outcomes 
(Chapter 5). 
 
Specific to the ethnicity targeted in this study, very few consistent population studies so far in 
Brazil have evaluated vitamin D status as well as vitamin D dietary intake. There is also a 
considerable lack of data in Brazilian populations regarding their response to vitamin D 
supplementation since, to our knowledge, to date no randomized controlled trials with vitamin 
D supplementation in healthy adult women have been conducted in Brazil. In addition to the 
general contribution to the field on the interaction of vitamin D supplementation and individual 
sunlight exposure, this thesis also aims to provide key data to inform the future and much 
needed specific dietary and sunlight exposure recommendations for vitamin D adequacy in 
Brazilian women. 
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2 
The D-SOL Study: Overview and Methods 
 
 
The D-SOL study (Interaction between vitamin D supplementation and Sunlight exposure in 
adult women living in Opposite Latitudes) aims to contribute high quality scientific evidence 
to prevent vitamin D deficiency and insufficiency in adult women, regardless of where they 
live, and to provide key data to contribute to dietary recommendations for vitamin D in 
Brazilian women specifically.  
 
The D-SOL study investigates the relative contribution of daily individual exposure to sunlight 
and vitamin D3 daily supplementation on serum 25(OH)D, by comparing directly, using the 
same methodology, same sex and ethnicity individuals living in a low latitude location in the 
Southern Hemisphere - where there is abundant sunlight exposure, and in a high latitude 
location in the Northern Hemisphere - where exposure to sunlight is limited. 
 
 
2.1 Hypotheses 
 
 
 Hypothesis 1: Dietary intakes of vitamin D are too low and sunlight exposure is 
insufficient for maintaining optimal vitamin D status throughout wintertime in 
Brazilian women, regardless of latitude of residence.  
 Hypothesis 2: Vitamin D supplementation is effective in raising and maintaining 
adequate 25(OH)D concentrations  throughout winter, regardless of latitude.  
 Hypothesis 3: The response of Brazilian women to vitamin D supplementation is 
dependent on baseline 25OHD levels.  
 Hypothesis 4: Circulating 25(OH)D and PTH concentrations are associated with bone 
health parameters.  
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2.2 Study design 
 
This was a multicentre study that consisted of two parallel, double-blinded randomised 
placebo-controlled trials. Participants were randomised to receive a daily supplement of 15 μg 
(600 IU) vitamin D3 or placebo, for 12 weeks during wintertime (Figure 2.1).  
 
The full study protocol can be found in Appendix II. The D-SOL study was registered at 
clinicaltrials.gov as NCT03318029.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening 
Health and lifestyle screening questionnaire 
Check inclusion and exclusion criteria 
Randomisation 
n = 80 
Randomisation 
n = 80 
ENGLAND 
TRIAL (51°N) 
BRAZIL 
TRIAL (16°S) 
Screening failures 
15 μg/day vitamin D3 
n = 40 
Placebo 
n = 40 
15 μg/day vitamin D3 
n = 40 
Placebo 
n = 40 
 
Figure 2.1 Flowchart of study design 
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2.2.1 Sample size and power calculation 
 
Using data from previously published research (100) , a total of 80 adult women (at 90% power) 
would be required to demonstrate a response to vitamin D supplementation in the range of 20 
-25 nmol/l at α = 0.05 (n = 32 in each intervention group). The study numbers of 40 subjects 
for the supplemented group and 40 for the placebo group includes a 25% drop-out rate factored 
in. 
 
 
2.2.2 Ethical approval  
 
The study was approved by the University of Surrey (UEC/2016/009/FHMS) and Federal 
University of Goiás Ethics Committees and by the Brazilian National Ethics Committee 
(CONEP) (CAAE 62149516.9.0000.5083, CEP-UFG nº2013222; CONPEP nº 1972029; 
respectively). Approval letters can be found in Appendix II. 
 
The study was conducted in accordance with the Helsinki Declaration and written informed 
consent was obtained from all participants. The consent form content for each country varied 
slightly, in order to be in accordance with the specific requirements of each country’s Ethics 
Committees (Appendix II). For participants living in England, the original consent form 
approved by the Ethic’s committee was translated from English to Portuguese and offered to 
participants in the England trial that felt more comfortable reading in their native language. For 
participants in Brazil, only a Portuguese version of the Brazil trial informed consent was 
provided. 
 
 
2.2.3 Study location 
 
The study trials were conducted in two opposite latitudes: Surrey, Southern England (51°N) 
and Goiás, Mid-west Brazil (16°S). Southern England has a temperate climate with a summer 
mean temperature of 22° C and winter mean temperature of 6° C, whereas Mid-west Brazil has 
a typical tropical savannah climate, with a summer mean temperature of 26° C and winter mean 
temperature of 24° C. While all four seasons in Southern England are well defined, with 
32 
 
significant differences between autumn/winter and spring/summer months, Mid-west Brazil is 
limited to two dominant seasons throughout the year, dry and wet, with high temperatures 
almost all year round. More importantly for the purposes of this thesis, the UV index never 
exceeds 8 in the UK (peaking towards the end of June), and in clear contrast, the minimum in 
Brazil is 8 reaching up to 14 during summer months. Table 2.1 presents these climatological 
differences in more detail. 
 
 
Table 2.1 Main differences in climatological factors between Southern England and Mid-west 
Brazil. 
 Surrey, UK1 Goiás, Brazil2 
Latitude 51° N 16° S 
Thermal zone Temperate Tropical 
Seasons 4 seasons well defined Wet/dry 
Day length during winter (in hours) ~ 8 ~ 11 
Day length during summer (in hours) ~ 16 ~ 13 
Temperature Summer a 
Minimum (in °C) 
Maximum  (in °C) 
 
10 
23 
 
20 
32 
Temperature Winter a 
Minimum (in °C)  
Maximum  (in °C) 
 
2 
8 
 
13 
31 
UV index year-round 0 to 8 8 to 14 
UVB availability during winter No Yes 
1 Met Office, UK 
2 Instituto Nacional de Meteorologia, Brazil 
a Average over past years 
~ Approximately  
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2.2.4 Recruitment 
 
Participants in England were recruited by Marcela Mendes, through advertisement among local 
Brazilian societies/groups within Surrey and London (latitude 51°N). Information posters 
(Appendix II) were positioned around the University of Surrey and commercial centres (with 
a focus on Brazilian themed places), with permission of the owners. 
 
In addition, Brazilian institutions in the UK, such as the Brazilian Embassy in London (Dr 
Juliana Bertazzo) and the Brazilian Researchers Association (ABEP-UK) agreed to circulate a 
recruitment letter to their contact list of Brazilians living in England. The letter was sent 
directly by the institutions (Appendix II).  
 
Participants in Brazil were recruited from the general public within the city of Goiânia (latitude 
16°S) by Marcela Mendes, with the assistance of undergraduate students Emanoelly Pires and 
Giovana Caixeta, through posters positioned around the Federal University of Goiás and 
commercial centres, with permission of the owner.  
 
For both trials, social media online platforms such as Facebook and Instagram were used to 
publicise the study: the recruitment poster was inserted as a photo with the permission of the 
administrators of the pages. 
 
 
2.2.5 Screening and inclusion/exclusion criteria 
 
If participants wished to be screened for participation in the study, they received a Participant 
Information Sheet (Appendix II) and were checked against the study inclusion and exclusion 
criteria (Table 2.2) using the ‘Screening Questionnaire’ (Appendix II), administered by 
Marcela Mendes over the phone or self-reported via email. The inclusion and exclusion criteria 
for participant recruitment are detailed in Table 2.2 below. 
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Table 2.2 Inclusion and exclusion criteria for the D-SOL study trials 
Inclusion Criteria Exclusion Criteria 
 Brazilian nationality (born 
in Brazil and having at least 
one parent born in Brazil)  
 Female  
 Aged 20-59 years 
 
 
 Currently receiving treatment for medical conditions that 
are likely to affect vitamin D metabolism (osteoporosis 
therapy, anti-estrogens treatment, antiepileptic drugs, 
breast-cancer treatment)  
 Hypercalcaemia (>2.5mmol/L) – assessed and excluded 
at baseline 
 Regular use of sun-beds  
 Having a holiday trip one month prior to commencing 
the study, plans for a holiday trip for more than 4 weeks 
out of the country of residence within the study period or 
a trip abroad within the last month of intervention 
 Use of supplements containing vitamin D (if the 
prospective participants agreed to stop Vitamin D 
supplementation to join the study, a wash-out period of 8 
weeks prior to commencing the trial was accepted) 
 Pregnant or planning a pregnancy during the study period 
 Not post-menopausal 
 Living in England for less than 2 months (for England 
trial only) 
 
 
2.2.6 Randomisation and blinding 
  
Enrolled participants were randomised stratified by age and BMI classification using a 
computer-generated block randomisation programme. Dr Sig Johesen, a statistician at the 
University of Surrey not involved in the study produced a consecutive list of study 
identification codes linked to an intervention group.  
 
The 15 μg vitamin D supplement and matching placebo were identical in appearance and taste, 
and were provided by Viridian Supplements (United Kingdom). The vitamin D3 supplements 
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contained cholecalciferol extracted from Lichen and therefore were suitable for vegans. Tablets 
were packed in identical, not identifiable, bottles labelled with the identification number. 
All study researchers and staff as well as participants remained blinded to the supplement dose 
throughout the duration of the study. A researcher from the University of Surrey not involved 
in the study was responsible for keeping the codes during the study.  
 
 
2.2.7 Intervention 
 
The first clinical trial was conducted in England (latitude 51°N) from October 2016 to March 
2017 (autumn-winter) followed by the second trial in Brazil (latitude 16°S) from April 2017 to 
September 2017 (autumn-winter). Both trials were conducted during the respective wintertime 
for each country to ensure minimal confounding from range differences in UVB radiation 
seasonal intensity. Marcela Mendes personally conducted and supervised both trials, as 
principal investigator. The 12-week intervention period was chosen to allow sufficient time for 
25(OH)D concentrations to rise (half-life of 25(OH)D is 3 weeks) and has been demonstrated 
to be an effective timeframe for supplementation of vitamin D in previous studies (110).  
 
The participants selected were randomly allocated to receive a daily supplement containing 
zero (placebo) or 15 μg (600 IU) vitamin D. The supplement dose was chosen to enable the 
study to be relevant to the IOM RDA recommendations for vitamin D3 daily intake (71).  
 
At baseline, participants were given a bottle with a total count of 100 tablets with either placebo 
or 15 μg Vitamin D3, enough for over 12 weeks supplementation. Bottles were labelled with 
participant identification code, D-SOL study logo and brief instructions with contact number 
of principal investigator. Participants were instructed to take the supplement at the same time 
every day and together with a meal. 
 
Participants were instructed to maintain their habitual sunlight exposure and protective 
measures (if part of habitual routine) as well as usual dietary intake and physical activity during 
the duration of the study and report any significant changes to their habits or normal routine. 
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Compliance was monitored by compliance interviews and by counting the remaining tablets 
from returned bottles at the end of the study. Throughout the intervention period, participants 
were contacted via telephone or email weekly to check for adverse events and encourage 
compliance.  
 
 
2.3 Data Collection 
 
Marcela Mendes conducted and supervised the data collection in both countries in person, as 
principal investigator. Data collection was assisted by Saskia Wilson-Barnes, Dr Philippa 
Gibson and Hajrah Mukthar in England, and Sáskia Vaz, Amanda Oliveira and Marília Bohnen 
in Brazil. 
 
Before starting the study procedures, participants were given a printed copy of the Participant 
Information Sheet, and given time to read the document and ask any questions regarding the 
study. If they wished to proceed in taking part in the study, informed consent was discussed 
and participants were asked to sign the consent form, and offered a copy to keep for themselves. 
 
Participants visited the respective universities, University of Surrey in England (with support 
from John Elliot) and University of Goiás in Brazil (with support from Walkiria Toledo and 
Aline Magalhaes Costa), on two occasions at the beginning and end of the trials: December 
2016 (baseline; week 0) and March (post-intervention; week 12) for the England trial and June 
2017 (baseline; week 0) and September 2017 (post-intervention; week 12) for the Brazil trial. 
Trial visits occurred in the morning between 7.00 and 11.30 am following overnight 8 hours 
fasting. Trial procedures at each visit are summarised in Figure 2.2 below, followed by a 
description of all data collection methods. Participants were contacted weekly by telephone or 
email to maintain good communication and for adverse event reporting. 
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2.3.1 Lifestyle questionnaire 
 
A lifestyle questionnaire was administered to assess for several cultural, behavioural and 
general lifestyle aspects. Participants were asked to complete the questionnaire by themselves 
during baseline visit, with a researcher from the D-SOL team (Marcela Mendes or Lara 
Nabuco) present to help with any eventual questions. Table 2.3 summarises the information 
collected from the lifestyle questionnaire. The full questionnaire can be found in Appendix II 
and included multi-choice as well as open questions regarding socio-demographics, behaviour 
towards sunlight exposure (sunscreen use and sunbathing habits), lifestyle and perceptions 
towards vitamin D and sunlight exposure.  
 
The questionnaire was piloted with one adult Brazilian women living in England and one adult 
Brazilian women living in Brazil. The questionnaire was adapted to each country to make 
questions appropriate (i.e. Planning a trip between “December and March” for England or 
 
 Informed consent form 
 Fasted blood sample 
 Anthropometrics and blood pressure 
 pQCT (England) or DXA scan (Brazil) 
 Lifestyle questionnaire  
 Provision of: UV dosimeters, food diaries, sunlight exposure diary 
and randomly assigned supplements 
 
 Final adverse event and compliance interview 
 Fasted blood sample 
 Anthropometrics and blood pressure 
 Return of: UV dosimeters, food diaries, sunlight exposure diary 
and supplements bottles 
Week 
0 
Week 
12 
Figure 2.2 Study procedures completed during study visits. (pQCT: peripheral quantitative 
computed tomography; DXA: Dual-energy X-ray absorptiometry) 
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“June and September” Brazil, respectively; “How many years living in England?” and “Where 
did you live before?” removed from Brazil trial questionnaire; pint as reference measure for 
England trial and replaced with 2 mugs for Brazil trial, both referring to 560ml). 
 
Table 2.3 Information collected from the lifestyle questionnaire 
 
 
2.3.2 Vitamin D and dietary intake  
 
Dietary intake of participants, particularly vitamin D and calcium, was determined by 4 
consecutive days of estimated diet diaries. Throughout the study, two diaries were collected  
for each participant (beginning – week 0, and end of the intervention – week 12). Participants 
were trained by the research team (Marcela Mendes or Lara Nabuco) on how to correctly 
complete the diary, using pre-filled forms and standard kitchen utensils for measurement 
standarization. They were also instructed to give as much detail as possible of every meal, 
including portion size. Records included days of the week and weekend as participants were 
instructed to always start on a Sunday, in order to be representative days.  
 
Dietary intake data obtained from participants in the England trial were analyzed using the 
Nutritics® nutritional analysis software and those collected in Brazil were analyzed via the 
Dietwin® software. Nutritics® software  is based on the UK Composition of Foods Integrated 
Health Socio-demographics 
Previous disease 
Previous medication/treatments 
Currently or might be pregnant 
Ever fractured any bones 
Plans to get pregnant within next 12 months 
Given birth in the last 3 months 
Breastfeeding 
 
Date of Birth 
Nationality and country of birth 
Ethno-race R1 
Skin type R2 
Education level 
Years living in England a 
Previous country of residence a 
     Plans to travel during study period 
Lifestyle Behaviour towards sunlight 
Physical Activity Habit and Frequency 
Alcohol Consumption 
Habit of Smoking 
Milk consumption (per day) 
Egg, oily fish and fish consumption (per week) 
Supplement use (currently and within the last year) 
Body parts exposed 
Sunscreen use 
Sunscreen SPF at home/during 
holiday 
Natural sunbathing habit 
     Artificial sunbeds use 
a Applicable to England trial participants only.  
References: R1 Official ethno-racial categories for the Brazilian population by the Brazilian Institute of 
Geography and Statistics (111) R2 The Fitzpatrick Classification Scale for Skin Types (112). 
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Dataset (CoFID) including McCance and Widdowson 7th edition (70). The Dietwin® software 
database includes the Brazilian Food Composition Table (TACO) (113) and the food 
compostion database from The Brazilian Institute of Geography and Statistics (IBGE), as well 
as the United States Department of Agriculture (USDA) food composition database. 
 
Portions were estimated based on the description recorded and from consulting the relevant 
food portion sizes guides, namely Food Portion Sizes (Maff Handbook), 3rd Edition 2002 (114) 
and Table for Evaluation of Food Consumption in Domestic Measures (Tabela para Avaliação 
de Consumo Alimentar em Medidas Caseiras, in Portuguese), 5th Edition, 2004 (115). All 
diaries, from both countries, were analysed by Marcela Mendes. Gaps in quantity information 
were entered as the standard medium portion for the respective food.  
 
 
2.3.3 Sunlight individual exposure  
 
To determine individual exposure to ambient UVB radiation, participants were asked to wear 
individual UV exposure dosimeter polysulphone film badges (provided by Prof Anna Webb 
and Dr Richard Kift, University of Manchester) on their outer clothing. Participants were 
instructed to wear their dosimeters around the upper shoulder/chest region from sunrise to 
sunset for a full week (7 consecutive days) at both week 0 (baseline) and week 12 (post-
intervention). They were instructed to store the dosimeter in the supplied envelope (of thick 
and dark material to prevent further UVB exposure during storage) and return on week 12 visit. 
 
All dosimeters, for both the England and Brazil trials, were read at the University of Surrey by 
Marcela Mendes, prior to and after use, with a Cecil Aquarius CE7200 Double Beam 
Spectrophotometer (which has a CV <1%) at 330 nm, to detect change in absorbency. The 
amount of UV captured by each dosimeter badge was then translated to a standard 
erythematous dose (SED) using the following formula (15): 
 
SED = 10.7 [ΔA330] + 14.3 [ΔA330]2 – 26.4 [ΔA330]3 + 89.1 [ΔA330]4 
ΔA330 = change in absorbance at 330 nm of the dosimeter from pre- to post-UVB exposure. 
 
1 SED = 100 J m−2 of erythemal (sun burning) UV radiation and is generally used as a measure 
of UV exposure. 
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Participants’ individual sun exposure was also evaluated by a sunlight exposure diary 
equivalent to the 12 weeks (~90 days) of intervention. The records were performed daily 
through calendar code entry (Figure 2.3). Participants were trained on how to properly 
complete the records by the research team. Individuals were also instructed to record in the sun 
exposure diaries eventual trips out of the state or country of residency, specifying the exact 
location and dates of travel and return. All sun exposure diaries were then transcribed by 
Marcela Mendes to a standardized worksheet to obtain scores related to the most frequent 
individual exposure.  
 
Figure 2.3 Daily outdoor sun exposure diary: entry codes  
 
Code Time spent outside today  
 
 
 
 
 
 
 
Code Sites exposed 
1 Less than 15 minutes A Face only 
2 Between 15 and 30 minutes B Hands and face 
3 
Between 30 minutes and 2 
hours 
C Hands and face plus arms and/or legs 
4 More than 2 hours D 
Hands and face plus arms and/or legs 
and some/all of the body 
 
 
2.3.4 Ethno-race and skin type 
 
Race and skin type were both self-reported via the lifestyle questionnaire (Appendix II). Race 
categories were based on the Brazilian ethno-race national demographic spectrum (Brazilian 
Institute of Geography and Statistics (111)), which includes: White, Black, Brown/Mixed 
(“Pardo” in Portuguese), Indigenous and “Yellow” (Asian-descendent). Participants were 
asked to indicate which category they most identified with. 
 
Skin type categories were based on the Fitzpatrick validated classification for skin photo-types, 
which classifies the skin according to the ability of each skin type to tan under sun exposure 
and its sensitivity and tendency to turn red under the solar rays (Table 2.4) (112). Participants 
were asked to choose one category only that best represented the effect of sunlight exposure 
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on their skins. For the purpose of this study, Fitzpatrick’s photo-types were combined into skin 
type categories as follow: Type I and II (white); Type III and IV (brown); Type V and VI 
(Black). 
 
Table 2.4 Fitzpatrick validated classification for skin photo-types 
Type Skin natural colour Skin reaction/sensitivity to sun exposure 
I White Always burns; Never tan; Very sensitive to the Sun 
II White Always burning; Very little tan; Sun sensitive 
III Light brown Burns moderately; Bronze moderately; Normal 
sensitivity to the Sun 
IV Moderate brown Burns a little; Always tan; Normal sensitivity to the Sun 
V Dark brown Rarely burns; Always tan; Not sensitive to the sun 
VI Black Never burn; Totally pigmented; Insensitive to the Sun 
 
 
2.3.5 Anthropometrics and blood pressure  
 
Before data collection commenced, anthropometric methods were standardized between the 
different researchers involved in the study performing the measurements in each country 
(Saskia Wilson-Barnes, Dr Philippa Gibson and Hajrah Mukthar in England, and Sáskia Vaz, 
Amanda Oliveira and Marília Bohnen in Brazil, were trained by Marcela Mendes) in order to 
minimize inter-evaluator variations (116). 
 
Participants were instructed to wear light clothing on the day of the trial visits, with gym clothes 
if possible, in order to minimize different added weight from clothing. For weight 
measurement, participants were asked to remove shoes, socks and heavy coats before stepping 
on the scale. For the England trial, weight to the nearest 0.1 kg and body fat was obtained using 
a Tanita Body Composition Analyser MC-180MA (Tanita Coopertatives, Tokyo, Japan). For 
the Brazil trial, weight was measured to the nearest 0.1 kg using a standard weighting scale 
(Balmak®) and body composition was determined via DXA scan.  
 
Standing height was measured using a wall stadiometer, to the nearest 0.1 cm, with participants 
in an up-right posture and barefoot with heels close together and as close as possible to the wall 
(116).  
42 
 
Waist circumference was measured with a non-extendable standard measure tape, at the 
narrowest point of the torso, to the nearest 0.1 cm. If point could not be estimated, the level of 
the belly button was used as reference point. 
 
For blood pressure measurements, participants were asked to sit and relax for 1 minute prior to 
taking the reading. They were positioned in an up right seated position with their arm supported 
on a levelled table. An automatic blood pressure monitor (Omron Healthcare Ltd, Kyoto, 
Japan) was used to obtain readings from the non-dominant arm. Blood pressure readings were 
repeated twice, with a one-minute interval between measures, and an average reading 
calculated. 
 
 
2.3.6 Blood sample collection and processing 
 
An overnight fasted (8 hours) blood sample was collected by venepuncture by trained 
phlebotomists at each visit (baseline and post-intervention). The following blood sample 
collection tubes were used for measurement of the specified metabolites: 
 
 10 ml BD Vacutainer® SSTTM tube: serum 25(OH)D, calcium and albumin 
 6 ml BD Vacutainer® EDTA tube: plasma PTH 
 
After collection, all blood samples were inverted 10 times as per manufacturer’s instructions 
before being processed by Marcela Mendes in the laboratory within the respective Clinical 
Investigation units of each University. For serum, the collected blood samples were left to clot 
for 1 hour at room temperature followed by centrifuge spinning at 3,000 g for 10 minutes at 4° 
C (England trial: Sigma 3-16K Centrifuge, SciQuip, Shropshire, UK; Brazil trial: Eppendorf™ 
5702R Centrifuge, UK).  For plasma, collected blood samples were spun immediately also at 
3,000 g for 10 minutes at 4° C. 
 
Processed serum and plasma samples were distributed into aliquots and stored at -80° C at the 
University of Surrey, prior to analysis. Samples collected in Brazil followed the exact same 
procedures and were temporarily stored at -80° C at the University of Goiás. The samples were 
then sent by air to the UK by World Courier Group Inc. UK Branch, arranged by Marcela 
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Mendes with the assistance of Dr Kathryn Hart, Dr Patrícia Botelho and MSc Anna Paula 
Gomes, to be stored at the University of Surrey as well, prior to analysis. 
 
 
2.3.7 Laboratory analysis 
 
All samples, from both countries, were analysed for 25(OH)D, PTH, serum calcium and serum 
albumin at Imperial College London, by Dr Emma Williams. 
 
Serum 25(OH)D concentrations were determined by HPLC-MS/MS method on a Waters 
Acuity TQD using a PFP column following supported liquid extraction (SLE). Laboratory 
intra- and interassay CVs were 5.6% and 7.8%, respectively.  
 
Due to the lack of global consensus as to the definition of vitamin D status, for the purpose of 
the D-SOL Study vitamin D status was defined as per Table 2.5 below. The references were 
chosen on the basis of current reference values followed in Brazil and in the United Kingdom. 
 
 
Table 2.5 Vitamin D status cut-off thresholds defined for the D-SOL study analysis 
Serum 25(OH)D concentration Status Reference 
< 25 nmol/l Deficiency SACN (2016) (74) 
25 – 49.9 nmol/l Insufficiency IOM (2011) (71) 
50 – 74.9 nmol/l Adequacy IOM (2011)(71) /SBEM (2017) (91) 
> 75 nmol/l Optimal Endocrine Society (2011) (72) 
SBEM: Brazilian Society of Endocrinology and Metabology 
 
Calcium, albumin, and PTH concentrations were measured by using Abbott Architect methods. 
Serum calcium was measured by using an endpoint spectrophotometric reaction based on the 
o-cresolphthalein complexone methodology, and serum albumin was measured by using an 
endpoint spectrophotometric reaction based on the bromocresol green solution dye binding 
methodology. Serum calcium concentrations were adjusted for albumin concentrations. Plasma 
intact PTH was measured by in vitro chemiluminescent microparticle immunoassay (CMIA). 
44 
 
The manufacturer’s quoted inter-assay CV for calcium was <3%, for albumin <3.8% and for 
PTH 4%. Intact PTH reference values for adults range from 1 to 6.9 pmol/l (117). Serum 
calcium concentrations were adjusted for albumin concentrations and serum corrected calcium 
reference values for adults range from 2.1 to 2.6 mmol/L (117). 
 
 
2.3.8 Bone parameters 
 
For the England trial, a peripheral quantitative computed tomography (pQCT; XCT 2000, 
Stratec Medizintechnik GmbH, Pforzheim, Germany) was performed on the participant’s non-
dominant forearm at the baseline visit only, to measure volumetric bone mineral density at the 
4% and 66% radial site. pQCT was performed by the same experienced operator to scan all 
participants' tibias. The pQCT scan allows for separate measurements of vBMD and bone 
mineral content (BMC) for trabecular and cortical sites (4% and 66% sites, respectively, 
defined as the percentage of the tibia length from the distal to the proximal end). T-scores for 
total density and trabecular density were calculated using previously published reference data 
for white Caucasian European women (118) using the equation: T-score = (individual value – 
reference mean) / reference Standard Deviation (SD). 
 
For participants in Brazil, body composition (absolute and relative amount of lean and fat 
mass), whole body bone mineral density and lower spine and femur bone mineral density was 
measured via DXA (dual energy X-ray absorptiometry, GE Healthcare LunarTM DPX 
NT+152000, GE Medical Systems, Madison, Wisconsin, US) scan at baseline only.  The same 
experienced operator performed all DXA scans with all participants. A DXA scan provides a 
two-dimensional estimate of an individual's bone mineral density (BMD) in the specific region 
of interest. T-scores of Brazilian participants for lumbar spine (L1-L4) and fêmur were 
automatically calculated by the DXA scan, which used as a reference white Caucasian Women 
(119,120).  
 
The same cut-off values for T-score classification (i.e., T-score ≥−1.0 defined as low-risk score, 
T-score between −1.0 and −2.5 defined as moderate, and ≤−2.5 defined as high-risk score for 
osteoporosis) were applied for pQCT and DXA scans. 
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3 
Exploring the concept of latitude-dependence of vitamin 
D status: impact of sunlight availability and individual UV 
radiation levels on serum 25-hydroxyvitamin D 
 
 
3.1 Background 
 
As previously discussed in Chapter 1, prolonged and severe vitamin D deficiency can lead to 
rickets in children and osteoporosis in adults. Vitamin D is naturally present in very few foods 
and in small quantities and the main source is considered to be casual exposure of the skin to  
the  UVB  portion  of  sunlight (290-350nm), which converts the molecule 7-
dehydrocholesterol naturally present in the epidermis, to pre-vitamin D. Serum 25(OH)D 
concentrations reflect both photo-chemically synthesised vitamin D in the skin and dietary 
intake being, therefore, considered the best indicator of the long-term vitamin D status. 
 
Populations living within the tropics, namely low latitude locations, are exposed to 
substantially higher levels of solar UV radiation throughout the year than those living in high 
latitude locations (17). The average ambient solar UV radiation in South America is about two 
to three times that in Northern Europe, rising even more with greater proximity to the equator. 
For instance, the maximum UV index (based on midday intensity in summer months) is 14 in 
Mid-west Brazil compared to only 7-8 in Southern England (121,122).  
 
Recent reports of an increasing prevalence of low vitamin D concentrations in both low and 
high latitude locations show that vitamin D deficiency is rapidly becoming, if not already, a 
major global public health issue (50,99,104). Moreover, vitamin D deficiency and insufficiency 
are common in immigrant groups coming from low latitude countries to live in high latitude 
countries, being far more prevalent amongst ethnic groups compared to native populations in 
these locations (58).  
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More studies are needed to accurately estimate the prevalence of insufficient serum 25(OH)D 
concentrations in sunny countries. In order to develop effective vitamin D guidelines, we need 
to fully understand the actual impact of sunlight on 25(OH)D concentrations, based not only 
on UV radiation availability (latitude) but also individual UV radiation exposure, as well as the 
relative contribution of key influential factors, such dietary intake, adiposity, skin pigmentation 
and lifestyle.  
 
 
3.2 Objectives 
 
 Objective 1:  
To compare the intensity of individual UV radiation levels between adult women living in 
England and adult women living in Brazil, and investigate the association with circulating 
25(OH)D concentrations. 
 
 Objective 2:  
To evaluate the habitual dietary Vitamin D and calcium intakes and associations with 
circulating 25(OH)D concentrations in adult women living in England and adult women living 
in Brazil. 
 
 Objective 3:  
To determine the prevalence of vitamin D deficient, insufficient, adequate and optimal status 
in adult women living in England and adult women living in Brazil. 
 
 Objective 4:  
To determine the relationship between serum 25(OH)D and plasma PTH concentrations and to 
investigate whether there is a threshold for serum 25(OH)D concentrations where a plateau in 
PTH is evident and useful in setting a cut-off threshold for vitamin D adequacy for this 
population. 
 
 Objective 5:  
To explore the relationship between serum 25(OH)D concentration, vitamin D intake, 
individual sunlight exposure and influential factors. 
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3.3 Methods 
 
The study recruited participants at the University of Surrey (51.°N) England, from October to 
December 2016 and participants at the University of Goiás (16°S), Brazil, from April to June 
2017. All participants at commencement of the study provided a written informed consent.  
Full clinical and methodological study details, including participant recruitment, 
randomization and data collection, are described in Chapter 2.  
 
 
3.3.1 Statistical analysis 
 
Statistical analysis of the data was undertaken using SPSS software for Windows (version 25.0; 
IBM Corp, Armonk, NY). 
 
Data was tested for normal distribution using the Kolmogorov-Smirnov tests. Non-normally 
distributed variables were log transformed and reported in the original scale. Non-parametric 
tests were used when log transforming did not normalise the data. Descriptive statistics were 
determined for all variables. Continuous variables are presented as mean ±SD for normally 
distributed variables or as median (25%, 75% percentiles) for not normally distributed. For 
categorical variables, frequency and percentage were reported. 
 
Baseline characteristics (age, weight, BMI, waist circumference, dietary intakes, UVB 
exposure and biomarkers) were compared between countries, by independent t-tests, or Mann-
Whitney U tests for non-normally distributed data. The distribution of skin type and BMI 
classification were compared between countries using chi squared tests.  
 
For the whole sample and in each country separately, Pearson correlation, or the corresponding 
non-parametric Spearmans rho correlation tests were used to investigate the relationship 
between circulating serum 25(OH)D and individual UV radiation levels,  dietary intakes of 
vitamin D and calcium, and anthropometric measures. Mean circulating serum 25(OH)D 
concentration was compared between different aspects of lifestyle, individual characteristics 
and individual UV radiation levels using independent t-tests, or Mann-Whitney U tests for non-
normally distributed data; or one-way ANOVA with post-hoc Tukey tests, or Kruskall-Wallis 
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for non-normally distributed data. Standard linear regression models were run to investigate 
the predictive ability of individual daily sunlight exposure on circulating serum 25(OH)D 
concentrations.  
 
A p value of <0.05 was considered significant. For comparisons between groups, effect size 
based on eta squared was defined as: 0.01 as a small effect, 0.06 as a medium effect and 0.14 
as a large effect (123). 
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3.4 Results 
 
3.4.1 Study participants 
 
A total of 335 adult Brazilian women were screened for the study, 148 in England and 187 in 
Brazil, of which: 131 were excluded based on the exclusion criteria; 53 decided not to 
participate after the screening process and 15 did not attend their baseline visit. Reasons for 
exclusion at screening are detailed in Figure 3.1. In the Brazil cohort one participant did not 
have valid laboratory results, and was therefore excluded from database. 
 
Of the participants enrolled for the D-SOL study after the screening process, 135 participants 
were included in this cross-sectional analysis (n = 56 in England and 79 in Brazil). In the 
England cohort five participants were post-menopausal. There were no differences between 
analyses including or excluding the 5 post-menopausal women, and therefore, only analyses 
including these participants are reported here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screened for eligibility  
(n= 148) 
 
 Excluded (n= 92): 
- Outside geographical range of study (n= 35) 
- Planned trip outside country of residence for 
more than 4 weeks during intervention (n= 5) 
- Refused to fast for blood test (n= 1) 
- Taking vitamin D supplements at the time of the 
study (n= 4) 
- Pregnant or breastfeeding (n= 6) 
- Undertaking medical treatment (n= 1) 
- Previously diagnosed with osteoporosis (n= 3) 
- Moved back to Brazil after screening (n= 3) 
  
 Declined to participate (n= 20) 
 No show for baseline visit (n= 15) 
Enrolled 
(n = 56) 
 
Enrolment 
 
 
 
England (Dec-Mar 2016) 
 
 
 
Brazil (Jun-Sep 2017) 
 
 
 
Screened for eligibility  
(n= 187) 
 
 Excluded (n= 108) 
- Outside geographical range of the study (n=13) 
- Planned trip outside country of residence for 
more than 4 weeks during intervention (n= 22) 
- Taking vitamin D supplements at the time of the 
study (n= 15) 
- Pregnant or breastfeeding (n= 3) 
- Undertaking medical treatment (n= 14) 
- Previously diagnosed with osteoporosis (n= 7) 
 
 
 
 Declined to participate (n= 33) 
 No valid baseline samples (n=1) 
 
Enrolled 
 (n = 79) 
 
Figure 3.1 Flow diagram of participant enrolment 
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3.4.2 Baseline characteristics 
 
3.4.2.1 Socio-demographic and anthropometric characteristics 
 
In the overall sample the median age was 29 (25, 35) years. Amongst the 135 participants, 63% 
identified themselves as white and 33.3% as Brown (mixed). The proportion of white women 
in the England cohort was significantly higher (p=0.012) while in the Brazil cohort there was 
an even distribution between white and brown (51.9% and 44.3%, respectively). In respect to 
skin type classification, the majority of participants classified themselves as type III and IV 
(63% overall, 66.1% of England and 60.8% of Brazil residents), which corresponds to light 
and moderate brown in the Fitzpatrick scale, with no differences in proportions between the 
two countries (Table 3.1). The majority of women had a university degree in both countries 
(70.4% overall), with a higher proportion in the England cohort (p=0.014). Two thirds of the 
England dwelling participants had been living in Southern England for more than 2 years 
(72.7%) (Table 3.1). 
 
Table 3.1 Socio-demographic characteristics of adult Brazilian women overall and by country 
of residence (n=135)1 
1 Values are median (25th, 75th percentile) or n (%). 2 Statistical analysis: Mann-Whitney U unless otherwise 
stated; a Pearson Chi Squares. References: R1 Official ethno-racial categories for the Brazilian population by the 
Brazilian Institute of Geography and Statistics (111) R2 The Fitzpatrick Classification Scale for Skin Types 
(112). N/A: Not Applicable 
 All England (n = 56) Brazil (n = 79) p2 
Age (years) 29 (25, 35) 33 (29, 41) 27 (24, 31) <0.001 
Ethno-race [n(%)]  R1 
White 
Black 
Brown (mixed) 
Yellow (Japanese-descendant) 
Indigenous (native Indian) 
 
85 (63%) 
3 (2.2%) 
45 (33.3%) 
1 (0.7%) 
1 (0.7%) 
 
44 (78.6%) 
1 (1.8%) 
10 (17.9%) 
0 
1 (1.8%) 
 
41 (51.9%) 
2 (2.5%) 
35 (44.3) 
1 (1.3%) 
0 
0.012a 
Skin type [n (%)] R2 
   Type I and II 
   Type III and IV 
   Type V and VI 
 
42 (31.1%) 
85 (63%) 
8 (5.9%) 
 
17 (30.4%) 
37 (66.1%) 
2 (3.6) 
 
25 (31.6%) 
48 (60.8%) 
6 (7.6) 
0.589a 
Education level [n(%)] 
Secondary school (> 16 yrs of age) 
A levels (18 yrs of age) 
University Degree 
 
3 (2.2%) 
37 (27.4%) 
95 (70.4%) 
 
1 (1.8%) 
8 (14.3%) 
47 (83.9%) 
 
2 (2.5%) 
29 (36.7%) 
48 (60.8%) 
0.014a 
Years living in England [n(%)] 
< 1 year  
1 – 2 years 
> 2 years 
 
N/A 
 
 
 
5 (9.1%) 
10 (18.2%) 
50 (72.7%) 
 
N/A 
 
 
 
N/A 
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In the overall sample (n=135), median BMI was 23.9 (20.9, 26.73) kg/m2 and a total of 61.5% 
of the women had a BMI within the healthy range of <25 kg/m2, while 23.7% were overweight 
(25 – 29.99 kg/m2) and 14.8% were obese (>30 kg/m2) (Table 3.1). 
 
Brazilian women living in England were older, heavier and had a greater waist circumference 
than those living in Brazil (p<0.01). There were no significant differences between Brazilian 
women living in England and in Brazil for BMI classification distributions although, in line 
with the weight data, the mean BMI was significantly greater for those residing in England 
(Table 3.2). 
 
Table 3.2 Baseline anthropometric characteristics of adult Brazilian women overall and by 
country of residence (n=135)1 
 
 
3.4.2.2 Lifestyle characteristics 
 
Overall, around half of the women reported being physically active (59.3%), of which most 
reported exercising 3 times a week or more (75%). Very few participants smoked (6.7%) and 
over half reported habitually consuming alcohol (57%). There were no significant differences 
in any of the characteristics or reported behaviours between women living in England and 
women living in Brazil. 
 All England (n = 56) Brazil (n = 79) p2 
 
Weight (kg) 
 
 
62.95 (55.85, 71.80) 
 
67.25 (60.77, 72.95) 
 
60.15 (54.1, 71.3) 
 
0.002 
Waist Circumference 
(cm) 
 
75.70 (68.20, 87.70) 86.05 (76.40, 93.77) 70.4 (66.1, 77.2) <0.001 
BMI (kg/cm2) 
 
23.9 (20.97, 26.73) 24.79 (22.69, 28.09) 23.34 (20.37, 26.38) 0.009 
BMI category [n (%)] R1 
   Healthy  
   Overweight  
   Obese  
 
 
83 (61.5%) 
32 (23.7%) 
20 (14.8%) 
 
29 (51.8) 
16 (28.6) 
11 (19.6) 
 
54 (68.3) 
16 (20.3) 
9 (11.4) 
0.140a 
Body fat (%)≠ 
 
35.46 ± 8.41 30.96 ± 5.84 38.65 ± 8.52 <0.001b 
1 Values are median (25th, 75th percentile), mean ± SD or n (%). 
2 Statistical analysis: Mann-Whitney U unless otherwise stated; a Chi Squares; b Independent t-test 
≠ Measurements derived from different methodologies (England: bio-impedance; Brazil: DXA scan) 
References: R1 World Health Organization BMI classification (124) 
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Overall, nearly a third of the participants reported never consuming milk (28.7%) and nearly a 
quarter reported never consuming oily fish (22.9%). There were differences in the frequency 
of consumption of milk and oily fish between the two countries. Around 30% of women living 
in England reported drinking more than 2 mugs of milk per day compared to 10% in Brazil 
(p=0.001), and over half (51.8%) in England consumed oily fish at least once a week compared 
to only 21.6% in Brazil (p=0.005). Overall, around half of the women across both countries 
(45.2%) reported consuming eggs at least 2-5 times a week and 77.1% reported never 
consuming liver (Table 3.3). 
 
In the total sample, the majority of participants (70%) had not taken supplements containing 
vitamin D or fish/fish liver oil supplements within the last 12 months, although the proportion 
was significantly higher amongst women living in Brazil (68.4% versus 57.2% for those living 
in England, p=0.002) (Table 3.3). 
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Table 3.3 Lifestyle characteristics of adult Brazilian women overall and by country of 
residence (n=135)1 
1 Values are median (25th, 75th percentile) or n (%). 2 Statistical analysis: Chi Squares. § Amongst participants who 
said “Yes” to previous item. 
 
 All England (n = 56) Brazil (n = 79) p2 
Physical Activity§ 
No 
Yes 
 
Physical Activity Frequency 
1-2 x 
3-4 x 
5-7 x 
     Missing 
 
 
55 (40.7%) 
80 (59.3%) 
 
18 (22.5%) 
42 (52.5%) 
14 (17.5%) 
6 (7.5%) 
 
 
32 (57.1%) 
24 (42.9%) 
 
7 (21.9%) 
19 (59.3%) 
7 (18.8%) 
0 
 
 
31 (39.2%) 
48 (60.8%) 
 
11 (26.2%) 
23 (54.7%) 
8 (19%) 
6 
 
0.673 
 
 
 
0.506 
Alcohol Consumption 
No 
Yes 
 
 
58 (43%) 
77 (57%) 
 
34 (60.7%) 
22 (39.3%) 
 
36 (45.6%) 
43 (54.4%) 
0.467 
Smoke 
No 
Yes 
 
126 
(93.3%) 
9 (6.7%) 
 
5 (8.9%) 
51 (91.1%) 
 
75 (94.9%) 
4 (5.1%) 
0.375 
Milk consumption (per day) 
Never 
Less than 1 mug (< 280 ml) 
1 mug (280 ml) 
2 mugs (560 ml) 
More than 2 mugs (> 560 ml) 
 
39 (28.7%) 
31 (23%) 
38 (28.1) 
21 (15.6%) 
4 (3%) 
 
13 (23.2%) 
17 (30.4%) 
9 (16.1%) 
13 (21.3%) 
4 (7.1%) 
 
28 (35.5%) 
14 (17.7%) 
29 (36.7%) 
8 (10.1%) 
0 
0.001 
 
Egg consumption (per week) 
Never 
Less than once 
Once 
2-5 times 
> 5 times 
 
4 (2.9%) 
21 (15.6%) 
29 (21.5%) 
61 (45.2%) 
20 (14.8%) 
 
1 (1.8%) 
9 (16.1%) 
17 (30.4%) 
24 (42.9%) 
5 (8.9%) 
 
3 (3.8%) 
12 (15.2%) 
12 (15.2%) 
37 (46.8%) 
15 (19%) 
0.203 
 
Oily fish consumption (per week) 
Never 
Less than once 
Once 
2-5 times 
      > 5 times 
 
31 (22.9%) 
58 (43%) 
33 (24.4%) 
12 (8.9%) 
1 (0.7%) 
 
10 (17.9%) 
17 (30.4%) 
21 (37.5%) 
8 (14.3%) 
0 
 
20 (25.3%) 
41 (51.9%) 
12 (15.2%) 
4 (5.1%) 
1 (1.3% 
0.005 
 
Liver consumption (per week) 
Never 
Less than once 
Once 
2-5 times 
      > 5 times 
 
 (77.1%) 
28 (20.7%) 
2 (1.5%) 
1 (0.7%) 
0 
 
 
10 (17.9%) 
17 (30.4%) 
21 (37.5%) 
8 (14.3%) 
0 
 
 
53 (73.4%) 
19 (24.1%) 
1 (1.3%) 
1 (1.3%) 
0 
 
0.520 
 
Supplement use (within the last year) 
None 
Vitamin D  
Fish/fish liver oil 
Fish/fish liver oil with vitamin D 
Multivitamins with vitamin D 
Calcium with vitamin D 
 
86 (70%) 
15 (11.1%) 
3 (2.2%) 
14 (10.4%) 
13 (9.6%) 
4 (3%) 
 
32 (57.2%) 
3 (5.4%) 
2 (3.6%) 
5 (8.9%) 
12 (21.4%) 
2 (3.6%) 
 
54 (68.4%) 
12 (15.2%) 
1 (1.3%) 
9 (11.4%) 
1 (1.3%) 
2 (2.5%) 
0.002 
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3.4.2.3 Sun exposure behaviour  
 
The patterns of all sunlight-related behaviours reported by the life-style questionnaire were 
significantly different between women living in England and women living in Brazil (all p ≤ 
0.05), except for sunscreen use in general and sun protection factor (SPF) during holidays (both 
p > 0.05) (Table 3.4). 
 
In regards to body part exposed when out in the sun reported in the life-style questionnaire, 
more than half (58.9%) of women in England reported usual exposure of hands and face only, 
while in Brazil most women (70.9%) reported the habit of exposing hands and face plus arms 
and/or legs (p<0.001). 
 
In total, around 70% if participants reported habitual use of sunscreen, although for use at 
home, within those living in England SPF of 15 or 20 was more common (52.3%) while in 
Brazil nearly all participants (95.4%) reported using SPF of 30, 40 or over (p=0.003). The 
proportion of participants that reported the habit of natural sunbathing was higher amongst 
women living in England than those living in Brazil (41.1% and 25.3% respectively, p=0.05), 
and only 3 women in England reported having ever used an artificial sunbed compared to none 
in Brazil. 
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Table 3.4 Behaviour towards sun exposure of adult Brazilian women overall and by country 
of residence (n=135)1 
1 Values are median (25th, 75th percentile) or n (%).2 Statistical analysis: Pearson Chi Squares. § Amongst 
participants who said “Yes” to previous item. SPF: Sun Protection Factor 
 
 
From the 90-days sun diary data, during winter months in England 22.9% of participants spent 
no more than 15 minutes outdoor per day on most days compared to 30.5% in Brazil. The 
majority in both countries spent 15 – 30 minutes outside on most days (56.3% in England and 
49.2% in Brazil). There were no statistically significant difference in proportions between the 
two countries (p=0.712) in total time spent outdoor per day on most days. There were also no 
significant differences in body part exposed on most days between the two countries. 38.8 % 
of women living in England and 50.8% of women living in Brazil reported exposing Hands 
 All England (n = 56) Brazil (n = 79) p2 
 
Body parts exposed 
Face only 
Hands and face 
Hands/face + arms and/or legs 
Hands/face + arms/legs + torso 
 
 
 
1 (0.7%) 
48 (35.6%) 
71 (52.6%) 
15 (11.1%) 
 
 
1 (1.8%) 
33 (58.9%) 
15 (26.8%) 
7 (12.5%) 
 
 
0 
15 (19%) 
56 (70.9%) 
8 (10.1%) 
 
<0.001 
Sunscreen use 
No 
Yes 
 
 
41 (30.4%) 
94 (69.6%) 
 
14 (25%) 
42 (75%) 
 
27 (34.2%) 
52 (65.8%) 
0.253 
SPF at home§ 
15 
20 
30 
40 or over 
Missing 
 
 
11 (11.7%) 
14 (14.8%) 
30 (31.9%) 
32 (34.0%) 
7 (7.4%) 
 
10 (23.8%) 
12 (28.5%) 
6 (14.2%) 
14 (32.5%) 
0 
 
1 (2.27%) 
1 (2.27%) 
23 (54.5%) 
18 (40.9%) 
7 
0.003 
SPF at holidays§ 
15 
20 
30 
40 or over 
Missing  
 
 
8 (8.4%) 
3 (3.2) 
34 (35.8%) 
39 (41%) 
11 (11.6%) 
 
7 (16.7%)  
2 (4.7%) 
17 (40.6%) 
15 (35.8%) 
1 (2.1%) 
 
1 (0.19%) 
1 (0.19%) 
17 (32.6%) 
24 (46.1%) 
9 (21.4%) 
0.06 
Natural sunbathing habit 
No 
Yes 
 
92 (68.1%) 
43 (31.9%) 
 
 
33 (58.9%) 
23 (41.1%) 
 
 
59 (74.7%) 
20 (25.3%) 
 
0.05 
Artificial sunbeds use 
No 
Yes 
Missing 
 
 
131 (97%) 
3 (2.2%) 
1 (0.8%) 
 
52 (92.9%) 
3 (5.4%) 
1 (1.7%) 
 
79 (100%) 
0 
0 
0.036 
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and face, and 49% in England and 40.7% in Brazil reported exposing hands, face, arms and/or 
legs, on most days. (Table 3.5) 
 
Table 3.5 Habitual exposure to sunlight by country1 
 England (n=48) Brazil (n=59) p value2 
Total time outdoor / day  
< 15 minutes 
15 – 30 minutes 
30 minutes – 2 hours 
> 2 hours 
 
 
11 (22.9%) 
27 (56.3%) 
7 (12.5%) 
3 (5.4%) 
 
18 (30.5%) 
29 (49.2%) 
10 (16.9%) 
2 (3.4%) 
0.712 
Body part exposed when outdoor 
Face only 
Hands and face 
Hands and face + arms and/or legs 
Hands and face + arms and/or legs + torso 
 
6 (12.2%) 
19 (38.8%) 
24 (49.0%) 
0 
 
4 (6.8%) 
30 (50.8%) 
24 (40.7%) 
1 (1.7%) 
0.396 
1 Values are median (25th, 75th percentile) or n (%).2 Statistical analysis: Chi squared 
 
 
3.4.3 Dietary vitamin D and calcium intakes 
 
Overall (n=119), mean habitual vitamin D dietary intake was 2.45 ± 1.91 μg/day and mean 
calcium intake was 625.05 ± 310.73 mg/day. Vitamin D and calcium intakes were significantly 
higher in English residents compared to Brazilian residents (p<0.001 and p=0.003, 
respectively).  
 
In total (n=119), 99.2% had intakes below the EAR of 10 μg/day proposed by SACN (74) and 
by the IOM (71), with only one participant recording intakes above this threshold. Overall, 
21.8% had dietary vitamin D intakes below 1 μg/day and 100% had intakes below the RDA of 
15 μg/day. Mean dietary vitamin D intakes were well below the recommended EAR value as 
shown in Figure 3.2. 
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Independent t-test with log transformed values: *** p < 0.001; Error bars represent standard error of the mean. 
Orange hashed line represent; SACN and IOM intake EAR recommendations of 10μg. 
 
 
 
 
For calcium, in the overall sample 72.8% had dietary intakes below the RNI of 700 mg/day 
(74), while only 8.8% met the 800 mg/day EAR reference (71). Mean dietary intake of women 
living in Brazil was below both recommendation references, while mean intake for those living 
in England was above the RNI value (Figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 
Independent t-test with log transformed values: ** p = 0.003; Error bars represent standard error of the mean. 
Orange and purple hashed lines represent the RNI and RDA intake recommendations of 700 mg and 1000 mg. 
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Figure 3.3 Mean daily calcium dietary intake in each country, compared to recommended values  
*** 
** 
Figure 3.2 Mean daily vitamin D dietary intake in each country, compared to 
recommended values. 
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England Brazil 
3.4.4 Individual UV radiation levels 
 
The average daily individual UV radiation levels at the beginning of winter measured by 
polyshulphone dosimeter badges are shown in Figure 3.4 for all participants, labelled by 
country of residence. Values are expressed in units of standard erythema dose (SED) (28). 
Individual UV radiation levels differed significantly between the two countries with 
concentrations ranging from 0.0031 to 0.0984 SED, for English residents and from 0.3283 to 
12.0393 SED for Brazilian residents. Mean daily individual UV radiation levels for England 
residents were significantly lower than for Brazil residents (0.035 ± 0.026 and 1.75 ± 2.32 
SED, respectively p<0.001). All England dwelling participants recorded daily exposure levels 
of less than 1 SED. For those living in Brazil, around half of participants (53.6%) recorded 
levels of less than 1 SED. 
 
 
 
 
 
Blue and green hashed lines represent mean daily individual UV radiation level for women living in England 
(measured between October to March) and Brazil (measured between June to September), respectively. 
 
 
Figure 3.4 Average daily individual UV radiation levels for women living in England (n=46) 
and women living in Brazil (n=69). 
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Brazil England 
3.4.5 Vitamin D Status  
 
3.4.5.1 Serum 25(OH)D concentrations 
 
Mean serum 25(OH)D concentration of England residents was significantly lower than Brazil 
residents (36.1 ± 14.7 nmol/l and 75 ± 22.1 nmol/l, respectively p<0.001). The statistical 
significance remained after controlling for daily UV radiation level, age, BMI and waist 
circumference (ANCOVA, p<0.001).  
 
Figure 3.5 shows the difference in serum 25OHD concentrations between the two countries, 
with concentrations ranging from 5.0 to 73.5 nmol/l within participants living in England and 
from 36.2 to 148.6 nmol/l within those living in Brazil.  
 
 
 
Orange, red and black hashed lines represent thresholds of 25 (deficiency), 50 (insufficiency) and 75 (optimal) 
nmol/l, respectively. 
 
Figure 3.5 Serum 25(OH)D concentrations for women living in England (n=56) and women 
living in Brazil (n=79). 
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3.4.5.2 Proportion of women with Deficient, Insufficient, Adequate and Optimal 
Baseline Vitamin D Status  
 
The proportions of women with deficient and insufficient levels were significantly higher in 
those living in England than in Brazil (p<0.001). Amongst women living in England 25% were 
vitamin D deficient, with serum 25(OH)D concentrations below 25 nmol/l, while there were 
no participants with concentrations below this threshold amongst those living in Brazil (Figure 
3.6). There were no participants living in England with concentrations above 75 nmol/l, while 
half (50.6%) of the participants in Brazil presented optimal levels, above this threshold. The 
majority (82.1%) of women living in England and 11.4% of those living in Brazil had 
concentrations below the insufficiency cut off value of 50 nmol/l.  
 
 
 
Figure 3.6 Proportion of women (total, England and Brazil trials) with deficient (<25 nmol/l), 
insufficient (25 – 49.9 nmol/l), adequate (50 – 74.9 nmol/l) and optimal (>75 nmol/l) serum 
25OHD concentrations at baseline. 
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3.4.6 Factors affecting Serum 25(OH)D Concentrations 
 
3.4.6.1 Socio-demographic Characteristics  
 
There were no significant differences in mean serum 25(OH)D concentrations between ethno-
race, skin type nor education level (all p> 0.081). Amongst England residents, those living in 
Southern England for more than 2 years had significantly lower 25(OH)D concentrations than 
those that had recently moved to the UK (less than a year) (p=0.039) (Table 3.6). 
 
Table 3.6 Associations between socio-demographic characteristics and serum 25(OH)D 
concentrations in nmol/l1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p = 0.032). 
 
 
 
 
 All England Brazil 
 n 25(OH)D p2 n 25(OH)D p2 n 25(OH)D p2 
 
Ethno-race   R1 
White 
Black 
Brown (mixed) 
Yellow (Japanese-
descendant) 
Native Indian 
 
 
85 
3 
45 
1 
 
1 
 
 
55.6± 25.8 
43.1±15.3 
66.3±29.5 
59.5 
 
42.9 
 
0.207 
 
 
44 
1 
10 
0 
 
1 
 
 
37.4±15.9 
25.7 
30.9±8.2 
n/a 
 
42.9 
 
 
0.529 
 
 
41 
2 
35 
1 
 
0 
 
 
75.2±19.3 
51.8±4.1 
76.4±25.2 
59.5 
 
n/a 
 
0.422 
 
Skin type 
I and II 
III and IV 
V and VI 
 
 
42 
85 
8 
 
 
61.0±24.9 
57.4±28.9 
63.0±21.0 
 
0.705 
 
 
17 
37 
2 
 
 
37.2±12.5 
35.7±16.0 
33.9±13.9 
 
0.927 
 
 
25 
48 
6 
 
 
77.3±16.6 
74.9±25.5 
72.7±11.4 
 
0.812 
 
Education level  
Secondary school  
A levels 
University Degree 
 
 
3 
37 
95 
 
 
71.3±29.4 
60.3±29.2 
57.9±28.7 
 
0.656 
 
 
1 
8 
47 
 
 
37.7 
32.6±10.9 
36.7±15.5 
 
0.770 
 
 
2 
29 
48 
 
 
88.3±5.09 
67.9±19.8 
78.7±22.9 
 
0.081 
 
Years living in 
England 
< 1 year  
1 – 2 years 
> 2 years 
 
    
 
 
5 
10 
40 
 
 
 
51.0±14.9a 
37.4±11.36 
33.5±14.6a 
 
0.039 
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3.4.6.2 Age and adiposity 
 
Overall (n=135), serum 25(OH)D concentration was significantly negatively correlated with 
age (r= -0.282, p=0.001, Figure 3.7), weight (r= -0.185, p= 0.031, Figure 3.8), waist 
circumference (r=-0.361, p<0.001, Figure 3.9), and a trend for a negative association with BMI 
(r= -0.169, p= 0.052), but not body fat (r= -0.052, p=0.706).  However, statistical significance 
was lost for all correlations when controlling for individual UV radiation level (all p > 0.270). 
 
 
 
Figure 3.7 Association between age and serum 25(OH)D concentrations in overall sample 
(n=135) 
 
r= -0.282 
p=0.001 
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Figure 3.8 Association between weight and serum 25(OH)D concentrations in overall sample 
(n=135) 
 
 
 
Figure 3.9 Association between waist circumference and serum 25(OH)D concentrations in 
overall sample (n=135) 
r= -0.185 
p= 0.031 
r=-0.361 
p<0.001 
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Within each country, no correlations were found between serum 25(OH)D concentration and 
age nor adiposity (weight, BMI, body fat or waist circumference) (all p > 0.406) either before 
and after controlling for individual UV radiation level (Table 3.7). There were also no 
significant differences in mean age, weight, waist circumference and BMI between vitamin D 
status groups, in either country (all p > 0.06) . 
 
Table 3.7 Correlations between age, weight, BMI and waist circumference with serum 
25(OH)D concentrations, after controlling for individual UV radiation level (n=135)1 
 All England Brazil 
 r p r p r p 
Age 0.002 0.938 0.061 0.688 0.051 0.678 
Weight -0.044 0.643 -0.039 0.800 -0.020 0.871 
BMI -0.090 0.342 -0.082 0.595 -0.027 0.828 
Waist circ. 
Body fat ≠ 
-0.104 
0.216 
0.269 
0.210 
-0.013 
0.001 
0.933 
0.994 
-0.040 
-0.116 
0.745 
0.345 
1Partial correlations; ≠ Measurements derived from different methodologies (England: bio-impedance; Brazil: 
DXA scan) 
 
 
Overall, women younger than 30 years of age had significantly higher mean 25(OH)D 
concentrations than those aged 30 – 44 years (64.7 ± 27.4 and 51.6 ± 27.2 nmol/l, p=0.027), 
however no significant differences amongst age groups were observed within each country 
(Table 3.8). There were no differences in mean 25(OH)D concentrations amongst healthy, 
overweight and obese women, either overall or within each country (all p > 0.08). 
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Table 3.8 Age and adiposity association with serum 25(OH)D concentrations1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a 0.027). 
 
 
3.4.6.3 Lifestyle  
 
There were no significant differences in serum 25(OH)D concentrations between individuals 
who were physically active and those who were not, nor between those who consumed alcohol 
and those who did not (all p> 0.231) (Table 3.10). 
 
Overall, those consuming eggs for more than five times per week had significantly higher 
25(OHD concentrations (77.5±30.5 nmol/l) compared to those consuming less than once or 
once a week (51.4±23.3 nmol/l, p=0.014 and 47.1±23.1 nmol/l, p=0.001, respectively). There 
was also a difference in mean concentrations amongst different frequencies of consumption of 
milk, although post-hoc tests did not identify which groups differed significantly (p=0.009). 
The same was observed for oily fish consumption for the overall sample, and a more clear 
difference was observed within England participants, with those consuming 2-5 times per week 
having significantly higher concentrations (48.4±21.2 nmol/l) compared to those consuming 
less than once a week (31.6±16.2 nmol/l, p=0.034). There were no significant differences 
between different frequencies of liver consumption (all p > 0.464) (Table 3.9). There were no 
significant differences in 25(OH)D concentrations amongst different supplement intakes (all  p 
>168) (Table 3.9). 
 
 All England Brazil 
 n 25(OH)D p2 n 25(OH)D p2 n 25(OH)D p2 
 
Age (years) 
< 30  
30 – 44 > 
44  
 
 
71 
48 
16 
 
 
64.7 ± 27.4 a 
51.6 ± 27.2 a 
54.8 ± 21.1 
 
0.030 
 
 
18 
29 
9 
 
 
 
13.2 ± 3.1 
15.7 ± 2.9 
14.9 ± 4.9 
 
0.483 
 
 
53 
19 
7 
 
 
74.1 ± 24.4 
78.2 ± 18.0 
72.5 ± 12.9 
 
 
0.761 
 
BMI 
Healthy 
Overweight 
Obese 
 
 
 
83 
32 
20 
 
 
62.9 ± 28.7 
52.3 ± 19.7 
52.4 ± 28.9  
 
0.088 
 
29 
16 
11 
 
 
 
36.3 ± 12.8 
39.0 ± 14.7 
19.3 ± 5.8 
 
0.430 
 
 
54 
16 
9 
 
 
77.2 ± 24.4 
65.6 ± 14.6 
78.0 ± 13.5 
 
 
0.163 
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Table 3.9 The association between lifestyle characteristics and with serum 25(OH)D 
concentrations1 
 1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p = 0.014, b0.001, c0.034) 
 
 All England Brazil 
 n 25(OH)D p2 n 25(OH)D p2 n 25(OH)D p2 
 
Physical Activity  
No 
Yes 
   
 
 
55 
80 
 
 
58.2±27.2 
59.2±27.2 
 
0.835 
 
 
24 
32 
 
 
37.1±16.1 
35.3±13.8 
 
0.663 
 
 
31 
48 
 
 
74.6±23.1 
75.2±21.7 
 
0.912 
Alcohol Consumption 
No 
Yes 
    
 
77 
58 
 
59.7±28.5 
57.7±25.6 
0.663  
34 
22 
 
38.0±16.5 
33.2±11.1 
 
0.232  
43 
36 
 
76.9±24.0 
72.6±19.6 
0.396 
Milk per day 
Never 
< ½ pint 
½ pint 
1 pint 
> 1 pint 
 
 
39 
31 
38 
21 
4 
 
65.9±30.1 
51.4±23.5 
65.0±26.5 
49.5±24.3 
31.3±6.7 
0.009  
12 
17 
9 
13 
4 
 
37.4±16.7 
37.1±16.2 
33.5±11.7 
35.0±14.8 
31.3±6.7 
0.929  
27 
14 
29 
8 
0 
 
78.6±25.7 
68.9±18.9 
74.7±21.8 
73.1±16.7 
0.613 
Egg per week 
Never 
Less than once 
Once 
2-5 times 
> 5 times 
 
 
3 
21 
29 
61 
20 
 
62.5±15.7 
51.4±23.3a 
47.1±23.1
b 
60.3±26.6 
77.5±30.5a
, b 
0.002  
1 
9 
17 
24 
5 
 
52.1 
30.7±13.0 
30.6±9.1 
39.5±15.7 
44.9±21.5 
0.093  
2 
12 
12 
37 
15 
 
67.8±18.2 
66.8±16.1 
70.4±15.0 
73.8±23.4 
88.3±25.1 
0.095 
Oily fish per week 
Never 
Less than once 
Once 
2-5 times 
     > 5 times 
 
 
30 
58 
33 
12 
1 
 
56.0 ± 
23.3 
64.7± 30.3 
51.7±24.2 
52.7±20.8 
109.7 
0.044  
10 
17 
21 
8 
0 
 
31.9±12.1 
31.6±16.2 
c 
37.1±8.7 
48.4±21.2 
c 
n/a 
0.039  
20 
41 
12 
4 
1 
 
68.1±17.4 
78.4±23.4 
75.8±22.9 
61.1±20.0 
109.7 
0.140 
Liver per week 
Never 
Less than once 
Once 
2-5 times 
    > 5 times 
 
 
10
0 
28 
2 
1 
0 
 
58.9±28.1 
55.9±25.5 
55.8±35.1 
84.7 
n/a 
0.759  
45 
9 
1 
0 
0 
 
36.8±15.1 
30.3±10.1 
31.00 
n/a 
n/a 
0.465  
55 
19 
1 
1 
0 
 
76.9±22.8 
68.0±21.2 
80.7 
84.7 
n/a 
0.483 
Supplement use (within 
the year) 
   None 
   Vitamin D  
   Fish/fish liver oil 
   Fish oil  w/ vit D 
   Multivitamins  
   Calcium w/ vit D 
 
 
85 
15 
3 
14 
13 
4 
 
 
61.7±28.0 
64.5±22.1 
45.4±30.5 
55.2±22.6 
41.9±25.2 
64.2±34.3 
0.169  
 
31 
3 
2 
5 
12 
2 
 
 
37.3±17.1 
42.9±7.2 
28.2±9.0 
30.4±5.3 
35.9±14.0 
37.5±2.1 
0.842  
 
54 
12 
1 
9 
1 
2 
 
 
75.7±22.9 
69.8±21.3 
80.0 
69.0±15.0 
113.3 
90.8±26.7 
0.372 
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3.4.6.4 Sun exposure behaviour 
 
Overall and within Brazil participants, there was a significant difference in serum 25(OH)D 
concentrations according to the amount body part exposed (both p < 0.04) as reported on the 
life-style questionnaire. Amongst Brazil participants, those reporting a recalled usual exposure 
of hands and face + arms and/or legs had significantly higher 25(OH)D concentrations than 
those exposing hands and face only (78.5 ± 21.8 and 62.2 ± 20.0 nmol/l, respectively; p = 
0.029) (Table 3.10). 
 
There were no significant differences in 25(OH)D concentrations between sunscreen users and 
non-users. However, overall, those reporting using a SPF 15 sunscreen during holidays had 
significantly lower levels than those reporting the use of SPF of 40 or more (34.1±16.6 and 
62.0±29.1, respectively; p = 0.034). A post-hoc exploratory analysis, showed that amongst 
those reporting having the habit of sunbathing, 60% reported the use of SPF of 30, 40 or more 
during holidays compared to 9% using SPF 15 or 20 (n=43). 
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Table 3.10 The association between sun exposure behaviour and serum 25(OH)D 
concentrations in nmol/l, from lifestyle questionnaire 1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p = 0.029 b p=0.034). 
 
There were no significant associations between mean serum 25(OH)D between habitual body 
part exposed when outdoors in England and in Brazil reported on 90-days sun diaries (Table 
3.11) (all p > 0.290), either overall or within each country. Serum 25(OH)D concentrations 
were significantly higher in those spending 15-30 minutes out in the sun compared to those 
spending less than 15 minutes (p=0.029). 
 
 
 
 
 
 All England Brazil 
 n 25(OH)D p n 25(OH)D p n 25(OH)D p 
 
Body parts exposed 
Face only 
Hands and face 
Hands/face + arms/legs 
Hands/face + arms/legs 
+ torso 
 
 
1 
48 
71 
15 
 
 
42.9 
44.1 ±21.3 
68.9 ±27.0 
59.4 ±25.2 
 
<0.001 
 
 
1 
33 
15 
7 
 
 
 
42.9 
35.8 ±16.4 
33.4 ±7.8 
42.2 ±18.2 
 
0.586 
 
 
0 
15 
56 
8 
 
 
n/a 
62.2 ±20.0a 
78.5 ±21.8a 
74.2 ±21.0 
 
0.038 
 
Sunscreen use 
No 
Yes 
 
 
 
41 
94 
 
 
58.1 ±24.6 
59.2 ±28.4 
 
 
0.836 
 
 
14 
42 
 
 
34.6±15.9 
36.6±14.5 
 
0.667 
 
 
27 
52 
 
 
70.3 ±18.9 
77.4 ±23.4 
 
0.177 
SPF at home§ 
15 
20 
30 
40 or over 
 
 
11 
1 
37 
24 
 
43.0 ±18.0 
54.9 
64.9 ±27.3 
67.1 ±34.0 
0.122  
10 
0 
13 
6 
 
 
40.3±16.4 
0 
38.3±13.3 
29.3±9.7 
 
0.306  
1 
1 
24 
18 
 
70.4 
54.9 
79.4 ±21.4 
78.8 ±29.3 
0.788 
SPF at holidays§ 
15 
20 
30 
40 or over 
 
 
 
8 
3 
34 
39 
 
34.1 ±16.6b 
42.6 ±6.6 
56.1 ±24.2 
62.0 ±29.1b 
0.007  
7 
2 
17 
15 
 
28.9 ±8.45 
39.3 ±5.0 
37.3 ±14.5 
36.6 ±14.7 
0.542  
1 
1 
17 
24 
 
70.4 
49.1 
74.8 ±15.9 
77.9 ±24.1 
0.589 
Natural sunbathing habit 
No 
Yes 
 
43 
92 
 
59.5 ±26.9 
57.4 ±28.2 
0.667  
33 
23 
 
34.9±12.9 
37.9±17.1 
0.461  
59 
20 
 
73.3±20.8 
79.9±20.8 
 
0.253 
69 
 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same superscript 
letters are significantly different (a p=0.029). 
 
3.4.6.5 Dietary Intake  
 
Overall (n = 119), vitamin D and calcium intakes were statistically negatively correlated with 
25(OH)D concentrations (r = -0.212, p = 0.021; r = -0.285, p = 0.002). The statistical 
significance was lost after controlling for individual sunlight exposure (r = -0.015, p = 0.875; 
r = -0.136, p = 0.160). Within each country, there were no significant correlations between 
vitamin D intake and 25(OH)D concentrations (all p > 0.117). 
 
Overall, there were no significant differences in mean vitamin D intake between vitamin D 
status groups, while calcium intakes were significantly lower (504.8 ± 226.8 mg/d) in women 
with levels above 75 nmol/l compared to those with levels below 25 and 50 nmol/l (836.6 ± 
449.2 mg/d, p=0.007 and 691 ± 296.1 mg/d, p=0.047, respectively). In England residents mean 
vitamin D intake was significantly lower in women with vitamin D status 25 - 50 nmol/l 
compared to those with levels above 50 nmol/l (2.66 ±1.43 and 4.29 ±2.97 µg/d, p=0.040) 
(Table 3.12 and 3.13). 
 
 
 
 
Table 3.11 Associations between habitual sun exposure behaviour and serum 25(OH)D concentrations in 
nmol/l, from 90-days sun diaries1 
 All England Brazil 
 n 25(OH)D p n 25(OH)D p n 25(OH)D p 
 
Body parts exposed 
Face only 
Hands and face 
Hands/face + arms/legs 
Hands/face + arms/legs + 
torso 
 
 
 
10 
49 
48 
1 
 
 
44.8 ±29.1 
60.0 ±29.9 
55.1 ±25.0 
63.2 
 
0.438 
 
 
6 
19 
24 
49 
 
 
 
29.7 ±7.6 
33.1 ±10.8 
38.3 ±17.0 
35.2 ±14.1 
 
0.291 
 
 
4 
30 
24 
1 
 
 
 
67.5 ±36.0 
77.1 ±25.2 
71.9 ±20.1 
n/a 
 
0.761 
Time outdoor / day  
< 15 minutes 
15 – 30 minutes 
30 minutes – 2 hours 
> 2 hours 
 
29 
56 
17 
5 
 
53.4 ±21.7 
58.4 ±32.2 
56.4 ±23.6 
49.1 ±22.3 
0.816  
11 
27 
7 
3 
 
38.1 ±14.8 
32.7 ±14.2 
35.1 ±7.6 
34.5 ±4.1 
0.419  
18 
29 
10 
2 
 
63.8 ±20.0a 
82.2 ±25.1a 
71.4 ±18.6 
71.0 ±19.3 
0.047 
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Table 3.12 Vitamin D status association with vitamin D mean dietary intakes1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p = 0.007; b p=0.047; c p=0.044). 
 
 
 
Table 3.13 Vitamin D status association with calcium mean dietary intakes1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p = 0.007; b p=0.047; c p=0.044). 
 
 
3.4.6.6 Individual UV radiation levels 
 
Overall, daily individual UV radiation level showed a strong significant positive correlation 
with serum 25(OH)D concentrations (n=112, r = 0.661, p<0.001; n=3 outliers removed from 
analysis due to daily SED > 10) (Figure 3.10) and remained statistically significant after 
controlling for vitamin D3 intake (dietary intake), age and BMI (r = 0.669, p<0.001). Within 
 All England Brazil  
  Vitamin D intake  Vitamin D intake  Vitamin D intake 
 n Mean ± SD p n Mean ± SD p n 
Mean ± 
SD 
p 
 
Vitamin D status 
 
< 25 nmol/l 
 
25-49.9 nmol/l 
 
50-74.9 nmol/l 
 
> 75 nmol/l 
 
 
 
 
12 
 
37 
 
36 
 
34 
 
 
 
2.57  ±1.22 
 
2.55 ±1.42 
 
2.83 ±2.66 
 
1.91 ±1.53 
 
0.191 
 
 
 
12 
 
29 
 
10 
 
0 
 
 
 
2.57 ±1.22 
 
2.66 ±1.43c 
 
4.29 ±2.97 c 
 
n/a 
 
0.040 
 
 
 
0 
 
8 
 
26 
 
34 
 
 
 
n/a 
 
2.18 ±1.38 
 
2.27 ±2.36 
 
1.91 ±1.5 
 
0.754 
 All England Brazil  
  Calcium intake  Calcium intake  Calcium intake 
 n Mean ± SD p n Mean ± SD p n Mean ± SD p 
 
Vitamin D status 
 
< 25 nmol/l 
 
25-49.9 nmol/l 
 
50-74.9 nmol/l 
 
> 75 nmol/l 
 
 
 
 
12 
 
37 
 
36 
 
34 
 
 
 
836.6 ±449.2a 
 
690.1 ± 296.1 b 
 
600.3± 297.9 
 
504.8 ± 226.8 a, b 
 
0.005 
 
 
 
12 
 
29 
 
10 
 
0 
 
 
 
836.6±449.2 
 
671.8 ± 256.5 
 
762.9 ± 292.8 
 
n/a 
 
 
0.305 
 
 
 
0 
 
8 
 
26 
 
34 
 
 
 
n/a 
 
760.3 ±425.1 
 
537.7 ±280.5 
 
504.8 ±226.8 
 
0.067 
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each country, there were no significant associations between daily UV radiation levels and 
25(OH)D concentrations (p>0.05). 
 
The scatterplot (Figure 3.10) shows the overall strong positive linear relationship between 
daily individual UV radiation levels and baseline serum 25(OH)D concentrations, (r= 0.673, 
p<0.001). In this linear model a daily exposure of 0.28 and 1.5 SED predicted a serum 
25(OH)D concentration of 50 nmol/l and 75 nmol/l, respectively. 
 
 
 
 
Figure 3.10 Relationship between baseline serum 25(OH)D concentration and baseline 
individual daily sunlight exposure level in participants with daily individual UVB exposure 
levels below 10 SED (n= 112) 
 
 
 
r = 0.661 
p < 0.001 
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Vitamin D status was associated with individual UV radiation (Table 3.14). Overall, women 
with serum 25(OH)D concentrations above 75 nmol/l had significantly higher mean UV 
radiation (2.26 ± 3.04 SED)  than those with deficient (0.02 ± 0.01 SED), insufficient (0.25 ± 
0.43 SED) and suboptimal (0.98± 1.00 SED) status (p<0.001).  
 
 
Table 3.14 Vitamin D status association with mean individual UV radiation level 1 
1 Values: mean ± SD 
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same column with same 
superscript letters are significantly different (a p=0.002; b p<0.001; c p=0.020). 
n/a: not applicable 
 
 
To further explore the relationship between daily individual UV radiation and serum 25(OH)D 
concentration, a series of models were assessed for best fit and a non-linear cubic regression 
model was selected (n=112, R2= 0.0445, p<0.001) to investigate whether there is a threshold 
UV radiation level at which a plateau in serum 25(OH)D is evident. As shown in Figure 3.11, 
25(OH)D concentrations seem to reach a maximum plateau around 75 - 85 nmol/l at daily UV 
radiation around 1.5 - 2.0 SED, based on the inflection point of the curve (i.e. the curve starts 
changing from being concave (concave upward) to convex (concave downward).  
 All England Brazil 
Vitamin D status 
n 
Mean ± SD 2 
p 1 n 
Mean ± SD 2 
p 1 n Mean ± SD 
2 
p 1 
 
< 25 nmol/l 
 
25 -49.9 nmol/l 
 
50 – 74.9 nmol/l 
 
> 75 nmol/l 
 
 
12 
 
34 
 
33 
 
36 
 
0.02 ± 0.01a 
 
0.25 ± 0.43b 
 
0.98± 1.00c 
 
2.26 ± 3.04 a,b,c 
 
 
<0.001 
 
12 
 
26 
 
8 
 
0 
 
0.02 ± 0.018 
 
0.038 ± 0.028 
 
0.037 ± 0.027 
 
n/a 
 
0.666 
 
0 
 
8 
 
25 
 
36 
 
 
n/a 
 
0.94 ± 0.42 
 
1.28 ± 0.97 
 
2.26 ± 3.04 
 
0.040 
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Figure 3.11 Relationship between daily individual UV radiation and baseline serum 25(OH)D 
concentration (cubic model, p<0.001). 
 
 
3.4.7 Prediction of circulating 25(OH)D concentrations: Mathematical Modelling 
 
Preliminary analyses ensured no violation of normality, linearity, generalizability (sample 
size), multicollinearity and homoscedasticity. 
 
Due to the differences in mean age and anthropometric measures and significant correlations 
with serum 25(OH)D, a hierarchical multiple regression was used to investigate the ability of 
daily individual UV radiation levels (SED) to predict 25(OH)D concentrations (nmol/l), after 
controlling for the influence of  age and adiposity (Table 3.14). There were no significant 
correlations between vitamin D intake and serum 25(OH)D concentrations either overall or 
within each country after controlling for individual UV radiation level, and therefore vitamin 
D dietary intake was not included in this model. 
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Age and BMI were entered at Step 1, explaining 7.7% of the variance in 25(OH)D 
concentrations. After entry of daily individual sunlight exposure level at step 2, the total 
variance explained by the model as a whole was 46.5%. The added UV radiation measure 
explained an additional 38.8% of the variance in baseline 25(OH)D concentrations, after 
controlling for the influence of age and BMI, (F (3, 111) = 32.16, p<0.001). In the final model, 
only UV radiation made a unique statistically significant contribution (Beta= 0.654, p<0,001) 
in predicting 25(OH)D concentrations. According to the slope coefficient for daily individual 
UV radiation levels, 25(OH)D concentration increases by 20.2 nmol/l for each extra SED of 
UV radiation, regardless of age and BMI. 
 
Table 3.14  Hierarchical multiple regression of daily individual UV radiation levels (SED) 
ability to predict 25(OH)D concentration 
     Change Statistics 
Model R 
R 
Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
R Square 
Change 
F 
Change 
Sig. F 
Change 
1 0.277a 0.077a 0.060 26.44 0.077 4.65 0.011 
2 0.682b 0.465b 0.451 20.22 0.388 80.57 <0.001 
a Predictors: (Constant), age, BMI, waist circumference  
b Predictors: (Constant), age, BMI, waist circumference, daily sunlight exposure 
c Dependent Variable: Baseline serum 25(OH)D concentrations 
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Coefficients a 
a Dependent Variable: Achieved serum 25(OH)D concentrations 
 
 
 
3.4.8 Plasma Parathyroid Hormone Concentrations  
 
Mean plasma PTH concentration in England residents was significantly higher than within 
Brazil residents (5.36 ±1.99 pmol/l and 4.49 ±1.47 pmol/l, respectively p=0.004). Plasma PTH 
concentrations ranged from 2.41 to 13.76 pmol/l within those living in England and from 2.18 
to 8.51 pmol/l in participants living in Brazil.  
 
PTH concentrations were negatively correlated with 25(OH)D concentrations (r= -0.285, p= 
0.001). A series of regression analyses were conducted to model the relationship between 
serum 25(OH)D and PTH, and a non-linear regression cubic model was found to have the best 
fit (n = 134, R2 = 0.113, p = 0.001), with PTH reaching a minimum plateau at 25(OH)D 
concentrations of around 70 - 80 nmol/l, based on the inflection point of the curve (i.e. 
the curve starts changing from being convex (concave upward) to concave (concave 
downward) (Figure 3.12).  
  Unstand. 
Coefficients 
Stand. 
Coefficients 
  95.0% Confidence 
Interval for B 
Correlations 
Model B 
Std. 
Error 
Beta t Sig. 
Lower 
Bound 
Upper 
Bound 
Parti
al 
Part 
1 (Constant) 96.13 13.69 
 
7.04 <0.001 69.06 123.19 
  
 
Age -0.69 0.29 -0.22 -2.36 0.022 -1.28 -0.1 -0.21 -0.21 
 BMI -0.63 0.51 -0.12 -1.20 0.224 -1.65 0.39 0.11 0.11 
ANOVA: F(2, 112) = 4.65 , p=0.011 
2 (Constant) 87.17 10.49 
 
8.310 <0.001 666.38 107.96 
  
 Age -0.08 0.23 -0.02 -0.330 0.742 -0.549 0.39 -.031 -0.02 
 BMI -0.56 0.39 -0.10 -1.426 0.157 -2.34 0.22 0.13 0.09 
 Sun 
exposure 20.26 2.25 -0.654 9.976 <0.001 15.78 14.73 0.65 0.64 
ANOVA: F(3, 111) = 32.16, p<0.001 
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Figure 3.12 Relationship between serum 25(OH)D and PTH concentrations (n=134; R2 = 
0.113, p = 0.001). 
 
 
There was a statistically significant difference in mean baseline PTH concentrations between 
the different vitamin D status groups [F (3, 130) = 6.5, p <0.001; n=134], with a large actual 
difference in mean PTH concentrations (effect size = 0.14). Post-hoc comparisons showed that 
mean PTH concentrations for deficiency (6.60 ± 2.47 pmol/l) were significantly different from 
insufficient (4.96 ± 1.70 pmol/l; p= 0.009), adequate (4.55 ± 1.39 pmol/l; p=0.001) and optimal 
(4.42±1.51 pmol/l; p <0.001) status women (Figure 3.13).  
 
 
** p<0.01; *** p<0.001 (ANOVA compared to [25(OH)D] < 25 nmol/l). Error bars represent SEM. 
Figure 3.13 Differences in mean PTH concentrations by different vitamin D status (n=134). 
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3.4.9 Calcium concentrations 
 
There were no significant differences in serum albumin-corrected calcium concentrations 
between England and Brazil residents (2.30 ± 0.07 and 2.28 ± 0.06 mmol/l respectively, p = 
0.066), with all participants with concentrations within the normal range of 2.1 - 2.6 mmol/L.  
 
 
3.4.10 Safety and adverse events 
 
Only participants living in Brazil had serum 25(OH)D concentrations above 100 nmol/l (n=3), 
of which two women had baseline concentrations above 130 nmol/l (134.9 and 148.6 nmol/l). 
Serum calcium concentrations were within the reference range for all participants (< 2.5 
mmol/l). 
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3.5 Discussion 
 
The present analyses aimed to examine serum 25(OH)D concentrations in Brazilian women 
living in different latitudes, and potential influential factors in the studied populations within 
each country in order to account for the latitude difference. Furthermore, this study investigates 
a threshold serum 25(OH)D concentration where a plateau in plasma PTH is evident.  
 
Altogether, 82.1 % of these otherwise healthy Brazilian women living in England and 11.4% 
in Brazil had insufficient 25OHD concentrations (<50 nmol/l) at the beginning of winter. More 
worryingly, if the threshold of 75 nmol/l recommended by the Endocrine Society (72) for 
optimal levels is applied, suboptimal status was universal amongst England residents and 
affected half (49.3%) of the women in Brazil. 
 
According to the 2001 UK Census, there were over 144,000 South Americans (defined by 
country of birth) living in England and Wales, with Brazilians representing by far the largest 
group (35%) (125). Although a higher prevalence of vitamin D deficiency in immigrant groups 
living in Northern latitudes in comparison to native Caucasian populations has been widely 
documented (58), the prevalence of vitamin D deficiency and insufficiency amongst a South 
American ethnic group living in England has not been demonstrated before in the 
literature. Moreover, recent studies show that with increasing duration of residence in the new 
country, immigrants’ health often worsens.  
 
In this cohort, Brazilian women who had been living in England for more than 2 years had 
indeed lower 25(OH)D concentrations than their Brazilian peers who had been in England for 
less than that. The proportions found in this study for Southern England dwelling women are, 
in fact, similar to the prevalence in Caucasian adult women in the UK of 21.7% deficiency over 
the year, according to the latest SACN report (74). A recent 1-year prospective cohort study 
with South Asian (n = 35) and Caucasian (n = 105) women, aged 20-55 years, living in Surrey 
– the same location as for this study’s England trial – reported 10% of Caucasian and 80.8% 
of South Asian women having deficient levels, in the winter (58).  
 
In contrast, amongst the women in this study living in Brazil, there were no records of levels 
below 25 nmol/l and therefore none of the participants were vitamin D deficient; 11.4% 
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presented insufficient levels (<50 nmol/l), 38 % suboptimal levels (< 75 nmol/l) and half of 
them (50.6%) had levels above 75 nmol/l at baseline. A study conducted with 369 women of 
child-bearing age (21-49 years) in the country’s capital Brasília (15°S) – the same Mid-west 
region as this study’s Brazil trial, observed a prevalence of 32% insufficient (< 50 nmol/l) and 
81% sub-optimal status (< 75 nmol/l), in summer/autumn (126). Another study, in the city of 
São Paulo (23°S), known for its high levels of pollution (127), reported a similar high 
prevalence of 38.45% insufficiency (< 50 nmol/l) and 75% suboptimal levels (< 75 nmol/l), 
amongst adults (men and women) during winter months (68). At an even closer to the equator 
latitude in Brazil, in Recife (8°S), with 894 men and women over 19 years of age, 28.5% and 
43.5% had insufficient (<50 nmol/l) and sub-optimal (< 75 nmol/l) vitamin D status, 
respectively (128). Similarly, in a study that analysed a national sample of 11,247 adults in 
Australia (25°S) enrolled in a health programme in 1999/2000, mean serum 25(OH)D 
concentration was 63 nmol/l, the prevalence of vitamin D insufficiency (<50 nmol/l) was 31% 
and 73% had levels <75 nmol/l (129). 
 
Although mean vitamin D and calcium intakes were higher amongst those living in the UK, 
the inadequate dietary Vitamin D intakes were universal in both countries, with all participants 
recording intakes well below the RDA recommendation of 15 μg/day. It is important to note 
that the differences in mean intake observed between the two countries could be due to 
differences in the food composition tables. Some foods may contain both vitamin D and 
25(OH)D forms, the latter being more potent. The UK both account take the total dietary 
25(OH)D amount when calculating vitamin D values (and therefore applying a conversion 
factor of 5), while the US and Brazil food composition tables estimates do not include 
25(OH)D. Since there is no consensus regarding which conversion factors to use, the variation 
in conversion factor values might explain the differences observed in dietary intake between 
the two countries. Nevertheless, the findings from this study were fairly similar to the estimated 
intake in the UK adult population of 2-4 µg/d for ages 1.5 to 64 years (74). Although there are 
very few naturally rich foods, vitamin D dietary sources are far from negligible and can be 
particularly significant during winter months for ethnic groups living abroad, where cultural 
adaptation is required in many aspects.  
 
For instance, it was shown in this cohort that women consuming eggs for more than 5 times a 
week had higher 25(OH)D concentrations compared to those eating once a week or less. 
Likewise, particularly more evident amongst those living in England, a more frequent 
80 
 
consumption of oily fish was associated with higher 25(OH)D concentrations. However, in this 
study there were no associations between vitamin D intake and serum 25(OH)D concentrations. 
Studies reporting a weak or not significant correlation between dietary vitamin D intake and 
serum 25(OH)D concentrations have suggested that vitamin D intake requirements to reach a 
given concentration of serum 25(OH)D may differ between individuals (24,130,131) and 
individual sunlight exposure might be a better predictor of 25(OH)D concentration than dietary 
vitamin D intake. 
 
Previous studies have largely reported significant associations between vitamin D status and 
body composition (132,133). In this cohort overall, serum 25(OH)D concentration was 
significantly negatively correlated with age, weight, waist circumference and BMI, but 
statistical significance did not remain after controlling for individual UV radiation level and 
was not observed within each country. It might be that significant associations between vitamin 
D status and adiposity was not evident in these sample due to the majority of the women 
(61.5%) having a healthy BMI and therefore the impact of adiposity not being a strong factor 
as sunlight exposure for this population. 
 
The influence of skin pigmentation has been well observed in studies showing poorer vitamin 
D status in dark-skinned individuals compared to white adults, with higher amounts of UVB 
required in pigmented skins to achieve a similar 25(OH)D concentrations as white skin. In the 
present study, no associations were found between 25(OH)D concentrations and self-declared 
ethno-race or skin type. The reason for this may be due to the potential inconsistency in self-
declared ethno-race and skin colour in the Brazilian population because of subjective 
definitions and cultural influence on ethnic identification. In fact, this was indeed observed in 
this study where amongst the same group of people 63% identified themselves as white and 
33.3% as brown while, conversely, 63% classified themselves as type III and IV (light and 
moderate brown) and 31.1% as type I and II (white). These findings suggest that simple and 
subjective classifications of ethnicity and skin colour to investigate the effect of skin 
pigmentation on vitamin D status might not be appropriate for some populations or countries. 
Other methods such as measures of melanin density via spectral reflectance of the skin (14) or 
classification by a trained researcher based on observed skin type characteristics might be 
better options in the Brazilian population.  
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Individual daily UV radiation levels were strongly positively correlated with serum vitamin D 
concentrations. Women with serum 25(OH)D concentrations above 75 nmol/l had remarkably 
higher mean UV radiation than those with deficient (< 25 nmol/l), insufficient (25.9 - 50 
nmol/l) and suboptimal (50 – 74.9 nmol/l) status (p<0.001). Moreover, 38.8% of the total 
variance in 25(OH)D concentrations was explained uniquely by daily individual UV radiation, 
after controlling for the influence of age and BMI. It was estimated that in this cohort, each 
extra SED of UV radiation would increase 25(OH)D concentration by 20.2 nmol/l, independent 
of age and BMI. 
 
A safe limit of daily UV radiation level enough to produce vitamin D has been previously 
reported to be 1 SED for skin types I-IV (74). This study predicted that daily individual UV 
radiation of around 0.5 SED would be sufficient to maintain serum 25(OHOD at 50 nmol/l and 
1.5 SED for 75 nmol/l. Furthermore, serum 25(OH)D concentrations seem to reach a maximum 
plateau around 75 - 85 nmol/l at daily UV radiation over 1.5 - 2.0 SED. These findings are in 
accordance with the tightly auto-regulated vitamin D metabolism, which responds promptly to 
excessive endogenous production of vitamin D via exposure of the skin to sunlight. With 
continuous exposure to sun radiation, pre-vitamin D3 and vitamin D3 in the epidermis are 
degraded into biologically inactive photoproducts (1,7). 
 
Amongst England dwelling D-SOL participants, 100% recorded daily exposure levels of less 
than 1 SED as well as around half of those living in Brazil. It is surprising that such a high 
proportion of participants in Brazil presented relatively low individual daily exposure levels, 
considering the still high minimum winter UV index in Brazil of 8.  
 
The input from the 90-days sun diaries showed a different picture in comparison to the habitual 
body part exposed reported by participants on the lifestyle questionnaire. When reporting 
recalled habitual body part exposed when out in the sun, more than half (58.9%) of women in 
England reported exposing hands and face only, while in Brazil most women (70.9%) reported 
the habit of exposing hands and face plus arms and/or legs, with a statistically different 
proportion between the two countries (p<0.001). However, from daily input collected by the 
sun diaries there were no differences in either time spent outdoors or body part exposed 
between the two countries. Interestingly, in both countries around half of women reported 
exposure of hands and face only on most days and roughly the other half reported exposure of 
hands and face plus arms and/or legs. One explanation for the similar body part exposure 
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pattern observed in these two opposite countries might be that the higher UV irradiation and 
hotter climate leads to more sun protection via clothing coverage. The little time spent outdoors 
(majority in both countries spending less than 30 minutes per day out in the sun) supports the 
building evidence on the influence of modern urban living on vitamin D status. These 
contradictory findings suggest that sun exposure behaviour, particularly in sunny tropical 
countries, might involve factors that are more complex and requires more detailed 
questionnaires/sun diaries to better define the patterns in behaviour towards sunlight. 
 
Furthermore, in Brazil specifically, 25(OH)D concentration was associated with recalled 
habitual body parts exposed, with higher concentrations amongst those reporting a usual 
exposure of hands and face + arms and/or legs compared to just hands and face, but no 
associations were observed from the data collected via the 90-days sun diary. Such 
observations build on the affirmation that individual UV radiation level is better determined by 
individual behaviour towards sunlight rather than estimated local UV radiation availability. 
 
Additionally, although there were no differences in mean 25(OH)D concentrations between 
sunscreen users and non-users, those reporting using a SPF 15 sunscreen during holidays had 
significantly lower levels (nearly half the mean concentration) than those reporting the use of 
SPF of 40 or more. This may be a reflection of higher factor use being a marker for higher 
overall exposure and greater likelihood of sunbathing. In fact, it was observed in this study that 
amongst those reporting having the habit of sunbathing, 60% reported the use of SPF of 30, 40 
or more during holidays compared to 9% using SPF 15 or 20. Such observations reinforce the 
importance of considering habitual behaviour towards sunlight and how it can affect 25(OH)D 
cutaneous production in the skin when determining vitamin D and sunlight exposure 
recommendations for different populations. From a holistic point of view, taking high factor 
sunscreen alone as an indicator of lower UV radiation reaching the skin, for instance, could 
potentially underestimate individual exposure UV radiation level if higher SPF is also a marker 
for greater length of time in the sun. 
 
While the FAO/WHO suggested that the most efficient physiological approach to acquiring 
vitamin D for populations at the equatorial latitude range (42°N - 42°S) is through endogenous 
synthesis form sunlight exposure, their report did consider the contribution of dietary intake 
(from diet or supplements) to counteract the potential detrimental effects of excessive exposure 
to sunlight. The report specifically suggests that daily exposure of arms and face, without 
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sunscreen, for approximately 30 minutes would be enough to maintain adequate vitamin D 
levels. This is in accordance with the findings of this study of women living in Brazil and 
spending 15-30 minutes out in the sun having significantly higher levels of 25(OHD 
concentrations than those spending less than 15 minutes per day outdoors. However, this 
amount of daily unprotected exposure to UV radiation in sunny locations can arguably increase 
the risk of skin cancer and aging effects on the skin, especially to fair skinned individuals.  
 
To the author’s knowledge, this is the first study in the literature to directly compare individual 
sunlight exposure levels and habitual behaviour towards sunlight between opposite latitudes 
during wintertime (minimizing confounding from sun radiation intensity) within the same 
ethnic group (minimizing confounding due to cultural habits and skin pigmentation). 
Furthermore, up to this date, this is also the first study to measure habitual UV radiation levels 
using a personal UV dosimeter in Brazil and the first study to show the strong correlation of 
individual levels with vitamin D serum concentrations in the Brazilian population. 
 
Although significant differences in serum vitamin D concentrations between the two countries 
were expected, it is no less remarkable that mean vitamin D concentrations of England residents 
were as low as 36 nmol/l compared to a mean 75 nmol/l in Brazil. Likewise, the difference in 
ranges between the two countries is still impressive: from 5.0 to 73.5 nmol/l within participants 
living in England and from 36.2 to 148.6 nmol/l within those living in Brazil. Similar serum 
concentrations to the observed in the present study in Brazil were observed in South Africa 
ranging from 70 to 170 nmol/l (134) and in individuals with reportedly high-UV exposure 
(tanners, surfers and outdoor workers) ranging between 25 – 162 nmol/l (89). 
 
In summer months individuals would have adequate sunlight availability to produce vitamin D 
in England and potentially increase individual UV radiation, whereas individuals in Brazil 
would be exposed to a extremely high UV radiation and hotter climate, which could lead to 
changes in behaviour towards sunlight as well as individual UV radiation. For instance, a study 
conducted at latitude 23°S (São Paulo, Brazil) with 603 (118 men and 485 women) healthy 
volunteers aged 18-90 years, showed a significantly higher prevalence of individuals with 
vitamin D levels below 75 nmol/l (77.4%) in winter compared to the end of summer months 
(37.3%) (69). A longitudinal study in the UK, with Caucasian and (n = 88) South Asian women 
(mean (±SD); age 48.2 years (14.4)), showed that individuals with a higher seasonal change in 
25(OH)D, adjusted for overall 25(OH)D concentration, showed increased levels of PTH, 
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suggest a possible detriment to bone health via increased levels of PTH in individuals with a 
larger seasonal change in 25(OH)D concentration. Further investigations with longitudinal 
study designs could provided further valuable information in regards to the seasonal cycling in 
25(OH)D concentrations within each latitude and its effects on bone health, as well as 
maximum concentrations achieved over the year.  
 
The definition of optimal status has been commonly derived from the level of 25OHD at which 
PTH levels reach a minimum plateau, i.e. the suppression of PTH secretion as a surrogate of 
optimal bone health, but this yields a wide range of estimates. Mean plasma PTH concentration 
in England residents was significantly higher than within Brazil residents, reflecting the 
significantly lower 25(OH)D concentrations in England dwelling women observed in this 
study.  PTH concentrations were negatively correlated with 25(OH)D concentrations and PTH 
clearly reached a minimum plateau at 25(OH)D concentrations of 70 - 80 nmol/l, being of great 
relevance for discussions regarding the estimation of optimal cut-offs for vitamin D levels in 
the Brazilian population. Additionally, mean PTH concentrations for vitamin D deficient (< 25 
nmol/l) status were significantly higher compared to insufficiency (25 – 49.9 nmol/l), adequate 
(50 – 74.9 nmol/l) and optimal (> 75 nmol/l) status, with a stronger statistical signficance 
compared to the latter. Serum 25(OH)D concentrations at which PTH levels reach a minimum 
plateau vary substantially between studies, probably influenced by factors such as diet, sunlight 
exposure, methodology, age and sex. There is a growing consensus that serum 25(OH)D 
concentrations of at least 75-80 nmol/l are required for optimal bone health (135). These data 
taken together, suggests that 25(OH)D concentrations above 70 nmol/l are optimal to reduce 
stimulation of the parathyroid gland in Brazilian women. 
 
Advisory agencies have consistently highlighted the challenges in establishing reference values 
for adequate vitamin D recommendations, particularly due to the differences in individual 
variation as well as the influence of environmental external factors. The inappropriateness of 
direct comparison of data from studies conducted in different locations is mainly due to 
significant variations in results between different laboratories, different latitudes and different 
populations / ethnic groups – and therefore influencing factors, adding greatly to the difficulty 
in finding a global consensus.  
 
Another important limitation to the current recommendations regarding dietary intakes and 
sunlight exposure to maintain adequate levels is that they are generally based on studies with 
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mainly Caucasian populations in high latitude countries, with limited robust data for other 
ethnicity and different geographical locations. Consequently, there is a substantial lack of 
evidence on the effect of individual sunlight exposure in low latitude countries and their native 
non-Caucasian populations.  
 
Although habitual exposure to sunlight has been long considered the most important 
determinant of adequate vitamin D status, still very few studies to this date have investigated 
the relationship between actual individual exposure to UV radiation and serum 25(OH)D 
concentrations, with most data derived from in vitro or animal studies (2,16,17). Additional 
evidence for this relationship comes largely from epidemiological studies in higher latutide 
countries, associating the prevalence of vitamin D inadequacy with latitude of residence or 
seasonal cycling of 25(OH)D concentrations, without actually measuring individual exposure 
(14, 15, 19).  
 
This cross-sectional analysis addresses these key knowledge gaps with two parallel trials, using 
identical methodologies to examine same ethnicity and sex individuals, in opposite (high North 
vs. low South) latitudes. Moreover, all samples were analysed at the same high standard 
laboratory, at Imperial College London, UK. The D-SOL study has specifically examined the 
relative contribution of sunlight exposure on serum 25(OH)D concentrations.  
 
The biggest contribution of the results here presented to the vitamin D field is the novel in vivo 
analysis confirming a strong and positive significant correlation between individual and 
habitual sunlight exposure and 25(OH)D concentrations, during wintertime, directly 
comparing countries located in opposite latitudes, and therefore with very different seasonal 
climatology. The present study also highlights the currently underappreciated variation in 
individual UV radiation level influenced by different behaviours towards sunlight exposure.  
 
 
3.5.1 Strengths and limitations 
 
The biggest strength of this cross-sectional analysis is the directly comparable data on serum 
25(OH)D and PTH concentrations and daily individual UV radiation measurement that 
represents personal and habitual solar radiation in a real life scenario. Further strengths of the 
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present study include: serum 25(OH)D measurement via liquid chromatography–mass 
spectrometry, the gold-standard method for assessing vitamin D status and data collection 
during the same season in both countries. The sample can be considered representative of the 
younger (<50 years of age) adult Brazilian women population which included an appropriate 
range of socio-demographic characteristics. 
 
Participants’ individual UV radiation exposure was measured with personal dosimeter badges 
worn for a 1-week period, building on the limited data on habitual individual radiation levels 
currently available. Additionally this study contributes valuable data to the current lack of 
studies on vitamin D status, sunlight exposure and influential factors in adult Brazilian women.  
 
 Limitations include data being restricted to healthy adult women, aged 20 to 59 years old, and 
might not reflect other populations such as men, children, adolescents and pregnant or older 
women. Participants on this study had a rather healthy BMI and therefore, findings may not 
reflect overweight and obese populations due to the known influence of adiposity in vitamin D 
status. These findings may also not be generalizable to other ethnic groups with different 
characteristics, habits or culture.  
 
Questions on behaviour regarding sunlight exposure and physical activity could have been 
more detailed in order to better reflect the habitual and cultural aspects of the studied population 
(i.e. to distinguish between indoor and outdoor activities, habitual use of hats, preference for 
staying in the sun/shadow when outdoors, habit of going into outdoor swimming pool / open 
water swimming, perceptions towards tanning,). Some participants recorded never consuming 
milk but have also noted on their questionnaires consuming vegan alternatives for milk. This 
might have underestimated the consumption of milk in regards to vitamin D and calcium 
associations with 25(OH)D concentrations if they were choosing fortified versions. 
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Conclusions 
 
In conclusion, this study has highlighted the strong association between vitamin D serum 
25(OH)D concentrations and individual UV radiation. The prevalence of vitamin D deficiency 
and insufficiency was extremely high in adult Brazilian women residing in southern England. 
Moreover, no participants living in England and only half of participants living in Brazil had 
optimal vitamin D status. Vitamin D deficiency or inadequacy, strongly associated with low 
individual UV radiation levels, could put these women at a greater risk of poor bone health at 
the end winter, particularly in England.  
 
When translating this into public health recommendations the data presented here suggests that 
current recommendation for the Brazilian adult population of 25(OH)D concentrations above 
50 nmol/l might not be sufficient to reduce stimulation of the parathyroid gland in this 
population and concentrations above 70 nmol/l would instead be required for optimal status. 
Moreover, a daily individual UV radiation of around 1.5 SED would be predictive of a serum 
25(OH)D concentration at 75 nmol/l, but a maximum plateau would be reached around 2.0 
SED, meaning further exposure would not be beneficial and can pose a unnecessary potential 
for harmful outcomes.  
 
Further work should focus on extending the sample to include a wider demographic range, 
including more overweight individuals, males and other age group, and assessing potential 
influencing factors in greater detail, both in Brazil itself and amongst Brazilian and Latin 
American ethnic groups living in the UK.   
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4 
Vitamin D supplementation in high versus low latitudes: 
efficacy, necessity and interactions  
 
 
 
4.1 Background 
 
Although far from negligible, vitamin D dietary sources are limited and therefore may not be 
sufficient to compensate for inadequate cutaneous synthesis. The increasing prevalence of 
vitamin D insufficiency worldwide warrants efficient nutritional strategies to correct low 
vitamin D concentrations, particularly in individuals with probable limited cutaneous 
synthesis. Fortified foods and supplementation have been investigated over the past decade in 
search for an efficient strategy to prevent vitamin D deficiency in risk groups as well as in the 
general population. 
 
There is still no consensus for a standard definition of the optimal serum levels of 25(OH)D 
which makes it difficult to critically interpret results from interventions with vitamin D 
supplementation. Consequently, it is still challenging to determine evidence-based 
recommendations for vitamin D supplementation intakes. Several studies have demonstrated 
the effect of vitamin D supplementation in raising serum 25(OH)D concentrations but these 
have included different doses, intervention regimens and populations, yielding variable results 
(10,83,136,137). Furthermore, the vast majority of randomized controlled trials of vitamin D 
supplementation have targeted white populations living in high latitude countries and mostly 
older participants (> 65 years).  
 
The most common recommendations for vitamin D intake for the general adult (19 – 70 years 
old) population range from 10 µg/day (UK) (74) to 15 µg/day  (US, Australia, Brazil) 
(54,71,138). With regards to supplementation strategies, it has been suggested that for healthy 
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individuals every 2.5 µg/day (100 IU/day) of supplemental vitamin D3, increases serum 
25(OH)D concentrations by approximately 1.7 to 2.5 nmol/l (0.7 to 1 ng/ml) (72). A systematic 
review including 76 trials with Caucasian individuals >50 years (n=6207) and vitamin D 
supplement doses ranging from 5 to 250 μg/d (median, 20 μg/d), reported an average increase 
in serum 25(OH)D concentrations of 1.9 nmol/l (0.8 ng/ml) per microgram of vitamin D3 per 
day (139).  However, it is important to note that several studies have also demonstrated that 
individuals with the lowest initial 25(OH)D concentrations present a greater response to 
supplementation (140).  
 
Although many trials have investigated the effect of vitamin D supplementation on skeletal 
clinical outcomes, particularly fracture risk, few have been design to specifically investigate 
the efficacy of vitamin D supplementation on raising serum 25(OH)D levels depending on 
concomitant individual sunlight exposure levels,  a fundamental factor to determining 
appropriate dietary recommendations. Consequently, public guidelines and policies should be 
adapted to the potentially different recommended vitamin D intakes necessary to achieve the 
optimal levels according to local ambient sunlight availability.  
 
Because vitamin D status is a function of several individual and environmental factors, 
conclusions about the need and efficacy of vitamin D supplementation must be context and 
country specific. To date, the need and efficacy of vitamin D supplemental intake to increase 
and maintain serum 25(OH)D concentration above insufficiency (50 nmol/l) in low sunny 
latitudes are unclear and, likewise, little is known regarding the interaction between vitamin D 
supplementation and individual exposure to sunlight. 
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4.2 Objectives 
 
 Objective 1:  
To compare the effectiveness of vitamin D supplementation of 15 μg/day compared to a 
placebo across opposite latitudes, in maintaining serum 25(OH)D concentrations above 
deficient and insufficient thresholds (25 and 50 nmol/l, respectively) in adult women. 
 
 Objective 2:  
To explore the interaction between vitamin D supplementation, latitude and individual 
exposure to sunlight. 
 
 Objective 3:  
To investigate the influence of baseline circulating 25(OH)D concentrations on post-
intervention concentrations. 
 
 Objective 4:  
To investigate the response of PTH concentrations to vitamin D supplementation of 15 μg/d 
compared to a placebo across opposite latitudes. 
 
 
4.3 Methods 
 
The study recruited participants at the University of Surrey (51.°N), England, at the end of 
autumn 2016 and participants at the University of Goiás (16°S), Brazil, at the end of autumn 
2017. All participants at commencement of the study provided a written informed consent.  
Full clinical and methodological study details, including participant recruitment, 
randomization and data collection, are described in Chapter 2.  
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4.3.1 Statistical Analysis 
 
Statistical analysis of the data was undertaken using SPSS software for Windows (version 25.0; 
IBM Corp, Armonk, NY).  
 
Data was tested for normal distribution using the Kolmogorov-Smirnov tests. Non-normally 
distributed variables were log transformed and reported in the original scale. Non-parametric 
tests were used when log transforming did not normalise the data.  
 
Descriptive statistics were determined for all variables. Continuous variables were presented 
as mean ±SD for normally distributed variables or as median (25%, 75% percentiles) for not 
normally distributed. For categorical variables, frequency and percentage were reported. 
 
The efficacy of intervention was tested by intention to treat (ITT) and per protocol (PP) 
analyses. There were no differences between the two analyses and therefore, only ITT analysis 
is reported in this chapter. For the ITT analysis, pairwise exclusion technique was used to 
handle missing data. (PP analysis details can be found in Appendix I) 
 
Paired t-tests were used to examine response to vitamin D supplementation (change in serum 
25(OH)D and plasma PTH concentrations from baseline to post-intervention) in the two 
intervention groups (placebo and 15 μg/ vitamin D) within each country of residence. One-way 
ANOVA with post-hoc Tukey’s test was used to analyse the differences in post-intervention 
serum 25(OH)D and plasma PTH concentrations and total change in 25(OH)D and PTH 
concentrations between the four intervention/country groups namely: placebo in England, 15 
μg/d in England, placebo in Brazil, 15 μg/d in Brazil. An analysis of covariance (ANCOVA) 
was also performed to examine these differences but controlling for baseline 25(OH)D 
concentrations, age and BMI. 
 
Chi squared tests were used to compare the distribution of serum 25(OH)D status, at baseline 
and post-intervention, according to the pre-defined cut-off thresholds between country and 
between intervention groups in each country. 
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Pearson’s correlation were used to analyse the relationship between baseline 25(OH)D 
concentrations, total  intake and individual UV radiation and post-intervention total change in 
25(OH)D concentrations. 
 
Factorial ANOVA was used to explore the interaction (individual and joint effect) of latitude 
and intervention (supplemented/placebo) on post-intervention serum 25(OH)D and total 
change in 25(OH)D concentrations.  
 
Standard linear and multiple regression models were run to investigate the predictive ability of 
total vitamin D intake (from diet and supplementation) and individual daily sunlight exposure 
on baseline and achieved serum 25(OH)D concentrations post wintertime (post-intervention). 
Preliminary analyses ensured no violation of normality, linearity, generalizability (sample 
size), multicollinearity and homoscedasticity. 
 
Baseline serum 25(OH)D concentrations were also added to the model predicting achieved 
serum 25(OH)D concentrations to investigate the effect of initial serum 25(OH)D levels 
(baseline).  
 
Due to the extremely large influence of initial serum 25(OH)D concentrations, a hierarchical 
multiple regression was chosen to assess the ability of total vitamin D intake (from diet and 
supplementation) and individual daily sunlight exposure to predict serum 25(OH)D 
concentrations achieved post-intervention, after controlling for the influence of initial serum 
25(OH)D concentrations. 
 
A p value of <0.05 was considered significant. 
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4.4 Results 
 
4.4.1 Recruitment 
 
A total of 335 adult Brazilian women were screened for the study, 148 in England and 187 in 
Brazil, of which: 131 were excluded based on the exclusion criteria; 53 decided not to 
participate after the screening process and 15 did not show for baseline visit (Figures 4.1 and 
4.2). (Reasons for exclusion at screening are detailed in Figure 3.1 in Chapter 3). 
 
After the screening process, 136 women attended the baseline visit (n = 56 in England and 80 
in Brazil). Of those, 122 completed the 12 weeks intervention and attended the final visit. The 
majority of dropouts were due to unwillingness or difficulty in attending final visit (n = 12). 
Other than that, one participant did not complete the study due to illness not related to the study 
and for one participant laboratory results were not available. 
 
The Intention To Treat analysis included all participants that had valid baseline data for serum 
25(OH)D concentration and were randomized into one of the intervention groups (n=135). 
Subjects were excluded from the Per Protocol analysis (n = 95) due to: intervention compliance 
below 75%  (n = 18), assessed by leftover tablets count; menopausal status (n = 5); no post-
intervention blood sample for serum 25OHD concentrations (n = 14). 
 
Compliance was satisfactory, with 86% of all participants achieving at least 75% compliance 
(84%, 100%, 84% and 80% achieving 75% compliance in the England Placebo, England 15 
μg/d, Brazil Placebo and Brazil 15 μg/d groups, respectively; p=0.123). There were no 
significant difference in compliance between the placebo and supplemented groups within each 
country (p=0.10 for the England trial and p=0.67 for the Brazil trial). 
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Screened for eligibility  
(n= 148) 
 
Excluded (n= 92) 
- Not meeting criteria (n= 57) 
- Declined to participate (n= 20) 
No show for baseline visit (n= 15) 
Randomized 
(n = 56) 
 
England  
15 μg/day (n= 27) 
England 
 placebo (n= 29) 
 
No show = 4 
Completed = 25 
No show = 2 
Completed = 25 
ITT analysis (n=29) 
PP analysis (n=17) 
    Breach of protocol 
     No final 25OHD sample 
  
Enrolment 
 
 
 
Allocation 
 
 
 
Final visit 
 
 
 
Analysis 
 
 
 
ITT analysis (n=27) 
PP analysis (n=23) 
    Breach of protocol 
     No final 25OHD sample 
  
England 
 
 
 
Brazil 
 
 
 
Screened for eligibility  
(n= 187) 
 
Excluded (n= 108) 
- Not meeting criteria (n= 74) 
- Declined to participate (n= 33) 
- No valid baseline samples (n=1) 
 
Randomized 
(n = 79) 
 
Brazil 
15 μg/day (n= 40) 
Brazil  
placebo (n= 39) 
 
No show = 6 
Completed = 33 
No show = 4 
Completed = 36 
ITT analysis (n=39) 
PP analysis (n=28) 
    Breach of protocol 
     No final 25OHD sample 
  
ITT analysis (n=40) 
PP analysis (n=27) 
    Breach of protocol 
     No final 25OHD sample 
  
Figure 4.1 CONSORT flow diagram of participant enrolment, randomisation 
and analysis by study intervention groups: England and Brazil Trial 
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4.4.2 Participant Characteristics 
 
4.4.2.1 Age, Adiposity and Skin Pigmentation 
 
The baseline anthropometric characteristics for study participants by intervention group for 
each country are shown in Tables 4.1. There were no significant differences for any of the 
anthropometric baseline characteristics between the two intervention groups (placebo/15 
μg/day vitamin D) in either country. Brazilian women living in England were significantly 
older, heavier and had a greater waist circumference than those living in Brazil. There were no 
significant differences between Brazilian women living in England and in Brazil for skin type 
distribution. 
 
Table 4.1 Baseline anthropometric characteristics of women living by intervention group for 
each country (n= 135)1 
 1 Values are median (25th, 75th percentile), mean ± SD or n (%). 
 Statistical analysis: 2 Between intervention group within each country: Mann-Whitney U test unless otherwise 
 stated; a Chi Squares. b  Independent t-test; 3 Between the four intervention groups: Kruskall-Wallis test unless 
 otherwise stated; a Chi Squares; c ANOVA ≠ Measurements derived from different methodologies (England: bio-
 impedance; Brazil: DXA scan). References: R1 (124);  R2 (112) 
 England (n=56) Brazil (n=79) 
p 3 
 Placebo 
(n=29) 
15 μg/day 
(n=27) 
p 2 Placebo 
(n=39) 
15 μg/day 
(n=40) 
p 2 
 
Age (years) 
 
 
33 (29, 41) 
 
33 (28, 43) 
 
1.000 
 
27 (24, 31) 
 
26 (24, 30) 
 
0.883 
 
<0.001 
Weight (kg) 65.5 
(58.9, 71.3) 
67.8 
(61.7, 83.6) 
0.476 59.25 
(53.0, 70.0) 
60.3 
(54.7, 72.5) 
0.980 <0.001 
 
Waist Circumference 
(cm) 
 
 
84.3 
(74.1, 93.0) 
 
88.3 
(80.0, 99.9) 
 
0.420 
 
70.5 
(65.2, 76.7) 
 
70.1 
(67.0, 78.3) 
 
1.000 
 
<0.001 
BMI (kg/cm2) 24.57 
(21.3, 27.9) 
25.21 
(23.3, 28.2) 
0.883 22.2 
(20.2, 25.0) 
23.5 
(20.9, 26.5) 
0.784 0.028 
BMI category [n 
(%)]R1 
   Healthy 
   Overweight  
   Obese  
 
 
16 (55.1) 
8  (27.6) 
5 (17.2) 
 
13 (48.1) 
8 (29.6) 
6 (22.2) 
 
0.762 
 
29 (74.4) 
6 (15.4) 
4 (10.3) 
 
25 (62.5) 
10 (25) 
5 (12.5) 
 
0.165a 
 
0.471a 
Body fat (%) 
 
30.3 ± 6.7 31.6 ± 4.7 0.384 b 37.2 ± 8.2 40.0 ± 8.6 0.149 b <0.001 c 
Skin type [n (%)]R2 
   Type I and II 
   Type III and IV 
   Type V and VI 
 
 
8 (27.6) 
19 (65.5) 
2 (6.9) 
 
9 (33.3) 
18 (66.7) 
0 (0) 
 
0.365 
 
13 (33.3) 
23 (59) 
3 (7.7) 
 
23 (30) 
25 (62.5) 
3 (7.5) 
 
0.946a 
 
0.875a 
96 
 
4.4.2.2 Individual UV Radiation Levels 
 
The average daily individual UV radiation levels, during wintertime, in week 0 (baseline) 
relative to week 12 (post-intervention) are shown in Figure 4.2 Values are expressed in units 
of standard erythema dose (SED). 
 
At both baseline and week 12, median daily individual UV radiation level for those living in 
England was significantly lower (0.029 (0.015, 0.045) and 0.055 (0.028, 0.100) SED at 
baseline and week 12, respectively) than for those living in Brazil (0.934 (0.721, 1.790) and 
1.197 (0.659, 1.861) SED, at baseline and week 12, respectively) (p<0.001). There were no 
significant differences for daily individual UV radiation level between intervention groups 
(placebo/15 μg/day vitamin D), for either country (Tables 4.2). Mean daily individual UV 
radiation for those living in England was significantly higher by the end of the trial compared 
to baseline period (p=0.002), while there were no significant differences between these two 
measurements for women living in Brazil (p=0.991). 
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A) Overall 
 
1 8 subjects removed from this graphic representation due to daily levels above 4 SED in order to avoid 
disproportionate influence on the width of the scatter 
B) England 
 
 
Figure 4.2 Average daily individual UV radiation levels respective to week 0 (baseline) and 
week 12 (post-intervention), in units of standard erythema dose (SED), for the overall sample 
(A) 1 and zoomed in to England participants (B) 
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Table 4.2 Daily individual UV radiation level by country and intervention group1 
1 Values are median (25th, 75th percentile), 
Statistical analysis with log transformed data:  
2 Between intervention group within each country: Independent t-test;  
3 Between the four intervention groups: ANOVA 
 
 
 
4.4.2.3 Dietary Vitamin D and Calcium Intakes 
 
There were no significant differences in mean vitamin D or calcium intakes between the 
intervention groups (15 μg & placebo) at baseline in either country (p>0.05). Both vitamin D 
and calcium intakes were significantly higher in England groups compared to Brazil. (Table 
4.3). By the end of intervention, in the England trial, mean vitamin D intake was significantly 
higher in the placebo group compared to the 15 μg/day group (3.4 ± 2.3 and 2.12 ± 1.18 μg/d, 
respectively; p=0.035).  There were no significant differences between placebo and 15 μg/day 
group for vitamin D intake in Brazil nor for calcium intake in either country.  
 
There were no significant differences between baseline and week 12 vitamin D intakes for any 
of the four intervention groups. Mean calcium intakes were significantly lower post-
intervention in the England 15 μg/day group, and in both (placebo and 15 μg/day) Brazil groups 
(all p < 0.015), but there were no changes over time for the England placebo group. The 
difference in calcium intakes meant that 56%, 62.5%, 80.6% and 85.3% of participants did not 
meet the RNI reference of 700 mg/day at week 12 compared to 40.7%, 58.3%, 65.7% and 
84.8% at baseline for England placebo, England 15 μg/day, Brazil placebo and Brazil 15 
μg/day groups respectively. (Table 4.3). 
 
 England Brazil 
p3 
 Placebo (n=24) 15 μg/day (n=22) p2 Placebo (n= 35) 15 μg/day (n=34) p2 
 
Baseline 
 
 
0.028 
(0.011, 0.054) 
 
0.031 
(0.017, 0.043) 
 
0.632 
 
0.909 
(0.735, 1.245) 
 
1.112 
(0.689, 2.009) 
 
0.418 
 
<0.001 
Week 12 0.050 
(0.026, 0.104) 
 
0.074 
(0.032, 0.100) 
0.630 1.262 
(0.643, 1.813) 
1.196 
(0.714, 1.952) 
0.820 <0.001 
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Table 4.3 Vitamin D and calcium intakes by country and intervention group1 
 England Brazil p3 
Intake / day Placebo (n=27) 15 μg/day (n=24) p2 Placebo (n=35) 15 μg/day (n=34) p2  
 
Vitamin D 
(μg) 
 
Baseline 
Week 12 
p4 
 
 
 
 
 
2.5 (1.5, 4.7) 
2.2 (1.5, 5.1) 
0.076 
 
 
 
 
2.6 (1.4, 3.9) 
2.2 (1.1, 3.2) 
0.620 
 
 
 
 
0.710 
0.035 
 
 
 
 
 
 
 
 
1.3 (0.69, 2.81) 
1.3 (1.3, 2.8) 
0.918 
 
 
 
 
1.6 (0.8, 2.7) 
1.4 (1.1, 2.6) 
0.815 
 
 
 
 
0.578 
0.254 
 
 
 
 
 
0.007 
Calcium 
(mg) 
 
Baseline 
Week 12 
p4 
 
 
 
713.6 (576.9, 876.9) 
676.9 (505.4, 889.1) 
0.141 
 
 
 
595.4 (321.9, 866.1) 
566.9 (496.2, 776.1) 
0.001 
 
 
 
0.108 
0.342 
 
 
 
 
 
573.5 (383.8, 753.2) 
412.2 (316.9, 640.1) 
0.013 
 
 
 
435.1 (330.1, 607.2) 
411.4  (309.5, 585.0) 
0.002 
 
 
 
 
0.080 
0.545 
 
 
 
<0.001 
1 Values are median (25th, 75th percentile), Statistical analysis with log transformed data: 2 Between intervention group 
within each country: Independent t-test; 3 Between the four intervention groups: ANOVA; 4 Between baseline and 
week 12: Paired t-test 
 
 
4.4.3 Intervention outcomes 
 
Per Protocol (PP) analysis did not change intervention outcomes, therefore only ITT is reported 
in this section. PP analysis can be found in Appendix I.  
 
4.4.3.1 Response to vitamin D supplementation 
 
There were no differences in serum 25(OH)D concentrations at baseline between the two 
intervention groups in either country (p>0.05).  
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Table 4.4 Serum 25OHD, plasma PTH and serum calcium concentrations at baseline and post-
intervention in England and Brazil trials (n=135)1 
1 Values mean ± SD; analysis of intention to treat 
2 Albumin corrected serum calcium concentrations 
Statistical analysis: ≈ Log transformed data 
3 Between intervention group within each country: Independent t-test; 
4 Between the four intervention groups: ANOVA. 
5 Between baseline and week 12: Paired t-test 
 
 
Post intervention, mean 25(OH)D in each group was 41.1±17.7 nmol/l for Placebo/England, 
55.2±12.2 nmol/l for Supplemented/England, 71.9±22.1 nmol/l for Placebo/Brazil and 
84.9±21.0 nmol/l for Supplemented/Brazil (Table 4.4). There was a significant effect of 
vitamin D supplementation on post-intervention serum 25(OH)D concentrations between the 
four intervention groups independent of baseline 25(OH)D concentrations, age and BMI 
(ANCOVA F(3,111) = 7.885, p<0.001, partial eta squared= 0.176) (Figure 4.3). In this model, 
baseline concentrations explained 44.4% (p<0.001), and intervention group 17.6% (p<0.001) 
of the variance in 25(OH)D post-intervention concentrations and neither age or BMI had a 
significant contribution to the difference observed (both > 0.360) (ANCOVA). 
 England Brazil p 4 
  Placebo 15 μg/day p 3 Placebo 15 μg/day p 3 
 
Serum 25(OH)D (nmol/l) 
Baseline 
Post-intervention 
Total Change 
p 5 
 
 
34.9 ±14.0 
41.1 ±17.7  
5.3 ±14.9 
0.094 
 
 
37.4  ±15.7 
55.2 ±12.2  
17.0 ±17.1 
<0.001
 
 
 
 
0.537  
0.002  
0.014  
 
 
74.4  ± 21.1 
71.9 ±22.1  
- 2.5 ±11.7 
0.221 
 
 
75.6 ±22.5 
84.9 ±21.0 
7.6 ± 23.0 
0.004 
 
 
0.821 
0.017  
0.022   
 
 
 
 
<0.001 
<0.001 
<0.001 
Plasma PTH (pmol/l) ≈ 
Baseline 
Post-intervention 
Total Change 
 p 5 
 
5.26 ±1.35 
6.44 ±2.15 
1.01 ±2.29 
0.046
 
 
 
 
5.48 ±2.53 
5.98 ±2.21 
0.30 ±2.35 
0.253
 
 
 
 
0.687  
0.475  
0.289  
 
 
4.71 ±1.47 
5.44 ±2.00 
0.67 ±2.07 
0.046 
 
4.27 ±1.47 
4.63 ±1.72 
0.28 ±1.60 
0.364
 
 
 
0.191 
0.072  
0.373  
 
 
 
0.022 
0.005 
0.526 
Serum Calcium (mmol/l)2 
   Baseline 
   Post-intervention 
  Total Change 
   p 5 
 
2.31 ±0.07 
2.30 ±0.06 
-0.01 ±0.06 
0.386 
 
2.30 ±0.08 
2.28 ±0.06 
-0.01 ±0.06 
0.322 
 
0.567  
0.374  
0.953  
 
2.27 ±0.05 
2.27 ±0.06 
-0.004 ±0.06 
0.447 
 
2.28 ± 0.07 
2.29 ± 0.06 
0.006 ± 0.05 
0.311  
 
0.407  
0.081  
0.464  
 
0.226 
0.224 
0.568 
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*** p<0.001 (ANCOVA).  
Error bars represent SEM. Hashed lines represent serum 25(OH)D thresholds of 25, 50 and 75 nmol/l. 
 
Figure 4.3 Effect of vitamin D supplementation and country of residence on post-intervention 
serum 25(OH)D concentrations between the four intervention group, controlling for baseline 
25(OH)D concentrations (ANCOVA). 
 
Mean total change in serum 25(OH)D concentrations in the supplemented groups was 17.0± 
17.1 nmol/l (45% increase from mean baseline, p<0.001) in England and 7.6 ± 23.0 nmol/l 
(10% increase from mean baseline, p=0.004) in Brazil. There were no significant changes in 
either of the placebo groups (p=0.087 and p=0.221, England and Brazil trials respectively) 
(Table 4.4). When the factors associated with 25(OH)D concentrations were added into a 
hierarchical multiple regression, 27% of the change in 25(OH)D concentrations was explained, 
with only baseline concentrations and intervention (15 μg & placebo) statistically significant, 
and intervention recording a higher beta value (beta: 0.319, p<0.001) than baseline 
concentrations (beta: -0.5, p<0.001). Country of residence did not have a unique statistically 
significant contribution to the model, neither did age or BMI.  
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*** p <0.001; * 
* p =0.004 (paired samples t-test). Error bars represent SEM. Red, orange and black hashed lines represent 
serum 25(OH)D thresholds of 25, 50 and 75 nmol/l, respectively. 
 
Figure 4.4 Change in serum 25(OH)D concentration in adult Brazilian women over the 12 
week trial by intervention and country of residence 
 
Differently from the placebo, vitamin D supplementation raised mean 25(OH)D concentrations 
from insufficiency (<50 nmol/l) to a mean concentration of 55.2 ±12.2 nmol/l in England and 
maintained mean concentration above adequacy (> 75 nmol/l) in Brazil (Figure 4.4).  (A 
supplementary figure for individual response to intervention according to baseline serum 
25(OH)D concentrations by intervention group and country can be found in Appendix I). 
 
 
4.4.3.2 Distribution of serum 25(OH)D concentrations by cut-off thresholds at baseline 
and post-intervention by intervention group 
 
Figure 4.5 illustrates the distribution of adult women with deficient (< 25 nmol/l), insufficient 
(25 – 49.9 nmol/l), adequate (50 – 74.9 nmol/l) and optimal (> 75 nmol/l) serum 25(OH)D 
concentrations by intervention group and country of residence, at baseline and post-
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intervention. At baseline there was no difference in the proportion of participants within each 
of the selected serum 25(OH)D concentrations cut-off thresholds by intervention group in each 
country separately (p=0.549 for England; p=0.892 for Brazil). In contrast, post-intervention 
there were significant differences between the placebo and 15 μg/d in each country (p=0.002 
in England; p=0.005 in Brazil) as well as between the four intervention groups (p<0.001).  
 
 
 
 
 
 
Figure 4.5 Proportion of women with deficient (< 25 nmol/l), insufficient (25 – 49.9 nmol/l), 
sufficient (50 – 74.9 nmol/l) and optimal (> 75 nmol/l) serum 25(OH)D concentrations by 
intervention group at baseline and post-intervention. 
 
Within women living in England, vitamin D supplementation prevented 25(OH)D 
concentrations below 30 nmol/l while nearly half (41.7%) in the placebo group had 
concentrations below this threshold. The 12-weeks supplementation clearly prevented vitamin 
D deficiency throughout winter in a high latitude location, with no supplemented women with 
post-intervention concentrations below 25 nmol/l compared to an 18.5% prevalence in this 
group at baseline. In the placebo group, 20.8% of women had post-intervention concentrations 
below 25 nmol/l compared to 31% at baseline. Furthermore, post-intervention 76% of the 
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supplemented group in England had a vitamin D status above the insufficiency threshold of 50 
nmol/l compared to 18.5% at baseline, while in the placebo group only 25% had post-
intervention levels above 50 nmol/l compared to 17.2% at baseline.  
 
Post-intervention in Brazil, 75% of the women in the supplemented group had 25(OH)D 
concentrations above the optimal cut-off of 75 nmol/l compared to 50% at baseline. In the 
placebo group only 36.4% had levels above 75 nmol/l compared to 51.3% at baseline. 
Furthermore, only one participant (2.8%) in the supplemented group had insufficient levels 
below 50 nmol/l compared to 10% at baseline, while 9.1% of women in the placebo group had 
levels below this threshold compared to 12.8% at baseline.  
 
 
4.4.3.3 Effect of Baseline Serum 25(OH)D Concentration 
 
There were strong significant negative correlations between baseline serum 25(OH)D 
concentration and total change in serum 25(OH)D concentrations over the trial period, in both 
supplemented groups (England: r = -0.728, p < 0.001; Brazil: r = -0.378, p = 0.021) (Figures 
4.6 and 4.7). This indicates that participants with the lowest baseline 25(OH)D concentrations 
had the greatest increase in response to vitamin D supplementation over the 12-week 
wintertime trial. The significant negative correlation remained in both supplemented groups 
after controlling for individual daily sunlight exposure at week 12, age and BMI (r= -753, p < 
0.001 for England; r= -0.464, p=0.01 for Brazil).  
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A) Placebo 
 
 
B) 15 μg vitamin D 
  
Figure 4.6 Relationship between baseline serum 25OHD concentration and change in total 
serum 25OHD in the A) placebo and B) supplemented groups in England. 
 
 
 
 
r = -0.728 
p < 0.001 
 
r = -0.300 
p = 0.155 
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A) Placebo 
 
 
B) 15 μg vitamin D 
 
 
Figure 4.7 Relationship between baseline serum 25OHD concentration and change in total 
serum 25OHD in the A) placebo and B) supplemented groups in Brazil.
r = -0.378 
p = 0.021 
r = -0.255 
p = 0.152 
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4.4.3.4 Effect of daily individual UVB exposure 
 
Overall, achieved serum 25(OH)D concentrations ranged from 19.5 to 84.7 nmol/l in 
England and from 31.3 to 141.5 nmol/l in Brazil. Considering supplementation 
combined with individual sunlight exposure levels, post-intervention half of the women 
receiving placebo and exposed to less than 1 SED were in the lowest quartile (58.1% 
below 50.4 nmol/l) of achieved serum 25(OH)D while half of the women vitamin D 
supplemented and exposed to 1 SED or over achieved the highest quartile (50% 
achieving over 63.7 nmol/l) (Table 4.5).  
 
 
Table 4.5 Achieved quartiles of 25(OH)D at 12 weeks by intervention group and 
individual daily sunlight exposure level 1 
Achieved 25(OH)D at 
12 weeks (nmol/l) 
< 1 SED  ≥ 1 SED 
Placebo 15 μg/d  Placebo 15 μg/d 
Q1 (19.5 to 50.4) n= 26 18 
(58.1%) 
7 
(21.2%) 
 1  
(5.3%) 
0 
Q2 (50.5 to 63.6) n= 25 5 
(16.1%) 
8 
(24.4%) 
 9 
(47.3%) 
3 
(16.6%) 
Q3 (63.7 to 83.1) n= 25 4 
(12.9%) 
12 
(36.3%) 
 3 
(15.8%) 
6 
(33.4%) 
Q4 (83.2 to 141.50) n= 25 4 
(12.9%) 
6 
(18.1%) 
 6 
(31.6%) 
9 
(50.0%) 
  1 Q = quartile; data presented as n (%) of participants in the intervention group achieving each quartile. 
 
Overall, daily individual UV radiation levels, at either baseline or week 12, were not 
correlated with total change in serum 25(OH)D concentrations (r = -0.062, p = 0.537 
and r = -0.097, p = 0.318) (Figures 4.8), even after controlling for baseline 25(OHD 
concentrations, age and BMI (all p> 0.05). 
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Figure 4.8 Relationship between daily individual UVB exposure levels at week 12 and 
change in total serum 25OHD (n=119) 
 
 
4.4.3.5 Effect of total vitamin D intake  
 
The relationship between achieved serum 25(OH)D concentrations and total vitamin D 
intake (diet plus supplemental vitamin D), in each latitude, in Brazilian adult women is 
shown in Figure 4.9. There was a significant positive correlation between total intake 
and achieved serum 25(OH)D concentrations in both countries, with a greater 
correlation coefficient for the England group (England: r = 0.443 p = 0.002; Brazil r = 
0.269, p = 0.029). 
 
 
 
 
 
 
r = -0.097 
p = 0.318 
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A) England 
 
B) Brazil 
 
1 Mean response (central line) and 95% confidence intervals (coloured lines). Horizontal hashed lines 
represent serum 25(OH)D thresholds of 25, 50 and 75 nmol/l. 
Note: Graphs in different scales for each country due to differences in range. 
 
Figure 4.9 Relationship between achieved serum 25(OH)D concentrations and total 
vitamin D intake by country 
 
r = 0.269 
p = 0.029 
r = 0.443 
p = 0.002 
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4.4.4 Vitamin D supplementation and latitude effects on serum 25(OH)D 
concentration: mathematical modelling  
 
4.4.4.1 Main effects and interaction of vitamin D supplementation and latitude 
 
A factorial ANOVA was used to compare the main effects of intervention (vitamin D 
supplementation or placebo) and latitude (low or high) and the interaction effect of 
vitamin D supplementation and latitude on achieved serum 25(OH)D concentrations, 
while controlling for baseline serum 25(OH)D concentrations.  
 
The model showed a significant main effect of intervention (F(1,113) = 21.29, p<0.001) 
and explained 68.2% in the variance of achieved serum 25(OH)D concentrations (R2= 
0.682). There was, however, no main effect of latitude (F(1,113) = 2.18, p = 1.42). 
There was also no significant interaction between the two factors (F(1,113) = <0.001, 
p = 0.996). This model confirms the ability of vitamin D supplementation of 15μg per 
day to raise serum 25(OH)D concentrations regardless of latitude. Adding age and BMI 
to the model did not change the reported outcomes, only increasing the R2 to 0.684. 
 
 
4.4.4.2 Inter-relationship amongst total vitamin D intake, baseline 25(OH)D 
concentrations and individual sunlight exposure in predicting achieved 
25(OH)D concentrations – overall sample 
 
Hierarchical multiple regression was used to assess the ability of vitamin D total intake 
(from diet and supplement) and individual sunlight exposure level at week 12 to predict 
achieved concentrations of serum 25(OH)D post wintertime (post-intervention) in the 
overall sample, after controlling for the influence of initial (baseline) serum 25(OH)D 
concentrations, country of residence, age, BMI and waist circumference (Table 4.6).  
 
Serum baseline 25(OH)D concentration, country of residence, age, BMI and waist 
circumference were entered at Step 1, explaining 62.6% of the variance in achieved 
25(OH)D concentrations. After entry of vitamin D total intake and individual sunlight 
exposure level at step 2, the total variance explained by the model as a whole was 
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67.5%. The two added measures explained an additional 4.9% of the variance in 
achieved 25(OH)D concentrations, after controlling for the influence of initial levels, 
country of residence, age, BMI and waist circumference, F (2, 99) = 7.393, p=0.001. In 
the final model, only baseline concentrations and total vitamin D intake made a unique 
statistically significant contribution: baseline 25(OH)D concentrations were the 
strongest predictor (Beta= 0.714, p<0,001) of post wintertime 25(OH)D concentrations 
explaining uniquely 24.4% of the variance, followed by total vitamin D intake 
explaining uniquely 4.8% of the variance (Beta= 0.226, p<0.001). Neither individual 
UVB exposure, country of residence, age, BMI or waist circumference made a unique 
contribution to the model. 
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Table 4.6 Hierarchical multivariate model of serum 25(OH)D: predictors of post 
wintertime 25(OH)D concentrations (n=119) 
     Change Statistics 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.791a 0.626 0.606 15.88656 0.626 31.815 5 95 <0.001 
2 0.822b 0.675 0.652 14.96983 0.049 6.996 2 93 0.001 
a Predictors: (Constant), Serum 25OHD at baseline, country of residence, age, BMI or waist circumference  
b Predictors: (Constant), Serum 25(OH)D at baseline, country of residence, age, BMI or waist circumference, total 
vitamin D intake, daily sunlight exposure 
c Dependent Variable: Achieved serum 25(OH)D concentrations 
        
 
Coefficients a 
 
  
Unstand. 
Coefficients 
Stand. 
Coefficien
ts 
  
95.0% 
Confidence 
Interval for B 
Correlations 
Model 
B 
Std. 
Error 
Beta t Sig. 
Lower 
Bound 
Upper 
Bound 
Partial Part 
1 (Constant) 33.98 17.14  1.982 0.050 -0.063 68.01   
 Baseline 
25OHD 
0.687 0.083 0.740 8.301 < 0.001 0.522 0.851 0.648 0.521 
 Age -0.097 0.206 -0.033 -0.468 0.641 -0.506 0.313 -0.048 -0.029 
 BMI 0.969 0.692 0.193 1.400 0.165 -0.405 2.342 0.142 0.088 
 Waist circ. -0.370 0.284 -0.199 -1.301 0.197 -0.935 0.195 -0.132 -0.082 
 Country  -0.085 5.649 -0.002 -0.015 0.988 -11.30 11.130 -0.002 -0.001 
ANOVA: F(5, 95) = 31.815, p<0.001 
2 (Constant) 27.84 16.44  1.693 0.094 -4.813 60.49   
 Baseline 
25OHD 
0.660 0.079 0.710 8.364 < 0.001 0.503 0.816 0.655 0.494 
 Age -0.003 0.196 -0.001 -0.016 0.998 -0.39 0.387 -.0002 -0.001 
 BMI 0.692 0.669 0.138 1.035 0.303 -0.635 2.020 0.107 0.061 
 Waist circ. -0.35 0.269 -0.189 -1.301 0.197 -0.886 0.185 -0.134 -0.077 
 Country  1.612 5.389 0.031 0.299 0.765 -9.089 12.31 0.031 0.018 
 Vitamin D 
intake 
0.754 0.203 0.225 3.714 < 0.001 0.351 1.158 0.359 0.220 
 Sun 
exposure 
0.175 0.590 -0.019 0.297 0.767 -0.996 1.346 0.031 0.018 
ANOVA: F(7, 93) = 27.592, p<0.001 
 a Dependent Variable: Achieved serum 25(OH)D concentrations 
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4.4.4.3 Inter-Relationship Amongst Total Vitamin D Intake, Baseline 25(OH)D 
Concentrations and Individual Sunlight Exposure in predicting achieved 
25(OH)D concentrations – within each country 
 
In each country separately, hierarchical multiple regressions models were used to assess 
the ability of vitamin D total intake (from diet and supplement) and individual sunlight 
exposure level at week 12 to predict achieved concentrations of serum 25(OH)D post 
wintertime (post-intervention), after controlling for the influence of initial (baseline) 
serum 25(OH)D concentrations. Age, BMI and waist circumference were not 
associated with 25(OH)D concentrations within each country sub-groups, and therefore 
not added to the following models. 
 
In the England trial serum baseline 25(OH)D concentration (entered at Step 1) 
explained 19.4% of the variance in of achieved 25(OH)D concentrations. After entry of 
vitamin D total intake and individual sunlight exposure level at step 2, the total variance 
explained by the model as a whole was 34.3%. The two added measures explained an 
additional 14.8% of the variance in achieved 25(OH)D concentrations, after controlling 
for the influence of initial levels, F(3, 38) = 6.592, p=0.001. In the final model, only 
baseline concentrations (Beta= 0.385, p=0.007) and total vitamin D intake (Beta= 
0.388, p=0.006) made a unique statistically significant contribution of 14% each, with 
similar strength. Individual UVB exposure did not make a unique contribution to the 
model (p = 0.976)  (Table 4.7). 
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Table 4.7 Hierarchical multivariate model of serum 25(OH)D: predictors of post 
wintertime 25(OH)D concentrations in England (n=49) 
a Predictors: (Constant), Serum 25OHD at baseline,  
b Predictors: (Constant), Serum 25(OH)D at baseline, total vitamin D intake, daily sunlight exposure 
c Dependent Variable: Achieved serum 25(OH)D concentrations 
 
 
Coefficients a 
  Unstandardized 
Coefficients 
Stand. 
Coef. 
  95.0% Conf. 
Interval for B 
Correlations 
Model B Std. 
Error 
Beta t Sig. Lower 
Bound 
Upper 
Bound 
Partial Part 
1 (Constant) 30.359 6.226  4.87 <0.001 17.77 42.94   
 Baseline 
25OHD 
0.495 0.160 0.440 3.10 0.004 0.173 0.818 0.440 0.44 
ANOVA: F(1, 40) = 9.622, p=0.004 
2 (Constant) 23.732 6.312  3.76 0.001 10.95 36.510   
 Baseline 
25OHD 
0.434 0.152 0.385 2.85 0.007 0.126 0.741 0.420 0.37 
 Vit D 
intake 
0.879 0.305 0.388 2.88 0.006 0.262 1.496 0.424 0.38 
 Sun 
exposure 
1.139 37.984 0.004 0.03 0.976 -75.75 78.034 0.005 0.004 
ANOVA: F(3, 38) = 6.592, p=0.001 
a Dependent Variable: Achieved serum 25(OH)D concentrations 
 
 
In the Brazil trial, serum baseline 25(OH)D concentration (entered at Step 1) explained 
50.1% of the variance in achieved 25(OH)D concentrations. After entry of vitamin D 
total intake and individual sunlight exposure level at step 2, the total variance explained 
by the model as a whole was 54.9%. The two added measures explained an additional 
6.3% of the variance in achieved 25(OH)D concentrations, after controlling for the 
influence of initial levels, ANOVA: F(3, 55) = 24.581, p<0.001. In the final model, 
only baseline concentrations and total vitamin D intake made a unique statistically 
significant contribution: baseline 25(OH)D concentrations were the strongest predictor 
(Beta= 0.705, p<0.001) of post wintertime 25(OH)D concentrations explaining 
uniquely 49% of the variance, followed by total vitamin D intake (Beta= 0.248, 
p=0.007) explaining uniquely 6% of the variance .  Individual UVB exposure did not 
make a unique contribution to the model (p = 0.803) (Table 4.8). 
     Change Statistics 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.440a 0.194 0.174 15.09923 0.194 9.622 1 40 0.004 
2 0.585b 0.343 0.292 13.99321 0.148 4.287 2 38 0.021 
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Table 4.8 Hierarchical multivariate model of serum 25(OH)D: predictors of post 
wintertime 25(OH)D concentrations in Brazil (n=69) 
     Change Statistics 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.714a 0.510 0.501 16.08605 0.510 59.284 1 57 <0.001 
2 0.757b 0.573 0.549 15.28779 0.063 4.054 2 55 0.023 
a Predictors: (Constant), Serum 25OHD at baseline,  
b Predictors: (Constant), Serum 25(OH)D at baseline, total vitamin D intake, daily sunlight exposure 
c Dependent Variable: Achieved serum 25(OH)D concentrations 
 
    
Coefficients a 
a Dependent Variable: Achieved serum 25(OH)D concentrations. 
 
 
 
 
 
4.4.4.4 Estimated vitamin D dietary requirements by country 
 
The relationship between total vitamin D intake (diet plus supplement from 
intervention) and achieved post-intervention serum 25(OH)D concentration in adult 
women was shown previously in Figure 4.9. To illustrate how recommendations might 
vary between the two countries investigated in this study, linear modelling of the total 
vitamin D intake and post-intervention serum 25(OH)D concentration was used to 
estimate vitamin D intakes that would maintain serum 25(OH)D concentrations above 
selected thresholds in each country (Table 4.9 and 4.10). 
 
  Unstandardized 
Coefficients 
Standardized 
Coefficients 
  95.0% Confidence 
Interval for B 
Correlations 
Model B Std. 
Error 
Beta T Sig. Lower 
Bound 
Upper 
Bound 
Partial Part 
1 (Constant) 23.564 7.459  3.159 0.003 8.628 38.499   
 Baseline 25OHD 0.735 0.095 0.714 7.700 <0.001 0.544 0.926 0.714 0.741 
ANOVA: F(1, 57) = 59.284, p<0.001 
2 (Constant) 17.225 7.427  2.323 0.024 2.370 32.139   
 Baseline 25OHD 0.725 0.091 0.705 7.939 <0.001 0.542 0.908 0.731 0.700 
 Vitamin D intake 0.729 0.261 0.248 2.796 0.007 0.207 1.252 0.353 0.246 
 Sun exposure 0.148 0.589 0.022 0.251 0.803 -1.032 1.328 0.022 0.022 
ANOVA: F(3, 55) = 24.581, p<0.001 
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The response to total vitamin intake (diet plus supplemental vitamin D) was 1.002 
nmol/l in England and 0.791 nmol/l in Brazil, for every 1 μg (40 IU) of vitamin D 
intake. The recommended EAR for women living in England would be 12 μg/d (480 
IU) of vitamin D intake to meet the 50 nmol/l threshold and 37 μg (1490 IU) to meet 
the 75 nmol/l threshold by the end of winter (p=0.001). The corresponding values for 
women in Brazil are 0 μg (0 IU) for the 50 nmol/l threshold and 4.5 μg (180 IU) daily 
for the 75 nmol/l threshold (p= 0.029). 
 
 
Table 4.9 Linear regression model of serum 25(OH)D: total vitamin D intake as a of 
post wintertime 25(OH)D concentrations in England (n=49) 
     Change Statistics 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.443a 0.196 0.179 15.05191 0.196 11.460 1 47 0.001 
a Dependent Variable: Achieved serum 25(OH)D concentrations 
  
 
Coefficients a 
 
a Dependent Variable: Achieved serum 25(OH)D concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Unstandardized 
Coefficients 
Standardized 
Coefficients 
  95.0% Conf. 
Interval for B 
Correlations 
Model B Std. 
Error 
Beta t Sig. Lower 
Bound 
Upper 
Bound 
Partial Part 
1 (Constant) 38.259 3.656  10.465 <0.001 30.904 45.614   
 Vit D intake 1.002 0.296 0.443 3.385 0.001 0.407 1.598 0.443 0.443 
ANOVA: F(1, 47) = 11.460, p=0.001 
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Table 4.10 Linear regression model of serum 25(OH)D: total vitamin D intake as a 
predictor of post wintertime 25(OH)D concentrations in Brazil (n=69) 
     Change Statistics 
Model R R 
Square 
Adjusted 
R Square 
Std. Error 
of the 
Estimate 
R 
Square 
Change 
F 
Change 
df1 df2 Sig. F 
Change 
1 0.269a 0.072 0.058 22.10926 0.072 4.985 1 64 0.029 
a Dependent Variable: Achieved serum 25(OH)D concentrations 
  
  
Coefficients a 
a Dependent Variable: Achieved serum 25(OH)D concentrations. 
 
 
 
 
4.4.5 Plasma parathyroid hormone concentrations  
 
At baseline, mean PTH concentration in England residents was significantly higher than 
within Brazil residents (5.36 ±1.99 pmol/l and 4.49 ±1.47 pmol/l, respectively 
p=0.004). Baseline PTH concentrations ranged from 2.41 to 13.76 pmol/l within those 
living in England and from 2.18 to 8.51 pmol/l in participants living in Brazil.  
 
There were no significant differences in plasma PTH concentrations at baseline 
between the placebo and intervention groups in either country (Table 4.4).  
 
Post-intervention, there was a significant increase in PTH in the placebo groups, in both 
England and Brazil residents, over the 12-week trials (England residents: 1.01 ± 2.2 
pmol/l, 19.2% increase, p=0.04; Brazil residents: 0.67 pmol/l, 14.2% increase, p=0.04) 
(Figure 4.10). Plasma PTH concentrations did not change significantly during the 
intervention period in either vitamin D3 supplemented group (p=0.253 and p=0.149 for 
women living in England and in Brazil, respectively, Table 4.4).  
 
 
  Unstandardized 
Coefficients 
Standardized 
Coefficients 
  95.0% Conf. 
Interval for B 
Correlations 
Model B Std. 
Error 
Beta t Sig. Lower 
Bound 
Upper 
Bound 
Partial Part 
1 (Constant) 71.379 5.256  16.772 <0.001 62.876 79.880   
 Vit D intake 0.791 0.354 0.269 2.233 0.029 0.083 1.499 0.269 0.269 
ANOVA: F(1, 64) = 4.985, p=0.029 
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* p=0.04; (paired samples t-test). Error bars represent SEM. 
 
Figure 4.10 Change in plasma PTH concentrations in adult women over the 12-week 
trial by intervention group. 
 
 
4.4.6 Calcium concentrations 
 
There were no significant differences at either baseline or post-intervention in serum 
corrected calcium concentrations between the intervention groups in each country 
(Table 4.4). There were also no significant changes within intervention groups post-
intervention (p>0.05) (Table 4.4). 
 
 
4.4.7 Safety and adverse events 
 
Only participants living in Brazil had serum 25(OH)D concentrations above 100 nmol/l, 
either at baseline or post-intervention. Of those, three women in the placebo group (of 
which two already had baseline concentrations > 100 nmol/l) and four in the 
supplemented group (all with initial concentrations below 100 nmol/l) had post-
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intervention concentrations between 100 – 120 nmol/l. One woman in the placebo 
group had baseline and post-intervention concentrations of 134.9 and 135.4 nmol/l 
respectively; and two women in the supplemented group had post-intervention 
concentrations of 140.9 and 141.5 nmol/l (with baseline concentrations of 148.6 and 
70.6 nmol/l respectively).  
 
Three participants (one in the England placebo, one in the England supplemented and 
one in the Brazil placebo group) had post-intervention plasma PTH concentrations 
above 10 pmol/l, of which two (both England dwelling) had 25(OH)D concentrations 
below 30 nmol/l and one (Brazil dwelling) above 80 nmol/l/. 
 
None of the participants, including those with such high 25(OHD and PTH 
concentrations, reported any adverse events throughout the duration of the study. Serum 
calcium concentrations were within the reference range for all participants (< 2.5 
mmol/l). 
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4.5 Discussion 
 
In the present study, vitamin D supplementation of 15 μg/day is shown to be 
significantly effective in raising serum 25(OH)D concentrations, regardless of latitude. 
Post-intervention mean serum vitamin D concentrations increased significantly in the 
supplemented group while remaining unchanged in the placebo group, in both 
countries. Supplementation over winter prevented vitamin D deficiency (< 25 nmol/) 
and maintained mean 25(OH)D concentrations above the insufficiency threshold (50 
nmol/l) in England and maintained mean 25 (OH)D concentration above the optimal 
threshold (> 75 nmol/l), with 75% of women presenting optimal levels, in Brazil. In 
comparison to the supplemented groups, post-intervention 20.8% of the women in the 
England trial placebo group presented deficient levels and two thirds (63.6%) of the 
women in Brazil had suboptimal levels. Furthermore, vitamin D supplementation of a 
low dose (15 μg/d) over 12 weeks was shown to be significantly beneficial to bone 
health, regardless of latitude, evidenced by a significant increase in plasma PTH in the 
placebo groups whilst supplementation prevented this seasonal increase in both 
countries.  
 
Although habitual exposure to sunlight has been long considered the most important 
determinant of adequate vitamin D status, few robust RCTs to this data have 
investigated the relative contribution of vitamin D dietary intake and photochemical 
production in the skin on serum 25(OH)D concentrations. Furthermore, advisory 
agencies have consistently highlighted the challenges in establishing reference values 
for adequate vitamin D status and dietary recommendations, particularly due to the 
differences in individual variation as well as the influence of environmental external 
factors. The unsuitability of direct comparison of data from studies conducted in 
different locations is mainly due to significant variations in results between different 
laboratories, different latitudes and different populations / ethnic groups – and therefore 
influencing factors, adding greatly to the difficulty in finding a global consensus.  
 
An important limitation to the current recommendations regarding dietary intakes and 
sunlight exposure to maintain adequate levels is that they are mostly based on RCT’s 
with Caucasian populations in high latitude countries, with limited robust data for other 
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ethnicity and different geographical locations. Consequently, there is a substantial lack 
of evidence on the effectiveness and even necessity of vitamin D supplementation as 
well as the effect of individual sunlight exposure in low latitude countries and their 
native non-Caucasian populations. 
 
In this study, the above‐described challenges and limitations are addressed with two 
parallel randomized placebo-controlled trials, using identical methodologies to 
examine same ethnicity and sex individuals, in opposite (high North vs. low South) 
latitudes, to shed light on the current controversies surrounding vitamin D 
recommendations. Moreover, all samples were analysed at the same high standard 
laboratory, at Imperial College London, UK. The D-SOL study has specifically 
examined the relative contribution of vitamin D supplemental intake and sunlight 
exposure on serum 25(OH)D concentrations and the efficacy of vitamin D 
supplementation in raising and maintaining adequate vitamin D serum levels 
throughout winter, concomitantly preventing increase in PTH concentrations, 
regardless of latitude. 
 
It has been suggested that the average adult would require initial treatment with up to 
1,250 μg (50,000 IU) of vitamin D orally once per week for 6–8 weeks followed by 20-
25 μg (800 - 1000 IU) orally thereafter to improve nutritional insufficiency (< 50 
nmol/l) and 800 to 1000 IU of vitamin D daily to improve suboptimal levels (50-75 
nmol/l) (141). A study with healthy white and African American men and women aged 
18–65 years in Long Island, US (40°N) proposed a dose of 95 μg/d (3800 IU) for those 
above a 25(OH)D threshold of 55 nmol/l and a dose of 125 μg/d (5000 IU) for those 
below that threshold to achieve concentrations above 75 nmol/l (142). Another study in 
a high latitude location, in Ireland (United Kingdom), a dose-response RCT 
conducted with young adults (20-40 years) during winter estimated an increase of 1.96 
nmol/l per 1 μg intake of vitamin D (143).  
 
Few studies have estimated the intake of vitamin D required to increased 25(OH)D 
concentrations in Brazil, with most studies with institutionalized elderly. For instance 
a study conducted in the city of São Paulo (23°S) estimated that supplementation with 
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175 μg (7,000 IU) per day would increase 25(OH)D concentrations an average of 22.5 
nmol/l after three months with this elevation achieving a plateau after six weeks (n=42) 
(144). In a similar elderly institutionalized population (n=46), a RCT estimated an 
average dose of 92.5 μg (3,700 IU) per day of vitamin D3 for six months to achieve 
concentrations of 86.5 nmol/l (145). However, these studies cannot be generalized to 
the wider adult population as there are many factors amongst institutionalized 
individuals, and particularly the elderly, that will not be the same for otherwise healthy 
adults, the main factor being probable likely variation in individual sunlight exposure. 
Up to this date, there are no published studies investigating vitamin D supplementation 
in healthy adult women in Brazil. 
 
The Brazilian Society of Endocrinology and Metabology recommends as a practical 
rule that for every 1 μg (40 IU) supplemented it can be expected to achieve a 0.7 – 1.0 
nmol/l increase in 25(OH)D concentrations, based on recommendations from US 
studies (138). In the present study, every 1 μg (40 IU) of vitamin D intake predicted an 
increase of 1.002 nmol/l in Brazilian women living in England and 0.791 nmol/l in 
Brazilian women living in Brazil. As shown in this chapter, total change in serum 
25(OH)D is strongly influenced by initial concentrations, which explains the smaller 
increase in serum 25(OH)D concentrations from vitamin D supplementation in women 
living in Brazil, that had significantly higher baseline concentrations then those in 
England. This study also showed that women living in Brazil may not need an intake 
of 15 μg (600 IU) as currently recommended as an EAR of 4.5 μg (180 IU) daily was 
estimated to be enough to meet the 75 nmol/l threshold during winter months for 50% 
of the population, as per analysis based on the mean. On the other hand, it was estimated 
that Brazilian women living in England would need a daily EAR of 480 IU (12 μg) of 
vitamin D intake to meet the 50 nmol/l threshold and a daily EAR of 37 μg (1490 IU) 
to meet the 75 nmol/l threshold during winter (144).  
 
From the regression analyses in the overall sample, 67.5% of the variance in 25(OH)D 
concentrations was explained by baseline serum 25(OH)D concentration, total vitamin 
D intake, and individual sunlight exposure level altogether. This represents a large 
predictive ability of these variables. Worth noting however, is that within each country 
baseline concentration was a remarkably stronger predictor in Brazil, explaining 
uniquely 49% of the variance in 25(OH)D concentrations while in England baseline 
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concentration contributed (explained uniquely 14%) as much to the variance in 
25(OH)D concentrations as total vitamin D intake from diet and supplement (explained 
uniquely 14%). Sunlight exposure did not have a unique contribution to any of the 
models. 
 
In fact, the total change in serum 25(OH)D concentrations from supplementation was 
negatively correlated with initial concentrations, meaning that participants with the 
lowest baseline 25(OH)D concentrations had the greatest increase in response to 
vitamin D supplementation over the 12-week wintertime trial. This is in accordance 
with several published studies that have reported a greater effect of vitamin D 
supplementation or stronger associations between serum 25(OH)D concentrations and 
health outcomes in individuals with lower baseline concentrations (139, 151). 
 
Exposure to sunlight is often said to be the most important determinant of adequate 
vitamin D levels (1, 14, 15, 31). Although individual sunlight exposure did not have a 
unique contribution to this analysis, mean baseline 25(OH)D concentrations in women 
living in Brazil was considerably high at the optimal threshold of 75 nmol/l. In low 
latitude countries, most people would easily achieve the daily minimum 1.0 – 1.5 SED 
for vitamin D production, as previously reported in Chapter 3. It might be that for such 
locations, where UV irradiation is very high throughout the year, a minimum sun 
exposure dose is associated with higher levels but an increased sun exposure is not as 
relevant to raising vitamin D levels as assumed, due to 25(OH)D concentrations 
reaching a maximum plateau from sunlight exposure, as also shown in Chapter 3 of this 
Thesis.  
 
Therefore, recommendations for increasing sun exposure time in such locations could 
needlessly expose individuals to a greater risk of detrimental overexposure, without 
having significant contribution to raising or maintaining vitamin D levels. Besides, 
because most people are likely to achieve the minimum exposure required, inadequate 
levels in some individuals in sunny countries might be better explained by other factors, 
and such individuals are likely to benefit more from recommending a higher vitamin D 
intake, either from diet or supplements, than changing sunlight exposure behaviour.  
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A few participants had baseline and/or achieved serum vitamin D concentrations above 
120 nmol/l but no adverse events or symptoms were reported, supporting the safety of 
both 15 μg daily doses, regardless of latitude or initial concentrations, as well as higher 
circulating levels.  
 
 
4.5.1 Strengths and limitations 
 
The strengths of this study are in its parallel directly comparable placebo-controlled 
trials, designed specifically to investigate the contribution of both vitamin D sources, 
food and endogenous production via sunlight exposure, on serum vitamin D 
concentrations. Conducting both trials in each country’s respective wintertime lessened 
extreme disparities in UV radiation between high and low latitudes. The study had a 
satisfactory intervention compliance and drop-out rates were low. Serum 25(OH)D 
concentrations from both trials were measured at the same laboratory in the UK and 
using the gold standard LC-MS/MS technique. Participants’ individual actual UV 
radiation exposure was measured at two time-points, building on the limited data on 
individual exposure levels currently available. Additionally this study contributes 
valuable data to the current lack of studies on vitamin D status, supplementation and 
sunlight exposure in adult Brazilian women. Supplement dose for intervention matches 
the current recommendation for the studied population, being therefore translatable to 
public health strategies.  
 
Limitations include the sample of Brazilian healthy adult women which may  not be 
generalizable to other ethnic groups, age ranges, or people with certain health issues or 
males. A larger sample within each latitude might have given more power to better 
determine influential factors relationships and interactions with vitamin D status. A 
longer duration of the study with additional mid-point measurements could have 
potentially giving further relevant information on the interaction between response to 
supplementation and any seasonal variations in vitamin D levels. There was also a lack 
of opportunity to generate a dose-response data that would have provided valuable 
insight into the response to vitamin D and thus better elucidate the interactions being 
investigated in the study. 
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Conclusions 
 
In conclusion, the D-SOL study parallel RCTs have demonstrated that a low dose 
vitamin D supplementation is a remarkably effective strategy in raising circulating 
25(OH)D levels and prevented vitamin D deficiency in a high latitude and maintaining 
optimal status in a low latitude location, over winter months. 
 
The results presented in this chapter suggest that those with the lowest baseline 
25(OH)D concentrations had the greatest increase in response to vitamin D 
supplementation over the 12-week wintertime trial. Sunlight exposure did not 
contribute independently to increasing vitamin D serum concentrations. Therefore, 
recommendations of increasing individual exposure to sunlight are not likely to be an 
effective approach to significantly changing circulating 25(OH)D concentrations, 
during wintertime. In a low latitude location, those presenting lower levels are in fact 
in the same high UV radiation ambient as their vitamin D sufficient native fellows, and 
therefore are more likely to be affected by other influential factors on vitamin D status. 
For those in high latitude locations, from October to March there is nearly no UVB 
radiation and therefore increased exposure to sunlight will not be effective in producing 
vitamin D in the skin. The findings also suggest that the recommended vitamin D intake 
of 15 μg (600 IU), particularly as a supplement, is an adequate recommendation and 
indeed required throughout winter for optimal bone health in Brazilian women living 
at high latitude.  
 
More importantly, it is evident from the findings reported in this thesis, that importance 
of recommendations for sunlight exposure and dietary intake for optimal vitamin D 
status elaborate specifically to Brazil. This is particularly relevant since the findings 
here presented indicate that current recommendation vitamin D intake based on US 
guidelines might be higher than the actual need for adult women living in this low 
latitude country. 
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5 
Vitamin D and Musculoskeletal Health  
 
 
5.1 Background 
 
Calcium and vitamin D have been long established as essential nutrients with a major 
role in bone health. Calcium is the most abundant mineral in the body and vital to 
functions related to vascular contraction, muscle function, nerve transmission, 
intracellular signaling and hormonal secretion (146,147). Ninety nine percent of the 
body’s calcium supply is stored in the bones and teeth where it supports structure and 
function. Bone acts as the calcium reservoir to maintain constant calcium homeostasis, 
with around 99% of the organism’s calcium supply stored in the bones and teeth. 
Vitamin D also plays a key role in calcium homeostasis, promoting calcium absorption 
in the gut and resorption in the kidney, as well as stimulating bone formation and 
remodeling (146). Therefore, optimal intakes of calcium and vitamin D  are generally 
regarded as fundamental factors in the prevention and treatment of osteoporosis. 
 
Calcium can be found naturally in foods such as milk, dairy and some vegetables 
(i.e. kale and broccoli), as well as in fortified foods, being also available as a dietary 
supplement and as a component of some medicines (such as antacids)(71). The EAR 
(IOM, US) for calcium from all sources, or the daily intake level estimated to meet the 
calcium requirement for 97.5% of the population, is 1,000 mg/day for men ≤70 years 
and women ≤50 years, and 1,200 mg/day for men >70 years and women >50 years 
whereas the EAR, requirement to cover 50% of the population, is 800 mg/day for men 
≤70 years and women ≤50 years, and 1,000 mg/day for men >70 years and women >50 
years (148). In the UK the equivalent value is the Recommended Nutrient Intake (RNI) 
of 700 mg/day for men and women > 19 years old (149). 
 
The two forms of vitamin D, ergocalciferol (vitamin D2) and cholecalciferol (D3) are 
found in few foods, such as oily fish, mushrooms and in smaller amounts in animal 
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origin foods including milk, eggs and meat (70). Vitamin D fortified foods and 
supplements are additional sources of vitamin D and intakes from these sources can 
vary substantially by product and country. The IOM recommends a dietary allowance 
(RDA) of 15 μg (600 IU) of vitamin D per day, with no distinction between children 
>1 year old and adults up to the age of 70 years and 800 IU for ages >70 years, whereas 
the SACN latest guidance report has recommended a daily intake of 10 μg (400 IU) for 
all adults and children > 1 year old for musculoskeletal health benefits (74,148). 
 
The associations of calcium intake, vitamin D intake and status with bone mineral 
density (BMD) and the risk of fractures have been studied extensively over the past 
decades (137,150,151). A considerable amount of human evidence supports the well-
recognized and intuitive contribution of calcium for bone homeostatic regulation and 
treatment strategies for osteoporosis. Observational studies as well as randomized 
controlled trials have generally shown that higher calcium and vitamin D intakes (either 
from food or supplementation), compared to lower, in the long-term may have relevant 
benefits to bone health and reduce the risk of osteoporosis by slowing the rate of bone 
loss associated with aging. (146,152–154).  
 
Parathyroid hormone (PTH), a hormone secreted by the parathyroid glands in response 
to low serum calcium levels, is also well recognized as a fundamental part of bone 
homeostasis. PTH triggers the hydroxylation of 25(OH)D to the active form 
1,25(OH2)D leading to enhanced intestinal absorption of calcium. Chronic elevated 
PTH concentrations can have significant negative impacts on BMD and consequently 
and increased risk of fractures over time (146,147,155). Low dietary calcium and 
vitamin D intakes, as well as inadequate vitamin D status, can be independent 
contributors to high PTH concentrations (8,43,50). The negative correlation between 
PTH and vitamin D, and negative effects of higher PTH on bone health, have been 
previously demonstrated but mostly in elderly and/or osteoporotic populations 
(50,108,156–158), and therefore there is still limited data on healthy adults, particularly 
in Latin America and Brazil (20). 
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5.2 Objectives 
 
 Objective 1 
To analyse the influence of habitual dietary vitamin D and calcium intakes on bone 
health parameters assessed by either pQCT or DXA in adult women. 
 
 Objective 2 
To examine the associations of serum 25(OH)D and plasma PTH concentrations with 
bone health parameters assessed by either pQCT or DXA in adult women. 
 
5.3 Methods 
 
All participants at commencement of the study provided a written informed consent. 
Full clinical and methodological study details are described in Chapter 2.  
 
This is a cross-sectional analysis of endocrine status, i.e. 25(OH)D and PTH 
concentrations, calcium and vitamin D intake and bone mineral density in healthy adult 
Brazilian women in living England (51°N) and adult Brazilian women living in Brazil 
(16°S), recruited for the D-SOL study. The participants were screened according to 
exclusion criteria that included potential cofounders likely to affect vitamin D 
metabolism and pregnant or planning a pregnancy during the study period, as detailed 
previously in Chapter 2 of this thesis. All participants at commencement of the study 
provided a written informed consent.  
 
For the England trial, a peripheral quantitative computed tomography (pQCT) was 
performed on the participant’s non-dominant forearm at the baseline visit only, to 
measure volumetric bone mineral density at the 4% and 66% radial site. For participants 
in Brazil, whole body bone mineral density and bone mineral content and lower spine 
and femur bone mineral density were measured via a DXA (dual energy X-ray 
absorptiometry) scan at baseline only. The same cut-off values for T-score 
classification (i.e., T-score ≥−1.0 defined as low-risk score, T-score between −1.0 and 
−2.5 defined as moderate, and ≤−2.5 defined as high-risk score for osteoporosis) (159) 
were applied for pQCT and DXA scans. 
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5.3.1 Statistical analysis 
 
Statistical analysis of the data was undertaken using SPSS software for Windows 
(version 25.0; IBM Corp, Armonk, NY). For this cross-sectional analysis, menopausal 
women (n=5) were excluded due to the know effects of menopause on bone metabolism 
(160,161). 
 
Data were tested for normal distribution using the Kolmogorov-Smirnov tests. Non-
normally distributed variables were log transformed and reported in the original scale. 
Non-parametric tests were used when log transforming did not normalise the data. 
Descriptive statistics were determined for all variables. Continuous variables are 
presented as mean ±SD for normally distributed variables or as median (25%, 75% 
percentiles) for not normally distributed. For categorical variables, frequency and 
percentage are reported. 
 
Baseline characteristics (age, weight, BMI, waist circumference, dietary intakes and 
biomarkers) were compared between countries, by independent t-tests, or Mann-
Whitney U tests if appropriate.   
 
For each country separately, ANOVA, or the corresponding non-parametric test 
Kruskal- Wallis, were used to compare bone parameter measurements between age 
tertiles and between vitamin D status groups. Pearson’s correlation, or the 
corresponding non-parametric Spearman rho, were applied to investigate the 
association between bone parameter measurements and 25(OH)D or PTH 
concentrations as well as vitamin D and calcium intakes. 
 
Results are presented separately for each country as measurements derived from 
different methodologies (England: pQCT scan of radius; Brazil: DXA scan of spine and 
femur). 
 
A p value of <0.05 was considered significant. 
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5.4 Results 
 
5.4.1 Baseline characteristics 
 
Baseline anthropometric, dietary and biochemical characteristics for this analysis are 
presented in Table 5.1, by country of residence, due to slightly different sample 
(excludes menopausal women) than presented previously in Chapter 3. Brazilian 
women living in England were significantly older (p<0.001), heavier (p=0.002) and had 
a greater waist circumference (p<0.001) than those living in Brazil.  
 
Overall (n=114), mean habitual vitamin D dietary intake was 2.44 ± 1.91 μg/day and 
mean calcium intake was 627 ± 315 mg/day. Mean vitamin D and calcium intakes were 
significantly higher in England residents compared to Brazil residents (p<0.001 and 
p=0.003, respectively). In total (n=119), 99.2% had intakes below the EAR of 10 
μg/day proposed by SACN (74) and by the IOM (71), and 100% had intakes below the 
RDA of 15 μg/day (71). For calcium, in the overall sample 77.2% had dietary intakes 
below the RNI of 700 mg/day (74), while 91.2% had average intakes below the 800 
mg/day EAR reference (71).  
 
In participants living in England mean 25(OH)D concentration was significantly lower 
and PTH concentration was significantly higher than within participants in Brazil. 
There were no significant differences between Brazilian women living in England and 
in Brazil for serum calcium concentrations. 
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Table 5.1 Baseline anthropometric characteristics of adult Brazilian women by country 
of residence (n=130)1 
1 Values are median (25th, 75th percentile) or mean ± SD. 
2 Statistical analysis: Mann-Whitney U unless otherwise stated; a Independent t-test 
3 Albumin corrected serum calcium concentrations 
≠ Measurements derived from different methodologies (England: bio-impedance; Brazil: DXA scan) 
 
 
5.4.2 Bone densitometry 
 
5.4.2.1 England cohort 
 
Radial bone parameter measurements, determined by pQCT, for Brazilian women 
living in England are shown in Table 5.2, stratified by tertile of age. Total volumetric 
BMD at both distal and diaphyseal sites was significantly higher in women younger 
than 29 years of age compared to those 30 or over (p=0.011). There were no significant 
differences between age groups in any of the other bone parameters. Only one 
participant in the England cohort (30-36 years old group) had a low t-score for total 
volumetric BMD at both distal and diaphyseal sites. 
 
 
 
 
 England (n = 51) Brazil (n = 79) p value2 
Age (years) 33 (28, 38) 27 (24, 31) <0.001 
Weight (kg) 66.7 (60.7, 73.5) 60.1 (54.1, 71.3) 0.002 
Waist Circumference (cm) 86.3 (77.0, 96.0) 70.4 (66.1, 77.2) <0.001 
BMI (kg/cm2) 24.6 (22.6, 28.4) 23.3 (20.3, 26.3) 0.009 
Body fat (%)≠ 30.95 ± 6.00 38.65 ± 8.52 <0.001 a 
Vitamin D (μg/day) 2.59 (1.55, 3.92) 1.57 (0.73, 2.79) <0.001 
Calcium (mg/day) 711.76 (537.22, 879.51) 479.97 (347.42, 704.92) 0.003 
Serum 25(OH)D (nmol/l) 35.2 ± 14.9 75 ± 22.1 <0.001a 
Plasma PTH (pmol/l) 5.39 ± 2.07 4.49 ±1.47 0.004 a 
Serum Calcium (mmol/l)3 2.30 ± 0.07 2.28 ± 0.06 0.066 a 
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Table 5.2 Radial bone densitometry assessed by pQCT of Brazilian women living in 
England by tertile of age (n= 51) 
Bone Parameter  
All 
Age  
Tertile 1 
(≤ 29 years) 
Tertile 2 
(30-36 years) 
Tertile 3 
(> 37 years) 
p value 
Number (n) 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD (mg/cm3) 
 
51 
 
1.07 ± 0.14 
353.23± 51.81 
199.29 ± 57.78 
 
18 
 
1.05 ± 0.15 
380.72 ± 60.82a 
205.61 ± 73.89 
 
16 
 
1.08 ± 0.13 
329.97 ± 37.07 a 
189.48 ± 44.14 
17 
 
1.08 ± 0.13 
346.12 ± 41.47 
201.85 ± 51.53 
 
 
0.821 
0.011 
0.709 
Radius diaphyseal site (66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD (mg/cm3) 
 
0.96 ± 0.14 
714.38 ±86.33 
1127.23 ± 36.44 
 
0.93 ± 0.15 
753.33 ± 68.57 
1140.09 ± 27.03 
 
0.97 ± 0.12 
693.10 ± 90.80 
1124.26 ± 37.61 
 
0.97 ± 0.14 
693.17 ± 89.02 
1116.43 ± 41.59 
 
0.557 
0.056 
0.147 
Calculated T-score n(%) 
Total vBMD (4%) 
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
 
Trabecular vBMD (4%) 
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
 
Total vBMD (6%) 
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
 
Cortical vBMD (66%) 
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
 
 
50 (98%) 
1 (2%) 
0 
 
 
51 (100%) 
0 
0 
 
 
50 (98%) 
1 (2%) 
0 
 
 
56 (100%) 
0 
0 
 
 
18 (100%) 
0 
0 
 
 
18 (100%) 
0 
0 
 
 
18 (100%) 
0 
0 
 
 
18 (100%) 
0 
0 
 
 
16 (94.8%) 
1 (5.2%) 
0 
 
 
16 (100%) 
0 
0 
 
 
16 (94.8%) 
1 (5.2%) 
0 
 
 
16 (100%) 
0 
0 
 
 
17 (100%) 
0 
0 
 
 
17 (100%) 
0 
0 
 
 
17 (100%) 
0 
0 
 
 
17 (100%) 
0 
0 
 
1 Values: mean ± SD or n(%); 2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. 
Values in same column with same superscript letters are significantly different (a p <0.001). 
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5.4.2.2 Brazil cohort 
 
Lumbar spine (L1-L4) and femur measurements, determined by DXA, for Brazilian 
women living in Brazil are shown in Table 5.3, stratified by tertile of age. There were 
no significant differences between age groups in any of the bone parameters. Overall, 
25% and 18% of participants had a low t-score for lumbar spine and femur, 
respectively, with the majority of those being under 30 years old. Those with a low t-
score had also predominantly a healthier BMI, with statistical significance for lumbar 
spine (90.5% BMI < 25 kg/m2, Pearson Chi-square= 0.038), but not for femur (72.7% 
BMI < 25 kg/m2, Pearson Chi-square=0.912).    
 
Table 5.3 Lumbar spine and femur bone densitometry assessed by DXA of Brazilian 
women living in Brazil by tertile of age (n=79) 
Bone Parameter  
All 
Age  
Tertile 1 
<=25 
Tertile 2 
26 - 30 
Tertile 3 
>31 
p 
value 
Lumbar Spine  
Number (n) 
BMD  
 
79 
1.13 ± 0.11 
 
33 
1.12 ± 0.12 
 
25 
1.13 ± 0.11 
 
21 
1.15 ± 0.11 
0.537 
Femur  
Number (n) 
BMD 
 
64 
0.98 ± 0.10 
 
27 
0.97 ± 0.10 
 
20 
0.97± 0.12 
 
17 
1.01 ± 0.11 
0.495 
Total BMC 
Number (n) 
BMC 
 
79 
2304.87 ± 401.76 
 
33 
2304.87 ± 401.76 
 
25 
2459.92 ± 377.29 
 
21 
2460.95 ± 338.42 
0.204 
T-score n(%) 
Lumbar Spine BMD  
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
Femur BMD 
Normal (> -1.0) 
Low (-1.0 – -2.5) 
Osteoporosis < 2.5 
 
 
58 (73.4%) 
20 (26.6%) 
0  
 
52 (81.2%) 
12 (18.8%) 
0 
 
 
23 (69.7%) 
9 (27.3) 
0 
 
22 (81.5%) 
5 (18.5%) 
0 
 
 
18 (72%) 
7 (28%) 
0 
 
15 (75%) 
5 (25%) 
0 
 
 
13 (81%) 
4 (19%) 
0 
 
15 (88.2%) 
2 (11.8%) 
0 
 
1 Values: mean ± SD or n(%); 2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test.  
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5.4.3 Correlations between bone parameters and age and adiposity 
 
5.4.3. England cohort 
 
BMC at radius distal site (4%) BMC at the distal site (4%) was positively correlated 
with weight and BMI (p=0.021 and p=0.024 respectively). Total vBMD at the 
diaphyseal site (66%) and cortical vBMD were negatively correlated with weight 
(p=0.016 and p=0.025 respectively) and BMI (p=0.018 and p=0.027 respectively) 
(Table 4). When weight and BMI were entered into a regression model as predictors of 
BMC at the distal site, the model did not achieve statistical significance to explain the 
variation (p=0.068). When weight and BMI were entered into a regression model as 
predictors of total vBMD at the diaphyseal site , 33.7% (p=0.055) of the total variation 
was explained by the model but none of the predictors had a significantly unique 
contribution. When weight and BMI were entered into a regression model as predictors 
of cortical vBMD, the model did not achieve statistical significance to explain the 
variation (p=0.08). 
 
Table 5.4 Correlations between age and adiposity and radial bone densitometry 
assessed by pQCT of Brazilian women living in England by tertile of age (n= 51) 
Bone Parameter Age (years) Weight (kg) BMI (kg/m2) Body fat (%) 
r value p value r value p value r value p value r value p value 
 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD 
(mg/cm3) 
 
 
 
0.186 
-0.143 
-0.007 
 
 
0.191 
0.316 
0.962 
 
 
0.323 
-0.005 
-0.118 
 
 
0.021 
0.970 
0.410 
 
 
0.317 
-0.028 
-0.112 
 
 
0.024 
0.847 
0.435 
 
 
0.118 
0.034 
0.085 
 
 
0.386 
0.814 
0.551 
Radius diaphyseal site 
(66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD 
(mg/cm3) 
 
 
0.216 
-0.213 
-0.223 
 
 
0.128 
0.134 
0.116 
 
 
0.256 
-0.335 
-0.313 
 
 
0.070 
0.016 
0.025 
 
 
0.253 
-0.330 
-0.309 
 
 
0.074 
0.018 
0.027 
 
 
-0.063 
-0.159 
-0.122 
 
 
0.345 
0.266 
0.393 
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5.4.3.2 Brazil cohort 
 
Age was positively correlated with BMD at the femur and with BMC (p=0.029 and 
p=0.017, respectively), but not BMD at the lumber spine (p=0.292). Weight, BMI and 
body were correlated with BMD at the lumbar spine and femur and with BMC (all 
p<0.01). (Table 5). When age along with either weight, BMI or body fat were entered 
into a regression model as predictors of BMD at the femur, 64.3% (p<0.001) of the total 
variation was explained by the model, and only BMI had a significantly unique 
contribution (p=0.027). When age along with weight, BMI or body fat were entered 
into a regression model as predictors of BMC, 67% (p<0.001) of the total variation was 
explained by the model, and only weight and BMI had a significantly unique 
contributions to the model (p<0.001 and p=0.004, respectively). When weight, BMI 
and body fat were entered into a regression model as predictors of BMD at the lumbar 
spine, 34.2% (p=0.025) of the total variation was explained by the model but none of 
the predictors had a significantly unique contribution. 
 
Table 5.5 Correlations between age and adiposity and lumbar spine and femur bone 
densitometry assessed by DXA of Brazilian women living in Brazil by tertile of age 
(n= 79) 
Bone Parameter Age (years) Weight (kg) BMI (kg/m2) Body fat (%) 
r value p value r value p value     
Lumbar Spine BMD (n=79) 0.120 0.292 0.337 0.002 0.298 0.008 0.252 0.025 
Femur BMD (n=64) 0.273 0.029 0.583 <0.001 0.612 <0.001 0.378 0.002 
Total BMC (n=79) 0.267 0.017 0.606 <0.001 0.585 <0.001 0.412 <0.001 
 
 
 
5.4.4 Correlations between bone parameters and habitual dietary vitamin D 
and calcium intakes  
 
5.4.4.1 England cohort 
 
There were no significant correlations between radial bone parameter measurements, 
determined by pQCT, and habitual dietary vitamin D and calcium intakes for Brazilian 
women living in England (Table 5.6).  
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Table 5.6 Correlations between habitual dietary vitamin D and calcium intakes and 
radial bone densitometry assessed by pQCT of Brazilian women living in England by 
tertile of age (n= 51) 
 
 
 
5.4.4.2 Brazil cohort 
 
There were no significant correlations between lumbar spine (L1-L4) and fêmur bone 
parameter measurements, determined by DXA, and habitual dietary vitamin D and 
calcium intakes for Brazilian women living in Brazil (Table 5.7). 
 
Table 5.7 Associations between habitual dietary vitamin D and calcium intakes and 
lumbar spine and femur bone densitometry assessed by DXA of Brazilian women living 
in Brazil by tertile of age (n= 79) 
Bone Parameter Vitamin D intakes Calcium intakes 
r value p value r value p value 
Lumbar Spine (L1-L4) BMD (n=68) 0.137 0.264 -0.128 0.297 
fêmur BMD (n=55) 0.216 0.113 -0.162 0.237 
Total BMC (n=68) 0.013 0.918 -0.151 0.218 
 
 
 
Bone Parameter Vitamin D intakes Calcium intakes 
r value p value r value p value 
 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD (mg/cm3) 
 
 
 
0.172 
0.195 
0.189 
 
 
0.254 
0.194 
0.209 
 
 
-0.180 
-0.054 
-0.065 
 
 
0.232 
0.721 
0.699 
Radius diaphyseal site (66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD (mg/cm3) 
 
0.255 
0.117 
0.097 
 
0.088 
0.439 
0.523 
 
-0.183 
0.144 
0.017 
 
0.224 
0.450 
0.908 
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5.4.5 Associations between bone parameters and 25(OH)D concentrations 
 
Correlations between bone parameter measurements and 25(OH)D concentrations are 
presented separately for each country as measurements derived from different 
methodologies (England: pQCT scan of radius; Brazil: DXA scan of spine and fêmur). 
 
 
5.4.5.1 England cohort 
 
There was a trend for a weak positive relationship between total volumetric BMD at 
the diaphyseal site and 25(OH)D concentrations, but significance was lost after 
controlling for age and BMI (p=0.171). There were no significant correlations between 
any other bone parameter measurements (Table 5.8). 
 
Table 5.8 Associations between 25(OH)D concentrations and radial bone densitometry 
assessed by pQCT of Brazilian women living in England (n= 51) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bone Parameter 25(OH)D 
r value p value 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD (mg/cm3) 
 
 
0.089 
-0.084 
0.017 
 
0.537 
0.562 
0.908 
Radius diaphyseal site (66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD (mg/cm3) 
 
-0.180 
0.278 
0.173 
 
0.214 
0.051 
0.229 
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5.4.5.2 Brazil cohort 
 
There were no significant correlations between lumbar spine (L1-L4) and fêmur bone 
parameter measurements, determined by DXA, and 25(OH)D concentrations for 
Brazilian women living in Brazil (Table 5.9). 
 
Table 5.9 Associations between 25(OH)D concentrations and lumbar spine and femur 
bone densitometry assessed by DXA of Brazilian women living in Brazil (n= 79) 
 
 
 
 
 
 
 
 
5.4.6 Associations between bone parameters and vitamin D status 
 
5.4.6.1 England cohort 
 
When stratified by baseline vitamin D status as previously defined in this thesis (Table 
2.5, section 2.4.7, Chapter 2), women with vitamin D deficiency (<25 nmol/l) had 
significantly lower total (p=0.0019) and cortical (p=0.039) vBMD at the diaphyseal site 
than women classed as insufficient (25 – 49.9 nmol/l), and significantly lower total 
vBMD at the diaphyseal site than women with levels above 50 nmol/l (0.044) (Table 
5.10). After controlling for age and BMI, the significant differences remained only for 
total vBMD at the diaphyseal site but not for cortical vBMD (ANCOVA p =0.047 and 
p=0.170, respectively). 
 
 
 
 
Bone Parameter 25(OH)D 
r value p value 
Lumbar Spine (L1-L4) BMD (n=79) 0.060 0.601 
femur BMD (n=64) 0.059 0.607 
Total BMC (n=79) 0.101 0.425 
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Table 5.10 Radial bone densitometry assessed by pQCT of Brazilian women living in 
England by vitamin D status (n= 51) 
Bone Parameter  
All 
25(OH)D in nmol/l  
< 25 25 – 49.9 50 – 74.9 p2 
Number (n) 
 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD (mg/cm3) 
 
51 
 
 
1.07 ± 0.14 
352.23 ± 51.81 
199.29 ± 57.78 
14 
 
 
1.06 ± 0.12 
355.81 ± 40.47 
189.56 ± 25.61 
28 
 
 
1.07 ± 0.15 
356.86 ± 57.76 
208.46 ± 63.39 
9 
 
 
1.10 ± 0.13 
337.95 ± 50.35 
185.91 ± 57.87 
 
 
 
0.782 
0.630 
0.462 
Radius diaphyseal site (66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD (mg/cm3) 
 
 
0.96 ± 0.14 
714.39 ± 86.33 
1127.23 ± 36.44 
 
 
0.97 ± 0.13 
658.54 ± 104.23a,b 
1107.74 ± 44.43 c 
 
 
 
0.96 ±  0.16 
732.91 ± 73.85 a 
1136.66 ± 31.41 c 
 
 
0.92 ± 0.05 
743.62 ± 53.80 b 
1128.24 ± 28.01 
 
0.642 
0.014 
0.049 
1 Values: mean ± SD  
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. Values in same row with same 
superscript letters are significantly different (a p = 0.019, b p = 0.044, c p = 0.039). 
 
5.4.6.2 Brazil cohort 
 
There were no significant differences in any bone parameter measurements by vitamin 
D status, for Brazilian women living in Brazil (Table 5.11). 
 
Table 5.11 Lumbar spine and fêmur bone densitometry assessed by DXA of Brazilian 
women living in Brazil by vitamin D status (n= 79) 
Bone Parameter  
All 
25(OH)D in nmol/l  
25 – 49.99 50 – 74.99 > 75 p value 
Lumbar Spine (L1-L4)  
Number (n) 
BMD 
 
79 
1.13  
±0.12 
 
9 
1.11 
±0.11 
 
30 
1.13 
±0.12 
 
40 
1.14 
±0.10 
0.716 
Femur  
Number (n) 
BMD 
 
64 
0.98  
± 0.10 
 
8 
0.94 
±0.10 
 
25  
0.97    
± 0.10 
 
31 
1.00 
±0.11 
0.728 
Total  
Number (n) 
BMC 
 
79 
23.95.43 ± 
381.24 
 
9 
2305.66 
± 372.97 
 
30 
2391.46 
± 448.47 
 
40  
2418.60 
± 331.93 
0.335 
1 Values: mean ± SD  
2 Statistical analysis: one-way ANOVA with post-hoc Tukey’s test. 
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5.4.7 Associations between bone parameters and PTH concentrations 
 
As previously reported, PTH concentrations were negatively correlated with 25(OH)D 
concentrations (r= -0.285, p= 0.001). A non-linear regression cubic model was found 
to have the best fit (n = 130, R2 = 0.113, p = 0.001), with a PTH reaching a minimum 
plateau at 25(OH)D concentrations of over 75 nmol/l (Section 3.4.9, Chapter 3).  
 
Overall (n=134), 10.4% of participants presented with secondary hyperparathyroidism 
(PTH concentrations > 6.9 pmol/l). The prevalence of secondary hyperparathyroidism 
according to vitamin D status was 28.6% (n=14) in vitamin D deficient participants 
(<25 nmol/l) and 12.2% (n=41) within vitamin D insufficient participants (25 – 49.9 
nmol/l), Only 3 (5%) participants with adequate levels (50 – 74.9 nmol/l) and 2 (2.6%,) 
participants with optimal levels (> 75 nmol/) presented with secondary 
hyperparathyroidism (p=0.086 for comparison of prevalence across status groups). 
(Figure 5.1)  
 
 
 
Figure 5.1 Prevalence of secondary hyperparathyroidism (PTH > 6.9 pmol/l) at 
baseline according to vitamin D status in Brazilian women recruited to a vitamin D 
supplementation study (n=134) 
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5.4.7.1 England cohort 
 
Correlations between radial bone parameter measurements, determined by pQCT, and 
PTH concentrations for Brazilian women living in England are shown in Table 5.12. 
There was a significant positive association between PTH concentrations and BMC at 
both distal and diaphyseal sites (p=0.0012 and p =0.001, respectively). Total vBMD at 
the diaphyseal site was significantly negatively correlated with PTH concentrations 
(p=0.026). However, after controlling for age and BMI significance remained only for 
BMC at diaphyseal site (p=0.039) but not for BMC at distal site or total vBMD at the 
diaphyseal site (p=0.064 and p=0.078, respectively). 
 
Table 5.12 Associations between PTH concentrations and radial bone densitometry 
assessed by pQCT of Brazilian women living in England (n= 51) 
Bone Parameter PTH 
r value p value 
Radius distal site (4%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Trabecular vBMD (mg/cm3) 
 
 
0.348 
0.108 
0.085 
 
0.012 
0.450 
0.553 
Radius diaphyseal site (66%) 
BMC (g/cm) 
Total vBMD (mg/cm3) 
Cortical vBMD (mg/cm3) 
 
0.435 
-0.312 
-0.184 
 
0.001 
0.026 
0.197 
 
 
5.4.7.2 Brazil cohort 
 
There were no significant correlations between lumbar spine (L1-L4) and femur bone 
parameter measurements, determined by DXA, and PTH concentrations for Brazilian 
women living in Brazil (Table 5.13). 
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Table 5.13 Correlations between PTH concentrations and lumbar spine and femur bone 
densitometry assessed by DXA of Brazilian women living in Brazil (n= 78) 
Bone Parameter PTH 
r value p value 
Lumbar Spine (L1-L4) BMD (n=78) 0.004 0.976 
Femur BMD (n=63) 0.215 0.900 
Total BMC (n=78) 0.114 0.319 
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5.5 Discussion 
 
Vitamin D is essential for musculoskeletal health, and there is a consensus that serum 
concentrations should be at least 25 nmol/l to prevent detrimental effects to bone.  The 
present cross-sectional analysis of healthy Brazilian adult women showed good bone 
health in women living in England, but 18% and 25% of women in Brazil presented 
with a low t-score for lumbar spine and femur, respectively. As a result of Chi-square 
test analysis, higher proportion of these women with a BMI < 25 kg/m2 was observed 
in the lower BMD t-score group compared to normal t-score, however the difference 
was statistically significant only for lumbar spine. Furthermore, association with bone 
parameters were significantly associated with adiposity in participants in the England 
cohort and with adiposity and age in the Brazil cohort. This study also found that 
amongst women living in England those with vitamin D deficiency (<25 nmol/l) had 
significantly lower total vBMD at the diaphyseal radius than those with greater 
concentrations, independent of age and BMI. There were no associations between 
25(OH)D status and any of the measures from DXA scan in participants from the Brazil 
cohort although the range of Vitamin D status was smaller and the generally better 
status of deficiency much lower which may have limited the effects on bone. 
 
The low t-score associated with a BMI < 25 kg/m2 and associations between bone 
parameters and adiposity suggest that the observed poorer bone health in this sample is 
likely to be due to lower weight. These findings are in agreement with several of studies 
that have demonstrated positive association of BMI with BMD that is likely explain by 
a greater load on weight-bearing bones (162–165). In a cross-sectional study, a total of 
412 Brazilian postmenopausal women, aged 40-75 years, with BMD assessed by DXA 
at the lumbar spine, higher BMI reduced risk for osteoporosis (166). A study with 393 
post-menopausal Brazilian women reported a lower prevalence of osteopenia and 
osteoporosis amongst obese women compared to those with eutrophic BMI (DXA-
derived BMD assessment) (167). Another study in São Paulo, with 413 Brazilian 
women (52.5% < 59 years and 47.5% > 60 years) BMI was shown to be a positive 
predictor for DXA-derived BMD at the femoral neck (168). 
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A considerable amount of human evidence supports the well-recognized and intuitive 
contribution of calcium intake for bone homeostasis maintenance.  Human 
supplementation cohorts have showed that higher calcium intake in the long-term could 
have relevant benefits to bone health and reduce the risk of osteoporosis by slowing the 
rate of bone loss associated with aging (169), and effects might be strongest in 
postmenopausal women, rather than peri-menopausal (early stages) (170).  In the 
United Kingdom, the latest national survey reported mean dietary calcium intakes of 
897 and 746 mg/day for men and women aged 19 - 64 years, respectively (NDNS years 
7-8, 2015–2016)(171). In Brazil, the latest national survey available to date reported 
that mean dietary calcium intakes were 546.4 and 476.4 mg/day for men and women 
aged 20 - 59 years, respectively (POF, 2008-2009)(109).  
 
To date, there are still few longitudinal studies that have investigated the association of 
long-term lower calcium intake bone health outcomes later in life, particularly from a 
younger age in adulthood i.e. < 30-35 years. A longitudinal study 5022 women (born 
between 1914 and 1948 and followed up for 19 years) and with modest dietary calcium 
intake reported that only the lowest quintile of calcium intake was associated with 
increased risk of fracture or osteoporosis (172). It has been suggested that the 
association between calcium and BMD might not be consistently linear, and a sufficient 
vitamin D level are likely to compensate for the negative effects of low calcium intake 
on bone (173–175). 
 
In this cohort, 72.8% of participants had dietary calcium intakes below the RNI of 700 
mg/day, while only 5.2% met the 1000 mg/day RDA reference, whilst 100% of 
participants had dietary vitamin D intakes below the 15 μg/day RDA recommended by 
the IOM (71) and 99.2% had intakes below the RNI of 10 μg/day proposed by SACN 
(74). Despite this there were  no significant correlations between bone parameter 
measurements and habitual dietary vitamin D and calcium intakes, either for England 
or Brazil dwelling participants perhaps again reflecting the narrow range of intakes and 
therefore lack of discriminatory power in this sample.  
 
Elevated concentrations of serum PTH are associated with several adverse outcomes, 
particularly musculoskeletal (35,89,176). Secondary hyperparathyroidism may lead to 
bone loss due to increased bone turnover rates (35,177). Several studies have shown 
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25(OH)D to be inversely correlated with PTH (8,35,135,178). The present study 
confirms this with 25(OH)D concentration being inversely correlated with PTH 
concentration. Additionally, 10.4% of participants had secondary hyperparathyroidism, 
with a higher prevalence amongst those with deficient and insufficient vitamin D status. 
 
Moreover, several studies have also shown an inverse correlation between serum PTH 
level and BMD (135,177,179). In this study, a negative correlation between PTH 
concentrations and total BMD at the diaphyseal radius site was seen, although this was 
not significant after controlling for age and BMI.  There were no associations with PTH 
and any of the measures from the DXA scan in participants from the Brazil cohort, 
which may be due to long-term detrimental consequences of higher PTH levels still not 
evident in the relative young women in these study. 
 
The associations between 25(OH)D, PTH and bone mineral density (BMD) are still 
much debated. Evidence is more robust in particular subgroups such as in those with 
low vitamin D levels (180), in osteoporotic subjects (50,51,152), post-menopausal 
women (50,135,181) or in the elderly (35,157,182). The findings presented here are in 
accordance with previous reports of studies that included healthy younger adults as well 
as those that encompass the whole spectrum of vitamin D status (i.e., deficient, 
sufficient and adequate), demonstrating the absence of any association between 
25(OH)D or PTH and BMD (156,183,184). The reasons for no effects on bone 
parameters might be due to the lack of power within the deficient subgroup and the 
relatively young participants, who might not be currently affected by potential long-
term detrimental outcomes from low 25(OH)D and high PTH concentrations. 
 
 
5.5.1 Strengths and limitations 
 
Strengths of this study includes the use of pQCT and DXA scan, both considered gold 
standard measurements for bone density, controlling for possible cofounders such as 
age and BMI. Although published reference data were used to calculate t-scores based 
on the recommendations for the Brazilian population (white American adult women), 
the DXA scan software reports using a combination of databases to calculated the t-
score, while for the pQCT data a specific published reference data was used. Ideally, 
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the method would have been used for both groups, and pQCT would have been the 
preferred option, were it available at the Clinical Investigation Unit in Brazil as well, 
as it is the gold-standard method and has been shown to provide a greater diagnostic 
sensitivity than DXA (185). This analysis would benefit from further measures of 
biochemical markers of bone turnover to further investigate the relationship of 
25(OH)D, PTH and bone health in these adult women. 
 
 
Conclusions 
 
In conclusion, adiposity was associated with bone parameters in healthy adult Brazilian 
women, assessed by pQCT in England-dwelling participants and DXA-derived in 
Brazil-dwelling participants. This analysis also showed that secondary 
hyperparathyroidism was more common amongst those with deficient and insufficient 
vitamin D status.  
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6 
Final Discussion and Conclusions 
 
 
 
6.1 Summary of thesis results and original contribution 
 
It is widely recognized that vitamin D inadequacy is a global public health issue and 
that whilst populations at higher latitudes are at greater risk of deficiency particularly 
during winter, the concern is now extended to tropical locations too. The issue appears 
in low latitude countries as a paradoxical situation with sunlight underexposure leading 
to vitamin D inadequacy while sunlight overexposure may lead to skin damage, aging 
and cancer. Targeting intervention strategies specific to each population, country and 
ambient setting is important if the balance of risk and benefit, of both sunlight exposure 
and vitamin D supplementation, is to be optimised. Therefore, studies specifically 
designed to investigate the effect of, and requirements for, vitamin D supplements and 
sunlight exposure in sunny countries are urgently required to contribute to an improved 
definition of vitamin D deficiency and country-specific recommendations.  
 
This is the first study to investigate the effect of vitamin D supplementation and 
individual sunlight exposure in healthy Brazilian adult women living in two opposing 
latitudes and the first to estimate vitamin D intake and sunlight exposure required to 
meet concentrations of 75 nmol/l in this population group in Brazil. The findings in this 
thesis confirm that both sunlight exposure and vitamin D supplementation can 
contribute greatly to achieving and/or maintaining optimal concentrations of serum 
25(OH)D. The present study demonstrates a strong positive correlation between 
individual UV radiation level and vitamin D serum concentrations. Furthermore, a 
relatively low daily dose of vitamin D via a supplement has an important positive 
impact on winter vitamin D status in adult women, regardless of latitude. Supplemental 
15 μg of vitamin D daily, for three months, significantly increased serum 25(OH)D 
concentrations and prevented seasonal increase in PTH concentrations, in a high 
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latitude as well as in a low latitude country. This relatively low dose was effective and 
therefore the intake of significantly larger doses, as has been recently proposed, to 
increase 25(OH)D is not supported by this data, regardless of latitude. 
 
More specifically, this study showed an optimal vitamin D status of 70-80 nmol/l for 
Brazilian adult women, based on the suppression of PTH. An individual UV radiation 
level of 0.28 SED was estimated as required to meet a serum 25(OH)D concentration 
of 50 nmol/l and 1.5 SED for a serum 25(OH)D concentration of 75 nmol/l, when only 
individual UV radiation was included in the model. For every 1 μg (40 IU) of vitamin 
D supplemented it would be expected an increase in 25(OH)D concentrations of 1.002 
nmol/l if living in a high latitude and 0.791 nmol/l if living in a low latitude for adult 
Brazilian women, when only vitamin D intake was included to the model.  
 
Nevertheless, this study has also evidenced that the recommended dose for vitamin D 
supplementation should not only be country-specific but, more importantly, take into 
consideration mainly the initial serum 25(OH)D concentrations of the individual. 
Moreover, recommendations must also take into account the availability of each 
vitamin D source (dietary intake, either from food or supplements, and endogenous 
production from sunlight exposure), individual characteristics and lifestyle aspects. The 
development of country specific risk scores for vitamin D deficiency, which would take 
into consideration all the aspects here discussed of vitamin D synthesis, metabolism 
and intake, might be a strategy to target those that would need and benefit more from 
vitamin D supplementation. Additionally, even if sunlight availability is not limited, it 
is important to identify situations where increasing sunlight exposure will not result in 
vitamin D status improvement, i.e. individual variation in cutaneous production, and 
vitamin D supplementation must be considered as an alternative options. 
 
 
6.2 Study impact and future directions 
 
Most recommendations on vitamin D intake and status assume no significant cutaneous 
synthesis of vitamin D through sun exposure. This is true in high latitudes during winter 
months, but in tropical countries individual UV radiation is likely to be high, and at a 
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sufficient minimum to produce vitamin D adequately throughout the year. Therefore, 
in low latitude countries the contribution of UV exposure must be considered when 
estimating optimal vitamin D intakes for populations. 
 
The data here presented provides robust and specific information that can contribute 
greatly to establishing specific recommendations for Brazil by the authoritative bodies 
responsible for formulating nutrition policy and public health guidelines. Specifically, 
the data generated in the present study: 1) confirms individual sunlight exposure as an 
important source of vitamin D in Brazil, even during winter; 2) indicates an optimal 
vitamin D status of 70-80 nmol/l for adult Brazilian women; 3) shows that 
supplementation is most helpful in persons with lower baseline concentrations; 4) 
suggests that a vitamin D daily intake of approximately a third of the current 
recommendation of 15 μg, based on US guidelines, is required by healthy adult 
Brazilian women at latitude of ≈16 °S to maintain 25(OH)D concentrations above 75 
nmol/l. In contrast, vitamin D daily intakes of 15 μg seem to be adequate to maintain 
25(OH)D concentrations above 50 nmol/l in Brazilian adult women in at  latitude of 
≈51 °N, although over twice as much (37 μg) would be required for concentrations 
above 75 nmol/l.  
 
Furthermore, while food fortification can be useful and effective in increasing vitamin 
D status in populations, this may not the be an appropriate strategy in a low latitude 
country. This is an important aspect of the discussion on the need for country-specific 
recommendations supported by the findings presented here. In low latitude countries, 
it is unlikely that the need for additional vitamin D is universal, as it may be for other 
nutrients that are added to foods (such as sodium in Brazil). Moreover, high 
concentrations of 25(OH)D are already observed in the Brazilian population (over 100 
nmol/l) and food fortification strategies could lead to overdosing and potentially toxic 
levels. Vitamin D supplementation might be a better targeted strategy in tackling 
particular cases of deficiency. 
 
Further vitamin D RCTs are now required in Brazil to help determine a general 
consensus on vitamin D recommendations for the wider Brazilian population, and to 
confirm whether the predicted values in this study can be generalised. Further 
investigation on the seasonal cycling of vitamin D concentrations in low latitudes is 
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also required to understand the interactions and necessity of vitamin D intake in this 
population throughout the year. 
 
Detailed investigations of environmental, biological and behavioural factors affecting 
vitamin D synthesis would provide valuable data for the development of vitamin D 
deficiency risk assessment tools. From a public health perspective this is of great 
relevance in a country such Brazil, which has approximately 200 million people and of 
which the majority relies on the public national health system. Such tools could 
potentially optimize detection of potential inadequacy and initiate treatment or 
prevention, without having to rely on biochemical analysis and waiting time for 
assessments, also reducing significantly the costs of vitamin D testing. 
 
 
6.3 Critical evaluation of the study 
 
The strengths and limitations of each analysis have been discussed in the respective 
chapters. A critical evaluation of the overall study design and protocol will be 
considered in this section. 
 
The RCT was specifically designed to investigate the effectiveness of vitamin D 
supplementation in improving vitamin D status by increasing mean 25(OH)D serum 
concentrations in the range of 20 -25 nmol/l, over wintertime in opposite latitudes. The 
power calculation, based on previously published research identified that a sample size 
of 64 women for each country plus a 16 women to account for a 20% dropout rate, to 
demonstrate a response to vitamin D supplementation in the range of 20 -25 nmol/l at 
α = 0.05.  In total 56 women in the England trial and 80 women in the Brazil trial were 
enrolled in the study. 
 
Recruitment for the England trial was more difficult, particularly due to the need for 
participants to take a train to attend the visits at the University of Surrey, as only 4 
participants were actually Guildford residents. This seems to have been the main factor 
as well for participants booked to their first visit not showing up at all. The use of social 
media to advertise the study proved to be the most efficient method of recruitment, in 
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both countries, and seems to have reached a broader public than it would have been 
with only posters on local establishments. 
 
The study protocol for the RCTs described in Chapter 2 and available in Appendix II, 
was followed rigorously throughout the study. The low dropout rate and satisfactory 
compliance was likely due to the regular communication maintained with participants 
throughout the duration of the study via weekly text messages, in both countries. 
Participants were instructed to return any missed supplements and informed that it was 
not a problem to miss any supplements as long as they were honest with the research 
team to ensure accurate measures of compliance.  
 
Blood samples were processed following the same protocol in both countries and stored 
frozen until being sent to analysis at Imperial College, London. Samples collected in 
Brazil were transported to the UK on dry ice by air via a specialized company (World 
Courier Group, Inc.) that assisted with all the paperwork and sample preparation for 
transport. The transportation box contained 2 digital thermometers that registered the 
temperature periodically throughout the whole journey. 
 
There were some minor issues with the lifestyle questionnaire, with some participants 
needing clarification for a few questions, as already mentioned in previous chapters. 
This suggests that the questionnaire could have been better tailored to this population. 
Also, some questions could have included more details, as already discussed in previous 
chapters, to better address the particularities of the two countries and the population 
studied.  
 
 
6.4 Study hypothesis critical review 
 
Hypothesis 1: Dietary intakes of vitamin D are too low and sunlight exposure is 
insufficient for maintaining optimal vitamin D status throughout wintertime in 
Brazilian women, regardless of latitude of residence. A high prevalence of women 
below the vitamin D sufficiency threshold was observed amongst those living in 
England, but vitamin D status in women living in Brazil was generally adequate. 
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Vitamin D intake was extremely low in both countries and sunlight exposure was 
strongly associated with vitamin D serum concentrations, and below 1 SED in all 
women living in England and in half of the women living in Brazil. 
 
Hypothesis 2: Vitamin D supplementation is effective in raising and maintaining 
adequate 25(OH)D concentrations  throughout winter, regardless of latitude. Vitamin 
D supplementation was significantly effective in raising and maintain mean serum 
vitamin D above the sufficiency threshold, compared to no significant changes in the 
placebo, in both latitudes over wintertime. 
 
Hypothesis 3: The response of Brazilian women to vitamin D supplementation is 
dependent on baseline 25OHD levels. Baseline concentration was the major contributor 
to the variation in the response to total vitamin D intake. 
 
Hypothesis 4: Circulating 25(OH)D and PTH concentrations are associated with bone 
health parameters. Circulating 25(OH)D was significantly negatively associated with 
PTH concentrations, but no associations between these two biomarkers and bone 
parameters were observed. 
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Concluding remarks 
 
Effective and meaningful evidence-based vitamin D recommendations are of great 
importance to prevent vitamin D deficiency and long-term detrimental effects to bone 
health especially.  Moreover, country and context specific recommendations are crucial 
to establish more precise requirements for vitamin D intake, sunlight exposure and 
optimal status.  
 
The main focus of the study was whether vitamin D supplementation in a high latitude 
country differed from a low latitude country with respect to response depending on 
individual sunlight exposure and whether there was a benefit compared to the placebo 
group regardless of latitude. This thesis provides robust evidence on the differences in 
response and the beneficial effect of vitamin D supplement in high latitude compared 
to low latitude was demonstrated as proposed. Furthermore, it provides evidence for an 
optimal vitamin D status for bone health of 75 nmol/l, a greater response to 
supplementation in those with lower concentrations, a required 1.5 SED for a serum 
25(OH)D concentration of 75 nmol/l and a required vitamin D daily intake of 4.5 μg at 
latitude of ≈16 °S to maintain 25(OH)D concentrations above 75 nmol/l and of 15 and 
37 μg to maintain 25(OH)D concentrations above 50 and 75 nmol/l, respectively at  
latitude of ≈51 °N, in Brazilian adult women. 
 
In conclusion, this study provides strong evidence of the need for country specific 
recommendations for optimal vitamin D status and confirms that the response to 
vitamin D supplementation, particularly in a sunny country, depends largely on initial 
vitamin D serum concentrations. 
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Appendix I 
Supplementary tables and figures 
 
 
 
Table I.1 Serum 25OHD, plasma PTH and serum calcium concentrations at baseline and post-
intervention in England and Brazil trials, Per Protocol Analysis (n=95)1 
1 Values mean ± SD; analysis of intention to treat 
2 Albumin corrected serum calcium concentrations 
Statistical analysis:  
≈ Log transformed data 
3 Between intervention group within each country: Independent t-test; 
4 Between the four intervention groups: ANOVA. 
5 Between baseline and week 12: Paired t-test 
 
 
 
 
 England Brazil p 4 
  Placebo 15 µg/day p 3 Placebo 15 µg/day p 3 
 
Serum 25(OH)D (nmol/l) 
Baseline 
Post-intervention 
Total Change 
p 5 
 
 
32.40 ± 14.68 
39.22 ± 16.62  
6.82 ± 10.66 
0.018 
 
 
37.56  ± 16.51 
55.29 ±12.40 
17.73± 17.01 
<0.001
 
 
 
 
0.313 
0.001  
0.026 
 
 
74.62  ± 24.64 
73.47±24.45  
- 1.15 ± 12.09 
0.619 
 
 
75.02 ±22.54 
86.70±22.98 
11.67 ± 19.82 
0.005 
 
 
0.951 
0.044 
0.005 
 
 
 
 
<0.001 
<0.001 
<0.001 
Plasma PTH (pmol/l) ≈ 
Baseline 
Post-intervention 
Total Change 
 p 5 
 
5.60 ± 1.40 
6.43 ± 17.1 
0.82 ± 1.90 
0.092 
 
 
5.42 ± 2.71 
5.91 ± 2.30 
0.23 ± 2.43 
0.339 
 
 
0.796 
0.440 
0.412  
 
 
4.54 ± 1.37 
5.65± 1.07 
1.17 ± 1.82 
0.003 
 
4.19 ± 1.60 
4.63 ± 1.74 
0.44 ± 1.54 
0.148 
 
0.398 
0.057  
0.124  
 
 
 
0.033 
0.024 
0.346 
Serum Calcium (mmol/l)2 
   Baseline 
   Post-intervention 
  Total Change 
   p 5 
 
2.30 ± 0.07 
2.30 ± 0.06 
-0.01 ± 0.05 
0.705 
 
2.29 ± 0.08 
2.28 ± 0.06 
-0.01 ± 0.06 
0.448 
 
0.483  
0.249 
0.815 
 
2.28 ± 0.05 
2.27 ± 0.07 
-0.001 ± 0.06 
0.311 
 
2.29 ± 0.07 
2.22 ± 0.07 
0.001 ± 0.05 
0.796 
 
0.609 
0.193  
0.370  
 
0.779 
0.367 
0.824 
A) England Placebo (n=24)    B) England 15 µg/d (n=25)  
 
 
 
 
 
 
 
 
 
 
 
C) Brazil Placebo (n=33)     D) Brazil 15 µg/d (n=36) 
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Black lines represent individuals with baseline serum 25(OH)D > 50 nmol/l, orange lines baseline serum 
25(OH)D of 25 – 49.9 nmol/l, and blue lines baseline serum 25(OH)D < 25 nmol/l. 
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Figure I.1 Individual response to intervention according to baseline serum 25(OH)D 
concentrations by intervention group and country A) England Placebo; B) England 15 µg/d; C) 
Brazil Placebo; D) Brazil 15 µg/d. 
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1.0 Background & Rationale 
 
Vitamin D is derived from two sources: the skin (endogenous) and the diet (exogenous).  It is generally 
believed that the major source of vitamin D is the exposure of the skin to UVB-rays contained in sunlight. 
However, the full characterization of the contribution of diet and sunlight to optimal vitamin D status 
remains unknown. Furthermore, the response of individuals to vitamin D supplementation is known to 
be variable in all population groups since several personal and environmental characteristics may affect 
the conversion of pre-vitamin D by sunlight, such as latitude, available UVB radiation throughout the 
year, skin pigmentation, age, individual behavior, diet and genetic factors. We urgently need to define 
more closely the interaction between nutrition and genetics in response to vitamin D supplementation.  
There is a considerable lack of data in both Brazil and UK populations. (Adams and Hewison, 2010; 
(Lanham-New et al, 2012) 
 
Based on the important contribution of sunlight exposure to the production and maintenance of serum 
25OHD levels, it would be reasonable to believe that vitamin D deficiency may be a problem restricted 
to countries situated at higher latitudes. However, several studies from sunny countries have shown 
that vitamin D deficiency is a more common phenomenon, despite the abundance of sunlight in these 
locations making it a global health problem. (Lips et al, 2001; Bandeira et al, 2010). Even though Brazil 
is geographically located such that there is potentially an abundance of sunlight and therefore of vitamin 
D available throughout the year, there is still evidence of sub-optimal levels of vitamin D in the 
population. A cross-sectional study conducted in Rio de Janeiro, (latitude 22 ° S), has shown a high 
incidence of inadequate serum 25 (OH) D (68.3 %) in healthy adults (Russo et al ,2009). Much of the 
UV in sunlight is absorbed by clouds, ozone and other forms of atmospheric pollution. In higher latitudes 
as the distance from the equator increases, zenith angle is increased during winter months and 
consequently, the UV radiation reaching the earth’s surface is reduced, and therefore the cutaneous 
production of vitamin D3 is also reduced. (Lips et al 2006; Wacker and Holick, 2013). Thus, the 
cutaneous synthesis of vitamin D is expected to be greater in low- latitude regions due to greater 
exposure to UVB radiation. In the UK, there is no UV radiation of the appropriate wavelength (280mm-
310mm) from the end of October to the end of March and for the remaining months of the year, 60% of 
the effective UV radiation occurs between 11.00am and 3.00pm. Moreover, studies have shown the 
influence of skin pigmentation in reducing the UVB-mediated synthesis of vitamin D. Greater 
quantification of the effect of sunlight exposure on vitamin D status is urgently required. Therefore, we 
wish to investigate the Brazilian population, suspecting that we could be underestimating the level of 
insufficiency or deficiency of vitamin D in this population, due to the false impression that the level of 
solar radiation would suffice for people living in sunny countries. 
 
Recent studies have suggested that genetic variation could be a reasonable explanation to the 
considerable differences on vitamin D levels among population independently of latitude and sunlight 
exposure. (Valdivielso 2004) Heritability of vitamin D levels has been reported to range from 28.8% to 
68.9% in an adolescent twin study and up to 80% in a genome-wide linkage scan. (Uinterlinden 2004, 
Santos 2012). Identifying genetic variants in the form of single nucleotide polymorphisms (SNPs) has 
been one of the key methods for identifying genetic variants associated with vitamin D levels. The data 
would be helpful for identifying those who may be at risk of deficiency and targeting treatment to reduce 
the impact of vitamin D deficiency. The study will undertake a Genome-wide analysis of leukocyte gene 
expression and its correlation with differences in vitamin D status. The Vitamin D Receptor (VDR) is a 
nuclear transcription factor which controls expression of a wide range of genes, including several that 
encode cytochrome P450 enzymes and cytokines.  Human leukocytes are known to express the VDR-
encoding gene and it is therefore envisaged that differences in vitamin D responses of individuals could 
be reflected by differences in leukocyte gene expression. Therefore we propose to analyse genome-
wide transcriptomic expression within leukocytes of selected participants in order to associate specific 
signal transduction and metabolic pathways to respective vitamin D responses.   Circulating 25(OH)D 
concentrations have been shown to be strongly related to SNPs located on exons of the vitamin D 
binding protein gene: i.e. minor SNP variants of DBP-1 (rs7041,  GG®TT (17.5%) and DBP-2 (rs4588, 
CC®AA (9%), resulting in 10-13% lower circulating 25OHD levels.   
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Our results will firstly enable determination of how important (as a % contribution) diet, sunlight 
exposure and genetic factors are to vitamin D status when directly comparing, using the same 
methodology, same ethnicity populations living in a Southern Hemisphere (where there is abundant 
sunlight exposure) and in a Northern Hemisphere (where there is only sufficient sunlight exposure 
during the months April to September).  
 
The data will provide both countries with key data on whether there should be consideration of further 
revisions to dietary recommendations for vitamin D in adult populations.  This study provides good 
‘value for money’ since it draws upon previously collected data in the UK and enables a strong study 
design to be conducted in the two Countries, simultaneously.   The data will be of great interest to the 
field of Nutritional Sciences by the provision and formulation of data, within a short period of time, 
examining the interaction of diet and the environment on vitamin D status and its functional 
consequences. The ‘systems level’ approach will enable us to identify differences in gene expression 
and whether this explains why some individuals are ‘good’ responders or ‘poor’ responders to vitamin 
D supplementation (Wang et al, 2010).  This has never been done before in the field, by examining two 
population groups living in different countries but following identical study designs. Also, to our 
knowledge, this is the first randomized control trial to analyse the effect of vitamin D supplementation 
in Brazilian women, either living in the UK or in Brazil.  
 
 
2.0 Objectives & Design 
 
 
2.1 Primary Objectives: To examine the response (in vitamin D status) to vitamin D 
supplementation and sunlight exposure, and its influencing factors within and between 
Brazilian female adults living in the UK and Brazilian female adults living in Brazil. 
 
2.2 Secondary Objectives 
  
(i) Analyze the difference regarding time and intensity of sun exposure between Brazilian 
women living in Brazil and Brazilian women living in the UK. 
(ii) Determine the prevalence of inadequate dietary Vitamin D intake in these women. 
(iii) Determine the prevalence of insufficient/deficient levels of vitamin D in these women. 
(iv) To elucidate the association between Vitamin D status and markers of calcium of calcium 
metabolism. 
(v) Examine the influence of latitude on vitamin D optimal levels. 
(vi) Analyze the influence of skin pigmentation on vitamin D optimal levels. 
(vii) Analyze if response to Vitamin D supplementation is dependent on initial vitamin D levels. 
(viii) Investigate the genetic and enzymatic mechanisms underlying the adolescents’ 
response to vitamin D supplementation via genotyping for polymorphisms related to vitamin 
D metabolism and comparing the high and low responders to supplementation (Genetic 
Sub-Study). 
 
 
2.3 Hypothesis 
 
The study hypothesis that, during winter, vitamin D supplementation is required to obtain Vitamin D 
optimal levels in Brazilian women residing in the UK as well as Brazilian women residing in Brazil and 
that this response is dependent on the initial levels, being also influenced by sunlight exposure, skin 
pigmentation and polymorphisms of the vitamin D receptor gene. 
 
H1: Dietary intakes of vitamin D are too low and sunlight exposure is insufficient for optimal vitamin D 
status in Brazilians living in the UK and Brazilians living in Brazil. 
 
H2: The response of subjects to vitamin D supplementation is dependent on baseline 25OHD levels.  
 
H3: Response to supplementation is influenced by sun light exposure. 
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H4: Skin pigmentation is an influential factor on vitamin D optimal levels. 
 
H5: There will be strong genetic influences on 25OHD changes in response to vitamin D 
supplementation; these will be similar in both groups.  
 
 
3.0 Experimental Design 
 
Two controlled, randomized, double-blind clinical trials will be developed and undertaken (one in Brazil 
and the other in the UK) with an intervention period of 12 weeks. 
 
A questionnaire to screen for the relevant inclusion and exclusion criteria (see section A) will be 
administered in order to select 80 Brazilian female subjects, aged 20 to 59 years, in each of the two 
countries. The women selected will be randomly divided into two groups: Placebo Group and 
Supplemented Group, the latter will receive 600UI UI of vitamin D.  
The first clinical trial will run in the UK from October 2016 to March 2017 (autumn-winter) and then the 
second will run in Brazil from April 2017 to September 2017 (autumn-winter). After the analysis of the 
effect of vitamin D supplementation compared to placebo, the results obtained in the supplemented 
group will also be analysed according to the genotypes for SNPs in the VDR gene. 
 
We have chosen 12 weeks (3 months) as the supplementation period as we consider this to be ample 
time for 25OHD levels to rise (half-life of 25OHD is 3 weeks) and this has been demonstrated to be an 
effective timeframe for supplementation of vitamin D in previous studies.   
 
We have chosen 600IU to enable the study to be relevant to the new IOM US recommendations for 
vitamin D, which are currently the reference document used in Brazil, even though the Brazilian 
nutritional table remains with the daily intake recommendation of 200 IU, which was the IOM 
recommendation in 1997.  Compliance will be checked by compliance interviews during the trial and by 
empty packaging count.   
 
We will genotype vitamin D related genes in DNA isolated from the study blood samples, DNA will be 
extracted and vitamin D polymorphisms will be determined by our genetic labs. These will include known 
candidate variants (VDR, vitamin D binding protein, CYP2R1, CYP27A1, CYP27B1, and CYP24A1), as 
well as variants identified by the ongoing genome-wide association analyses on 25OHD.  We will 
construct a genetic risk score based on these polymorphisms. The Genome-wide expression profiling 
of RNA from leukocytes will focus on 48 participants (each at two sampling time points) that represent 
equally both groups, encompassing the best and worst supplementation-responders in each group. We 
will identify the complete spectrum of genes that are, by statistical criteria, either significantly up-or 
down-regulated (i.e. differentially expressed) between groups. The major comparison will be between 
the ‘good’ and ‘poor’ responders in each group; gene expression prior to supplementation will be 
compared to   after supplementation for each subject analysed.  
 
 
3.1 Sample Size and randomisation 
 
A total of 80 subjects (at 90% power) are required for recruitment into the 600 IU vitamin D group vs 
placebo group for the RCT to be conducted in the UK and a total of 80 subjects (at 90% power) are 
required for recruitment into the 600 IU vitamin D group vs. placebo group for the RCT to be conducted 
in Brazil.  This will enable us to detect a 0.6 SD size effect at 90% power in serum 25OHD levels 
between placebo and 600 IU in UK-dwelling Brazilian populations and Brazilians living in Brazil.  These 
study numbers of 40 subjects for the vitamin D group and n 40 for the placebo group includes a 20% 
drop-out rate factored in.  
 
 
3.2 Recruitment 
 
Detailed Protocol D-SOL Study  Page 5 of 13 
Final Version  
 
Participants in the UK will be recruited through advertisement among local Brazilian societies/groups 
within Surrey and London. Informative posters will be positioned around the University of Surrey and 
commercial centres (with a focus on Brazilian themed places), with permission of the owner.  
 
As recruitment method, we will ask, after clearly explaining our intentions of divulgating the study, 
Brazilian institutions in the UK, such as the Brazilian Consulate and the Brazilian Researchers 
Association (ABEP-UK) to circulate a recruitment letter to their contact list of Brazilians living in the UK.  
If we succeed in this arrangement, this letter will be send directly to those in the lists by the institution, 
therefore we will not need to have access to people’s contact details. 
 
Social media sites such as Facebook will be used to publicise the study: the poster or flyer will be 
inserted as a photo with permission of the administrator of the Facebook pages.  
Facebook pages we intend to target :  
Science Without Borders UK students: https://www.facebook.com/groups/489494047812445/ and 
https://www.facebook.com/groups/csf2014/ 
Brazilians in London: https://www.facebook.com/groups/301278086667948/  
Brazilian Students in the UK Association (ABEP): https://www.facebook.com/ABEPUK/?fref=ts  
General Consulate of Brazil in London: https://www.facebook.com/cglondres/info/ 
 
Participants in Brazil will be recruited from the general public within the city of Goiânia through posters 
to be positioned around the Federal University of Goiás and commercial centres, with permission of the 
owner.  
Social media sites such as Facebook will be used to publicise the study: the poster or flyer will be 
inserted as a photo with permission of the administrator of the Facebook pages.  
Facebook pages we intend to target:  
Federal University of Goias: https://www.facebook.com/universidadefederaldegoias/?fref=ts 
Faculty of Nutrition, Federal Uni of Goias: https://www.facebook.com/fanut.ufg.5?fref=ts 
Faculty of Nutrition Postgrads, Federal Uni of Goias: 
https://www.facebook.com/mestrado.fanut.7?fref=ts 
 
The recruitment end date for the UK subjects will be 14th December 2016. Recruitment end date for the 
Brazilian subjects will be the 13th June 2017. 
 
Subjects will be reimbursed for their travel expenses. 
 
 
3.3 Selection & Withdrawal of Participants  
 
3.3.1 Inclusion Criteria 
 
 Brazilian nationality  
 Female 
 Aged 20-59 years 
 
 
3.3.2 Exclusion Criteria 
 
 Currently receiving treatment for medical conditions that are likely to affect vitamin D 
metabolism ( osteoporosis therapy, anti-estrogens treatment, antiepileptic drugs, breast-cancer 
treatment) 
 Hypercalcaemia (>2.5mmol/L) – assessed and excluded at baseline 
 Regular use of sun-beds 
 Having a holiday trip one month prior to commencing the study or plans for a holiday trip for 
more than 4 weeks out of the country of residence within the study period.  
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 Use of vitamin supplements containing vitamin D (if the prospective participants agrees to stop 
Vitamin D supplementation to join the study, a wash-out period of 8 weeks prior to commencing 
the trial would be acceptable).  
 Pregnant or planning a pregnancy during the study period.  
 
If a participant is subsequently found to be ineligible for the study their screening questionnaire will be 
destroyed due to the questionnaire containing sensitive information. 
 
 
3.3.3 Withdrawal 
 
All participants will be notified during the consenting process that they are free to withdraw from the trial 
at any time, without giving a reason. 
 
Participants will be withdrawn from the trial by the Principal Investigator if: 
1. The participant develops a medical condition or becomes pregnant either prior to entering 
the study or during, which may adversely affect the outcome of the study. 
2. It is clearly demonstrated that the participant is non-compliant completing study activities 
and the control procedures requested of them. 
3. A participant suffers an adverse event, which will be reviewed and recorded at each visit 
and at each phone call, following the immediate discontinuation of the participant during 
the visit, if necessary. 
 
All data prior to subject withdrawal will be used in analysis; unless the participant specifically requests 
that their data is not to be used. Withdrawn participants will not be replaced as an anticipated drop-out 
rate of 20% has been accounted for in the recruitment targets. 
 
 
4.0 Trial Procedures 
 
4.1 Trial visit activities 
 
During this study the subjects will be asked to visit the Clinical Investigation Unit, FHMS, University of 
Surrey in the UK or the Research Clinic, Faculty of Nutrition, Federal University of Goias in Brazil, on 
two occasions, at the beginning of the study for baseline measurements and at the conclusion of the 
study. 
We will examine four to eight fasted subjects per study morning.   
Trial visits will last approximately 45-60 minutes each and take place in the morning (7am-11am). 
Participants will be offered refreshments at the end of their appointment. 
 
 
Consenting and Screening 
 
If participants wish to be screened for participation in the study, they will receive the Participant 
Information Sheet and then be checked against the study inclusion and exclusion criteria using the 
‘Screening Questionnaire’ (Section A), to be administered by a member of the D-SOL Research Team 
by phone or self-reported by email. 
 
Baseline visit  
 
If eligible, participants will be invited for the baseline visit. At this visit, they will first be given time to 
discuss the Participant Information Sheet and any questions they may have regarding the study. 
Informed consent will be discussed and participants will be asked to sign the consent form, and will be 
offered a copy to keep for themselves. 
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 Health and Lifestyle questionnaire to be administered by a member of the D-SOL Research 
Team. 
 Anthropometrics and blood pressure measured, and fasted blood sample taken (serum 25OHD 
levels, 1,25-dihydroxy vitamin D, serum calcium, albumin, parathyroid hormone, C-terminal 
telopeptide (CTX) ≈25ml) with an additional ≈10 ml for genetic profiling and ≈15 for storage for 
future measurements of nutritional markers. 
 pQCT scan of the non-dominant forearm for UK trial or DEXA scan for Brazil trial. 
 Bioelectrical impedance analysis (BIA) for body composition. 
 Provision of randomly assigned daily supplement (30 days’ supply), food diaries and dosimeter 
(to be returned via SAE provided) and sunlight exposure diary to be returned at 12 week visit. 
Follow-up appointment details arranged (including interim visit telephone appointments and for 
re-supply of supplement). 
 
 
Final visit 
 
 Final adverse event/compliance interview completed with investigator. 
 Daily outdoor exposure diary received from participant and check for consistency at visit. 
 Anthropometrics and blood pressure measured, and blood sample taken (serum 25OHD levels, 
1,25-dihydroxy vitamin D, serum calcium, albumin, parathyroid hormone, C-terminal 
telopeptide (CTX) ≈25ml) with an additional ≈10 ml for genetic profiling and ≈15 for storage for 
future measurements of nutritional markers. 
 Bioelectrical impedance analysis (BIA) for body composition. 
 Dosimeter and 4-day food diary received from participant (sent to participant prior to 
appointment). 
 
 DNA profiling procedure - After 12 weeks RCT 
 
 Selection of 48 participant samples encompassing the best and worst 
supplementation-responders in each group, subject to previous consent form 
participant. Vitamin D related genes will be genotyped in DNA isolated from the study 
blood samples, DNA will be extracted and vitamin D polymorphisms will be determined 
by University of Surrey’s genetic labs. 
 
A trained phlebotomist will take the blood samples required as part of the trial protocol. Medical cover 
will be available at all times.  
 
Throughout the duration of the trial, the participants will be contacted via telephone on a fortnightly basis 
to discuss any issues with any adverse event and compliance and to maintain good communication 
with the participants. (Please see AE reporting form). In the case of a serious adverse event (SAE) this 
will be recorded (please see SAE reporting form) and we will report it to both the Sponsor (University 
of Surrey) and the Surrey Ethics Committee. 
The final interview will be completed at the final study visit. Participants have also be asked to return 
any supplements that were missed to confirm compliance. 
 
For University of Surrey participants: A peripheral quantitative computed tomography (pQCT) scan was 
performed on the participant's non-dominant forearm at the baseline visit, to measure volumetric bone 
mineral density at the 4% and 66% radial site. This will allow for separate measurements of trabecular 
vBMD and trabecular area (4% site) and cortical vBMD and cortical area (66% site), as well as strength 
strain index, a measure of bone strength. pQCT also measures bone geometry alongside bone density. 
Therefore the muscle cross sectional area can be determined, which is a measure of muscle force, to 
which bone strength is adapted to. One scan was performed at baseline only and effective exposure 
doses were between ~1.5-1.8uSv. 
 
For Federal University of Goiás participants: Body composition (absolute and relative amount of lean 
and fat mass), whole body mineral density and lower spine and femur bone mineral density was 
measured with the use of DEXA (located at the Nutrition Clinic based at the Federal University of Goias), 
at baseline only. Two scans were performed at baseline for each participant: one to assess the whole 
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body mineral density and body composition, and the other to specifically assess fracture risk by 
scanning the spine and femoral head. Effective exposure doses for theses scans are ~8uSv and ~4uSv 
respectively. 
 
Results of the body composition, vitamin D status and dietary intake from the self-reported food diaries 
will be made available to the subjects upon request. The results from the blood analysis will be reported 
to the subject if there are any health concerns raised. If the results are within healthy ranges the 
participants will not be contacted unless they specifically request for this information.  The investigators 
will not be contacting their GPs if there are any concerns raised in the study however we will stress that 
they should contact their GP themselves to discuss the results we found.  
 
 
5.0 Benefits and risks of participants in the D-SOL Study 
 
Results of the body composition, vitamin D status and dietary intake from the self-reported food diaries 
will be made available to the subjects upon request.  
 
We do not anticipate identifying anything of concern via either the blood tests or bone scan, as we’re 
not measuring any markers that would actually indicate any serious pathology is occurring. A letter 
informing that the participant is on the trial will be sent the participant’s GP. A response from the GP 
will not be required unless the GP had concerns and no results will be sent to them afterwards. If the 
results are within healthy ranges the participants will not be contacted unless they specifically request 
for this information. If abnormal results came back for a participant, they will be offered support in 
approaching the GP, all the information regarding their test results, details on the intervention, etc, will 
be made available.  
 
Due to the trial being food based, the risk of side-effects is minimal. However, gastrointestinal discomfort 
may occur following supplement consumption. 
 
A blood sample must be taken at each trail visit, including screening, and due to the nature of the 
procedure, some light bruising may occur. Occasionally, fainting in some individuals can occur relating 
to venepuncture. TO help reduce the risk of this, participants will have their blood sample taken either 
whilst they are supine on a bed or reclined on a chair that has the capacity to be adapted quickly to 
allow the participant to lie supine safely if they do become unwell. 
 
pQCT and DXA scans use a low level of radiation (much lower than standard X-ray examination) to 
which participants will be exposed. The amount of radiation absorbed from the scan is very small and 
similar to the radiation we receive from the environment. 
 
Although health problems linked to vitamin D are very rare, there is some evidence that vitamin D 
supplementation can cause blood calcium levels to go higher than normal in some people who already 
have high blood calcium levels. Upon commencing the study, all participants will have their blood 
calcium levels checked to ensure that the vitamin D would be unlikely to cause any problems. 
 
6. Ethics and regulatory approval 
 
The trial will be conducted in compliance with the principles of the Declaration of Helsinki (2008), the 
principles of GCP and in accordance with The Medicines for Human Use (Clinical Trials) Regulations 
2004 and Amended Regulations 2006. 
 
This protocol and supporting documents will be submitted for review by the University of Surrey Ethics 
Committee and the Federal University of Goias, Brazil. Annual progress reports and a final report will 
be submitted to the ethics committees as defined in their respective regulations. 
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7.0 Study Evaluation and Statistical Analysis 
 
Statistical analysis will be undertaken with support from the University of Surrey statistical department. 
Data will be checked for normality using appropriate testing. Appropriate parametric/non-parametric 
analysis will be applied.   
The database will be stored and analysed using SPSS ® version 13.0. 
The descriptive analysis, including mean ± standard deviation, median and lower limit and higher will 
be held for all quantitative variables Data will be checked for normality using appropriate testing. 
Appropriate parametric/non-parametric analysis will be applied. Student t test or Mann-Whitney test, 
depending on the distribution of data, will be applied to evaluate differences between supplemented 
and placebo. For analysis between Brazil and UK groups an ANOVA test will be undertaken. Linear 
correlation, Pearson or Spearman, will be calculated in accordance with the presence / absence of 
normal distribution, respectively, between vitamin D intake, sun exposure, skin pigmentation and 
vitamin D serum concentration. Multiple linear regression analysis will be performed to determine the 
variants that influence blood concentrations of vitamin D. In order to determine whether supplemental 
response differs between genotypes, these will be separated into wild homozygotes, heterozygotes and 
homozygotes for the variant. In this approach, the results will be evaluated with the test ANOVA or 
Kruskal-Wallis, in cases of variables with normal distribution or not, respectively. To describe the 
relationship between food intake aspects and features biochemical independent of energy intake, intake 
values of nutrients of interest will be adjusted to energy in accordance with the method.  
Significance considered as standard will be 5%. 
 
 
8.0 Data Handling 
 
The Principal Investigator will act as custodian for the trial data. The following guidelines will be strictly 
adhered to: 
 
 Participants data will be completely anonymised 
 All anonymised data will be stored in a secure location on the University’s servers and on a 
password-protected computer these will be in line with best practice as recommended in the 
University of Surrey Research and Information Governance policies.  
 All trial data will be stored and archived as indicated by The Medicines for Human Use (Clinical 
Trials) Amended Regulations 2006. 
 When a subject does not meet the inclusion criteria, all questionnaires and collected data will 
be destroyed. 
 As part of the collaboration agreement with the Federal University of Goias, Brazil, all data 
collected in both countries will be shared between the two institutions. 
 
 
9.0 Publication policy 
 
The results of the study will be reported and disseminated to the scientific community via peer-reviewed 
journals and international conferences. The general public will be engaged via the release of results to 
the local and national media, relevant charities and community networks and an invited talk at the 
University.  
 
10.0 Finance 
 
Full funding to conduct the D-SOL Study is provided by the Science Without Borders Program through 
the National Counsel of Technological and Scientific Development of Brazil (CNPq).  
 
11.0 Signatures 
 
Principal Investigator:      Date: 
Miss Marcela Moraes Mendes      17 January 2016 
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SECTION A 
 
THE D-SOL STUDY 
SCREENING QUESTIONNAIRE 
 
The purpose of this questionnaire is to assess whether you are suitable to take part in the study and 
that it is safe for you to do so. We would be grateful if you would answer the following questions, even 
if you are still not sure if you wish to take part in our study. Please answer the questions as honestly 
and accurately as you can and remember there are no right or wrong answers to the questions. Your 
answers to the questions on this questionnaire will also be kept completely confidential.  
If you feel uncomfortable answering any of the questions on this questionnaire you do not have to 
answer the question. Please ask one of the D-SOL Research Team if you would like help answering 
any of the questions. 
  
 
Name:                                                   
 
DOB:              Age:    Gender:    
 
Address: 
 
 
 
Contact telephone number: Place of birth:            Nationality:  
Mother’s nationality:                                             Father’s nationality: 
Email address: 
Preferred method of contact:       Phone                   Email                    Post 
 
 
 
 
 
 
 
Height (cm): ………………………. Weight (kg): …………………   
Are you currently receiving treatment for any medical conditions?  
 Medical condition: …………………………… Treatment: ………………………. 
Are you on any medication prescribed by your GP or any other health care provider? 
       If yes, please specify: ………………………………………………………. 
 
1. Do you live in the UK?  
If yes, please state the date you arrived: 
 
 
 
       /          /   
 
  
CONTACT DETAILS 
HEALTH AND LIFESTYLE  
Yes No 
Yes No 
Yes No 
 
   
  
/      /  
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2. Please tick all medical conditions that apply: 
 Prior/ present history of coronary heart disease, angina, heart attack or stroke 
 Prior/present history of Type 1 and Type 2 Diabetes. 
 Prior/present history of Thyroid disease 
 Prior/present history of osteoporosis, osteopenia or other musculoskeletal disease 
 Prior/present history of haematological disease (except mild anaemia) 
 Prior/present history of malignancy 
 Prior/present history of a gastrointestinal disorder, such as Crohns Disease, Coeliac 
Disease or Irritable Bowel Syndrome. 
 Prior/present history of liver or kidney disease. 
 
 
3. Do you have any allergies or food intolerances? 
If yes, please specify: ……….………………………………………………………… 
………………………………………………………………………………………… 
 
4. Do you regularly take vitamin supplements containing vitamin D? 
 
If yes please specify:  
How many months you have been taking the supplements?................................ 
The dose of the supplements (if known): ……………………………………… 
  The brand of the supplements (if known):  ……………………………………. 
 
5. Are you currently on a weight-reducing diet or other dietary restrictions (except 
vegetarianism)? 
If yes, please provide details: ………………………………………………………….. 
6. Have you been abroad on holiday during the past 6 months? 
If yes, please specify where this was and the month this holiday was taken: 
Country of visit…………………………………………………….. 
Month/year…………………………………………………….. 
  Country of visit…………………………………………………….. 
Month/year…………………………………………………….. 
   
   
6. Are you planning any holidays abroad during the next 12 months? 
If yes, please specify where this visit is planned to be and when this holiday will be 
taken: 
Country of visit…………………………………………………….. 
Month/year ……………………………………………………..  
Country of visit…………………………………………………….. 
Month/year ……………………………………………………..  
Yes No 
Yes No Don’t know 
Yes No 
Yes No 
Yes No 
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7. Do you use sunbeds? 
If yes, please state how often you use them: 
 
  Once a week 
Once a month 
  More than 6 times per year 
  Less than 6 times per year 
  Occasionally  
8. Are you currently pregnant or planning a pregnancy during the next 12 months? 
 
9. Are you currently breastfeeding? 
 
 
 
 
10. Are you in menopause? 
 
 
 
 
 
 
We are planning to see participants in the morning between 8.00am and 12.00 noon. 
Are there any particular day or days which would be best for you? 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this questionnaire. 
 
Participant signature: __________________________________________________ Quest. No:  
Date: ___/___/_____ 
 
 
 
 
 
Yes No 
Yes No 
Yes No 
 
 
                                                                                         
Research Integrity & Governance 
Office (RIGO) 
Senate House  
Guildford, Surrey GU2 7XH UK 
 
T: +44 (0)1483 68 9103/2051 
F: +44 (0)1483 68 3791 
 
ethics@surrey.ac.uk 
www.surrey.ac.uk 
 
University Ethics Committee  
 
31 August 2016 
 
 
Dear Miss Moraes Mendes 
 
UEC ref: UEC/2016/009/FHMS 
Study Title: A systems biology approach to the interaction between vitamin D supplementation and 
sunlight exposure in Brazilian women living in opposite latitudes (The D-SOL Study) 
 
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the submitted protocol and supporting documentation. 
 
Date of confirmation of ethical opinion: 31 August 2016 
 
The final list of documents reviewed by the Committee is as follows: 
 
Document  Version Date 
Cover letter from researcher in response to comments from RIGO, sent 08 
Jul 2016 
 Submitted. 
30 Aug 2016 
Cover letter from researcher in response to comments from UEC and RIGO, 
sent 26 May 2016 
 16 Jun 2016 
Ethics Application Form  Submitted. 
28 Apr 2016 
Detailed Protocol - tracked copy 3 27 Jun 2016 
Section A, Screening Questionnaire 3 17 Jun 2016 
Participant Information Sheet - tracked copy 5 30 Aug 2016 
Consent Form - tracked copy 5 30 Aug 2016 
Daily outdoor exposure diary 4 15 Jul 2016 
Food diary 3 27 Jun 2016 
Questionnaire 3 27 Jun 2016 
D-SOL invitation letter  4 15 Jul 2016 
Recruitment Poster - tracked copy 4 15 Jul 2016 
Risk Assessment  23 Mar 2016 
Miss Marcela Moraes Mendes 
School of Biosciences and Medicine 
Faculty of Health and Medical Sciences 
 
 Clinical Research Insurance Proforma  Sub. 
28 Apr 2016 
Adverse Event and Compliance Interview 1 27 Jun 2016 
Report of Serious Adverse Event 1 22 Jun 2016 
Letter from HTA representative  30 Aug 2016 
Clinical Trials Insurance Certificate  14 Jul 2016 
 
This opinion is given on the understanding that you will comply with the University's Ethical Principles 
& Procedures for Teaching and Research. 
If the project includes distribution of a survey or questionnaire to members of the University 
community, researchers are asked to include a statement advising that the project has been reviewed 
by the University’s Ethics Committee. 
 
If you wish to make any amendments to your protocol please address your request to the Secretary of 
the Ethics Committee and attach any revised documentation. 
 
The Committee will need to be notified of adverse reactions suffered by research participants, and if 
the study is terminated earlier than expected with reasons.  Please be advised that the Ethics 
Committee is able to audit research to ensure that researchers are abiding by the University 
requirements and guidelines. 
 
You are asked to note that a further submission to the Ethics Committee will be required in the event 
that the study is not completed within five years of the above date. 
 
Please inform me when the research has been completed. 
 
Yours sincerely 
 
 
 
Miss Rebecca Green 
Research Integrity and Governance Co-ordinator, Research & Enterprise Support 
 
Copy to.  
Professor Susan Lanham-New, School of Biosciences and Medicine, FHMS 
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T: +44 (0)1483 68 9103/2051 
F: +44 (0)1483 68 3791 
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University Ethics Committee 
23 September 2016 
 
Dear Miss Moraes Mendes 
 
UEC ref: UEC/2016/009/FHMS Amendment 1 
Study Title: A systems biology approach to the interaction between vitamin D supplementation and 
sunlight exposure in Brazilian women living in opposite latitudes (The D‐SOL Study) 
 
I am writing to inform you that the Chairperson, on behalf of the Ethics Committee, has considered the 
Amendment  requested  to  the  above  protocol  and  supports  a  favourable  ethical  opinion  on  the 
understanding that the University's Ethics Handbook for Teaching and Research is observed. Please be 
advised that the Ethics Committee is able to audit research to ensure that researchers are abiding by 
the University requirements and guidelines.  
 
If  the  project  includes  distribution  of  a  survey  or  questionnaire  to  members  of  the  University 
community, researchers are asked to include a statement advising that the project has been reviewed 
by the University’s Ethics Committee. 
 
Date of confirmation of ethical opinion: 31 August 2016 
 
Date of favourable ethical opinion of amendment to protocol: 23 September 2016 
 
The list of amended documents reviewed and approved by the Chairperson is as follows:‐ 
 
Document  Version  Date 
Email from researcher    22/09/2016 
Notification of amendment form  Filename: 
v2 
Submitted: 
22/09/2016 
Detailed Protocol  4.0  13/09/2016 
Participant Information Sheet  6.0  13/09/2016 
Please note: you should only be using the versions of the documents referred to in this letter.  If you 
intend to update these documents, you must notify the University Ethics Committee. 
 
   
Miss Marcela Moraes Mendes 
School of Biosciences and Medicine 
FHMS 
  
Yours sincerely 
 
Miss Madeleine Blair 
Research Integrity and Governance Co‐ordinator, Research & Enterprise Support 
 
Copy to. Prof Susan Lanham‐New, School of Biosciences and Medicine, FHMS 
                                                                                         
Research Integrity & Governance 
Office (RIGO) 
Senate House  
Guildford, Surrey GU2 7XH UK 
 
T: +44 (0)1483 68 9103/2051 
 
ethics@surrey.ac.uk 
www.surrey.ac.uk 
 
 
University Ethics Committee 
30 November 2016 
 
Dear Miss Moraes Mendes 
 
UEC ref: UEC/2016/009/FHMS Amendments 2 and 3 
Study Title: A systems biology approach to the interaction between vitamin D supplementation and 
sunlight exposure in Brazilian women living in opposite latitudes (The D‐SOL Study) 
 
I am writing to inform you that the Chairperson, on behalf of the Ethics Committee, has considered the 
Amendment  requested  to  the  above  protocol  and  supports  a  favourable  ethical  opinion  on  the 
understanding that the University's Ethics Handbook for Teaching and Research is observed. Please be 
advised that the Ethics Committee is able to audit research to ensure that researchers are abiding by 
the University requirements and guidelines.  
 
If  the  project  includes  distribution  of  a  survey  or  questionnaire  to  members  of  the  University 
community, researchers are asked to include a statement advising that the project has been reviewed 
by the University’s Ethics Committee. 
 
Date of confirmation of ethical opinion: 31 August 2016 
 
Date of favourable ethical opinion of amendment to protocol: 30 November 2016 
 
The list of amended documents reviewed and approved by the Chairperson is as follows:‐ 
 
Document  Version  Date 
Email from researcher    29/11/2016 
Email from researcher    25/11/2016 
STANDARD OPERATING PROCEDURE pQCT Scan    Submitted: 
25/11/2016 
Risk assessment – The D‐SOL Study  3  23/11/2016 
Email from researcher    18/11/2016 
Notification of Amendment form    18/11/2016 
Detailed Protocol D‐SOL Study  6.0  14/11/2016 
D‐SOL Participant Information Sheet  8.0  14/11/2016 
Notification of Amendment form    27/10/2016 
D‐SOL Questionnaire  4.0  25/10/2016 
Miss Marcela Moraes Mendes 
School of Biosciences and Medicine 
FHMS 
  
Document  Version  Date 
pQCT Scanner & DXA Routine Assessment    25 May 2016 
Radiation Protection Report Commisioning Survey: STRATEC XCT 
2000L 
  05/05/2016 
Radiation Protection Report Commisioning Survey: Hologic Horizon    05/05/2016 
RADIOLOGICAL PRIOR RISK ASSESSMENT – Hologic Horizon W (DXA) 
and PQCT (Quantitative computed tomography) 
  05‐02‐2016 
FORM‐ RPS‐UOS‐FR‐006 Local Rules for 06AX00    29‐01‐2016 
 
Please note: you should only be using the versions of the documents referred to in this letter.  If you 
intend to update these documents, you must notify the University Ethics Committee. 
 
Yours sincerely 
 
Miss Madeleine Blair 
Research Integrity and Governance Co‐ordinator 
 
Copy to. Prof Susan Lanham‐New, School of Biosciences and Medicine, FHMS 
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DADOS DO PARECER
INTRODUÇÃO
Ao longo dos últimos 15 anos, a vitamina D tem sido bastante estudada pela comunidade científica. Embora
existam muitas questões ainda controversas em relação à concentração ideal de vitamina D sérica e o
impacto da ingestão de vitamina D sobre a saúde humana, há um consenso de que a deficiência de
vitamina D é um problema de saúde pública em razão de suas implicações em diversas doenças entre elas,
a osteopenia, osteomalacia, doenças cardíacas, diabetes tipo I e II, doenças inflamatórias, esclerose
múltipla e artrite reumatóide. A vitamina D é derivada de duas fontes: da pele (endógena) e da dieta
(exógena). A principal fonte de vitamina D é a exposição da pele aos raios UV-B contidos na luz solar, uma
vez que esta é capaz de estimular a conversão do 7-dehidrocolesterol na pele a pré-colecalciferol. Desta
forma, considerando a expressiva contribuição da fonte endógena de vitamina D, a sua concentração pode
ser influenciada por diversos fatores, a destacar: fatores ambientais,
Apresentação do Projeto:
Genética Humana:
(Haverá envio para o exterior de material genético ou qualquer material biológico
humano para obtenção de material genético, salvo nos casos em que houver
cooperação com o Governo Brasileiro;);
(Haverá armazenamento de material biológico ou dados genéticos humanos no
exterior e no País, quando de forma conveniada com instituições estrangeiras ou
em instituições comerciais;);
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como a latitude e as condições meteorológicas, atributos pessoais, tais como a pigmentação da pele, idade,
vestuário, uso do protetor solar, ambiente de trabalho, atividade física e exposição ao sol e fatores
genéticos. Com base na importante contribuição da exposição à luz solar para a produção e manutenção
dos níveis séricos de 25(OH)D, seria razoável se constatar que a deficiência de vitamina D é um problema
restrito a países situados em latitudes mais altas.
No entanto, vários estudos realizados em países ensolarados, como o Brasil, têm demonstrado que a
deficiência de vitamina D é um fenômeno comum, apesar da abundância de luz solar nestes locais, o que
evidencia a influência também da dieta e de fatores genéticos sobre o metabolismo da vitamina. Quanto aos
fatores dietéticos, o Brasil ainda não possui recomendações de ingestão diária de vitamina D específicas
para a sua população. Atualmente, são utilizadas as Dietary Reference Intakes (DRI) do Instituto de
Medicina dos Estados Unidos (IOM) de 600UI/dia ou 15g/d de vitamina D. No entanto, essa recomendação
tem sido alvo de crítica de especialistas da área, que defendem que este valor seja insuficiente para manter
a concentração sérica adequada. Em relação aos fatores genéticos, estudos tem demonstrado que o gene
para o receptor da vitamina D (VDR) desempenha um papel importante no metabolismo dessa vitamina.
Polimorfismos nesse gene podem potencialmente influenciar a estabilidade do mRNA e, consequentemente
a expressão e a concentração sérica dessa vitamina.
Um grupo de Porto Alegre encontrou uma prevalência de 33% de deficiência de vitamina D em adolescentes
brasileiras saudáveis e demonstrou que esta pode estar associada a polimorfismos do gene do receptor
específico da vitamina D (VDR). Desta forma,
considerando que a ingestão dietética de vitamina D é baixa e o tempo de exposição solar pode ser
insuficiente para a manutenção dos níveis adequados de vitamina D em populações do Brasil e do Reino
Unido, é de extrema importância avaliar o efeito da suplementação dessa vitamina em populações de
mesma etnia, porém residentes em latitudes diferentes de modo a verificar a influência da exposição solar e
dos fatores genéticos sobre a resposta a suplementação.
HIPÓTESE
H1: A suplementação de vitamina D é necessária para se obter a concentração sérica ideal tanto em
brasileiras residentes no Brasil quanto no Reino Unido.
H2: A ingestão dietética e a exposição a luz solar na população brasileira, tanto em mulheres residentes no
Brasil quanto no Reino Unido, é insuficiente para manutenção da concentração sérica adequada de vitamina
D.
H3: A reposta a suplementação de vitamina D é dependente dos níveis séricos iniciais.
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H4: A resposta à suplementação é influenciada pela incidência de luz solar.
H5: A resposta à suplementação com vitamina D é influenciada por polimorfismos do gene do receptor da
vitamina D.
H6: A pigmentação da pele é um fator influente sobre a concentração sérica ideal de vitamina D.
METODOLOGIA
O estudo é um ensaio clínico controlado, randomizado, duplo-cego com duração de 12 semanas. Durante o
recrutamento, será realizada a aplicação de um questionário com os fatores de inclusão e exclusão de forma
a selecionar 80 indivíduos do sexo feminino, brasileiras, com idade entre 20 e 59 anos em cada um dos
países, que concordem com o termo de consentimento livre e esclarecido. Para o cálculo da amostra foi
utilizado um poder estatístico de 90% com margem de erro de 3,5%, resultando em uma necessidade de
pelo menos 30 participantes em cada grupo para ser possível avaliar alterações significativas nos níveis
séricos de vitamina D entre os grupos. A amostra de 40 indivíduos para o grupo vitamina D e 40 para o
grupo placebo inclui uma taxa de abandono de 20%. As 80 mulheres selecionadas em cada país serão
divididas em dois grupos: Grupo Placebo e Grupo Suplementado, que receberá 600UI de vitamina D. O
primeiro ensaio clínico será executado no Reino Unido de novembro de 2016 a marco de 2017
(outonoinverno)
e, em seguida, o segundo será executado no Brasil de maio de 2017 a outubro de 2017 (outonoinverno).
O projeto foi propositalmente delineado de forma que possam ser excluídas quaisquer exposições exógenas
a raios UVB durante este período no Reino Unido. No Brasil, considerando que as estações do ano não são
bem definidas, haverá uma exposição a luz solar o que permitirá avaliar diferenças na resposta a
suplementação em função da associação com a exposição solar. Optou-se por 12 semanas (3 meses) como
o período de suplementação por estudos anteriores terem mostrado ser um período de tempo eficaz
para a suplementação de vitamina D. Já a suplementação com 600IU foi escolhida por ser as
recomendações do IOM dos EUA para a vitamina D, que são atualmente as recomendações adotadas no
Brasil. A aderência será verificada regularmente por telefone e pessoalmente na última visita, pela contagem
das embalagens vazias. Os resultados obtidos nos grupos suplementados também serão analisados de
acordo com os genótipos para os seguintes SNPs no gene do VDR: FokI TC (rs10735810), BsmI AG
(rs1544410), Apal GT (rs7975232), e Taql CT (rs731236). Serão realizadas coletas de sangue,
antropometria e avaliação da pigmentação da pele no início e no final da intervenção (T0 e T12s) e
composição corporal e densitometria óssea
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apenas em T0. As amostras de soro (no início do estudo e após
12 semanas) serão identificadas e armazenadas em freezers -80 ° C, no laboratório “Nutritional Metabolism”
da Universidade de Surrey. As seguintes análises bioquímicas serão realizadas: concentração de 25 (OH)
D3, 1,25 (OH) D3, fósforo, cálcio, perfil lipídico, glicose, insulina, albumina, hormônio paratireoide, CTX
(telopepitídio C-terminal). A ingestão alimentar dos indivíduos será avaliada por meio de
registros alimentares de 4 dias consecutivos no início e no final da intervenção. Para verificação da
exposição à luz solar os indivíduos usarão broches dosímetros de exposição a raios UV individuais no
começo e no final do período de coleta. Os valores de massa livre de gordura (MLG), o percentual de
gordura corpórea (%G) e a densitometria óssea serão avaliados no Laboratório de Investigação em Nutrição
Clínica e Esportiva da Faculdade de Nutrição da Universidade Federal de Goiás (UFG), utilizando o método
de absorciometria radiológica de feixe duplo (DXA) em equipamento modelo DPX NT. As análises
de DNA serão realizadas nos laboratórios de genética da Universidade de Surrey. O DNA genômico será
extraído com o auxílio do kit comercial High Pure PCR Template Preparation (Roche®, Mannheim,
Alemanha), a partir de leucócitos presentes em sangue periférico. A quantidade de pigmento melanina na
pele será mesurada por meio de questionário validado de classificação do fototipo de pele de
Fitzpatrick.METODOLOGIA DE ANÁLISE DE DADOS:
O banco de dados será elaborado utilizando o programa SPSS ®, versão 13.0 com dupla entrada para a
conferência dos dados por meio do validate. A análise descritiva, incluindo média ± desvio-padrão, mediana
e limite inferior e superior serão realizados para todas as variáveis quantitativas. Inicialmente, os dados
serão testados quanto a sua distribuição, por meio do teste de Shapiro-Wilk. Teste t de Student ou Mann-
Whitney, dependendo da distribuição dos dados serão aplicados para avaliar diferenças entre o grupo
suplementado e placebo. Para análise conjunta dos quatros grupos será realizada a ANOVA. Correlações
lineares de Pearson ou Spearman serão calculadas de acordo com a presença/ausência de distribuição
normal, respectivamente, entre ingestão de vitamina D, exposição ao sol e concentração sérica de vitamina
D.A análise de regressão linear múltipla será realizada para determinar as variáveis que mais influenciaram
as concentrações sanguíneas de vitamina D.A fim de determinar se a resposta a suplementação difere entre
os genótipos, estes serão separados em homozigotos selvagens, heterozigotos e homozigotos para a
variante. Nesta abordagem, os resultados serão avaliados com o teste de ANOVA ou Kruskal-Wallis, em
casos de variáveis com distribuição normal ou não, respectivamente. Correlações
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lineares de Pearson ou Spearman serão calculadas também de acordo com a presença/ausência de
distribuição normal, respectivamente. O equilíbrio de Hardy-Weinberg será verificado por meio do teste de
Qui-Quadrado com o auxílio da calculadora para marcadores bialélicos. Para descrever a relação entre
aspectos do consumo alimentar e características bioquímicas independente da ingestão de energia, os
valores de ingestão dos nutrientes de interesse serão ajustados ao valor energético, de acordo com o
método residual proposto por Willet, Howe and Kushi. O nível de significância adotado como padrão será
5%.
DESFECHO PRIMÁRIO:
Concentração sérica de vitamina D.
DESFECHO SECUNDÁRIO:
Concentração sérica de cálcio, perfil lipídico, glicose, insulina, albumina, hormônio paratireoide, CTX
(telopepitídio C-terminal).
CRITÉRIOS DE INCLUSÃO
Sexo feminino, brasileira, com idade entre 20 e 59 anos.
CRITÉRIOS DE EXCLUSÃO
Mulheres em uso de medicamento ou com doenças que possam afetar o metabolismo da vitamina D; uso de
suplementos; que utilizaram camas de bronzeamento artificial; mulheres grávidas ou amamentando;
mulheres em menopausa ou reposição hormonal.
OBJETIVO PRIMÁRIO
Avaliar o efeito da suplementação de vitamina D sobre marcadores do metabolismo ósseo em mulheres
adultas brasileiras residentes no Brasil e no Reino Unido.
OBJETIVOS SECUNDÁRIOS
(I) Avaliar a diferença em relação ao tempo e intensidade de exposição ao sol entre mulheres adultas
brasileiras que vivem no Brasil e mulheres adultas brasileiras que vivem no Reino Unido.
(II) Determinar a prevalência de ingestão inadequada de vitamina D em mulheres adultas brasileiras
residentes no Brasil e no Reino Unido.
(III) Determinar a prevalência de níveis insuficientes / deficientes de vitamina D em mulheres adultas
brasileiras residentes no Brasil e no Reino Unido.
(IV) Investigar a influência da pigmentação da pele sobre a concentração de vitamina D em mulheres
adultas brasileiras residentes no Brasil e no Reino Unido.
(V) Investigar se a resposta à suplementação de vitamina D é dependente da concentração inicial
Objetivo da Pesquisa:
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dessa vitamina.
(VI) Determinar a influência de fatores genéticos nas respostas a suplementação de vitamina D.
(VII) Avaliar a associação entre níveis séricos de vitamina D e marcadores do metabolismo ósseo.
(VIII) Determinar a influência da latitude na manutenção dos níveis séricos adequados de vitamina D.
RISCOS:
O risco é mínimo e somente associado ao desconforto da coleta de sangue (inchaço e rubor) e a um
possível constrangimento durante a entrevista. No entanto, o participante pode se recusar a responder
qualquer uma das perguntas sem que isto lhe traga qualquer prejuízo. Não foram identificados riscos
relacionados à ingestão de cápsulas de vitamina D com dosagem 600UI em pesquisas anteriores.
Exposição ao raio-X do equipamento DXA é considerada mínima e não acarreta prejuízos a saúde.
BENEFÍCIOS:
Resultados dos exames de composição corporal, densitometria óssea e marcadores do metabolismo ósseo
serão disponibilizados aos participantes. Participantes do grupo suplementado terão menor risco de níveis
deficientes de vitamina D ao final do estudo. A identificação dos fatores relacionados à manutenção de
níveis adequados de vitamina D no sangue em mulheres brasileiras permitirá o desenvolvimento de
recomendações e orientações de saúde mais especificas e eficazes para esse grupo populacional.
Avaliação dos Riscos e Benefícios:
Respostas ao Parecer Consubstanciado CONEP nº 1.905.040 de 03/02/2017.
Ensaio clínico controlado, randomizado, duplo-cego com duração de 12 semanas com 80 indivíduos do sexo
feminino, brasileiras, com idade entre 20 e 59 anos em cada um dos países (Brasil e Reino Unido). As 80
mulheres selecionadas em cada país serão divididas em dois grupos: Grupo Placebo e Grupo
Suplementado, que receberá 600UI de vitamina D. O primeiro ensaio clínico será executado no Reino Unido
de novembro de 2016 a março de 2017 (outono-inverno) e, em seguida, o segundo será executado no Brasil
de maio de 2017 a outubro de 2017 (outono-inverno).
Serão coletados dados socioeconômicos, características da pele, de estilo de vida e saúde (por meio de
questionários aplicados por entrevistadores treinados), dados antropométricos (peso, altura e circunferência
da cintura), de padrão alimentar (por meio de diário alimentar de 4 dias consecutivos), exposição a luz solar
(por meio de diário e broches dosímetros de raio-ultravioleta).
Comentários e Considerações sobre a Pesquisa:
74.001-970
(62)3521-1215 E-mail: cep.prpi.ufg@gmail.com
Endereço:
Bairro: CEP:
Telefone:
Prédio da Reitoria Térreo Cx. Postal 131
Campus Samambaia
UF: Município:GO GOIANIA
Fax: (62)3521-1163
Página 06 de  11
UFG - UNIVERSIDADE
FEDERAL DE GOIÁS
Continuação do Parecer: 2.013.222
Amostras de sangue serão coletadas para análises bioquímicas de marcadores do metabolismo ósseo e
para análises genéticas (SNPs no gene do
receptor de vitamina D - VDR no grupo suplementado). Para verificação da exposição à luz solar os
indivíduos usarão dosímetros de exposição a raios UV individuais no começo e no final do período de
coleta. A pigmentação da pele será determinada por meio de
questionário de fototipo de pele de Fitzpatrick.
Serão realizadas coletas de sangue e avaliação da composição corporal no início e no final da intervenção
(T0 e T12s) e densitometria óssea no início apenas (T0). As análises bioquímicas serão realizadas no
Departamento de Medicina da Universidade Imperial College London e no laboratório de genética da
Universidade de Surrey, sob a responsabilidade da Dra. Lanham-New (Inglaterra). As amostras de sangue
coletadas que não forem utilizadas no estudo serão devidamente descartadas.
A pesquisa será custeada pela taxa de bancada da bolsa de doutorado no exterior concedida pelo Programa
Ciências Sem Fronteiras, com apoio do CNPq. Os suplementos e placebos serão fornecidos gratuitamente
pela Viridian Nutrition Co. (Registration number: 03750310).
Trata-se de projeto de doutorado de Marcela Moraes Mendes da Faculdade de Nutrição da Universidade
Federal de Goiás sob orientação da Dra. Patrícia Borges Botelho.
Em resposta ao Parecer Consubstanciado CONEP nº 1.905.040 de 03/02/2017 foram postados em
15/03/2017 os seguintes documentos:
• PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf de 15/03/2017
• Carta_resposta_DSOL.pdf
• Aprovacao_Comite_de_Etica_traduzido.pdf
• Declaracao_de_uso_do_material_biologico_no_exterior.pdf
• ORCAMENTO_REVISADO.pdf
• TERMO_DE_ACORDO_INTERINSTITUCIONAL_EM_PESQUISA.pdf
• termo_anuencia_traduzido.pdf
• Declaracao_estudos_futuros.pdf
• TERMO_DE_CONSENTIMENTO_LIVRE_E_ESCLARECIDO_REVISADO.pdf
• 2_DSOL_PROTOCOLO_REVISADO.pdf
• Detalhamento_operacional_e_de_infraestrutura_do_Lanucli.pdf
• Detalhamento_operacional_e_infraestrutura_do_laboratorio_da_Universidade_de_Surrey.pdf
• Viridian_Supplements.pdf
Considerações sobre os Termos de apresentação obrigatória:
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Documentos postados na submissão inicial (18/11/2016):
• PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf de 18/11/2016
• 18_Aprovacao_conselho_diretor.pdf
• 17_Comprovante_taxa_bancada2.pdf
• 16_Comprovante_taxa_bancada.pdf
• 15_treinamento_pessoal.pdf
• 14_instituicao_coresponsavel.pdf
• 13_COMPROMISSOS_VANTAGENS_PAIS.pdf
• 12_Compromissos_vantagens_sujeitos.pdf
• 11_Aprovacao_Comite_etica_UK.pdf
• 10_Termo_anuencia_University_Surrey.pdf
• 9_Termo_anuencia.pdf
• 8_Termo_compromisso.pdf
• 7_Curriculo_Patricia.pdf
• 6_Curriculo_Susan.pdf
5_Curriculo_Marcela.pdf
• 4_TCLE.pdf
• 3_ORCAMENTO.pdf
• 2_DSOL_PROTOCOLO.pdf
• 1_Carta_de_encaminhamento.pdf
• 2_folha_rosto.pdf
Carta Resposta ao atendimento da recomendação da CONEP
Versão do documento da Viridian supplements
2. Quanto ao Protocolo de Pesquisa:
2.4.1 - Solicita-se apresentar declaração da empresa ratificando a doação dos suplementos e dos placebos
para o estudo.
RESPOSTA: Declaração anexada (Arquivo: Viridian supplements).
ANÁLISE: PENDÊNCIA ATENDIDA. Foi inserido na Plataforma Brasil a versão traduzida deste documento.
   Verifica-se que a recomendação emanada pela CONEP foi atendida.
Conclusões ou Pendências e Lista de Inadequações:
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   Após análise dos documentos postados somos favoráveis à aprovação do presente protocolo de pesquisa,
smj deste Comitê.
Informamos que o Comitê de Ética em Pesquisa/CEP-UFG considera o presente protocolo APROVADO, o
mesmo foi considerado em acordo com os princípios éticos vigentes.  Reiteramos a importância deste
Parecer Consubstanciado, e lembramos que o(a) pesquisador(a) responsável deverá encaminhar ao CEP-
UFG o Relatório Final baseado na conclusão do estudo e na incidência de publicações decorrentes deste,
de acordo com o disposto na Resolução CNS n. 466/12. O prazo para entrega do Relatório é de até 30 dias
após o encerramento da pesquisa, prevista para junho de 2018.
Considerações Finais a critério do CEP:
Este parecer foi elaborado baseado nos documentos abaixo relacionados:
Tipo Documento Arquivo Postagem Autor Situação
Informações Básicas
do Projeto
PB_INFORMAÇÕES_BÁSICAS_DO_P
ROJETO_781859.pdf
05/04/2017
10:51:34
Aceito
Outros Carta_resposta_Parecer_2_D_SOL.pdf 05/04/2017
10:49:57
Patrícia Borges
Botelho
Aceito
Declaração do
Patrocinador
Viridian_supplements_traduzido.pdf 05/04/2017
10:48:45
Patrícia Borges
Botelho
Aceito
Outros Carta_resposta_DSOL.pdf 15/03/2017
05:54:06
Patrícia Borges
Botelho
Aceito
Outros Aprovacao_Comite_de_Etica_traduzido.
pdf
15/03/2017
05:48:14
Patrícia Borges
Botelho
Aceito
Outros Declaracao_de_uso_do_material_biologi
co_no_exterior.pdf
15/03/2017
05:47:37
Patrícia Borges
Botelho
Aceito
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Orçamento ORCAMENTO_REVISADO.pdf 15/03/2017
05:46:13
Patrícia Borges
Botelho
Aceito
Outros TERMO_DE_ACORDO_INTERINSTITU
CIONAL_EM_PESQUISA.pdf
15/03/2017
05:45:18
Patrícia Borges
Botelho
Aceito
Outros termo_anuencia_traduzido.pdf 15/03/2017
05:44:27
Patrícia Borges
Botelho
Aceito
Outros Declaracao_estudos_futuros.pdf 15/03/2017
05:41:19
Patrícia Borges
Botelho
Aceito
TCLE / Termos de
Assentimento /
Justificativa de
Ausência
TERMO_DE_CONSENTIMENTO_LIVR
E_E_ESCLARECIDO_REVISADO.pdf
15/03/2017
05:39:25
Patrícia Borges
Botelho
Aceito
Projeto Detalhado /
Brochura
Investigador
2_DSOL_PROTOCOLO_REVISADO.pdf 15/03/2017
05:38:20
Patrícia Borges
Botelho
Aceito
Declaração de
Manuseio Material
Biológico /
Biorepositório /
Biobanco
Detalhamento_operacional_e_de_infrae
strutura_do_Lanucli.pdf
15/03/2017
05:36:04
Patrícia Borges
Botelho
Aceito
Declaração de
Manuseio Material
Biológico /
Biorepositório /
Biobanco
Detalhamento_operacional_e_infraestrut
ura_do_laboratorio_da_Universidade_de
_Surrey.pdf
15/03/2017
05:35:47
Patrícia Borges
Botelho
Aceito
Outros 18_Aprovacao_conselho_diretor.pdf 18/11/2016
17:54:53
Patrícia Borges
Botelho
Aceito
Outros 17_Comprovante_taxa_bancada2.pdf 18/11/2016
17:53:28
Patrícia Borges
Botelho
Aceito
Recurso Anexado
pelo Pesquisador
16_Comprovante_taxa_bancada.pdf 18/11/2016
17:51:12
Patrícia Borges
Botelho
Aceito
Outros 15_treinamento_pessoal.pdf 18/11/2016
17:47:28
Patrícia Borges
Botelho
Aceito
Outros 14_instituicao_coresponsavel.pdf 18/11/2016
17:46:37
Patrícia Borges
Botelho
Aceito
Outros 13_COMPROMISSOS_VANTAGENS_P
AIS.pdf
18/11/2016
17:45:23
Patrícia Borges
Botelho
Aceito
Outros 12_Compromissos_vantagens_sujeitos.
pdf
18/11/2016
17:44:35
Patrícia Borges
Botelho
Aceito
Outros 11_Aprovacao_Comite_etica_UK.pdf 18/11/2016
17:43:30
Patrícia Borges
Botelho
Aceito
Outros 10_Termo_anuencia_University_Surrey.
pdf
18/11/2016
17:41:01
Patrícia Borges
Botelho
Aceito
Outros 9_Termo_anuencia.pdf 18/11/2016
17:39:52
Patrícia Borges
Botelho
Aceito
Outros 8_Termo_compromisso.pdf 18/11/2016
17:38:34
Patrícia Borges
Botelho
Aceito
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GOIANIA, 12 de Abril de 2017
João Batista de Souza
(Coordenador)
Assinado por:
Outros 7_Curriculo_Patricia.pdf 18/11/2016
17:37:43
Patrícia Borges
Botelho
Aceito
Outros 6_Curriculo_Susan.pdf 18/11/2016
17:33:18
Patrícia Borges
Botelho
Aceito
Outros 5_Curriculo_Marcela.pdf 18/11/2016
17:32:10
Patrícia Borges
Botelho
Aceito
Outros 1_Carta_de_encaminhamento.pdf 18/11/2016
17:26:34
Patrícia Borges
Botelho
Aceito
Folha de Rosto 2_folha_rosto.pdf 18/11/2016
17:20:42
Patrícia Borges
Botelho
Aceito
Situação do Parecer:
Aprovado
Necessita Apreciação da CONEP:
Não
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PARECER CONSUBSTANCIADO DA CONEP
Pesquisador:
Título da Pesquisa:
Instituição Proponente:
Versão:
CAAE:
Efeito da suplementação com vitamina D e do nível de exposição à luz solar em
mulheres brasileiras residentes em latitudes opostas (The D-SOL Study)
Patrícia Borges Botelho
Universidade Federal de Goiás - UFG
2
62149516.9.0000.5083
Área Temática:
DADOS DO PROJETO DE PESQUISA
Número do Parecer: 1.972.029
DADOS DO PARECER
INTRODUÇÃO
Ao longo dos últimos 15 anos, a vitamina D tem sido bastante estudada pela comunidade científica. Embora
existam muitas questões ainda controversas em relação à concentração ideal de vitamina D sérica e o
impacto da ingestão de vitamina D sobre a saúde humana, há um consenso de que a deficiência de
vitamina D é um problema de saúde pública em razão de suas implicações em diversas doenças entre elas,
a osteopenia, osteomalacia, doenças cardíacas, diabetes tipo I e II, doenças inflamatórias, esclerose
múltipla e artrite reumatóide. A vitamina D é derivada de duas fontes: da pele (endógena) e da dieta
(exógena). A principal fonte de vitamina D é a exposição da pele aos raios UV-B contidos na luz solar, uma
vez que esta é capaz de estimular a conversão do 7-dehidrocolesterol na pele a pré-colecalciferol. Desta
forma, considerando a expressiva contribuição da fonte endógena de vitamina D, a sua concentração pode
ser influenciada por diversos fatores, a destacar: fatores ambientais, como a latitude e as condições
meteorológicas,
Apresentação do Projeto:
Genética Humana:
(Haverá envio para o exterior de material genético ou qualquer material biológico
humano para obtenção de material genético, salvo nos casos em que houver
cooperação com o Governo Brasileiro;);
(Haverá armazenamento de material biológico ou dados genéticos humanos no
exterior e no País, quando de forma conveniada com instituições estrangeiras ou
em instituições comerciais;);
CNPQPatrocinador Principal:
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atributos pessoais, tais como a pigmentação da pele, idade, vestuário, uso do protetor solar, ambiente de
trabalho, atividade física e exposição ao sol e fatores genéticos. Com base na importante contribuição da
exposição à luz solar para a produção e manutenção dos níveis séricos de 25(OH)D, seria razoável se
constatar que a deficiência de vitamina D é um problema restrito a países situados em latitudes mais altas.
No entanto, vários estudos realizados em países ensolarados, como o Brasil, têm demonstrado que a
deficiência de vitamina D é um fenômeno comum, apesar da abundância de luz solar nestes locais, o que
evidencia a influência também da dieta e de fatores genéticos sobre o metabolismo da vitamina. Quanto aos
fatores dietéticos, o Brasil ainda não possui recomendações de ingestão diária de vitamina D específicas
para a sua população. Atualmente, são utilizadas as Dietary Reference Intakes (DRI) do Instituto de
Medicina  dos Estados Unidos (IOM) de 600UI/dia ou 15g/d de vitamina D. No entanto, essa recomendação
tem sido alvo de crítica de especialistas da área, que defendem que este valor seja insuficiente para manter
a concentração sérica adequada. Em relação aos fatores genéticos, estudos tem demonstrado que o gene
para o receptor da vitamina D (VDR) desempenha um papel importante no metabolismo dessa vitamina.
Polimorfismos nesse gene podem potencialmente influenciar a estabilidade do mRNA e, consequentemente
a expressão e a concentração sérica dessa vitamina. Um grupo de Porto Alegre encontrou uma prevalência
de 33% de deficiência de vitamina D em adolescentes brasileiras saudáveis e demonstrou que esta pode
estar associada a polimorfismos do gene do receptor específico da vitamina D (VDR). Desta forma,
considerando que a ingestão dietética de vitamina D é baixa e o tempo de exposição solar pode ser
insuficiente para a manutenção dos níveis adequados de vitamina D em populações do Brasil e do Reino
Unido, é de extrema importância avaliar o efeito da suplementação dessa vitamina em populações de
mesma etnia, porém residentes em latitudes diferentes de modo a verificar a influência da exposição solar e
dos fatores genéticos sobre a resposta a suplementação.
HIPÓTESE
H1: A suplementação de vitamina D é necessária para se obter a concentração sérica ideal tanto em
brasileiras residentes no Brasil quanto no Reino Unido.
H2: A ingestão dietética e a exposição a luz solar na população brasileira, tanto em mulheres residentes no
Brasil quanto no Reino Unido, é insuficiente para manutenção da concentração sérica adequada de vitamina
D.
H3: A reposta a suplementação de vitamina D é dependente dos níveis séricos iniciais.
H4: A resposta à suplementação é influenciada pela incidência de luz solar.
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H5: A resposta à suplementação com vitamina D é influenciada por polimorfismos do gene do receptor da
vitamina D.
H6: A pigmentação da pele é um fator influente sobre a concentração sérica ideal de vitamina D.
METODOLOGIA
O estudo é um ensaio clínico controlado, randomizado, duplo-cego com duração de 12 semanas. Durante o
recrutamento, será realizada a aplicação de um questionário com os fatores de inclusão e exclusão de forma
a selecionar 80 indivíduos do sexo feminino, brasileiras, com idade entre 20 e 59 anos em cada um dos
países, que concordem com o termo de consentimento livre e esclarecido. Para o cálculo da amostra foi
utilizado um poder estatístico de 90% com margem de erro de 3,5%, resultando em uma necessidade de
pelo menos 30 participantes em cada grupo para ser possível avaliar alterações significativas nos níveis
séricos de vitamina D entre os grupos. A amostra de 40 indivíduos para o grupo vitamina D e 40 para o
grupo placebo inclui uma taxa de abandono de 20%. As 80 mulheres selecionadas em cada país serão
divididas em dois grupos: Grupo Placebo e Grupo Suplementado, que receberá 600UI de vitamina D. O
primeiro ensaio clínico será executado no Reino Unido de novembro de 2016 a marco de 2017 (outono-
inverno) e, em seguida, o segundo será executado no Brasil de maio de 2017 a outubro de 2017 (outono-
inverno). O projeto foi propositalmente delineado de forma que possam ser excluídas quaisquer exposições
exógenas a raios UVB durante este período no Reino Unido. No Brasil, considerando que as estações do
ano não são bem definidas, haverá uma exposição a luz solar o que permitirá avaliar diferenças na resposta
a suplementação em função da associação com a exposição solar. Optou-se por 12 semanas (3 meses)
como o período de suplementação por estudos anteriores terem mostrado ser um período de tempo eficaz
para a suplementação de vitamina D. Já a suplementação com 600IU foi escolhida por ser as
recomendações do IOM dos EUA para a vitamina D, que são atualmente as recomendações adotadas no
Brasil. A aderência será verificada regularmente por telefone e pessoalmente na última visita, pela contagem
das embalagens vazias. Os resultados obtidos nos grupos suplementados também serão analisados de
acordo com os genótipos para os seguintes SNPs no gene do VDR: FokI TC (rs10735810), BsmI AG
(rs1544410), Apal GT (rs7975232), e Taql CT (rs731236). Serão realizadas coletas de sangue,
antropometria e avaliação da pigmentação da pele no início e no final da intervenção (T0 e T12s) e
composição corporal e densitometria óssea apenas em T0. As amostras de soro (no início do estudo e após
12 semanas) serão identificadas e armazenadas em freezers -80 ° C, no laboratório “Nutritional
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Metabolism” da Universidade de Surrey. As seguintes análises bioquímicas serão realizadas: concentração
de 25 (OH) D3, 1,25 (OH) D3, fósforo, cálcio, perfil lipídico, glicose, insulina, albumina, hormônio
paratireoide, CTX (telopepitídio C-terminal). A ingestão alimentar dos indivíduos será avaliada por meio de
registros alimentares de 4 dias consecutivos no início e no final da intervenção. Para verificação da
exposição à luz solar os indivíduos usarão broches dosímetros de exposição a raios UV individuais no
começo e no final do período de coleta. Os valores de massa livre de gordura (MLG), o percentual de
gordura corpó-rea (%G) e a densitometria óssea serão avaliados no Laboratório de Investigação em
Nutrição Clínica e Esportiva da Faculdade de Nutrição da Universidade Federal de Goiás (UFG), utilizando o
método de absorciometria radiológica de feixe duplo (DXA) em equipamento modelo DPX NT. As análises
de DNA serão realizadas nos laboratórios de genética da Universidade de Surrey. O DNA genômico será
extraído com o auxílio do kit comercial High Pure PCR Template Preparation (Roche®, Mannheim,
Alemanha), a partir de leucócitos presentes em sangue periférico. A quantidade de pigmento melanina na
pele será mesurada por meio de questionário validado de classificação do fototipo de pele de Fitzpatrick.
METODOLOGIA DE ANÁLISE DE DADOS:
O banco de dados será elaborado utilizando o programa SPSS ®, versão 13.0 com dupla entrada para a
conferência dos dados por meio do validate. A análise descritiva, incluindo média ± desvio-padrão, mediana
e limite inferior e superior serão realizados para todas as variáveis quantitativas. Inicialmente, os dados
serão testados quanto a sua distribuição, por meio do teste de Shapiro-Wilk. Teste t de Student ou Mann-
Whitney, dependendo da distribuição dos dados serão aplicados para avaliar diferenças entre o grupo
suplementado e placebo. Para análise conjunta dos quatros grupos será realizada a ANOVA. Correlações
lineares de Pearson ou Spearman serão calculadas de acordo com a presença/ausência de distribuição
normal, respectivamente, entre ingestão de vitamina D, exposição ao sol e concentração sérica de vitamina
D.A análise de regressão linear múltipla será realizada para determinar as variáveis que mais influenciaram
as concentrações sanguíneas de vitamina D.A fim de determinar se a resposta a suplementação difere entre
os genótipos, estes serão separados em homozigotos selvagens, heterozigotos e homozigotos para a
variante. Nesta abordagem, os resultados serão avaliados com o teste de ANOVA ou Kruskal-Wallis, em
casos de variáveis com distribuição normal ou não, respectivamente. Correlações lineares de Pearson ou
Spearman serão calculadas também de acordo com a presença/ausência de distribuição normal,
respectivamente. O equilíbrio de Hardy-Weinberg será verificado por meio do
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teste de Qui-Quadrado com o auxílio da calculadora para marcadores bialélicos. Para descrever a relação
entre aspectos do consumo alimentar e características bioquímicas independente da ingestão de energia, os
valores de ingestão dos nutrientes de interesse serão ajustados ao valor energético, de acordo com o
método residual proposto por Willet, Howe and Kushi. O nível de significância adotado como padrão será
5%.
DESFECHO PRIMÁRIO:
Concentração sérica de vitamina D.
DESFECHO SECUNDÁRIO:
Concentração sérica de cálcio, perfil lipídico, glicose, insulina, albumina, hormônio paratireoide, CTX
(telopepitídio C-terminal).
CRITÉRIOS DE INCLUSÃO
Sexo feminino, brasileira, com idade entre 20 e 59 anos.
CRITÉRIOS DE EXCLUSÃO
Mulheres em uso de medicamento ou com doenças que possam afetar o metabolismo da vitamina D; uso de
suplementos; que utilizaram camas de bronzeamento artificial; mulheres grávidas ou amamentando;
mulheres em menopausa ou reposição hormonal.
OBJETIVO PRIMÁRIO
Avaliar o efeito da suplementação de vitamina D sobre marcadores do metabolismo ósseo em mulheres
adultas brasileiras residentes no Brasil e no Reino Unido.
OBJETIVOS SECUNDÁRIOS
(I)     Avaliar a diferença em relação ao tempo e intensidade de exposição ao sol entre mulheres adultas
brasileiras que vivem no Brasil e mulheres adultas brasileiras que vivem no Reino Unido.
(II)    Determinar a prevalência de ingestão inadequada de vitamina D em mulheres adultas brasileiras
residentes no Brasil e no Reino Unido.
Objetivo da Pesquisa:
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(III)   Determinar a prevalência de níveis insuficientes / deficientes de vitamina D em mulheres adultas
brasileiras residentes no Brasil e no Reino Unido.
(IV)    Investigar a influência da pigmentação da pele sobre a concentração de vitamina D em mulheres
adultas brasileiras residentes no Brasil e no Reino Unido.
(V)     Investigar se a resposta à suplementação de vitamina D é dependente da concentração inicial dessa
vitamina.
(VI)    Determinar a influência de fatores genéticos nas respostas a suplementação de vitamina D.
(VII)   Avaliar a associação entre níveis séricos de vitamina D e marcadores do metabolismo ósseo.
(VIII)  Determinar a influência da latitude na manutenção dos níveis séricos adequados de vitamina D.
RISCOS:
O risco é mínimo e somente associado ao desconforto da coleta de sangue (inchaço e rubor) e a um
possível constrangimento durante a entrevista. No entanto, o participante pode se recusar a responder
qualquer uma das perguntas sem que isto lhe traga qualquer prejuízo. Não foram identificados riscos
relacionados à ingestão de cápsulas de vitamina D com dosagem 600UI em pesquisas anteriores.
Exposição ao raio-X do equipamento DXA é considerada mínima e não acarreta prejuízos a saúde.
BENEFÍCIOS:
Resultados dos exames de composição corporal, densitometria óssea e marcadores do metabolismo ósseo
serão disponibilizados aos participantes. Participantes do grupo suplementado terão menor risco de níveis
deficientes de vitamina D ao final do estudo. A identificação dos fatores relacionados à manutenção de
níveis adequados de vitamina D no sangue em mulheres brasileiras permitirá o desenvolvimento de
recomendações e orientações de saúde mais especificas e eficazes para esse grupo populacional.
Avaliação dos Riscos e Benefícios:
Respostas ao Parecer Consubstanciado CONEP nº 1.905.040 de 03/02/2017.
Ensaio clínico controlado, randomizado, duplo-cego com duração de 12 semanas com 80
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indivíduos do sexo feminino, brasileiras, com idade entre 20 e 59 anos em cada um dos países (Brasil e
Reino Unido). As 80 mulheres selecionadas em cada país serão divididas em dois grupos: Grupo Placebo e
Grupo Suplementado, que receberá 600UI de vitamina D. O primeiro ensaio clínico será executado no Reino
Unido de novembro de 2016 a março de 2017 (outono-inverno) e, em seguida, o segundo será executado
no Brasil de maio de 2017 a outubro de 2017 (outono-inverno).
Serão coletados dados socioeconômicos, características da pele, de estilo de vida e saúde (por meio de
questionários aplicados por entrevistadores treinados), dados antropométricos (peso, altura e circunferência
da cintura), de padrão alimentar (por meio de diário alimentar de 4 dias consecutivos), exposição a luz solar
(por meio de diário e broches dosímetros de raio-ultravioleta). Amostras de sangue serão coletadas para
análises bioquímicas de marcadores do metabolismo ósseo e para análises genéticas (SNPs no gene do
receptor de vitamina D - VDR no grupo suplementado).
Para verificação da exposição à luz solar os indivíduos usarão dosímetros de exposição a raios UV
individuais no começo e no final do período de coleta. A pigmentação da pele será determinada por meio de
questionário de fototipo de pele de Fitzpatrick.
Serão realizadas coletas de sangue e avaliação da composição corporal no início e no final da intervenção
(T0 e T12s) e densitometria óssea no início apenas (T0). As análises bioquímicas serão realizadas no
Departamento de Medicina da Universidade Imperial College London e no laboratório de genética da
Universidade de Surrey, sob a responsabilidade da Dra. Lanham-New (Inglaterra). As amostras de sangue
coletadas que não forem utilizadas no estudo serão devidamente descartadas.
A pesquisa será custeada pela taxa de bancada da bolsa de doutorado no exterior concedida pelo Programa
Ciências Sem Fronteiras, com apoio do CNPq.  Os suplementos e placebos serão fornecidos gratuitamente
pela Viridian Nutrition Co. (Registration number: 03750310).
Trata-se de projeto de doutorado de Marcela Moraes Mendes da Faculdade de Nutrição da Universidade
Federal de Goiás sob orientação da Dra. Patrícia Borges Botelho.
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Em resposta ao Parecer Consubstanciado CONEP nº 1.905.040 de 03/02/2017 foram postados em
15/03/2017 os seguintes documentos:
• PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf de 15/03/2017
• Carta_resposta_DSOL.pdf
• Aprovacao_Comite_de_Etica_traduzido.pdf
• Declaracao_de_uso_do_material_biologico_no_exterior.pdf
• ORCAMENTO_REVISADO.pdf
• TERMO_DE_ACORDO_INTERINSTITUCIONAL_EM_PESQUISA.pdf
• termo_anuencia_traduzido.pdf
• Declaracao_estudos_futuros.pdf
• TERMO_DE_CONSENTIMENTO_LIVRE_E_ESCLARECIDO_REVISADO.pdf
• 2_DSOL_PROTOCOLO_REVISADO.pdf
• Detalhamento_operacional_e_de_infraestrutura_do_Lanucli.pdf
• Detalhamento_operacional_e_infraestrutura_do_laboratorio_da_Universidade_de_Surrey.pdf
• Viridian_Supplements.pdf
Documentos postados na submissão inicial (18/11/2016):
• PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf de 18/11/2016
• 18_Aprovacao_conselho_diretor.pdf
• 17_Comprovante_taxa_bancada2.pdf
• 16_Comprovante_taxa_bancada.pdf
• 15_treinamento_pessoal.pdf
• 14_instituicao_coresponsavel.pdf
• 13_COMPROMISSOS_VANTAGENS_PAIS.pdf
• 12_Compromissos_vantagens_sujeitos.pdf
• 11_Aprovacao_Comite_etica_UK.pdf
• 10_Termo_anuencia_University_Surrey.pdf
• 9_Termo_anuencia.pdf
• 8_Termo_compromisso.pdf
• 7_Curriculo_Patricia.pdf
• 6_Curriculo_Susan.pdf
• 5_Curriculo_Marcela.pdf
Considerações sobre os Termos de apresentação obrigatória:
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• 4_TCLE.pdf
• 3_ORCAMENTO.pdf
• 2_DSOL_PROTOCOLO.pdf
• 1_Carta_de_encaminhamento.pdf
• 2_folha_rosto.pdf
Verificar item "Conclusões ou Pendências e Lista de Inadequações".
Recomendações:
Análise de respostas ao Parecer Consubstanciado CONEP nº 1.905.040 de 03/02/2017:
1 .  Q u a n t o  a o s  a r q u i v o s  " 1 0 _ T e r m o _ a n u e n c i a _ U n i v e r s i t y _ S u r r e y . p d f " e
“11_Aprovacao_Comite_etica_UK.pdf": Solicita-se apresentar, além das versões originais, as versões
traduzidas para o Português.
R E S P O S T A :  A s  v e r s õ e s  t r a d u z i d a s  p a r a  o  P o r t u g u ê s  d o s  d o c u m e n t o s :
10_Termo_anuenc ia_Un ive rs i t y_Sur rey .pd f  (A rqu i vo :  Te rmo  anuênc ia  t raduz ido )  e
11_Aprovacao_Comite_etica_UK.pdf (Arquivo: Aprovação comitê de ética traduzido) foram anexadas. No
entanto, não consta as asssinaturas visto que os órgãos competentes de Surrey não assinam documentos
em uma língua que não seja a original.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.   Quanto ao Protocolo de Pesquisa:
2 . 1  Q u a n t o  a o  P r o t o c o l o  d e  P e s q u i s a :  N o  i t e m  " R i s c o s "  d o  d o c u m e n t o
"PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf", lê-se: "O risco é mínimo e somente
associado ao desconforto da coleta de sangue (inchaço e rubor) e a um possível constrangimento durante a
entrevista. No entanto, o participante pode se recusar a responder qualquer uma das perguntas sem que
isto lhe traga qualquer prejuízo. Não foram identificados riscos relacionados à ingestão de cápsulas de
vitamina D com dosagem 600UI em pesquisas anteriores. Exposição ao raio-X do equipamento DXA é
considerada mínima e não acarreta prejuízos à saúde.". Solicita -se
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adequação informando os potenciais riscos associados ao uso da vitamina D e/outros riscos também
associados à pesquisa explicitando ainda as providências e as cautelas a serem tomadas para evitar que
ocorram os riscos. Solicita-se ainda adequação do projeto detalhado.
RESPOSTA: O texto foi adequado conforme solicitação, explicitando os riscos e a forma como serão
minimizados. Ver documento: TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE)
REVISADO, página 5 e 6 e no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf” no item
acrescentado denominado “5.12 DESCONFORTOS E RISCOS ESPERADOS”, na página 23 e no
APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 5 e 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.2. No item "BENEFÍCIOS" do documento "PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf",
lê-se: "Resultados dos exames de composição corporal, densitometria óssea e marcadores do metabolismo
ósseo serão disponibilizados aos participantes. Participantes do grupo suplementado terão menor risco de
níveis deficientes de vitamina D ao final do estudo. A identificação dos fatores relacionados à manutenção
de níveis adequados de vitamina D no sangue em mulheres brasileiras permitirá o desenvolvimento de
recomendações e orientações de saúde mais especificas e eficazes para esse grupo populacional.". Solicita
-se exclusão do trecho "Resultados dos exames de composição corporal, densitometria óssea e marcadores
do metabolismo ósseo serão disponibilizados aos participantes" por se tratar de um direito do participante de
pesquisa (e não benefício). Caso o estudo não antecipe qualquer benefício direto ao participante, essa
informação deve constar no arquivo da Plataforma Brasil e no projeto detalhado. Solicitam-se adequações.
RESPOSTA: O texto foi adequado conforme solicitação na plataforma Brasil e no documento TERMO DE
CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE) REVISADO, página 6 , bem como no projeto
detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE
E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
2 . 3  N o  i t e m  “ P a í s e s  d e  R e c r u t a m e n t o ”  d o  d o c u m e n t o
"PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf" lê-se “País: BRASIL/ Nº de participantes da
pesquisa: 80”. Considerando que o protocolo de pesquisa prevê “selecionar 80 indivíduos do sexo feminino,
brasileiras, com idade entre 20 e 59 anos em cada um dos países”, solicita-se adequação informando o
número de participantes brasileiras que também serão recrutadas no Reino Unido.
70.750-521
(61)3315-5878 E-mail: conep@saude.gov.br
Endereço:
Bairro: CEP:
Telefone:
SEPN 510 NORTE, BLOCO A 3º ANDAR,  Edifício Ex-INAN - Unidade II - Ministério da Saúde
Asa Norte
UF: Município:DF BRASILIA
Página 10 de  28
COMISSÃO NACIONAL DE
ÉTICA EM PESQUISA
Continuação do Parecer: 1.972.029
RESPOSTA: Considerando que o recrutamento dos participantes no Reino Unido já aconteceu em Outubro
a Dezembro de 2016, não foi possível acrescentar o recrutamento com data passada nas informações
básicas do projeto na Plataforma Brasil.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.4 - No "APÊNDICE 8 - ORÇAMENTO FINANCEIRO DETALHADO E REMUNERAÇÃO DO
PESQUISADOR" lê-se: "Os suplementos e placebos serão fornecidos pela Viridian Nutrition
Co.(Registration number: 03750310) gratuitamente.".
2.4.1 - Solicita-se apresentar declaração da empresa ratificando a doação dos suplementos e dos placebos
para o estudo.
RESPOSTA: Declaração anexada (Arquivo: Viridian supplements).
ANÁLISE: PENDÊNCIA PARCIALMENTE ATENDIDA. Solicita-se submeter na Plataforma Brasil a versão
traduzida deste documento.
2.4.2 - Solicita-se acrescentar o valor da doação dos suplementos e placebos no orçamento financeiro do
estudo.
RESPOSTA: Foi acrescentado o valor da doação dos suplementos e placebos no orçamento financeiro do
estudo no documento ORÇAMENTO REVISADO e no projeto detalhado “2_DSOL_PROTOCOLO
REVISADO.pdf”, APÊNDICE 8 - ORÇAMENTO FINANCEIRO DETALHADO E REMUNERAÇÃO DO
PESQUISADOR.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.5 - Solicita-se esclarecer se o uso da vitamina D conforme a proposição do estudo deve ser constante ou
se há um prazo delimitado para o uso. Caso seja necessário o uso constante da vitamina D, solicita-se
esclarecer como ocorrerá o fornecimento de suplemento pós-estudo.
RESPOSTA: Conforme o item III.3.d. deve-se assegurar a todos os participantes ao final do estudo, por
parte do patrocinador, acesso gratuito e por tempo indeterminado, aos melhores métodos profiláticos,
diagnósticos e terapêuticos que se demonstraram eficazes. Ainda, o acesso também deve ser garantido no
intervalo entre o término da participação individual e o final do estudo, podendo, nesse caso, esta garantia
ser dada por meio de estudo de extensão, de acordo com análise devidamente justificada do médico
assistente do participante. O uso da vitamina D conforme a proposição do estudo tem um prazo delimitado
de 12 semanas (período total de
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intervenção do estudo), não havendo necessidade de uso constante.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.6 - No projeto detalhado foi informado que o recrutamento dos voluntários será realizado nas
dependências da UFG por meio do convite a alunos e funcionários que tenham interesse em participar e
que apresentem os critérios de elegibilidade estabelecidos. ALÉM DISSO, SERÁ REALIZADA A
DIVULGAÇÃO DA PESQUISA PELAS REDES SOCIAIS. Durante o recrutamento, será realizada a
aplicação de um questionário. Diante do exposto:
2.6.1 - Solicita-se esclarecer a forma de recrutamento dos participantes por meio da rede social e, caso
necessário, solicita-se apresentação do texto para análise ética.
RESPOSTA: Foi acrescentada a informação de recrutamento solicitada no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, item 5. DELINEAMENTO DO ESTUDO E METODOLOGIA,
página 15. O recrutamento nas redes sociais será realizado por meio de postagem na página oficial da
FANUT-UFG com texto convite e informações básicas para contato, no caso de interesse. Segue texto para
análise ética: “Projeto: Ingestão de vitamina D e exposição a luz solar e sua relação com os níveis séricos
de vitamina D em mulheres brasileiras residentes em latitudes opostas – The D-SOL Study. Se você é
mulher, tem entre 20 e 59 anos e não iniciou a menopausa, participe da nossa pesquisa! Exames a serem
realizados: + Composição corporal (% de gordura) + Exame de sangue (vitamina D, cálcio, hormônio da
paratireoide); + Perfil genético de genes ligados a concentração de vitamina D no sangue; + Composição
óssea Caso participe dessa pesquisa, você estará ajudando a ciência a entender melhor como a vitamina D
age no nosso corpo e qual a importância dela para a saúde dos ossos! - Sua participação requer apenas 2
encontros e a ingestão diária de vitamina D (ou placebo) por 3 meses. - Resultados dos exames serão
disponibilizados individualmente para os participantes. Para participar ou para ter mais informações entre
em contato: Marcela Mendes (62) 81036716 Ou dsol@surrey.ac.uk Esta pesquisa foi aprovada pelos
Comitês de Éticas da Universidade Federal de Goiás e da Universidade de Surrey.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.6.2 - Solicita-se esclarecer a forma de recrutamento e atendimento das participantes brasileiras na
Inglaterra.
RESPOSTA: Foi acrescentada a informação de recrutamento solicitada no projeto detalhado
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“2_DSOL_PROTOCOLO REVISADO.pdf”, item 5. DELINEAMENTO DO ESTUDO E METODOLOGIA,
página 15.
ANÁLISE: PENDÊNCIA ATENDIDA.
2.7 - No documento “2_DSOL_PROTOCOLO.pdf”, postado em 18/11/2016, na página 18 de 52, lê-se
“Dosímetros são broches pequenos os quais podem ser lidos por um espectrofotômetro a 320nm, antes e
após uso [...].”. Solicita-se apresentar as especificações técnicas do produto citado no trecho.
RESPOSTA: Foram acrescentadas as especificações técnicas do produto dosímetro no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, item 5.5 AVALIAÇÃO DA EXPOSIÇÃO SOLAR, página 19,
conforme solicitado.
ANÁLISE: PENDÊNCIA ATENDIDA.
3 - Quanto à constituição de biorrepositório, a análise do Protocolo de Pesquisa indica que haverá formação
de biorrepositório. Assim sendo todos os aspectos relativos à formação de biorrepositório ao longo da
execução de uma pesquisa deverão ser seguidos conforme explicitado na Resolução CNS 441/11 e Portaria
MS 2201/11, ainda que o armazenamento do material biológico seja temporário sem previsão de uso futuro.
Solicita-se uma revisão das referidas normativas e apresentar:
3.1 - Justificativa quanto à necessidade e oportunidade para utilização futura das amostras biológicas
armazenadas no estudo em tela (Item 2.I, da Resolução CNS nº 441 de 2011), se pertinente.
RESPOSTA: A princípio toas as amostras coletadas serão enviadas para os laboratórios no Reino Unido
imediatamente após os 3 meses de estudo e utilizadas apenas para os propósitos descritas no protocolo,
sendo destruídas após utilização. Não há, portanto, previsão de utilização futura das amostras biológicas
armazenadas no estudo em tela. Caso haja futuramente possibilidade de utilização futura em nova pesquisa
das amostras biológicas armazenadas, confirmamos em declaração anexada que toda nova pesquisa a ser
realizada com o material armazenado em biorrepositório será submetida para aprovação do Comitê de Ética
em Pesquisa (CEP) institucional e da Comissão Nacional de Ética em Pesquisa (CONEP) (Item 2.III, da
Resolução CNS nº 441 de 2011).
ANÁLISE: PENDÊNCIA ATENDIDA.
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3.2 - Declaração de que toda nova pesquisa a ser realizada com o material armazenado em biorrepositório
será submetida para aprovação do Comitê de Ética em Pesquisa (CEP) institucional e, quando for o caso,
da Comissão Nacional de Ética em Pesquisa (CONEP) (Item 2.III, da Resolução CNS nº 441 de 2011), se
pertinente.
RESPOSTA: Declaração anexada (Arquivo: declaração estudos futuros).
ANÁLISE: PENDÊNCIA ATENDIDA.
3.3 - Regulamento dos laboratórios envolvidos no armazenamento do material biológico: detalhamento
operacional e de infraestrutura, bem como as condições de armazenamento do material, que podem estar
contidos no projeto de pesquisa detalhado ou em forma de declaração. Cabe ressaltar que o prazo de
armazenamento de material biológico humano em biorrepositório deve estar de acordo com o cronograma
da pesquisa correspondente e pode ser autorizado por até dez anos. Solicita-se explicitar no projeto de
pesquisa o tempo de armazenamento.
RESPOSTA: Declarações anexadas (Arquivos: Detalhamento operacional e de infraestrutura do Lanucli e
Detalhamento operacional e de infraestrutura do laboratório da Universidade de Surrey) e tempo de
armazenamento explicitado no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, item “5.3
AVALIAÇÃO LABORATORIAL” página 18.
ANÁLISE: PENDÊNCIA ATENDIDA.
3.4 - Termo de Acordo em pesquisa envolvendo mais de uma instituição (acordo interinstitucional),
assinado, contemplando formas de operacionalização, compartilhamento e utilização do material biológico
humano armazenado no Biorrepositório, inclusive a possibilidade de dissolução futura da parceria e a
consequente partilha e destinação dos dados e materiais armazenados. Em se tratando de biorrepositório
compartilhado, o Termo de Acordo deve ser assinado pelos pesquisadores responsáveis de cada instituição
envolvida e pelos seus responsáveis institucionais.
RESPOSTA: Termo de Acordo interistitucional em pesquisa anexado.
ANÁLISE: PENDÊNCIA ATENDIDA.
3.5 - Declaração garantindo aos pesquisadores e às instituições brasileiras o direito ao acesso e utilização
do material biológico humano armazenado no exterior (Resolução CNS 441/2011, item 14).
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RESPOSTA: Declaração anexada (Arquivo: Declaração de uso do material biológico no exterior).
ANÁLISE: PENDÊNCIA ATENDIDA.
3.6 - Compromisso dos pesquisadores no exterior quanto à vedação do patenteamento e da utilização
comercial do material biológico humano armazenado em biorrepositório (Item 16, da Resolução CNS nº 441
de 2011).
RESPOSTA: Declaração anexada (Arquivo: Declaração de uso do material biológico no exterior).
ANÁLISE: PENDÊNCIA ATENDIDA.
3.7 - Em relação ao envio de material biológico ao exterior, o pesquisador e a instituição nacionais devem
estar atentos às normas e disposições legais sobre remessa de material para o exterior e às que protegem a
propriedade industrial e/ou transferência tecnológica (Lei nº 9.279 de 14/05/96 que regula direitos e
obrigações relativos à propriedade industrial, Decreto nº 2.553/98 que a regulamenta e Lei nº 9.610/98 sobre
direito autoral).
RESPOSTA: As pesquisadoras responsáveis por este projeto confirmam estarem atentas às normas e
disposições legais sobre remessa de material para o exterior e às que protegem a propriedade industrial
e/ou transferência tecnológica.
ANÁLISE: PENDÊNCIA ATENDIDA.
3 . 8  -  N o  c a d a s t r o  d o  P r o t o c o l o  d e  P e s q u i s a  n a  P l a t a f o r m a  B r a s i l
(“PB_INFORMAÇÕES_BÁSICAS_DO_PROJETO_781859.pdf” de 18/11/2016) foi informado que não
haverá retenção de amostras para armazenamento em banco. O termo "banco" é equivocadamente
interpretado como "biobanco", quando, na realidade, aplica-se tanto a biobanco quanto a biorrespositório.
Assim, sempre que houver coleta de material biológico em uma pesquisa, este campo da Plataforma Brasil
deverá ser assinalado com a opção “SIM”. Solicita-se adequação.
RESPOSTA: Informação corrigida.
ANÁLISE: PENDÊNCIA ATENDIDA.
4 - Quanto ao Termo de Consentimento Livre e Esclarecido:
4.1. Considerando os trechos abaixo:
i. Na página 1 de 8, lê-se: "Os dados coletados nesta pesquisa serão analisados nos laboratórios
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da Universidade de Surrey E OS RESULTADOS SERÃO DISPONIBILIZADOS TAMBÉM À UNIVERSIDADE
FEDERAL DE GOIAS." (Destaque nosso).
ii. Na página 4 de 8, item "DIVULGAÇÃO DOS RESULTADOS", lê-se: Os resultados desta pesquisa serão
divulgados das seguintes maneiras: - Consulta para retorno dos resultados dos exames de sangue e da
avaliação nutricional aos pacientes que solicitarem este servico . - Publicação em artigos científicos de
revistas internacionais e nacionais; - Dissertação de doutorado.
iii. Na página 6 de 8, lê-se: "4- Todos os resultados obtidos serão confidenciais, sigilosos e privativos.
Também é garantido o acesso irrestrito dos voluntários aos resultados do estudo, tendo eles a opção de
tomar ou não conhecimento dessas informações.".
iv. Na página 5 de 8, no item "GARANTIA DE ESCLARECIMENTO, RECUSA E SIGILO" lê-se: "Os dados
serão divulgados de forma anônima e apenas para pesquisa, artigos e eventos científicos, RESPEITANDO
A DECLARAÇÃO INTERNACIONAL SOBRE OS DADOS GENÉTICOS HUMANOS. Diante do exposto, o
TCLE deve ser explícito em relação à confidencialidade e anonimização dos dados, assegurando que:
4.1.1. Solicita-se mencionar que os dados do participante da pesquisa são confidenciais e somente serão
encaminhados a terceiros, como por exemplo, Universidade de Surrey e Universidade Federal de Goiás,
após a devida anonimização.
RESPOSTA: Texto foi adequado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” no item “"GARANTIA DE ESCLARECIMENTO, RECUSA E SIGILO ", página 6, bem
como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE
CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.1.2. Deve-se explicar como será o mecanismo utilizado para garantir a confidencialidade e a anonimização
dos dados (exemplo: codificação dos dados, senha de acesso aos bancos de dados, etc.).
RESPOSTA: Texto foi adequado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” no item “"GARANTIA DE ESCLARECIMENTO, RECUSA E SIGILO ", página 6, bem
como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE
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CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.1.3. Se o prontuário médico for consultado pelos pesquisadores, esta informação deverá constar no TCLE.
RESPOSTA: Não haverá consulta de prontuário médico pelos pesquisadores.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.1.4. Solicita-se alteração do trecho "RESPEITANDO A DECLARAÇÃO INTERNACIONAL SOBRE OS
DADOS GENÉTICOS HUMANOS" para “respeitando as normativas éticas brasileiras homologadas pelo
Conselho Nacional de Saúde/Ministério da Saúde do Brasil.”.
RESPOSTA: Texto foi adequado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” no item “"GARANTIA DE ESCLARECIMENTO, RECUSA E SIGILO ", página 6, bem
como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE
CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.2. Na página 1 de 8, lê-se: "Em caso de dúvida sobre a pesquisa, você poderá entrar em contato a cobrar
com os pesquisadores responsáveis, Patrícia Borges Botelho e Marcela Moraes Mendes (62) 3209-6270
(ramal 205), Endereço: Rua 227 Qd. 68 s/nº - Setor Leste Universitário - Goiânia - Goiás - Brasil - CEP:
74.605-08 ou pelo endereço de email dsol@surrey.ac.uk.". Solicita-se informar ainda um meio de contato de
fácil acesso ao participante de pesquisa em caso de urgência (24 horas por dia, 7 dias por semana).
RESPOSTA: Texto foi adequado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” página 1, bem como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”,
APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 1.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.3. Na página 1 de 8, lê-se: "Ela foi criada pela Resolução do CNS 196/96 e tem como principal função
examinar os aspectos éticos das pesquisas que envolvem seres humanos.". Solicita-se exclusão desse
trecho para evitar confundir o participante de pesquisa, visto que a Resolução CNS 196/96 já foi revogada.
RESPOSTA: Trecho excluído como solicitado.
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ANÁLISE: PENDÊNCIA ATENDIDA.
4.4. Na página 1 de 8, lê-se: "A CONEP está localizada na Esplanada dos Ministérios (Ministério da Saúde)
no Edifício Anexo Bloco G Ala B Sala 13-B, e em caso de qualquer dúvida sobre seus direitos como
participante da pesquisa você poderá entrar em contato com a CONEP pelo telefone (61) 3315-2951 no
horário de 08 às 17h de segunda a sexta ou pelo e-mail conep@saude.gov.br.". Solicita-se alterar o trecho
para "A CONEP está localizada no Setor de Edifícios Públicos Norte - SEPN 510 NORTE, BLOCO A, 3º
Andar Edifício Ex-INAN - Unidade II - Ministério da Saúde; CEP: 70750-521 - Brasília-DF, e em caso de
qualquer dúvida sobre seus direitos como participante da pesquisa você poderá entrar em contato com a
CONEP pelo telefone (61) 3315-5881 no horário de 08 às 20h de segunda a sexta ou pelo e-mail
conep@saude.gov.br.".
RESPOSTA: Texto foi alterado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” página 1, bem como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”,
APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 1.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.5. Na página 2 de 8, lê-se: "A deficiência de vitamina D é considerada um importante problema de saúde
pública por suas implicações em diversas doenças como osteoporose, doenças cardíacas, diabetes tipo I e
II, DOENÇAS INFLAMATÓRIAS E AUTO-IMUNES e esclerose múltipla." (Destaque nosso). Solicita-se
exemplificar doenças inflamatórias e autoimunes.
RESPOSTA: Foram exemplificadas as doenças inflamatórias e autoimunes. Ver documento “Termo de
Consentimento Livre e Esclarecido revisado” página 2, bem como no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE), página 2.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.6. Na página 2 de 8, solicita-se incluir informações acerca da dose diária de suplementação de vitamina D
(600IU) por 12 semanas.
RESPOSTA: Informações incluídas. Ver documento “Termo de Consentimento Livre e Esclarecido revisado”
página 2, bem como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO
DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 2.
ANÁLISE: PENDÊNCIA ATENDIDA.
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4.7. Solicita-se esclarecer sobre a possibilidade de inclusão do participante em grupo controle ou placebo,
explicitando, claramente, o significado dessa possibilidade.
RESPOSTA: A possibilidade de inclusão no grupo placebo foi esclarecida. Ver documento “Termo de
Consentimento Livre e Esclarecido revisado” página 4, bem como no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE), página 4.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.8. Na página 2 de 8, lê-se: "Todos os resultados que conseguirmos com os seus dados e amostras
estarão disponíveis para você, caso queira recebê-los ou não, e eles não serão divulgados sem a sua
autorização. VOCÊ PODERÁ SOLICITAR UMA CONSULTA RETORNO PARA RECEBER OS
RESULTADOS DOS SEUS EXAMES A PARTIR DE DEZEMBRO DE 2017.". Solicita-se adequação do
trecho, tendo em vista que, caso o participante necessite de orientação, deve ser agendada a qualquer
momento que ele necessite.
RESPOSTA: Texto foi alterado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” página 4, bem como no projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”,
APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 4.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.9. Na página 3 de 8, item "RESSARCIMENTO", lê-se: "Você não terá nenhum gasto para participar da
pesquisa e será ressarcido (você e acompanhantes) das despesas que a pesquisa possa oferecer, NA
FORMA DE BILHETES OU O DINHEIRO DA (S) PASSAGEM (NS) DO TRANSPORTE PÚBLICO PARA O
DESLOCAMENTO PARA AS ATIVIDADES DA PESQUISA." (Destaque nosso). O ressarcimento é a
compensação material, exclusivamente de despesas do participante e seus acompanhantes, quando
necessário, tais como transporte (mas não limitado a transporte público ou bilhetes) e alimentação (II.21. da
Resolução CNS nº 466 de 2012). Portanto, o TCLE deve assegurar de forma clara e afirmativa o
ressarcimento de todos os gastos que o participante e seu(s) acompanhante(s) terão ao participar da
pesquisa.
RESPOSTA: O texto foi alterado para assegurar de forma clara e afirmativa o ressarcimento de todos os
gastos que o participante possa ter com a pesquisa, conforme solicitação. Ver documento “Termo de
Consentimento Livre e Esclarecido revisado” item “RESSARCIMENTO” página 5, bem como no projeto
detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE
E ESCLARECIDO (TCLE), página 5.
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ANÁLISE: PENDÊNCIA ATENDIDA.
4.10. Na página 3 de 8, item "RESSARCIMENTO, lê-se: "A PESQUISA SERÁ IMEDIATAMENTE
INTERROMPIDA SE OFERECER ALGUM RISCO OU DANO À SUA SAÚDE" (Destaque nosso). Ainda, na
página 7 de 8, lê-se: "8- A pesquisa será imediatamente interrompida se for percebido algum risco ou dano à
saúde do participante da pesquisa, consequente à mesma, não previsto no termo de consentimento.". Cabe
lembrar que, de acordo com o item V.3 da Resolução CNS Nº 466 de 2012, “O pesquisador responsável, ao
perceber qualquer risco ou dano significativos ao participante da pesquisa, previstos, ou não, no Termo de
Consentimento Livre e Esclarecido, DEVE COMUNICAR O FATO, IMEDIATAMENTE, AO SISTEMA
CEP/CONEP, e avaliar, em caráter emergencial, a necessidade de adequar ou suspender o estudo.”.
Solicita-se adequação.
RESPOSTA: Documento foi adequado de forma a incluir trecho solicitado. Ver documento “Termo de
Consentimento Livre e Esclarecido revisado” item “ESCLARECIMENTOS DADOS PELO PESQUISADOR
SOBRE A GARANTIA DO SUJEITO DA PESQUISA”, número 9, página 8, bem como no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE), página 8.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.11. Na página 3 de 8, item "RESSARCIMENTO", lê-se: "e caso ocorra algum prejuízo causado pela
participação na pesquisa, você receberá A ASSISTÊNCIA, ACOMPANHAMENTO e indenização, sob
responsabilidade dos pesquisadores e da Faculdade de Nutrição da Universidade Federal de Goiás."
(Destaque nosso). Ainda na página 7 de 8, lêse: "8- A pesquisa será imediatamente interrompida se for
percebido algum risco ou dano à saúde do participante da pesquisa, conseqüente à mesma, não previsto no
termo de consentimento.". O TCLE deve assegurar, de forma clara e afirmativa, que o participante de
pesquisa receberá a assistência integral e imediata, de forma gratuita, pelo tempo que for necessário em
caso de danos decorrentes da pesquisa.
RESPOSTA: O documento foi adequado para assegurar, de forma clara e afirmativa, que o participante da
pesquisa receberá a assistência integral e imediata, de forma gratuita, pelo tempo que for necessário em
caso de danos decorrentes da pesquisa. Ver documento “Termo de Consentimento Livre e Esclarecido
revisado” item “ESCLARECIMENTOS DADOS PELO PESQUISADOR SOBRE A GARANTIA DO SUJEITO
DA PESQUISA”, número 8, página 8, bem como no projeto detalhado “2_DSOL_PROTOCOLO
REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página
8.
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ANÁLISE: PENDÊNCIA ATENDIDA.
4.12. Solicita-se correção do número das páginas, tendo em vista que a numeração se encontra entre
alguns trechos do TCLE. Solicitam-se adequações para que a numeração possa ser encontrada no início ou
no fim de cada página.
RESPOSTA: A paginação do documento TCLE foi formatada.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.13. Na página 5 de 8, lê-se: "Não foram identificados riscos relacionados a ingestão de cápsulas de
vitamina D em pesquisas anteriores.". Sabe-se que o excesso de vitamina D pode ter efeitos secundários.
Pode ter efeitos colaterais nos rins, no coração e sistema cardiovascular, como arritmia cardíaca e sopro
cardíaco. Outros sintomas de excesso de vitamina D incluem náuseas, perda de peso etc. Consumir muita
vitamina D durante a gravidez pode aumentar o nível de cálcio no sangue que podem levar à deficiência
mental e deficiência física como malformação da estrutura óssea do feto. A ingestão excessiva de vitamina
D também pode causar alguns defeitos congênitos. Portanto, os riscos do estudo com relação à ingestão de
vitamina D não devem ser subestimados. Solicita-se adequação informando os potenciais riscos associados
ao uso da vitamina D e/outros riscos também associados à pesquisa explicitando ainda as providências e as
cautelas a serem tomadas para evitar que ocorram os riscos.
RESPOSTA: O texto foi adequado conforme solicitação, explicitando os riscos e a forma como serão
minimizados. Ver documento “Termo de Consentimento Livre e Esclarecido revisado” no item
“DESCONFORTOS E RISCOS ESPERADOS página 5 e 6, bem como no projeto detalhado
“2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE), página 5 e 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.14. Na página 5 de 8, item "BENEFÍCIOS QUE PODERÃO SER OBTIDOS" lê-se: "VOCÊ TERÁ ACESSO
AOS RESULTADOS DOS SEUS EXAMES (EXAME DE SANGUE, SAÚDE DO OSSO E PORCENTAGEM
DE GORDURA CORPORAL, E EXAME GENÉTICO) GRATUITAMENTE POR MEIO DE CONSULTA
RETORNO. Os resultados gerias desta pesquisa irão contribuir para sejam elaboradas melhores
recomendações e orientações de saúde em relação à vitamina D e mais específicas e eficazes para
mulheres brasileiras.". O TCLE deve apresentar, de forma clara e objetiva, os potenciais benefícios da
pesquisa ao participante, sem supervalorizá-los. Portanto, solicita-se exclusão do trecho "VOCÊ
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TERÁ ACESSO AOS RESULTADOS DOS SEUS EXAMES (EXAME DE SANGUE, SAÚDE DO OSSO E
PORCENTAGEM DE GORDURA CORPORAL, E EXAME GENÉTICO) GRATUITAMENTE POR MEIO DE
CONSULTA RETORNO" por se tratar de um direito do participante de pesquisa (e não benefício). Caso o
estudo não antecipe qualquer benefício direto ao participante, essa informação deve constar do TCLE de
forma explícita. Solicita-se adequação.
RESPOSTA: O texto foi adequado conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” no item “BENEFÍCIOS QUE PODERÃO SER OBTIDOS” página 6, bem como no
projeto detalhado “2_DSOL_PROTOCOLO REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO
LIVRE E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.15. Na página 6 de 8, lê-se: "ESCLARECIMENTOS DADOS PELO PESQUISADOR SOBRE A GARANTIA
DO SUJEITO DA PESQUISA". Solicita-se alterar sujeito da pesquisa para participante da pesquisa,
conforme definição da Resolução CNS nº 466 de 2012.
RESPOSTA: Alterado conforme solicitado. Ver documento “Termo de Consentimento Livre e Esclarecido
revisado” no item “ESCLARECIMENTOS DADOS PELO PESQUISADOR SOBRE A GARANTIA DO
PARTICIPANTES DA PESQUISA” página 7, bem como no projeto detalhado “2_DSOL_PROTOCOLO
REVISADO.pdf”, APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página
7.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.16. Considerando que haverá análise genética, e em cumprimento da Resolução CNS nº 340 de 2004,
solicita-se adequação quanto às seguintes informações:
4.16.1. O TCLE deve trazer, de forma explícita, os genes/segmentos de DNA/RNA que serão estudados.
Contudo, se for inviável do ponto de vista prático listar todos os genes, é aceitável que o pesquisador
descreva os genes a serem estudados de forma agrupada segundo funcionalidade ou efeito (carta circular
CONEP 041/2015).
RESPOSTA: Os genes/segmentos de DNA/RNA que serão estudados foram explicitados como solicitado.
Ver documento “Termo de Consentimento Livre e Esclarecido revisado” no item “ANÁLISE GENÉTICA”
página 4, bem como no projeto detalhado 2_DSOL_PROTOCOLO REVISADO, APÊNDICE 2 - TERMO DE
CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 4.
ANÁLISE: PENDÊNCIA ATENDIDA.
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4.16.2. O TCLE deve assegurar, de forma clara e afirmativa, que os dados genéticos são confidenciais e
que não serão repassados a terceiros (como, por exemplo: seguradoras, empregadores, supervisores
hierárquicos, entre outros). Além do mais, os mecanismos de proteção dos dados genéticos devem ser
explicados no TCLE.
RESPOSTA: O texto foi adequado, conforme solicitação. Ver documento “Termo de Consentimento Livre e
Esclarecido revisado” no item “"GARANTIA DE ESCLARECIMENTO, RECUSA E SIGILO ", página 6, bem
como no projeto detalhado 2_DSOL_PROTOCOLO REVISADO, APÊNDICE 2 - TERMO DE
CONSENTIMENTO LIVRE E ESCLARECIDO (TCLE), página 6.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.16.3. Quando aplicável, o TCLE deve assegurar, de forma clara e afirmativa, que o patrocinador oferecerá
ao participante de pesquisa o aconselhamento genético e o acompanhamento clínico necessários. Deve-se
informar, também, quem realizará esses procedimentos (ou onde serão realizados).
RESPOSTA: Não aplicável.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.16.4. O TCLE deve assegurar, de forma clara e afirmativa, que os resultados de exames serão informados
ao participante de pesquisa se assim ele quiser. O texto foi adequado conforme solicitação.
RESPOSTA: Ver documento “Termo de Consentimento Livre e Esclarecido revisado” no item “"ANÁLISE
GENÉTICA" página 4 e “DIVULGAÇÃO DOS RESULTADOS “, na página 5, bem como no projeto detalhado
2_DSOL_PROTOCOLO REVISADO , APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE), página 4 e 5.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.16.5. Quando aplicável, o TCLE deve informar que o resultado dos exames genéticos pode trazer riscos
ao participante de pesquisa. Neste caso, o TCLE deve informar que o participante tem a opção de conhecer
ou não o resultado desses exames.
RESPOSTA: Não aplicável.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.17. No TCLE não há menção do destino das amostras biológicas ao final do estudo. Cabe
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ressaltar que o prazo de armazenamento de material biológico humano em biorrepositório deve estar de
acordo com o cronograma da pesquisa correspondente e pode ser autorizado por até dez anos. O TCLE
deve conter o consentimento de autorização para a coleta, armazenamento e utilização das amostras
biológicas conforme a Resolução CNS 441/11 e Portaria MS 2.201/11. O documento deve informar se as
amostras serão utilizadas apenas para os propósitos descritos no protocolo (e destruídas após a sua
utilização) e/ou se haverá armazenamento para utilização em investigações futuras. Solicita-se adequar o
documento, esclarecendo ao participante que, em caso de utilização das amostras em pesquisas futuras,
ele será contatado novamente para fins de convite e autorização expressa do novo uso.
RESPOSTA: Informação adicionada no item “ARMAZENAMENTO DE MATERIAL BIOLÓGICO, página 7 do
documento “Termo de Consentimento Livre e Esclarecido revisado” e do projeto detalhado
2_DSOL_PROTOCOLO REVISADO , APÊNDICE 2 - TERMO DE CONSENTIMENTO LIVRE E
ESCLARECIDO (TCLE).
ANÁLISE: PENDÊNCIA ATENDIDA.
4.18. O documento apresenta inúmeros erros de digitação que podem interferir na autonomia do participante
da pesquisa. Solicita-se adequação.
RESPOSTA: O documento foi revisado por completo para correção de erros de digitação.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.19. O documento apresenta diversos termos técnicos que podem não ser de compreensão do participante
da pesquisa, interferindo em sua autonomia no momento de decisão. Solicita-se a retirada de tais termos, ou
que após a citação haja uma breve explicação de seu significado.
RESPOSTA: O documento foi revisado por completo para substituição/explicação de termos técnicos.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.20. Solicitam-se esclarecimentos e/ou adequação em relação aos trechos “... na qual serão avaliadas
moléculas presentes na sua SALIVA” e “... durante a COLETA DE SALIVA ou na entrevista...” (destaques
nosso), considerando que o projeto não prevê a coleta de saliva.
RESPOSTA: O termo utilizado está inadequado e foi substituído para “sangue”.
ANÁLISE: PENDÊNCIA ATENDIDA.
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4.21. Na página 6 de 8, lê-se “Autorizo armazenagem armazenamento e a utilização do material biológico
(amostras de sangue) até o final desta pesquisa: ( ) Sim ( ) Não”. Solicita-se exclusão do trecho nesta parte
do documento, pois não corresponde à sequência das informações apresentadas.
RESPOSTA: O termo foi retirado, como solicitado.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.22. Considerando que o estudo prevê apenas o recrutamento de participantes femininas, solicita-se
adequação de trechos, tais como “Você está sendo convidado (a) ”, “voluntário (a) ”, “você não será
penalizado (a) ”, “Você será informado”, etc.
RESPOSTA: Os trechos foram corrigidos, conforme solicitado.
ANÁLISE: PENDÊNCIA ATENDIDA.
4.23. Todos os aspectos abordados no TCLE foram destinados a mulheres adultas brasileiras residentes no
Brasil, por exemplo: “Entrevista que ocorrerá na Clínica escola da FANUTUFG”, “Após 3 meses, você
deverá retornar a Clínica Escola...”, “...você receberá a assistência, acompanhamento e indenização, sob
responsabilidade dos pesquisadores e da Faculdade de Nutrição da Universidade Federal de Goiás”, “As
suas amostras de sangue serão guardadas na Faculdade de Nutricao, Universidade Federal de Goiás...”.
Considerando que a primeira fase do projeto será executada no Reino Unido, solicita-se adequação do
documento contemplando também a realidade das participantes brasileiras residentes no exterior.
RESPOSTA: A primeira fase do projeto, que inclui apenas mulheres brasileiras residentes no Reino Unido,
já ocorreu e estas foram contempladas nos documentos aprovados pelo Comitê de Ética da Universidade de
Surrey, incluindo TCLE específico para esta fase do projeto. Pedimos cordialmente reconsideração desta
solicitação, por entendermos que neste TCLE não é necessário mencionar tal informação, pois refletiria uma
realidade das participantes residentes no Reino Unido e não das do Brasil, o que poderia acabar por
confundir as participantes as quais este TCLE se aplica. Acréscimo de informação no Protocolo de Pesquisa
Aproveitamos a oportunidade, para comunicar o acréscimo de informação a respeito de uma análise
adicional de expressão gênica de RNAm no projeto detalhado 2_DSOL_PROTOCOLO REVISADO nos itens
“2.5 INFLUÊNCIA DOS FATORES GENÉTICOS SOBRE A CONCENTRAÇÃO DE VITAMINA D” página 9 e
10, e “5.8 EXTRAÇÃO DE DNA E DETERMINAÇÃO DOS POLIMORFISMOS E EXPRESSÃO GÊNICA”
página 21.
ANÁLISE: PENDÊNCIA ATENDIDA.
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Diante do exposto, a Comissão Nacional de Ética em Pesquisa - Conep, de acordo com as atribuições
definidas na Resolução CNS nº 466 de 2012 e na Norma Operacional nº 001 de 2013 do CNS, manifesta-se
pela aprovação do projeto de pesquisa proposto, devendo o CEP verificar o cumprimento das questões
acima, antes do início do estudo.
Situação: Protocolo aprovado com recomendação.
Considerações Finais a critério da CONEP:
Este parecer foi elaborado baseado nos documentos abaixo relacionados:
Tipo Documento Arquivo Postagem Autor Situação
Informações Básicas
do Projeto
PB_INFORMAÇÕES_BÁSICAS_DO_P
ROJETO_781859.pdf
15/03/2017
05:58:14
Aceito
Outros Carta_resposta_DSOL.pdf 15/03/2017
05:54:06
Patrícia Borges
Botelho
Aceito
Outros Aprovacao_Comite_de_Etica_traduzido.
pdf
15/03/2017
05:48:14
Patrícia Borges
Botelho
Aceito
Outros Declaracao_de_uso_do_material_biologi
co_no_exterior.pdf
15/03/2017
05:47:37
Patrícia Borges
Botelho
Aceito
Orçamento ORCAMENTO_REVISADO.pdf 15/03/2017
05:46:13
Patrícia Borges
Botelho
Aceito
Outros TERMO_DE_ACORDO_INTERINSTITU
CIONAL_EM_PESQUISA.pdf
15/03/2017
05:45:18
Patrícia Borges
Botelho
Aceito
Outros termo_anuencia_traduzido.pdf 15/03/2017
05:44:27
Patrícia Borges
Botelho
Aceito
Outros Declaracao_estudos_futuros.pdf 15/03/2017
05:41:19
Patrícia Borges
Botelho
Aceito
TCLE / Termos de
Assentimento /
Justificativa de
Ausência
TERMO_DE_CONSENTIMENTO_LIVR
E_E_ESCLARECIDO_REVISADO.pdf
15/03/2017
05:39:25
Patrícia Borges
Botelho
Aceito
Projeto Detalhado /
Brochura
Investigador
2_DSOL_PROTOCOLO_REVISADO.pdf 15/03/2017
05:38:20
Patrícia Borges
Botelho
Aceito
Declaração de
Manuseio Material
Biológico /
Biorepositório /
Biobanco
Detalhamento_operacional_e_de_infrae
strutura_do_Lanucli.pdf
15/03/2017
05:36:04
Patrícia Borges
Botelho
Aceito
Declaração de
Manuseio Material
Detalhamento_operacional_e_infraestrut
ura_do_laboratorio_da_Universida
15/03/2017
05:35:47
Patrícia Borges
Botelho
Aceito
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Biológico /
Biorepositório /
Biobanco
de_de_Surrey.pdf 15/03/2017
05:35:47
Patrícia Borges
Botelho
Aceito
Declaração do
Patrocinador
Viridian_Supplements.pdf 15/03/2017
05:33:20
Patrícia Borges
Botelho
Aceito
Outros 18_Aprovacao_conselho_diretor.pdf 18/11/2016
17:54:53
Patrícia Borges
Botelho
Aceito
Outros 17_Comprovante_taxa_bancada2.pdf 18/11/2016
17:53:28
Patrícia Borges
Botelho
Aceito
Recurso Anexado
pelo Pesquisador
16_Comprovante_taxa_bancada.pdf 18/11/2016
17:51:12
Patrícia Borges
Botelho
Aceito
Outros 15_treinamento_pessoal.pdf 18/11/2016
17:47:28
Patrícia Borges
Botelho
Aceito
Outros 14_instituicao_coresponsavel.pdf 18/11/2016
17:46:37
Patrícia Borges
Botelho
Aceito
Outros 13_COMPROMISSOS_VANTAGENS_P
AIS.pdf
18/11/2016
17:45:23
Patrícia Borges
Botelho
Aceito
Outros 12_Compromissos_vantagens_sujeitos.
pdf
18/11/2016
17:44:35
Patrícia Borges
Botelho
Aceito
Outros 11_Aprovacao_Comite_etica_UK.pdf 18/11/2016
17:43:30
Patrícia Borges
Botelho
Aceito
Outros 10_Termo_anuencia_University_Surrey.
pdf
18/11/2016
17:41:01
Patrícia Borges
Botelho
Aceito
Outros 9_Termo_anuencia.pdf 18/11/2016
17:39:52
Patrícia Borges
Botelho
Aceito
Outros 8_Termo_compromisso.pdf 18/11/2016
17:38:34
Patrícia Borges
Botelho
Aceito
Outros 7_Curriculo_Patricia.pdf 18/11/2016
17:37:43
Patrícia Borges
Botelho
Aceito
Outros 6_Curriculo_Susan.pdf 18/11/2016
17:33:18
Patrícia Borges
Botelho
Aceito
Outros 5_Curriculo_Marcela.pdf 18/11/2016
17:32:10
Patrícia Borges
Botelho
Aceito
Outros 1_Carta_de_encaminhamento.pdf 18/11/2016
17:26:34
Patrícia Borges
Botelho
Aceito
Folha de Rosto 2_folha_rosto.pdf 18/11/2016
17:20:42
Patrícia Borges
Botelho
Aceito
Situação do Parecer:
Aprovado com Recomendação
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BRASILIA, 21 de Março de 2017
Jorge Alves de Almeida Venancio
(Coordenador)
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THE D-SOL STUDY 
	
	
Vitamin D supplementation and sunlight exposure in Brazilian women living in 
opposite latitudes  
	
Consent	Form			
	
	 	 Please	initial	each	box																											
	
• I	have	read	and	understood	the	Information	Sheet	provided	(version	8,	date	14/11/16).		I	have	been	given	
a	full	explanation	by	the	investigators	of	the	nature,	purpose,	location	and	likely	duration	of	the	study,	and	
of	what	I	will	be	expected	to	do.			
	
	
• I	have	been	advised	about	any	disadvantages/discomfort	which	may	result	from	participating.		I	have	been	
given	 the	opportunity	 to	 ask	 questions	 on	 all	 aspects	 of	 the	 study	 and	have	understood	 the	 advice	 and	
information	given	as	a	result.																																																																																																													
	
	
• I	agree	to	comply	with	the	requirements	of	the	study	as	outlined	to	me	to	the	best	of	my	abilities.		
	
	
• I	understand	that	in	accordance	with	the	English	law,	insurance	is	in	place	which	covers	harm	that	is	likely	
to	result	from	my	participation	in	this	study	as	detailed	in	the	participant	information	sheet.																																																																																																
	
	
• I	 agree	 for	 my	 anonymised	 data	 and/or	 samples	 to	 be	 used	 for	 this	 study	 that	 will	 have	 received	 all	
relevant	legal,	professional	and	ethical	approvals.	
	
	
• I	agree	to	be	part	in	the	genetic	study	to	be	conducted	after	the	trial,	as	detailed	in	the	
	participant	information	sheet,	and	allow	my	data	and	blood	sample	to	be	used	for	genetic	analyses.																																																																																																
	
	
• I	understand	that	all	project	data	will	be	held	for	at	least	6	years	and	all	research	data	for	at	least	10	years	
in	 accordance	 with	 University	 policy	 and	 that	 my	 personal	 data	 is	 held	 and	 processed	 in	 the	 strictest	
confidence,	and	in	accordance	with	the	UK	Data	Protection	Act	(1998).	
	
	
• I	agree	for	the	researchers	to	contact	me	about	future	studies.	
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• I	 agree	 for	 my	 personal	 and	 research	 data	 to	 be	 transferred	 to	 Federal	 University	 of	 Goias	 –	 Brazil.	 I	
understand	that	my	personal	data	may	not	be	held	under	the	same	stringent	laws	as	in	the	UK.	
	
	
• 	If	I	withdraw	from	the	study,	unless	I	specifically	request	my	data	be	withdrawn,	it	will	still	be	used	in	the	
analysis.	
	
	
• I	understand	that	I	can	request	withdraw	of	my	data	until	the	end	of	data	collection	(March	2017),	without	
needing	to	justify	my	decision,	without	prejudice	and	without	my	legal	rights	being	affected.	
	 	
	
• I	 confirm	 that	 I	have	 read	and	understood	 the	above	and	 freely	 consent	 to	participating	 in	 this	 study.	 	 I	
have	been	given	adequate	time	to	consider	my	participation.	
	
	
	
	
	
Name	of	participant	(BLOCK	CAPITALS)			 	 ......................................................	 	
	
Signed	 	 ......................................................	 	
	
Date	 	 ......................................................	 	
	
	 	
	
	 																																																								
	
Name	of	researcher	taking	consent	 	……..............................................	
(BLOCK	CAPITALS)		 	
	 	
Signed	 	 	....................................................	
	
Date	 	 ………………………………………………..																																																									
	
	
	
 
 
 
 

 D-SOL invitation letter 
Version 4.0 15/07/16 
Department of Nutritional Science 
         Faculty of Health and Medical Sciences 
   University of Surrey,  
   Guildford, Surrey, GU2 7XH 
         T: +44 (0) 1483 689222 
         dsol@surrey.ac.uk 
 
Invitation Letter to the D-SOL Study 
10/09/2016 
Dear Ms./Mrs.,  
The Nutritional Sciences research team at the University of Surrey is writing to inform you of a new 
study called “Vitamin D Supplementation and sunlight exposure in Brazilian women living in Opposite 
Latitudes” (the D-SOL Study), that will take place over the next year, in collaboration with the Federal 
University of Goias, Brazil. This research is funded by the Science Without Borders Program. 
Our research team is interested in looking at the importance of vitamin D supplementation and sunlight 
exposure to the maintenance of adequate vitamin D levels, and the influence of diet, skin colouring and 
genetics for optimal vitamin D status, in Brazilian women living in Brazil and in the UK. Several studies 
from sunny countries have shown that vitamin D deficiency is a common problem, despite the 
abundance of sunlight in these locations making it a global health problem, emphasizing the importance 
to study vitamin D in both countries.  
To take part in this study, you would be asked to visit us on two separate dates, 3 months apart (visits 
can be made at a day which is convenient for you). Your participation would involve completing a range 
of brief questionnaires, using a small badge on your clothes for one week to measure sunlight exposure, 
taking some body measures (height, weight and waist circumference), a full-body bone scan and blood 
sample collection. You would also be asked to take vitamin D supplement tablets daily (which may 
contain vitamin D or will be a placebo containing no vitamin D) for a period of 3 months.  
Upon completion of the study, you can request information on your bone health and nutritional status, 
as well as vitamin D levels. Any travel costs will be reimbursed.  
If you are interested in learning more about this study, please contact us at dsol@surrey.ac.uk or 
+44 (0) 1483 689222. 
We appreciate your time and consideration and look forward to hearing from you.  
 
 
Sincerely on behalf of D-SOL Team, 
 
Marcela M. Mendes (PhD Reseacher Fellow) 
Professor Susan Lanham-New (Academic Supervisor)  
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THE D-SOL STUDY 
 
Participant Information Sheet  
Version 6, 13/09/2016 
 
 
Vitamin D supplementation and sunlight exposure in Brazilian women living in opposite latitudes 
(The D-SOL Study) 
 
 
Introduction 
 
 We, the D-SOL team from the University of Surrey, would like to invite you to take part in a 
research project as part of a PhD program, funded by the Science without Borders. Before you 
decide whether you would like to participate, it is important for you to understand why the research 
is being done and what it will involve. Please take the time to read the following information 
carefully and ask questions about anything you do not understand. Talk to others about the study 
if you wish. 
 Please do not hesitate to ask us if there is anything that is not clear or if you would like any 
more information (contact Miss Marcela Mendes, PhD Research Fellow and Principal Investigator 
of this study on email dsol@surrey.ac.uk or telephone +44 (0) 1483 689222) 
 
What is the purpose of the study? 
 
 It is generally believed that the major source of vitamin D is the exposure of the skin to UV 
B-rays contained in sunlight. However, several studies from sunny countries have shown that 
vitamin D deficiency is common, despite the abundance of sunlight in these locations. We still 
don’t know how much of our vitamin D comes from our food and how much comes from sun in 
different countries including the UK and Brazil. Also we know that not everyone gets the same 
benefit from supplements and this may be due to genetic differences.   
 Therefore we want to look at the importance of vitamin D supplementation and sunlight 
exposure to the maintenance of adequate vitamin D levels, and the influence of diet, skin coloring 
and genetics for optimal vitamin D status, comparing Brazilian women living in Brazil, where there 
is abundant sunlight exposure and Brazilian women living in the UK, where there is limited 
exposure to adequate sunlight. 
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Why have I been invited to take part in the study? 
 
 You have been invited to participate on our study as you meet the following criteria: 
Brazilian, aged 20-59 years and female.  
 To be eligible to take part in the study, you must meet the following criteria: 
o Brazilian 
o Female 
o Aged 20 – 59 years 
o Not currently suffering from any conditions or taking any medication likely to affect 
your vitamin D status and bone metabolism as listed in the screening questionnaire 
(exclusion criteria). 
 
 About 80 participants living in Brazil will take part in this study and 80 participants living in 
the UK.   
 
Do I have to take part? 
 
 No, you do not have to participate. You can withdraw at any time without giving a reason 
and without prejudice. Data collection will take place from November 2016 to March 2017. 
 If you withdraw from the study this will mean the following for your participation and data: 
with your permission, we intend on retaining data already collected. However, no further data will 
be collected nor will any other research procedure be carried out on you. If you wish, you can 
contact us to request the data be withdrawn up to the end of data collection (March 2017). Unless 
you specifically request the data to be withdrawn it will still be used in the analysis. 
 
What will my involvement require? 
 
 If you are interested in taking part on our study, you will be asked to answer a screening 
questionnaire, either by email or phone, and receive this information sheet by post or email. 
 If you are eligible for the study and wish to participate you will be invited to come to your 
first visit. On this visit, you will be given the opportunity to clarify any doubts you may have 
regarding the study. If you are still happy to take part, you will then be asked to sign a consent 
form and will receive a copy of your consent form and this information sheet, to keep for yourself. 
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 The research will last 1 year but you would only be asked to visit us at the Clinical 
Investigation Unit at the University of Surrey, Guildford, on two separate dates (3 months apart). 
Visits can be made at a day which is convenient for you. 
 
 On your first visit you will be asked to:  
o complete 1 questionnaire;  
o go through a dual energy X-ray absorptiometry (DEXA) scan*; 
o have your weight, height and waist circumference measured and blood sample 
(equivalent of 5 teaspoons) collected by a trained phlebotomist ;  
o have your melanin amount in your upper and forearm skin measured by a 
reflectance spectrophotometer**; 
o complete food and activity diaries for 4 days; 
o wear a small dosimeter badge on your clothes for a week; 
o take Vitamin D or placebo supplements (provided by the study) daily for the total 
period of 3 months. 
 
 On your second (final) visit you will be asked to:  
o have your weight, height and waist circumference measured and blood sample 
collected; 
o have your melanin amount in your upper and forearm skin measured by a 
reflectance spectrophotometer**; 
o return completed food and activity diaries; 
o return dosimeter badge; 
o return supplements emptied bottles. 
 
* A DEXA (DXA) scan is a quick and painless procedure that involves lying on your back on an 
X-ray table so that an area of your body can be scanned. No special preparations are needed 
before having a DEXA scan, during which X-rays will be passed through your body. DEXA scans 
use a much lower level of radiation than standard X-ray examinations. 
** A reflectance spectrophotometer is a very easy and non-invasive quick tool to determine the 
colour of the skin, where a receiver measures the light reflected by skin pigmentation. 
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 After your final visit you might be select to be part on a genetic analysis to determine the 
influence of genetic mutation on the vitamin D supplementation response. On your first visit we will 
ask for your consent to have your blood sample used for this purpose. However, being part on the 
genetic analysis does not require any further visits from you.  
 The visits will be held in December 2016 and February/March 2017 on a day and at a 
time which is suitable for you.  
 At your first visit you will be given 12 weeks supply of small tablets, which may contain 
vitamin D or will be a placebo containing no vitamin D.  
 Throughout the study we will also keep in touch with you by telephone in 5 occasions (2 
weeks apart from each other), to see how you are getting on with the study.  
 Any travel costs will be reimbursed.  
 After the completion of the study, the D-SOL team may wish contact you regarding future 
studies. However, you do not have to participate again if you do not wish to. You can refuse to 
take part in any future studies without giving a reason and without prejudice. 
 
What will I have to do? 
 
 First we will ask you some questions via a phone call to make sure you are eligible to take 
part in the study. We will then invite you to visit us on two occasions. On your first visit we will go 
through all the details of the study and discuss any questions you may have. Then you will be 
asked to sign a consent form, which means you are happy with all the information you have 
received and you are willing to take part on our study. The visits will take around 30 minutes to 
complete and will be scheduled in the morning on a day of your choice.  
 
What will happen to data/samples that I provide? 
 
 Research data are stored securely for at least 10 years following their last access and 
project data (related to the administration of the project, e.g. your consent form) for at least 6 years 
in line with the University of Surrey policies. 
 Personal data will be handled in accordance with the UK Data Protection Act (1998). 
 With your consent, to make the most of your participation and support efficient 
advancements in science, any anonymised data/samples may be used for future research. We 
cannot tell you at this moment in time what this research will entail or what analyses will be carried 
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out but we can assure you that all appropriate legal, ethical and other approvals will be in place. 
For practical reasons your consent will not be sought again.  
 
What are the possible disadvantages or risks of taking part? 
 
 Study visits might be inconvenient as they required coming to the University during work 
hours. Some people may also find taking supplement tablets everyday and/or keeping diaries 
inconvenient or unpleasant. Some may also find taking blood sample unpleasant, and due to the 
nature of the procedure, some light bruising may occur. 
  DEXA scans use a low level of radiation (much lower than standard X-ray examination) to 
which you will be exposed. The amount of radiation absorbed from the scan is very small and 
similar to the radiation we receive from the environment. 
 Throughout the duration of the trial, you will be contacted via telephone on a fortnightly 
basis to discuss any issues with any adverse event and compliance and to maintain good 
communication with our team.  
 
What are the possible benefits of taking part? 
 
 You will receive information on your bone health and nutritional status, as well as vitamin D 
levels. The information that you provide to this study will be of great value to science and will 
provide both countries with key data on whether there should be consideration of further revisions 
to dietary recommendations for vitamin D in adult populations. Even more, contributing to a study 
that focus on Brazilian women, you will be helping to determine specific considerations regarding 
vitamin D for this group, in which you are included and therefore directly benefited. 
 
What happens when the research study stops? 
 
 Once the study finishes, the data collected will begin to be analysed. As part of the 
collaboration agreement with the Federal University of Goias, Brazil, all data collected in both 
countries will be shared between the two institutions. This means that personal and research data 
will be transferred to Federal University of Goias – Brazil and may not be held under the same 
stringent laws as in the UK. 
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 Once we are done with all the data collection and examination, if you wish, you can request 
a report with our overall findings and your personal results, from October 2017. 
 
What if there is a problem? 
 
 If you are unsatisfied with any aspect of the study please contact Miss Marcela Mendes 
(email: m.moraesmendes@surrey.ac.uk or telephone 01483 689222) or Prof. Susan Lanham-New, 
PhD Supervisor (email: s.lanham-new@surrey.ac.uk or telephone 01483 686476) or Prof. Bruce 
Griffins, Professor of Nutritional Metabolism at the University of Surrey (email: 
b.griffin@surrey.ac.uk or telephone 01483 68 9724).  
  
Will my taking part in the study be kept confidential? 
 
 Yes. Your details will be held in complete confidence and we will follow ethical and legal 
practice in relation to all study procedures, including data shared with the collaborative institution, 
although this shared data may not be held under the same stringent laws as in the UK. For thesis 
and publications purposes, you will be identified by a unique code and not your name. 
 
Full contact details of researcher and academic supervisor 
 
Name: Miss Marcela Moraes Mendes (PhD research fellow) 
Address: Department of Nutritional Sciences, Faculty of Health & Medical Sciences, University of 
Surrey, Guildford, Surrey GU2 7XH 
Telephone: +44 (0) 1483 689222 
Email: m.moraesmendes@surrey.ac.uk 
 
Name: Professor Susan Lanham-New (Academic supervisor) 
Address: Department of Nutritional Sciences, Faculty of Health & Medical Sciences, University of 
Surrey, Guildford, Surrey GU2 7XH 
Telephone: +44 (0) 1483 6896476 
Email: s.lanham-new@surrey.ac.uk 
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Who is organising and funding the research? 
 
 This research is organised by the University of Surrey, UK, and by the Federal University of 
Goias, Brazil, and funded by the Science Without Borders Program.  
 
Who has reviewed the project? 
 
 This study has been reviewed by and received a favorable ethical opinion from the 
University of Surrey Ethics Committee. 
 
Thank you for taking the time to read this Information Sheet. 
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SECTION A 
 
THE D-SOL STUDY 
SCREENING QUESTIONNAIRE 
 
The purpose of this questionnaire is to assess whether you are suitable to take part in the study and 
that it is safe for you to do so. We would be grateful if you would answer the following questions, even 
if you are still not sure if you wish to take part in our study. Please answer the questions as honestly 
and accurately as you can and remember there are no right or wrong answers to the questions. Your 
answers to the questions on this questionnaire will also be kept completely confidential.  
If you feel uncomfortable answering any of the questions on this questionnaire you do not have to 
answer the question. Please ask one of the D-SOL Research Team if you would like help answering 
any of the questions.  
 
  
 
Full name:  Click	here	to	enter	text.                                                    
Date of birth: Click	here	to	enter	text.             
 
Address:Click	here	to	enter	text. 
 
City:Click	here	to	enter	text. 
County:Click	here	to	enter	text. 
 
Contact telephone number: Click	here	to	enter	text.  
Place of birth:  Click	here	to	enter	text.           
Nationality:  Click	here	to	enter	text. 
Mother’s nationality:  Click	here	to	enter	text. 
Father’s nationality:  Click	here	to	enter	text. 
Email address:  Click	here	to	enter	text. 
Preferred method of contact:       ☐Phone                  ☐ Email                    ☐ Post 
 
 
 
 
 
 
Height (cm):  Click	here	to	enter	text.  Weight (kg):  Click	here	to	enter	text.   
Are you currently receiving treatment for any medical conditions?     ☐Yes    ☐No 
 Medical condition:  Click	here	to	enter	text. Treatment: Click	here	to	enter	text. 
Are you on any medication prescribed by your GP or any other health care provider? 
☐ Yes    ☐ No      If yes, please specify: Click	here	to	enter	text. 
 
 
CONTACT DETAILS	
HEALTH AND LIFESTYLE 	
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1. Do you live in the UK? ☐ Yes    ☐ No 
If yes, please state the date you arrived:  Click	here	to	enter	text. 
 
2. Please tick all medical conditions that apply to you: 
☐ Prior/ present history of coronary heart disease, angina, heart attack or stroke 
☐ Prior/present history of Type 1 and Type 2 Diabetes. 
☐ Prior/present history of Thyroid disease 
☐ Prior/present history of osteoporosis, osteopenia or other musculoskeletal disease 
☐ Prior/present history of haematological disease (except mild anaemia) 
☐ Prior/present history of malignancy 
☐ Prior/present history of a gastrointestinal disorder, such as Crohns Disease, Coeliac 
Disease or Irritable Bowel Syndrome. 
☐ Prior/present history of liver or kidney disease. 
 
 
3. Do you have any allergies or food intolerances? ☐ Yes    ☐ No 
If yes, please specify: Click	here	to	enter	text. 
 
4. Do you regularly take vitamin supplements containing vitamin D? 
☐ Yes    ☐ No 
If yes please specify: Click	here	to	enter	text. 
How many months you have been taking supplements?  Click	here	to	enter	text. 
The dose of the supplements (if known): Click	here	to	enter	text. 
  The brand of the supplements (if known):  Click	here	to	enter	text. 
 
5. Are you currently on a weight-reducing diet or other dietary restrictions (except 
vegetarianism)? ☐ Yes    ☐ No 
If yes, please provide details: Click	here	to	enter	text. 
6. Have you been abroad on holiday during the past 6 months? ☐ Yes    ☐ No 
If yes, please specify where this was and the month this holiday was taken: 
Country of visit: Click	here	to	enter	text. 
Month/year: Click	here	to	enter	text. 
  Country of visit: Click	here	to	enter	text. 
Month/year: Click	here	to	enter	text.   
   
6. Are you planning any holidays abroad during the next 12 months? ☐ Yes    ☐ No 
If yes, please specify where this visit is planned to be and when this holiday will be 
taken: 
Country of visit: Click	here	to	enter	text. 
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Month/year:  Click	here	to	enter	text. 
Country of visit:  Click	here	to	enter	text. 
Month/year:  Click	here	to	enter	text.   
 
7. Do you use sunbeds? ☐Yes    ☐No 
If yes, please state how often you use them:  Choose	an	item. 
 
 Are you currently pregnant or planning a pregnancy during the next 12 months? 
 ☐ Yes    ☐ No 
8. Are you currently breastfeeding? 
 
☐ Yes    ☐ No 
 
9. Are you in menopause? 
 
☐ Yes    ☐ No 
 
 
 
 
 
We are planning to see participants from in the morning between 8.00am and 12.00 
noon in December 2016 and February/March 2017. Are there any particular day or 
days which would be best for you? 
 
 
Click	here	to	enter	text. 
 
 
  
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this questionnaire. 
 
Participant signature: Click	here	to	enter	text. 
Date: Click	here	to	enter	text. 
 
 
 
 
 
 
 
 
 
Quest. No (for D-SOL team use only):	
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THE D-SOL STUDY 
 
 
Thank you for expressing an interest in participating in this research study. We would be 
grateful if you would answer the following questions. 
 
Prior to completing this questionnaire please read the Participant Information sheet and 
complete the consent form if you would like to take part. This questionnaire should take you 
no more than 15 minutes to complete and we thank you for your time.  
 
 
 
  
 
 
 
Participant name:__________________________________________________________                                                  
DOB:  ____/____/_______         
 
Address: ___________________________________________________________________ 
 
Post code: __________ 
 
Contact telephone number: _________________________ 
 
Nationality: ________________________________________________________________ 
 
Email address: ______________________________________________________________ 
 
Preferred method of contact:   (   ) Phone              (   ) Email                (   ) Post 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PERSONAL AND CONTACT DETAILS 
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1. Your colour or race is: 
 
 (   ) White   (   ) Black    (   ) Brown (Pardo)   (   )  Yellow (Amarelo)     (   )   Indigenous 
 
  
 2. Are you planning to travel abroad frequently between December 2016 and February 2017? 
 
(   ) Yes (   ) No 
 
If yes, please specify where this visit is planned to be and when this holiday will be taken: 
 
Country of visit: ______________  Month/year: ______________ 
   
Country of visit: ______________  Month/year: ______________ 
 
Country of visit: ______________  Month/year: ______________ 
 
 
3. In the past three years have you suffered from any of the following? 
 
(   ) Osteoporosis  (   ) Severe Chrons disease  (   ) Asthma  
(   ) Coeliac disease (   ) Breast Cancer   (   ) Skin Cancer 
(   ) Thyroid Disease (   ) Severe Rheumatoid Arthritis 
(   ) Any other disease: __________________________________________________ 
 
 
4. Do you or have you ever taken any of the following over the last year? 
 
(   ) Hormone Replacement Therapy (HRT) (   ) Diuretics 
(   ) Steroids (tablets or inhales) (   ) Tamoxifen (   )  Bone medications 
(   ) Any other medication (if yes, please give details): ___________________________ 
 
 
5. Are you or might you be pregnant?  (   ) Yes    (   ) No 
 
 
6. Are you intending to become pregnant in the next year? (   ) Yes    (   ) No 
 
 
7. Have you had a baby in the last 3 months? (   ) Yes    (   ) No 
 
 
8. Are you breastfeeding? (   ) Yes    (   ) No 
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9. How many years have you lived in Southern England? __________ 
 
 
10. Where did you live before? City: ___________ Country: ______________ 
 
 
11. In which country were you born? ___________________ 
 
 
12. What is the highest level of education you have completed? 
 
(   ) Secondary School (up to 16 years of age)   (   ) A levels (up to 18 years of age) 
(   ) University Degree Course                            (   ) Other Qualification (please give details) 
___________________________________________________________________________ 
 
13. Do you smoke? (   ) Yes    (   ) No  
(If yes, please give details) 
 
Number of cigarettes per day: _______   Number of years smoking: _______ 
Age at which started smoking: ________ 
 
 
14. Do you drink alcohol? (   ) Yes    (   ) No 
 
If yes, how many units per week: ______________________ 
   
(please see below for a guide on number of units of alcohol in common drinks). 
 
 
15. Have you ever broken / fractured any bones? (   ) Yes    (   ) No   (   ) Not sure 
 
 
16. When you go outdoors, which body parts are usually exposed? 
 
(   ) Face only  (   ) Hands and face + arms and/or legs 
(   ) Hands and face (   ) Hands and face + arms and/or legs + some/all of the torso 
 
 
Alcohol Measure Unit 
Ordinary strength lager (4%) (e.g. Carling, Fosters) Pint 2.3 
Strong lager (5.2%) (e.g. Stella Artois, Kronenburg) Pint 3 
Strong lager (e.g. Stella Artois, Carlsberg Export, Grolsch) 440ml can 2.2 
Beer/ordinary strength Ale (e.g. John Smith’s, Guinness) Pint 2.3 
Red/White Wine Std 175ml 2 
Red/White Wine Lg. 250ml 3 
Spirits Std 25ml 1 
Spirits Lg. 35ml 1.4 
Alcopop e.g. Smirnoff Ice, Bacardi Breezer, Reef 275ml 1.5 
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17. When you are out in the sun do you wear sunscreen (this can be at any time of the year)? 
 
(   ) Yes    (   ) No  
 
If yes, please specify the factor of sunscreen (SPF) used when at home (in the UK) and on 
holiday (holiday can include beach holidays or skiing holidays): 
 
 At home: ________________ On holiday: _________________ 
 
 
18. Do you have the habit of natural sunbathing?    (   ) Yes    (   ) No 
If yes, please state how often you sunbathe. 
 
(   ) At least once a week  (   ) At least twice a month 
(   ) Once a month  (   ) Less than 6 times per year 
(   ) More than 6 times per year  (   ) Occasionally 
 
19. Do you use sunbeds?  
(   ) Yes    (   ) No 
 
If yes, when was the last time?  ________weeks ago 
 
 
20. Where does your skin fit in? 
 
(   ) Type I - always burns, never tans (pale white). 
(   ) Type II - usually burns, tans with difficulty (white) 
(   ) Type III - sometimes mild burn, tans uniformly (cream white) 
(   ) Type IV - burns minimally, always tans well (moderate brown) 
(   ) Type V - very rarely burns, tans very easily (dark brown) 
(   ) Type VI - Never burns, never tans (deeply pigmented dark brown to darkest brown) 
 
 
21. Do you usually do physical activities? (   ) Yes (   ) No 
 
What do you do as an exercise? _________________________________________________ 
   
How often? ___________ 
 
 
22. How familiar are you with the importance of having enough vitamin D in the body?   
 
(not familiar at all)     0      1      2      3      4      5      6      7      8      9      10    (very familiar) 
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23. In your own words, what is vitamin D needed for, who needs it and how much? 
 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
__________________________________________________________________________ 
 
 
24. Which, if any, of the following are a source of vitamin D? (tick any that apply) 
 
(   )  Red meat            (   ) Cheese       (   ) Cod liver oil        (   ) Milk (   ) Oily fish  
(   ) Vegetables          (   ) Sunlight     (   ) Eggs                     (   ) Don’t know 
(   ) Chicken               (   )White fish   Other: _______________ 
 
 
25. Are you currently taking any of the following supplements? (tick any that apply)  
 
(   ) Vitamin D (go to Question 6)        (   ) Fish Oil with Vitamin D (go to Question 6) 
(   ) Calcium with Vitamin D (go to Question 6)       (   )Cod Liver Oil (go to Question 6)         
(   ) Multi-Vitamin with Vitamin D(go to Question 6)          (   ) None 
 
26. If no, have you taken any of the following supplements within the last year? (tick any that 
apply) 
 
(   ) Vitamin D                 (   ) Fish Oil with Vitamin D                (   ) Calcium with Vitamin D 
(   ) Cod Liver Oil           (   ) Multi-Vitamin with Vitamin D       (   ) None (go to Question 9) 
 
27. How frequently do/did you take this? (tick one option only) 
 
(   ) Less than once a month                   (   ) Once a month                (   ) Once every 2 weeks    
(   ) Once a week                                      (  ) 2 - 3 times a week     (  ) 4 - 6 times a week            
(   ) Daily                                                  (   ) Other: __________________________ 
 
28. If known, what supplement do/did you take and what dose of vitamin D does/did it 
provide? 
Supplement: __________________________________   Dose: _________________ 
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29. Was the supplement prescribed by your GP or other Health Professional? (   ) Yes (   ) No 
 
 
30. Have you ever had your vitamin D status measured? (   ) Yes    (   ) No 
 
If yes, what was the reason for the test and what was the result (if known)? 
 
Reason: 
___________________________________________________________________________
___________________________________________________________________________ 
 
Results: ____________________________________________________________________ 
 
 
31. How much milk do you have per day? 
 
(   ) Never        (   ) Less than ½ pint         (   ) ½ pint        (   ) 1 pint      (   )  More than 1 pint 
 
 
32. How often do you eat the following per week: 
 
Eggs (   ) Never (   ) less than once (   ) once (   ) 2-5 times (   ) + 5 
 
Oily fish* (   ) Never  (   ) less than once (   ) once (   ) 2-5 times (   ) + 5 
*such as sardines, tuna, salmon, mackerel, herring, kippers, trout and pilchards. 
 
Liver  (   ) Never  (   ) less than once (   ) once (   ) 2-5 times (   ) + 5 
 
 
 
Thank you for taking time to answer our questionnaire. Your help is greatly 
appreciated! 
 
 
 
IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT  
 
Miss Marcela Mendes (m.moraesmendes@surrey.ac.uk) telephone (01483) 689222.  
An answering machine will pick up any calls if we are unavailable.  
 
If you have any concerns about the study please contact Dr Susan Lanham-New  
(s.lanham-new@surrey.ac.uk), telephone (01483) 686476.  
